<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1605245315
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2017
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        PRALUENT 75 mg Prefilled Pen
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        ALIROCUMAB
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        75
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Subcutaneous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection in pre-filled pen
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Pre-filled pen
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Biological
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store in a refrigerator (2°c – 8°c)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        1755.00
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Sanofi aventis Deutschland GmbH" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Sanofi aventis Deutschland GmbH
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 2218]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Sanofi Arabia Trading Co. Ltd
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SANOFI AVENTIS GROUPE
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        C10AX14
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Praluent is<br />&bull; Praluent contains the active substance alirocumab.<br />&bull; Praluent is a monoclonal antibody (a type of specialised protein designed to attach to a target substance in the body). Monoclonal antibodies are proteins that recognise and bind to other unique proteins. Alirocumab binds to PCSK9.<br />How Praluent works<br />Praluent helps lower your levels of &ldquo;bad&rdquo; cholesterol (also called &ldquo;LDL cholesterol&rdquo;). Praluent blocks a protein called PCSK9.<br />&bull; PCSK9 is a protein secreted by liver cells.<br />&bull; &ldquo;Bad&rdquo; cholesterol is normally removed from your blood by binding to specific &ldquo;receptors&rdquo; (docking stations) in your liver.<br />&bull; PCSK9 lowers the number of these receptors in the liver &ndash; this causes your &ldquo;bad&rdquo; cholesterol to be higher than it should.<br />&bull; By blocking PCSK9, Praluent increases the number of receptors available to help remove the &ldquo;bad&rdquo; cholesterol &ndash; this lowers your &ldquo;bad&rdquo; cholesterol levels.<br />What Praluent is used for<br />&bull; Adults with high cholesterol levels in their blood (hypercholesterolaemia [heterozygous familial and non-familial] or mixed dyslipidaemia).<br />&bull; Adults with high cholesterol levels in their blood and with cardiovascular disease to reduce cardiovascular risk.</p><p>It is given:<br />- together with a statin (a commonly used medicine that treats high cholesterol) or other cholesterol lowering medicines, if the maximum dose of a statin does not lower levels of cholesterol sufficiently or,<br />- alone or together with other cholesterol lowering medicines when statins are not tolerated or cannot be used.<br />Continue to follow your cholesterol-lowering diet while taking this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not use Praluent<br />&bull; if you are allergic to alirocumab or any of the other ingredients of this medicine (listed in section 6).<br />Warnings and precautions<br />Talk to your doctor, pharmacist or nurse before using Praluent.<br />If you develop a serious allergic reaction, stop using Praluent, talk to your doctor right away. Sometimes serious allergic reactions such as hypersensitivity, including angioedema (difficulties breathing, or swelling of the face, lips, throat or tongue), nummular eczema (reddish skin spots sometimes with blisters), and hypersensitivity vasculitis (which is a specific form of a hypersensitivity reaction with symptoms such as diarrhoea, with a rash, or purple-coloured skin spots on the skin) have occurred. For allergic reactions that may occur while taking Praluent, see section 4.<br />Tell your doctor if you have kidney or liver disease before using this medicine, because Praluent has been studied in few patients with severe kidney disease and not in patients with severe liver disease.<br />Children and adolescents<br />Do not give this medicine to children and adolescents under 18 years old because there is no experience of using the medicine in these age groups.<br />Other medicines and Praluent<br />Tell your doctor, pharmacist or nurse if you are using, have recently used or might use any other medicines.<br />Pregnancy and breast-feeding<br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.<br />Praluent is not recommended during pregnancy or breast-feeding.<br />Driving and using machines<br />This medicine is not expected to have any effect on your ability to drive or use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use this medicine exactly as your doctor, pharmacist or nurse has told you. Check with your doctor, pharmacist or nurse if you are not sure.<br />How much to inject<br />Your doctor will tell you which dose is right for you and how often to inject (75 mg or 150 mg once every 2 weeks, or 300 mg once every 4 weeks/monthly)). Your doctor will check your cholesterol levels and may adjust the dose (up or down) during treatment.<br />Always check the label of your pen to make sure you have the right medicine and the right strength.<br />When to inject<br />Inject Praluent once every 2 weeks (for the 75 mg or 150 mg dose), or once every 4 weeks/monthly (for the 300 mg dose). To give the 300 mg dose, give two 150 mg injections in a row at two different injection sites.</p><p>Before you inject<br />Praluent should be allowed to warm to room temperature prior to use.<br />Read the detailed instructions for use leaflet before you inject Praluent.<br />Where to inject<br />Praluent is injected under your skin into the thigh, abdomen or upper arm.<br />Read the detailed instructions for use leaflet on where to inject.<br />Learning how to use the pre-filled pen<br />Before you use the pen for the first time, your doctor, pharmacist or nurse will show you how to inject Praluent.<br />&bull; Always read the &quot;Instructions for Use&quot; provided in the box.<br />&bull; Always use the pen as described in the &ldquo;Instructions for Use&rdquo;.<br />If you use more Praluent than you should<br />If you use more Praluent than you should, talk to your doctor, pharmacist or nurse.<br />If you forget to use Praluent<br />If you miss a dose of Praluent, inject your missed dose as soon as you can. Then take your next dose at your regular scheduled time. This will keep you on the original schedule. If you are not sure when to inject Praluent, call your doctor, pharmacist or nurse.<br />If you stop using Praluent<br />Do not stop using Praluent without talking with your doctor. If you stop using Praluent, your cholesterol levels can increase.<br />If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.<br />If you develop a serious allergic reaction, stop using Praluent, talk to your doctor right away. Sometimes serious allergic reactions such as hypersensitivity (difficulties breathing), nummular eczema (reddish skin spots sometimes with blisters), and hypersensitivity vasculitis (which is a specific form of a hypersensitivity reaction with symptoms such as diarrhoea, with a rash, or purple-coloured skin spots on the skin) have occurred (may affect up to 1 in 1,000 people).<br />Other side effects are:<br />Common (may affect up to 1 in 10 people)<br />&bull; redness, itching, swelling, pain/tenderness where the medicine was injected (local injection site reactions)<br />&bull; upper respiratory tract signs or symptoms such as sore throat, running nose, sneezing<br />&bull; itching (pruritus).<br />Rare (may affect up to 1 in 1,000 people)<br />&bull; red and itchy raised bumps or hives (urticaria)<br />Not Known<br />The following side effects have been reported since the marketing of Praluent, but how often they occur is not known:<br />&bull; flu-like illness<br />&bull; difficulties breathing, or swelling of the face, lips, throat or tongue (angioedema)</p><p><strong>To report any side effect(s):<br />&bull; Saudi Arabia:</strong><br />- The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-2356-2340.<br />o SFDA call center : 19999<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc<br />&bull; Sanofi- Pharmacovigilance: KSA_Pharmacovigilance@sanofi.com</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.<br />Do not use this medicine after the expiry date which is stated on the label and carton after EXP. The expiry date refers to the last day of that month.<br />Store in a refrigerator (2&deg;C to 8&deg;C). Do not freeze.<br />Keep the pen in the outer carton in order to protect from light.<br />If needed, individual pre-filled pens may be kept outside the refrigerator below 25&deg;C for a maximum of 30 days. Protect from light. After removal from the refrigerator, Praluent must be used within 30 days or discarded.<br />Do not use this medicine if it looks discoloured or cloudy, or if it contains visible flakes or particles.<br />After use put the pen into a puncture-resistant container. Ask your doctor, pharmacist or nurse how to throw away the container. Do not recycle the container.<br />Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&bull; The active substance is alirocumab.<br />Praluent 75 mg solution for injection in pre-filled pen<br />Each single-use pen contains 75 milligrams of alirocumab.</p><p>&bull; The other ingredients are histidine, sucrose, polysorbate 20 and water for injections.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Praluent is a clear, colourless to pale yellow solution for injection that comes in a pre-filled pen.
Praluent 75 mg solution for injection in pre-filled pen
Each pre-filled pen with green button contains 1 ml of solution, delivering one single dose of 75 milligrams of alirocumab.
It is available in pack size of 1, 2 or 6 pre-filled pens.
Not all presentations and pack sizes may be marketed.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder</strong><br />sanofi-aventis groupe<br />54, rue La Bo&eacute;tie<br />F &ndash; 75008 Paris<br />France<br /><strong>Manufacturer</strong><br />Sanofi-Aventis Deutschland GmbH<br />Industriepark Hoechst<br />Br&uuml;ningstra&szlig;e 50<br />65926 Frankfurt am Main<br />Germany<br /><strong>Manufacturer -&nbsp;</strong>Genzyme Ireland Ltd-IDA Industrial Park- Old Kilmeaden Road -Waterford - Ireland</p><p>For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                03/2020
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>يحتوي ب ا رليوينت على المادة الفعالة أليروكوماب.</p><p>ب ا رليوينت هو جسم مضاد أحادي النسيلة )وهو نوع من البروتين المتخصص مُص مم للارتباط بمادة<br />مُستهدَفة في الجسم(. الأجسام المضادة أحادية النسيلة هي بروتينات تتعرف على البروتينات الفريدة<br />الأخرى وترتبط بها. أليروكوماب يرتبط بالبروتين المسمى PCSK9 .<br />كيف يعمل ب ا رليوين ت<br />ب ا رليوينت يساعد على خفض مستويات الكولسترول &quot;السيئ&quot; )والمُس مى أيضا &quot;البروتين الدهني المنخفض<br />الكثافة&quot;(. يعيق ب ا رليوينت عمل البروتين المُس مى PCSK9 .<br />&bull; PCSK9 هو بروتين تفرزه خلايا الكبد.<br />&bull; تتم إ ا زلة الكوليسترول &quot;السيئ&quot; عادة من الدم عن طريق الارتباط ب &quot;مستقبلات&quot; مُح ددة )محطات<br />الالتحام( في الكبد.<br />&bull; يخفض PCSK9 عدد هذه المستقبلات في الكبد &ndash; وهذا يسبب ارتفاع الكولسترول &quot;السيء&quot; لديك<br />أكثر مما ينبغي .<br />&bull; يزيد ب ا رليوينت من عدد المستقبلات المتاحة عن طريق إعاقة PCSK9 وذلك للمساعدة في إ ا زلة<br />الكولسترول &quot;السيء&quot; &ndash; وهذا يقلل من مستويات الكولسترول &ldquo;السيء&rdquo; لديك في الدم.<br />ما هي دواعي استخدام لب ا رليوين ت<br />&bull; البالغون الذين يعانون من ارتفاع مستويات الكوليسترول في الدم )فرط الكوليسترول في الدم ]متخالف<br />الجينات العائلي وغير العائلي[ أو ما يُعرف بخلل دهون الدم المُ خ تلط(.<br />&bull; البالغ ون الذين يعانون من ارتفاع مستويات الكوليسترول في الدم مع أم ا رض القلب والأوعية الدموية<br />للحد من المخاطر على القلب والأوعية الدموية .<br />يتم إعطاؤه :<br />- جنبا إلى جن ب مع أحد أدوية مجموعة الستاتينات )دواء شائع الاستخدام يُعا ل ج ارتفاع الكوليسترول<br />في الدم( أو غيرها من أدوية خفض الكولسترول، إذا كانت الجرعة القصوى من الستاتين لم تخفض<br />مستويات الكوليسترول بما فيه الكفاية، أ و&nbsp;بمفرده أو مع أدوية أخرى لخفض الكوليسترول عندما لا يتم تح م ل الستاتينات أو يتع ذر استخدامها.<br />استمر في اتباع الحمية الغذائية الخاصة بك التي تخفض الكوليسترول أثناء تناول هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا تستخدم ب ا رليوين ت<br />&bull; إذا كنت تعاني من حساسية من أليروكوماب أو أي من المكونات الأخرى لهذا الدواء )المدرجة<br />في القسم 6 .)<br />تحذي ا رت واحتياطا ت<br />تحدث مع طبيبك أو الصيدلي أو الممرض)ة( قبل استخدام ب ا رليوينت .<br />إذا عانيت من رد فعل تحسسي خطير، توقف عن استخدام ب ا رليوينت، تحدث إلى طبيبك على الفور. تم<br />الإبلاغ أحيا نا عن حدو ث ردود فعل تحسسية خطيرة مثل فرط الحساسية، بما في ذلك الوذمة الوعائية<br />)صعوبات في التنفس، أو تورم في الوجه أو الشفاه أو الحلق أو اللسان(، والأكزيما النُّم ية )بقع جلدية<br />محمرة أحيانا مع بثور(، التهاب الأوعية الدموية التحسسي )وهو شكل معين من تفاعلات فرط الحساسية<br />مع أع ا رض مثل الإسهال أو الطفح الجلدي أو بقع جلدية أرجوانية ال لون على الجلد(. للاطلاع على ردود<br />الفعل الأرجية )التحسسية( التي قد تحدث أثناء استخدام ب ا رليوينت، ا رجع القسم 4 .<br />أخبر طبيبك إذا كنت تعاني من أم ا رض ال ك لى أو الكبد قبل استخدام هذا الدواء، لأن ب ا رليوينت تمت<br />د ا رسته في عدد قليل من المرضى الذين يعانون من أم ا رض ال ك لى الشديدة ولم تتم د ا رسته في المرضى<br />الذين يعانون من أم ا رض الكبد الشديدة.<br />الأطفال والم ا رهقو ن<br />لا تُع ط هذا الدواء للأطفال والم ا رهقين دون سن 18 سنة لأنه لا توجد خبرة في استخدام الدواء في هذه<br />الفئات العمرية.<br />الأدوية الأخرى وب ا رليوين ت&nbsp;أخبر طبيبك أو الصيدلي أو الممرض)ة( إذا كنت تستخدم أو استخدمت مؤخ ا ر أو قد تستخدم أي أدوية<br />أخرى .<br />الحمل والرضاعة الطبيعي ة<br />إذا كن ت حاملا أو مرضعة، تعتقدين أنك قد تكونين حاملا أو تخططين لذلك، فاطلبي من طبيب ك أو<br />الصيدلي المشورة قبل استخدام هذا الدواء.<br />لا يُنصح باستخدام ب ا رليوينت أثناء الحمل أو الرضاعة الطبيعية .<br />القيادة واستخدام الآلات<br />لا يتوقع أن يكون لهذا الدواء أي تأثير على قدرتك على قيادة السيا ا رت أو استخدام الآلات .</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>استخدم هذا الدواء دائما حسب ارشادا ت طبيبك أو الصيدلي أو الممرض)ة( تماما. تحقق مع طبيبك أو<br />الصيدلي أو الممرض)ة( إذا لم تكن متأكدا .<br />الجرعة<br />سيصف لك طبيبك الجرعة المناسبة لك وكيفية تك ا رر الحقن ) 75 مجم أو 150 مجم مرة واحدة كل<br />أسبوعين ) 2 أسبوع(، أو 300 مجم مرة واحدة كل 4 أسابيع / شهريا((. سوف يفحص طبيبك مستويات<br />الكوليسترول في الدم وقد يضبط الجرعة )أكثر أو أقل( أثناء العلاج .<br />تح قق دائم ا من الملصق على القلم الخاص بك للتأكد من أ ن لديك الدواء الصحيح والتركيز الصحيح.<br />متى يتم الحق ن<br />احقن ب ا رليوينت مرة واحدة كل أسبوعين ) 2 أسبوع( وذلك )لجرعة 75 مجم أو 150 مجم(, أو مرة واحدة<br />كل 4 أسابيع / شهريا )لجرعة 300 مجم(. لإعطاء جرعة 300 مجم، يجب إعطاء حقنتين من 150<br />مجم على التوالي في موقعين مختلفين للحقن.<br />قبل الحقنيجب السماح لب ا رليوينت أن يصل إلى درجة ح ا ررة الغرفة قبل الاستخدام .<br />اق أ ر نشرة التعليمات التوضيحية للاستخدام قبل حقن ب ا رليوينت .<br />مواضع الحقن<br />يتم حقن ب ا رليوينت تحت جلدك في الفخذ أو البطن أو الجزء العلوي من الذ ا رع. اق أ ر نشرة التعليمات<br />التوضيحية للاستخدام فيما يخص مواضع الحقن .<br />كيفية استخدام القلم المملوء مسب ق ا<br />قبل استخدام القلم للمرة الأولى، سوف يشرح لك طبيبك أو الصيدلي أو الممرض)ة( كيفية حقن ب ا رليوينت.<br />&bull; اق أ ر دائما &quot;إرشادات الاستخدام&quot; الموجودة داخل العلبة<br />&bull; استخدم القلم دائ ما كما هو موضح في &quot;إرشادات الاستخدام&quot;<br />إذا استخدمت ب ا رليوينت أكثر مما يج ب<br />إذا استخدم ت ب ا رليوينت أكثر مما يجب فتحدث إلى طبيبك أو الصيدلي أو الممرض)ة(.<br />إذا نسيت استخدام ب ا رليوينت<br />إذا نسيت حقن جرعة من ب ا رليوينت، فقم بحقن جرعتك المنس ية في أقرب وقت ممكن. ثم احقن الجرعة<br />التالية في الوقت المحدد المعتاد الخاص بك. هذا سوف يساعدك على الالت ا زم بالجدول الزمني الأصلي.<br />إذا لم تكن متأكدا من موعد حقن ب ا رليوينت فاتصل بطبيبك أو الصيدلي أو الممرض)ة(.<br />إذا توقفت عن استخدام ب ا رليوين ت<br />لا تتوقف عن استخدام ب ا رليوينت دون التحدث مع طبيبك. إذا توقفت عن استخدام ب ا رليوينت فيمكن أن<br />تزيد مستويات الكوليسترول لديك.<br />إذا كان لديك أي أسئلة أخرى حول استخدام هذا الدواء فاسأل طبيبك أو الصيدلي أو الممرض)ة(.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، يمكن أن يسبب هذا الدواء أع ا رضا جانبية، على الرغم من أنها لا تحدث لدى<br />الجميع .<br />إذا تع رضت لرد فعل تحسسي خطير فتوقف عن استخدام ب ا رليوينت وتحدث إلى طبيبك على الفور.<br />تحدث في بعض الأحيان ردود فعل تحسسية خطيرة مثل فرط الحساسية )صعوبات في التنفس(،<br />والأكزيما النُّم ية )بقع جلدية محمرة أحيا نا مع بثور(، والتهاب الأوعية الدموية التح سسي )وهو شكل محدد<br />من تفاعلات فرط الحساسية مع أع ا رض مثل الإسهال، مع طفح جلدي، أو بقع جلدية أرجوانية ال لون<br />على الجلد( )قد يؤثر على ما يصل إلى 1 في 1000 شخص(.<br />الأع ا رض الجانبية الأخرى هي:<br />شائعة )قد تؤثر على ما يصل إلى 1 من كل 10 أشخاص(<br />&bull; احم ا رر، حكة، تورم، ألم / إيلام في موضع حقن الدواء )ردود الفعل الموضعية في موضع الحقن (<br />&bull; علامات أو أع ا رض في الجهاز التنفسي العلوي مثل التهاب الحلق، وسيلان الأنف، والعطس<br />&bull; حكاك.<br />نادرة )قد تؤثر على ما يصل إلى 1 في 1000 شخص(<br />شرى أو نتوءات بارزة محمرة ومسببة للحك ة<br />غير معروف ة<br />تم الإبلاغ عن الأع ا رض الجانبية التالية منذ تسويق ب ا رليوينت، ولكن تواتر حدوثها غير معروف :<br />&bull; مرض يشبه الانفلون ا ز<br />&bull; صعوبات في التنفس، أو تورم في الوجه أو الشفاه أو الحلق أو اللسان )وذمة وعائية (<br /><strong>للإبلاغ عن أي أع ا رض جانبية :<br />&bull; المملكة العربية السعودية :</strong></p><p><strong>المركز الوطني للتيقظ والسلامة الدوائية<br />o فاكس: ٧٦٦٢ - ٢٠٥ - ١١ - ٩٦٦ +<br />o للاتصال بالإدارة التنفيذية للت ي قظ وإدارة الأزما ت:<br />o هاتف: ٨٢٢٢ - ٢٠٣ - ١١ - ٩٦٦ +<br />تحويلة: ٢٣١٧ &ndash; 2356 - 2340<br />o الرقم المُو ح د للهيئة العا مة للغذاء وال دواء: 19999<br />o البري د الإلكتروني: npc.drug@sfda.gov.sa<br />o الموقع الإلكتروني: www.sfda.gov.sa/npc<br />&bull; سانوفي للتيقظ الدوائ ي KSA_Pharmacovigilance@sanofi.com</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>احفظ هذا الدواء بعيدا عن م أ رى ومتناول الأطفال.<br />لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على الملصق والكرتون بع د كلمة EXP . يشير<br />تاريخ انتهاء الصلاحية إلى اليوم الأخير من ذلك الشهر.<br />يُحفظ في الثلاجة ) 2 درجة مئوية إلى 8 درجات مئوية(. لا تجمده .<br />احفظ القلم في الكرتون الخارجي من أجل حمايته من الضوء.<br />يمكن الاحتفاظ بالأقلام المملوءة مسب قا للاستخدام الفردي خارج الثلاجة تحت درجة ح ا ررة 25 درجة<br />مئوية لمدة أقصاها 30 يو م ا إذا لزم الأمر. يجب حمايته من الضوء. يجب استخدام ب ا رليوينت عند حفظه<br />خارج الثلاجة في غضون 30 يوما أو التخ لص منه .<br />لا تستخدم هذا الدواء إذا كان يبدو مل ونا أو ع ك ا ر، أو إذا كان يحتوي على جسيما ت أو جزيئات مرئية .</p><p>ضع القلم بعد الاستخدام في حاوية مُ قاومة لل ث قب. اسأل طبيبك أو الصيدلي أو الممرض)ة( عن كيفية<br />التخ لص من الحاوية. لا تقم بإعادة تدوير الحاوية .<br />لا تتخ لص من أي أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية<br />التخ لص من الأدوية التي لم تعد تستخدمها. ستساعد هذه التدابير على حماية البيئة .</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هي أليروكوماب.<br />ب ا رليوينت 75 مجم محلول للحقن في قلم مملوء مسبق ا<br />يحتوي كل قلم ذو الاستخدام الواحد على 75 مليج ا رم من أليروكوماب.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p style="text-align:right">ب ا رليوينت هو محلول صافٍ عديم ال لون إلى أصفر شاحب مخ صص للحقن و يتوف رفي قلم مملوء مسب قا .<br />ب ا رليوينت 75 مجم محلول للحقن في قلم مملوء مسبق ا<br />يحتوي كل قلم مملوء مسبقا مع زر أخضر على 1 مل من المحلول، ويعطي جرعة واحدة من<br />أليروكوما ب مقدارها 75 مليج ا رم .</p><p style="text-align:right">قد لا يتم تسويق كافة أحجام العبوة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>حامل رخصة التسوي ق</strong><br />مجموعة سانوفي-أف انتي س<br />54 طريق لا بويت ي<br />إف &ndash; 75008 باري س<br />فرنسا<br /><strong>الشركة المصنع ة</strong><br />سانوفي-أفنتيس دوتشلاند جي إم بي إت ش<br />إندستري بارك ه وكس ت<br />50 بروينينغ شت ا رس ي<br />65926 ف ا رنكفورت<br />ألماني ا<br /><strong>الشركة المصنع ة</strong><br />جين ا زيم إيرلن دا ليمت د<br />أي دي إيه إندستريال بار ك<br />طريق كيلميدن القدي م<br />ووترفور د - أيرلندا</p><p>للحصول على أي معلومات حول هذا الدواء، يرجى الاتصال بالممثل المحلي لحامل رخصة التسوي ق</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            2020/03
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Praluent 75 mg solution for injection in pre-filled pen
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Praluent 75 mg solution for injection in pre-filled pen
Each single-use pre-filled pen contains 75 mg alirocumab in 1 ml solution.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for injection (injection)
Clear, colourless to pale yellow solution.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Primary hypercholesterolaemia and mixed dyslipidaemia<br />Praluent is indicated in adults with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, as an adjunct to diet:<br />- in combination with a statin or statin with other lipid lowering therapies in patients unable to reach LDL-C goals with the maximum tolerated dose of a statin or,<br />- alone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.<br />Established atherosclerotic cardiovascular disease<br />Praluent is indicated in adults with established atherosclerotic cardiovascular disease to reduce cardiovascular risk by lowering LDL-C levels, as an adjunct to correction of other risk factors:</p><p>- in combination with the maximum tolerated dose of a statin with or without other lipid-lowering therapies or,<br />- alone or in combination with other lipid-lowering therapies in patients who are statin-intolerant, or for whom a statin is contraindicated.<br />For study results with respect to effects on LDL-C, cardiovascular events and populations studied see section 5.1.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />Prior to initiating alirocumab secondary causes of hyperlipidaemia or mixed dyslipidaemia (e.g., nephrotic syndrome, hypothyroidism) should be excluded.<br />The usual starting dose for alirocumab is 75 mg administered subcutaneously once every 2 weeks. Patients requiring larger LDL-C reduction (&gt;60%) may be started on 150 mg once every 2 weeks, or 300 mg once every 4 weeks (monthly), administered subcutaneously.<br />The dose of alirocumab can be individualised based on patient characteristics such as baseline LDL-C level, goal of therapy, and response. Lipid levels can be assessed 4 to 8 weeks after treatment initiation or titration, and dose adjusted accordingly (up-titration or down-titration). If additional LDL-C reduction is needed in patients treated with 75 mg once every 2 weeks or 300 mg once every 4 weeks (monthly), the dosage may be adjusted to the maximum dosage of 150 mg once every 2 weeks.<br />If a dose is missed, the patient should administer the injection as soon as possible and thereafter resume treatment on the original schedule.<br />Special populations<br />Elderly<br />No dose adjustment is needed for elderly patients.<br />Hepatic impairment<br />No dose adjustment is needed for patients with mild or moderate hepatic impairment. No data are available in patients with severe hepatic impairment (see section 5.2).<br />Renal impairment<br />No dose adjustment is needed for patients with mild or moderate renal impairment. Limited data are available in patients with severe renal impairment (see section 5.2).<br />Body weight<br />No dose adjustment is needed in patients based on weight.<br />Paediatric population<br />The safety and efficacy of Praluent in children and adolescents less than 18 years of age have not been established. No data are available.<br />Method of administration<br />Subcutaneous use.<br />Alirocumab is injected as a subcutaneous injection into the thigh, abdomen or upper arm.<br />Each pre-filled pen is for single use only.<br />To administer the 300 mg dose, two 150 mg injections should be given consecutively at two different injection sites.<br />It is recommended to rotate the injection site with each injection.<br />Alirocumab should not be injected into areas of active skin disease or injury such as sunburns, skin rashes, inflammation, or skin infections.<br />Alirocumab must not be co-administered with other injectable medicinal products at the same injection site.<br />The patient may either self-inject alirocumab, or a caregiver may administer alirocumab, after guidance has been provided by a healthcare professional on proper subcutaneous injection technique.<br />Precautions to be taken before handling or administering the medicinal product<br />The solution should be allowed to warm to room temperature prior to use (see section 6.6).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Traceability<br />In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded.<br />Allergic reactions<br />General allergic reactions, including pruritus, as well as rare and sometimes serious allergic reactions such as hypersensitivity, nummular eczema, urticaria, and hypersensitivity vasculitis have been reported in clinical studies. Angioedema has been reported in the postmarketing setting (see section 4.8). If signs or symptoms of serious allergic reactions occur, treatment with alirocumab must be discontinued and appropriate symptomatic treatment initiated (see section 4.3).<br />Renal impairment<br />In clinical studies, there was limited representation of patients with severe renal impairment (defined as eGFR &lt; 30 ml/min/1.73 m2) (see section 5.2). alirocumab should be used with caution in patients with severe renal impairment.<br />Hepatic impairment<br />Patients with severe hepatic impairment (Child-Pugh C) have not been studied (see section 5.2). Alirocumab should be used with caution in patients with severe hepatic impairment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Effects of alirocumab on other medicinal products<br />Since alirocumab is a biological medicinal product, no pharmacokinetic effects of alirocumab on other medicinal products and no effect on cytochrome P450 enzymes are anticipated.<br />Effects of other medicinal products on alirocumab<br />Statins and other lipid-modifying therapy are known to increase production of PCSK9, the protein targeted by alirocumab. This leads to the increased target-mediated clearance and reduced systemic exposure of alirocumab. Compared to alirocumab monotherapy, the exposure to alirocumab is about 40%, 15%, and 35% lower when used concomitantly with statins, ezetimibe, and fenofibrate, respectively. However, reduction of LDL-C is maintained during the dosing interval when alirocumab is administered every two weeks.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />There are no data from the use of Praluent in pregnant women. Alirocumab is a recombinant IgG1 antibody, therefore it is expected to cross the placental barrier (see section 5.3).<br />Animal studies do not indicate direct or indirect harmful effects with respect to maintenance of pregnancy or embryo-fetal development; maternal toxicity was noted in rats, but not in monkeys at doses in excess of the human dose, and a weaker secondary immune response to antigen challenge was observed in the offspring of monkeys (see section 5.3).<br />The use of Praluent is not recommended during pregnancy unless the clinical condition of the woman requires treatment with alirocumab.<br />Breast-feeding<br />It is not known whether alirocumab is excreted in human milk. Human immunoglobulin G (IgG) is excreted in human milk, in particular in colostrum; the use of Praluent is not recommended in breast-feeding women during this period. For the remaining duration of breast-feeding, exposure is expected to be low.<br />Since the effects of alirocumab on the breast-fed infant are unknown, a decision should be made whether to discontinue nursing or to discontinue Praluent during this period.<br />Fertility<br />In animal studies, there were no adverse effects on surrogate markers of fertility (see section 5.3). There are no data on adverse effects on fertility in humans.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Praluent has no or negligible influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Summary of the safety profile<br />The most common adverse reactions, at recommended doses, are local injection site reactions (6.1%), upper respiratory tract signs and symptoms (2.0%), and pruritus (1.1%). Most common adverse reactions leading to treatment discontinuation in patients treated with alirocumab were local injection site reactions.<br />The safety profile in ODYSSEY OUTCOMES was consistent with the overall safety profile described in the phase 3 controlled trials.</p><p>No difference in the safety profile was observed between the two doses (75 mg and 150 mg) used in the phase 3 program.<br />Tabulated list of adverse reactions<br />The following adverse reactions were reported in patients treated with alirocumab in pooled controlled studies and/or post-marketing use (see Table 1).<br />Frequencies for all adverse reactions identified from clinical trials have been calculated based on their incidence in pooled phase 3 clinical trials. Adverse reactions are presented by system organ class. Frequency categories are defined as: very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000 to &lt;1/100); rare (&ge;1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000) and not known (cannot be estimated from the available data).<br />The frequency of adverse reactions reported during post-marketing use cannot be determined as they are derived from spontaneous reports. Consequently, the frequency of these adverse reactions is qualified as &quot;not known&quot;.</p><p><img src="data:image/jpeg;base64,/9j/4AAQSkZJRgABAQEAYABgAAD/4RESRXhpZgAATU0AKgAAAAgABAE7AAIAAAAYAAAISodpAAQAAAABAAAIYpydAAEAAAAwAAAQ2uocAAcAAAgMAAAAPgAAAAAc6gAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAE11aGFtbWVkLCBVc21hbiAvU0EvRVhUAAAFkAMAAgAAABQAABCwkAQAAgAAABQAABDEkpEAAgAAAAM4MgAAkpIAAgAAAAM4MgAA6hwABwAACAwAAAikAAAAABzqAAAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAMjAyMTowMToxMSAwOTo0MTozMwAyMDIxOjAxOjExIDA5OjQxOjMzAAAATQB1AGgAYQBtAG0AZQBkACwAIABVAHMAbQBhAG4AIAAvAFMAQQAvAEUAWABUAAAA/+ELKmh0dHA6Ly9ucy5hZG9iZS5jb20veGFwLzEuMC8APD94cGFja2V0IGJlZ2luPSfvu78nIGlkPSdXNU0wTXBDZWhpSHpyZVN6TlRjemtjOWQnPz4NCjx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iPjxyZGY6UkRGIHhtbG5zOnJkZj0iaHR0cDovL3d3dy53My5vcmcvMTk5OS8wMi8yMi1yZGYtc3ludGF4LW5zIyI+PHJkZjpEZXNjcmlwdGlvbiByZGY6YWJvdXQ9InV1aWQ6ZmFmNWJkZDUtYmEzZC0xMWRhLWFkMzEtZDMzZDc1MTgyZjFiIiB4bWxuczpkYz0iaHR0cDovL3B1cmwub3JnL2RjL2VsZW1lbnRzLzEuMS8iLz48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOnhtcD0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wLyI+PHhtcDpDcmVhdGVEYXRlPjIwMjEtMDEtMTFUMDk6NDE6MzMuODIxPC94bXA6Q3JlYXRlRGF0ZT48L3JkZjpEZXNjcmlwdGlvbj48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOmRjPSJodHRwOi8vcHVybC5vcmcvZGMvZWxlbWVudHMvMS4xLyI+PGRjOmNyZWF0b3I+PHJkZjpTZXEgeG1sbnM6cmRmPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5LzAyLzIyLXJkZi1zeW50YXgtbnMjIj48cmRmOmxpPk11aGFtbWVkLCBVc21hbiAvU0EvRVhUPC9yZGY6bGk+PC9yZGY6U2VxPg0KCQkJPC9kYzpjcmVhdG9yPjwvcmRmOkRlc2NyaXB0aW9uPjwvcmRmOlJERj48L3g6eG1wbWV0YT4NCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgPD94cGFja2V0IGVuZD0ndyc/Pv/bAEMABwUFBgUEBwYFBggHBwgKEQsKCQkKFQ8QDBEYFRoZGBUYFxseJyEbHSUdFxgiLiIlKCkrLCsaIC8zLyoyJyorKv/bAEMBBwgICgkKFAsLFCocGBwqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKv/AABEIAX4DFQMBIgACEQEDEQH/xAAfAAABBQEBAQEBAQAAAAAAAAAAAQIDBAUGBwgJCgv/xAC1EAACAQMDAgQDBQUEBAAAAX0BAgMABBEFEiExQQYTUWEHInEUMoGRoQgjQrHBFVLR8CQzYnKCCQoWFxgZGiUmJygpKjQ1Njc4OTpDREVGR0hJSlNUVVZXWFlaY2RlZmdoaWpzdHV2d3h5eoOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4eLj5OXm5+jp6vHy8/T19vf4+fr/xAAfAQADAQEBAQEBAQEBAAAAAAAAAQIDBAUGBwgJCgv/xAC1EQACAQIEBAMEBwUEBAABAncAAQIDEQQFITEGEkFRB2FxEyIygQgUQpGhscEJIzNS8BVictEKFiQ04SXxFxgZGiYnKCkqNTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqCg4SFhoeIiYqSk5SVlpeYmZqio6Slpqeoqaqys7S1tre4ubrCw8TFxsfIycrS09TV1tfY2dri4+Tl5ufo6ery8/T19vf4+fr/2gAMAwEAAhEDEQA/APpGiiigAooqhrGh6b4gs0tNas4b21WQSmCdA8bkZxuU8Ec5x7UAX6K8P+Fvg3w5qHi7x6lzolgfsGu4s3W2QNahSSBGcfIAQOBxXQX3xK1zTfG2m6beWeni1vdXbTGtoyZJYhjKSmZXK5YEHyiisPpg0R961utvxt/mD05m+l/wv/keoUV4No+r6j4PvPihrOhwWBt9N1hZ57WWJh5ybfmCMpARuSckNz271p3mrWdl+0AniEwFIf8AhDWvZQFAdgH3c++AB+FJNNJ+V/8AyXm/QaTbaX9apfqezUV558P/AIhar4tvLX7XpUyWd9ZG7juI9OuIYrY5AELSyDbKSDkOmBwRjvVX422yjQdHvUknSZdZs4vkuHVCjScgoDtOfcdh6VVmmk+rt+Nibqza6f5XPTaKhu7u2sLOW7vriK2toVLyzTOERFHUljwB7msSD4geDbm4jgtvFuhTTSsEjjj1KFmdicAABskk9qW+gzoaKoa5q1toei3OoXtxDbxQr/rJ5AiKScLljwBkjk15f8GfFEf/AAknirwlLrMGs/Zbx7+zvYJVkWeKU7mwVJHDNzz1Y+lC1bXlf+vzB6K56/RXgXjTXrrxx4P0zxHNa6elhH4mht9PHkt9pjRZtjOZCcfOV+6FXGBya7o+LfE1v8RtZ8MX0mlRD+z/ALZo0ospCZsvtxJ++5KkgEDGc5yvShar7/yT/UbVnb+t2vzPQ6K8r1L4o6xaeKtQ0ax0x9Sl0RbZb2Oz0u5ma8eQAv5bRllgCg5HmFt3I4xmtWLxV4ovviL4h8M6eulBbC1t7q0lngkHEh5STD8nAOCAMeh6U7Xt5iem539Fec2vxEvYvEuuWuuSWdgulR3E39lyWkiXM0EYJWaOYvslDAZICjbnBPHL/h/8QtV8W3lr9r0qZLO+sjdx3EenXEMVscgCFpZBtlJByHTA4Ix3pLXb+t/8n+W4PTf+v6v+ux6HRXEeKvFmtaN8R/C2haeli9nrguFkM0TmSJo03BgwcDHI4254PPPGJrvxK1/R9ebw/Fp8V7q1hpq3t2tlp1zcrdOxIEUQjyYs4+/JkDIGD1o7ef6f8MNq39fI9Soryvx58T9d8KW9xqEGnWcVpbQ204tbpS89ysrBXztcG3KE4y6MGPA54ran8Xa5rHjPUfD/AITXTI5tKtbe4uDqKyMJjLz5alCNmFGd2H5IG2nZi8zuqK8zXVfE918b9X0yHVLGOzsdHSaKCWyeRRvbnkSr825Rlj1AwAOtc/4D8e3i+C/CWn6Vp+nWF74g1C8iDBJZILfYzOz7Gk3sSe28Dn8KUfeV1/WrX6B38v8AK57ZRXkOq/FrWoPDSXWn22n/AG+18Sf2FepNHIY5DnHmR4cFMjBwd2M45xmtGL4ieITa+NLddNt77UPDl5HFEbS3ciSJ8EuYt5Zii5JUMN2OMUef9dP80DunZ/1v/kz02isDwXrh8ReG49R/tOw1NZHYLcWEDwoR6NG7MyOOhBNb9Nqwk7hRRRSGFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABVbUtQtdI0q71LUJfJtLOF555NpbYiKWY4AJOADwBmrNc38R/8Aklniv/sC3n/oh6AD/hPNI/58/EH/AITmof8Aximv470lkYC18QoSMBh4bv8AI9+YK6aigDy3wlF4f8H6xqmo2l/41vZNVlM93HeeHLkpJKf4/ks1IPXgEDnp0rPTw54KiuLeaJ/GiNbaw2sxf8SK9IWZvvLza8qcDrk+/WvYqKa0aa6f1+gPW9+v9fqeUXWmeDbufUiyeL47fV7j7RqdomgX3l3rA5UPm2LKB0whXI65qe6g8K3njhfE0o8WeaLE6cbIeHLv7O0BByhX7Lu6nPDfpxXqFFLpb+trfloO7/r7/wAzzvwpfaB4Q04afp8vjC4sYifs1tdaBeutspOdikWwYqM8bi2Kr+MpNC8bQ20F9e+M7K3tpknWGy8OXIDSocq5L2jNkemceor0yih6u7Ftocta+NtLt7SKKVPEl06IFaeXw3fB5CP4jttwuT7AD2qX/hPNI/58/EH/AITmof8AxiukooA4bVfEOm6nqOn3SXni+yWyk8z7PbeG7ry5z0w++1YkYyOCOueuCMXVLfw9qfj228XC/wDGtnqFrGIY0tfDtysZj7owNmWYHn7xOM8Y4r1OijYDyOfQvBFzZTafLH4y/syS/wD7QSwj0XUI44ZuSShW3DgEnOCxAPTFb97qfha/8SaVrtxY+JDe6VHLHbt/wj2oYIkAB3ZgyenHPWu9oo2/r5fkD13PN2l8NJ4ym8S2B8XWF5dxLFexW3h+9EV2qjC7w1sSCBwGUqfejT5/D2neO9R8VRzeMJbvUYVhmt5fD14YQq427QLUMMc/xdznNekUULQHqeeXV74a1DVor3U4/FN6kCSLDaz+Hb1o4zICrkH7NvOVYrgsVA6AUnhS+0Dwhpw0/T5fGFxYxE/Zra60C9dbZSc7FItgxUZ43FsV6JRRsG55trc3h7XfF+i+Ip5vGFvc6KWNtDB4duxE2/h9wa1JORxwRx0weadqE/hu98XQeJbY+LdN1OOH7PLJaeHr3bcxZzskV7ZgRnuMEetej0UbW8geu55Brvh7wT4huNdlvR4zT+3EgW6WLQ77AMP3GXdbEg8c5JB9K05P+EZ/4SmDxDaP4vstRS2W0uJLfw/egXkQ6CUG2IJGPvLtI9a9Moo2B67nnE1x4bfxXceIbf8A4S60vrmy+xS+T4fvirKDlWw1sfmU9Ox7g1kaPofhDRPDtjpNpN4zb+zbtrywu5PD12ZrWRgQ20i0CkHLcMrdfpj16ihabf1rf8w/r8LfkePXnh7wfd6Cml+f40hUas2ryXEfh6682W5JJ3MTaEYGeAAOgzmtLRl8PaJrOt6nbXfjSS41qZJ7jzPD92Ajr90rttRgY4wcgjrmvT6KNv69P8l9wPXf+v6uzgtK8TeGPCel3ssn/CQ7ZJHvL6+u/D14hdto3SOVt1RQFUZwAABWz/wnmkf8+fiD/wAJzUP/AIxR8R/+SWeK/wDsC3n/AKIeukoA5v8A4TzSP+fPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/wAYrpKKAOb/AOE80j/nz8Qf+E5qH/xij/hPNI/58/EH/hOah/8AGK6SigDm/wDhPNI/58/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/ABiukooA5v8A4TzSP+fPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/wAYrpKKAOb/AOE80j/nz8Qf+E5qH/xij/hPNI/58/EH/hOah/8AGK6SigDm/wDhPNI/58/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/ABiukooA5v8A4TzSP+fPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/wAYrpKKAOb/AOE80j/nz8Qf+E5qH/xij/hPNI/58/EH/hOah/8AGK6SigDm/wDhPNI/58/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/ABiukooA5a5+Iug2drLdXkWuQW8KGSWWXw9fqkagZLMTDgAAZJNS/wDCeaR/z5+IP/Cc1D/4xR8R/wDklniv/sC3n/oh66SgDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDll+IugtdSWqxa4biNFkeIeHr/eqsWCsR5OQCUYA99p9DUv/AAnmkf8APn4g/wDCc1D/AOMUWP8AyVPXf+wLpv8A6Pvq6SgDm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xiukooA5v/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YrpKKAOb/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GK6SigDm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xiukooA5v/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YrpKKAOb/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GK6SigDm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xiukooA5v/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YrpKKAOb/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GK6SigDm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xiukooA5v/AITzSP8Anz8Qf+E5qH/xigePdE86COWPWLfz5o4EkudCvYY98jhEBd4Qq5ZlGSQMmukrm/Hn/Iu2v/Ya0r/04W9AHSUUUUAFFFFABXN/Ef8A5JZ4r/7At5/6Ieukrm/iP/ySzxX/ANgW8/8ARD0AbOrX/wDZei3t+IHuPssDzeTH96TapO0e5xXI+DvGl54osLPU7S+0fVLO4ObmKwV1m08eWW2uCzGRtwC5xH1zg11+pm9GlXR0pY2vfKb7OspwhfHy7j2GetednwH53xF0rXtH8OHw3eWk5fUr2C4jEF9EVO6NURtzksR8zonTPPFEfi1/4YH8P3nUab8Q/Der6ZNqGm3N5cW0N0tnIy6bc5WYnATaY89SATjAJGcVag8Y6NdanNYWs1zNNCZFZo7Kdoi0f31WUJsZh0KqxOQRjIrB0fwpcaX8WNcv7WdBpGoQw3ktrjJF386bh6AqMnrk4PGKbp3hjUNK+Ij32iQXenaZeGWXU4HuEktJ3OdrxJnekpOC3yhSO5NHT5fj/wAPf8Ael/60/q34ljwz8T9E8Q+HLzXJPtFhY287RiS6tZYw43lF2sVw7MR91SSCQCM1fvfiH4Y07S7fUL7UXgtri6FmrSWkwKTH/lnIuzMZ/wB8LXmY+G3ih/g5F4fNkI9S0rWTfxRreKgvUErPhJFOUyG4J2kEdutafizwVfSeDbSLwr4V1EXdzrNvqN9Bdaok0w8vG5mklmYEkKAMMffFNW0+X6Xf5+lhy0bt5/rb9PvOuuvit4Lsnu47vWfJmspfLuYHtZhLF0+Zk2bgnI+fG3kc811T3dvFYteSTxrbLH5rTFgFCYzuz6Y5zXiXiDwf4r1Gf4mPbeFrkt4ijto9Pdrm1BYRgK27978o/i+g9eK9Ml0G51n4VtoFyrWF1c6T9jdXKsYXMW3kqSDg+hNS/gbW9l+X6BpzpdNf0/r5FnT/ABtoGqeZ9hvJJGS3N0qG1lVpoQM+ZEpUGVeRym4ZOKg0z4heF9YsYLyw1Tfa3EM0yTvBLGmyI4kJZlAXHocHHI4ri9G8L+JY9f8ACt1eaPNbxeG9CnspdtzCRdzFVRVjw/3Tt3Avt7ZxTPC3hq90X9nXUtB8XaPcW80cF351vHcw7pVYs4KOrFR94D5u46Y61KyUmun+bX+TFHWyfdflf89DtNN+I/hjVdQeys72481Lf7UzTafcQxrDgkSGR4woQ4OGzg9s1Np3jzw7qtzc21jfSPcW1v8Aamha0mR3h/56RqyAyKezJuB4x1ryvwjeSXWsXEtzoutp4jk0NtM0qLW9FNjaTpGpYRt+8cOxxlidoI6KK0PCvg3xVpfjmz13UdFKx/8ACLmymjgngAjuQ27y0QMFVeyhflHcjmnJJXt2f/t1vyXzYo67+X6X/N/cd7o/xK8J69Np0Wl6qZW1TzBZl7aaNZjH99QzIBuH90nPfFbmraxYaFp7Xuq3At4FYIDtLMzE4VVUAlmJ4CgEnsK8P8LeBPGGl2fw5gvPDlwjaDf3Ut8wurYhElb5WGJctwckDng+2fRvih4c1jXtJ0m58PKk97o+qQ6itm7hBdBM5TceAeeCeKJJJ6d7fLTUfX5f56fgvvM/xL8THt7jwvN4Xktbqy1TWl0q9S7tZUmiYnkAEqUYYPDKeo/Hpp/Hnhu31qPSptSC3Mtx9lRvJkMJn/55edt8sSf7G7d7VyfxE0vxH4lm8G3eneHLpv7P1iK/uoWubcPDGg5BzJtLZJwFLDjqM4rnvEPgrxlrOtJetoVtGtp4shv40tJoYlltEGPNIyN8h7l/m4wOKIpOyff8Pd/zbE77+X/yX/APVP8AhLtG/t46OtxM92snlOUtJmhR9u/Y0wXy1bbztLA8j1FO0XxXpHiCd4tJmnm2J5gke0mijkTON0buoWRc91JFc3d+GdQt/iHBrHh+3u7FbqUnVv8ASI2s7yILtG6MncJuFwyrjGcntTvBfhnUPDniS9isYryx8OtDuWwurhJo47gkEm3IJZY8bgVbbz0GKUddxy02/r+v67HdUUUUgCiiigAooooAKKKKAOb+I/8AySzxX/2Bbz/0Q9dJXN/Ef/klniv/ALAt5/6IeukoAKKKKACiiigCO4uIrW1luLhwkUSF3Y9FUDJNcT4T8VeIPHdiNd0VdP07Q2ldLZLuCSae7VSV35V0EQJBwMPXY6jYxappd1YXOTDdQvDJj+6wIP6GuB+H2l+I/h94fi8K3eiTatbWsr/ZNSsriFUMbOWHmpI6upBPO0PQt3f5fqD2VvmdK/i+10u2to/Eo+x6nOJG+xWkct0+xGILgIhYpjB3FQOe1F3498NWU+kxTampOsgnT3ihkkS4wM4V1Urn2JyaxNZ0DWoviFpniy3svt5TTJdPubS2lRTGWcMrqZCoZRyCcg9CB2rjtI8DeKtF0z4bWz6NNdto13Pdai0dzB/o/mE4QbnG7G7+HI44zTWtr9/1f6WYPRO39af56HfQfFbwVcPAkWuIXmuPs2xreVWil3bQkoK5iJIIG/bnBxmrWofEPwzpWrahpl9fTR3um24urmEWU7lYuPnG1DuUZ5K5xznoa8jufA3jCXwdq9lH4TuVu73xZ/ayj7Xac2+7dyfN+8MYx7/Wuo8Q+H/Et38Q/FGp2nhy6ms7/wANHTbaUXNuN8xyehkBA+bGT6Htipe1/wCvhT/PQf2rdNP/AEqz/DU7bSviF4V1vVoNN0nWYbq5uImmh8tH2SquC22TGxiMjKg5HcCptP8AG3h7VL+OzsdREskzOkLmF1jnZM7ljkKhJCMHIUkjFeX6F4M8Twa98OWufDdxa22habPa6hL9otiI3kQpkBZCWGRuJA6MO+QLOjeAfEdhaeC/D8ti62/hzWJbubUlni8uaL94ybV3b8neFIKjHPUc1o4xva/9Xav91n5kXdn/AF0/z0O4tfij4Qu5FSHVXBa+/s4mWznjCXP/ADzYsgCn0zjPNdbXz3N4D8ZtoGo26eGLozT+MhrUafa7Xm369fNxu46e9fQYOVBIIJHQ9qn7N/62T/NtfIuWkrL+tX+lhaKKKQgooooA5v4j/wDJLPFf/YFvP/RD10lc38R/+SWeK/8AsC3n/oh66SgAooooAKKKKACiiigAooooA4X4ueLdb8DeCX1/QfsDm3lRJYb23eTzA7BRgrIu3Gc8g59qgi8X+JNL+IWi+HNYTT9Wh1e2efz9OtJLd7MIM5kVpJAVJIAOV59aj+N2ha34p+Hcuh+HNIm1G6upo3JWaGNIgjhjuMjr17YB98VkaZ4V1/wR4wtdc8GeHZv7F1eILq+grPbxNaSqMCWMeZ5f1Ct/9Zwt17/p/n1Ce2nb9f60O8Hjvw4dbi0kakPtU8zW8TeTJ5Ukq/ejWbb5Zcd1DZHpUcXj/wANzXt5Zx30v2iyu47K4jazmUxyyNtQHKdCcfN93kc8ivNrrwb4yv8AxFpepXOgwQiy8VNetFaTQxx/ZcACUKGG5zyWLfOTjtwOs8DaLrOn/EbxtqWqaPLZ2mrXMMlpcPNC/mLGmzojlhnqMgcHseKI6q7/AK+H/N/NCk2np/W/+S+86iHxdodxrjaRDfB7xZDFgRv5ZkAyYxJjYXA5KA7gOcVs15N4J+HM+j+IbyPxDpN5di31aXUtN1JNVcWw3nIzbiQYkAZhnyyDnrXrNL7KYfaaCiiigYUUUUAFFFFABRRRQBzdj/yVPXf+wLpv/o++rpK5ux/5Knrv/YF03/0ffV0lABRRRQAUUUUAFebeOfHXiTwL4hjvbmys9R8KKYzevb27rdWauSoYnzCrgFST8q9QPevSa59kn1DxNqVjqGg3DaXPZpCbuZ4WhmwXLLsDl+Q+OVHQ+2VrfQeltSKDX5BcXWsXWs6UfC62Ud1DKsDK4Vs/M0pkKlflPRB94enM9v410O6s724t7idzYw/aJoGtJUm8vBIcRModlODhgCDjg1wa/CC8sPA3i/wnpmos2n6iEfSRPIT9nGS5iPU7d/f0b1zVyw8M6/qfjy61q902XS7ceGhpSJPPE3mzFySf3bN8owME4PzdOopy2du2n3N/noEfPv8Aql+V2dZ4H8X2/jfwzDrFpb3NukpJCT27x8ZO3DMAH4xkqSM5Ga5zw38S5JJPEx8VCNIdI1k6bA+n2M8jSA/d3IvmNknjIwM49a1/hdpOp6B8OdK0fW7M2l3YxGF181XD4Y/MCpIwQRjPPqBXm9v4L8aaZr+u+JdM0a+Gop4gN/Y2bX0AhvbeQFJFYebhW2kkMRkZGM8gU7Ko0tv+Cv0uTG7p3e//AAH+tj0y/wDiX4V0y+vbK/v7iG5sbZbu5ibT7jdHCcfPgR8gZGcdOc4wavXvjPQbCOzeW+Mv26H7RbJawSXDyRYB8wJGrNtGRlsYGa8y8R+GvFes+K/FmqQeF7xItX8MjTrdXurXPnnBKn97wBkjP+yfbN/QvCHiDRbjwlrb6TNNPYeHzo95p6Tw+ZE+QVkBLhCuQc4bOMcHkVP2b/19r/JfePr/AF/d/wA39x3D+PvDaarpenLqDS3Grx+bYeRbSypcLzkrIqleMc88d+tM0v4geHdagjm0y4vLhJLtrIFdNuRiZRllIMfy4AOScAYPNcFZfDXxBbfCjwjYxbYfEOjalHe/NIrCFXlbzFznBARzkA87eK6vwt4QuvDfjbxBPEi/2LdNHdWcYYZE7Jsl47fcByeu8+9U0k38/wBP+D80J+X9b/8AAfoWrD4oeENSktUtNVcm7vGsYjJZzxr9oAyYmLIAregbGe2a62vnyHwJ4yXQNLt28MXQmt/GJ1mRTd2vFvnPXzfvc9PY+1fQdKy5U+v/AAE/zbXyDr/Xdr8rBRRRSGFFFFABXN+PP+Rdtf8AsNaV/wCnC3rpK5vx5/yLtr/2GtK/9OFvQB0lFFFABRRRQAVzfxH/AOSWeK/+wLef+iHrpK5v4j/8ks8V/wDYFvP/AEQ9AHSUEZBB6GiigCho2iaf4f08WWkwNDbhiwVpWkwSc9WJOPQdB0FX6KKACiiigAooooAKgvbK21Gyls76BJ7eZSkkUgyrA9jU9FAGRpnhjTNJuftFst1LMAQkl5fT3RjB6hDK7bAcdFxWvRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38R/+SWeK/wDsC3n/AKIeukrm/iP/AMks8V/9gW8/9EPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38R/+SWeK/8AsC3n/oh66Sub+I//ACSzxX/2Bbz/ANEPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzdj/yVPXf+wLpv/o++rpK5ux/5Knrv/YF03/0ffV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfjz/kXbX/sNaV/6cLeukrm/Hn/ACLtr/2GtK/9OFvQB0lFFFABRRRQAVzfxH/5JZ4r/wCwLef+iHrpK5v4j/8AJLPFf/YFvP8A0Q9AHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AdJRXN/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHQB0lFc39u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdAHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AdJRXN/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHQB0lFc39u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdAHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AdJRXN/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHQB0lFc39u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdAHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AdJRXN/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHQB0lFc39u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdAHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AHxH/5JZ4r/wCwLef+iHrpK878fXnjFvht4lW80LQ4rc6TdCWSLWpndV8lslVNqoYgdASM+o610H27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAB8R/wDklniv/sC3n/oh66SvO/H154xb4beJVvNC0OK3Ok3Qlki1qZ3VfJbJVTaqGIHQEjPqOtdB9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQAWP8AyVPXf+wLpv8A6Pvq6SvO7O88Y/8ACydZZdC0M3B0mwDxnWpgir515tIb7LkkktkYGMDk5IHQfbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJXN+PP+Rdtf+w1pX/pwt6Pt3jf/AKF7w/8A+D6f/wCQ6w/Fl34ql0uxTVdG0e2tDrWl+ZLbavLNIv8Ap8GMI1sgPOB94YHPPQgHoFFFFABRRRQAVzfxH/5JZ4r/AOwLef8Aoh66Sub+I/8AySzxX/2Bbz/0Q9AHSUVV1OytdR0u4tNQtobq2ljIkhnjDo49Cp4NeQeB9QuPCHw18DJ4b0nTF/t68FvezSlkcsxchsKvzHCkZJ4wBjHQWrt6fiD2v6/ge00V5he+PvEunaTr13Oukyt4d1OO1uQlvKv2uN/LIKAyHymAlHJLgkHgU7VfH3iezXxnNFaaTFD4YeOQI3mytcxFPMK5yoRipHOGAORg9aP6/L/MOtj02ivOtT8aeIbC91mzH9lmWHQTrNm/2eQrGAxBikHmAvnHDDZ/u0r+NvEQ1DQkgh0yZNW0GXUBC6SRFJ40RseYGb5D5nTYSMdTmjpf+uv/AMiw62/rp/8AJI9Eorzfw98QNau5PCtxrUOnraeIdOmufLtY3DwPGgfO5mIZSpPG0EHuad4Y+Ier67r2lD+yriXStWhaQSJpF3B9g+Xcu+eQeXKGHG5duDjG4HNVyu9v66/5CurXPRqK47xX4uuNB8QWtnJc2Wl2c0BdL7ULaR4ZZskCIyKyrEfunLZznAGapz+KfEGmeJ9c03VZ9L8qPTTfaQ0NpJum+YqVbMvzFTsBC7d28HK9Klar7/wK2/D8TvaK4RfF2rWfimDRNdvdK0+4ZIVj86zmSO/dsF/JlMm1SPmURncxIByAawNJ8V63oY8VXuqXcOoFvEP9n28cOnzMyOVjAbajOzKE/gVckg/Nzwdf67pfqLpf+tr/AKHrVFeVt8RvFcNvEjaLCWOs22ni9vLK6sI7mKYjDxwyguCDuU5YgYB5ziptU8d+JtMsPFcrDSJH8LzI0pFvKBdwuiuFA8z92wDY3ZcEj7op2v8A16f5oOtv66/5Hp1QNf2iXRtXuoFuFjMpiMgDhBwWx1xyOelZfibxGvh3wpNq/kec4EawwltoeSRgiKW7Dcwyewrz2d9b0P4razqUsGkXOpp4XNwGgie2jm2zdH5diQFwDnnA4XtLdnr5/gmw3V15fi0v1PWbe4hu7aK4tJo54JkDxyxMGV1IyCCOCCO9SV5y/wAQr9LHw9cX02n6RDqmlx3TXl5bStbSTuv+pEgcCHBIOXLZBwBmrWp+L9dnfxDN4cj05oPDhC3EN1G7PeMIllZUdWAjwrYBKvk9hVSXK3fpf8NAj71rdf1O8qGe8traSFLm4ihed9kSyOFMjeig9T7CvPdM8e+Ite8QzxadaaVbaZDp9nqge4eR5Xt5ixYHGAr7VOOoyByc8Y2p6hqHiHWPh74mvYdOSzvNT8yzSOBvtNvE0EjBWlLENuABICrggD5utPlaevf+v1+4V002u1/wuew0V5hp/wASde1a9spdI0d7yy1FZPKV9LvIFtcKTG8l0yGN0YgA7F4zxupLDx74sufAlj4nvLbTILO+CAvb2s9y1ll3DSPGrAumAn3SpBJJOBUj62PUKKzdA1JdX0WG+ivbK/jmLGO4sSTFIu4gEZJwcdRk4Oa0qbVmG4UUUUgOb+I//JLPFf8A2Bbz/wBEPXSVzfxH/wCSWeK/+wLef+iHrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+I/wDySzxX/wBgW8/9EPXSVzfxH/5JZ4r/AOwLef8Aoh60vEVhZ6n4cv7XUrWG7t3gYtDPGHQkDIJB44IB+oqZPlTY4q7saVFfPt4sB/ZkjtP+EDukgGlx3Ivyll5Qm2DNxgTeZk/3tm7npXodtq9/4X8UWuiTDSLHw3Jpclxp4gsmjZHjALxsfM28Al+FGRnpjJ0lHlbXb9CVqk+//A/zO/orznT/ABJ45u/EaeHrldBtrx9IGoi5+zzMu4uFCNF5gIxyD859f9mq/wDwtC/v9K05LCz+y6lcWs00+NMutQSN4pTEUCQDdhmVsOSMADgk4qdv69f8mP8Ar77W/M9OorzLTvHPjTXNcsNNttE0/SZbvSTfmLUvO8xHWVEdGXClRy2OvBUn+6bEPxJe3h1ufVprOK40uOeeTRjbSw3Sxx5CsGZiJVbAO9VCjOOcU2rfj+DsC1/D8T0WivLpfiN4mtrPWpRowu0s9NfUILqfS7zT4UKn5oHMykuwXkMuA2Oi9auw+OPEcF6kF1YWV9LeeH21a0trKN1YSJtBiLFjvBLjBCqR0wetFv6+/wDyYf1+X+aO/urq3sbWS5vZ47e3iUtJLK4REHqSeAKkyNu7IxjOa82vviHqUHw61LX9IvNF1i4sAgmQQzWpgYkhleFmZwwyuFJXPzcjilbUvEyfFPxF9lvLCe3stGgngs54HQHcZSF8wOdp3LktsbIwABjNJ6b/ANaXBa7f1rY9Etbq3vbWO5sp47i3lUNHLE4dXB6EEcEUTXdvbSQpcTxRPO/lwrI4UyPgnauepwCcDsDXn+meNfEN5H4J1O5OmQaV4giVboC1kMkU5jLqqv5mArYwMqcEd88Tt4s8SWmreHobldKuLLXNRngSeKKSN0iVHaM7C7BiQmS24dQNveqcWnb5CurX8rnfUV4zYeIPHOmeFPEevw6lpF5HY63cJdJPpkpcRRuEd1K3AGFQZCY6D71el6VqN9qOv32y4s5dIgjiSIxwsJGlZQ7HfvKldrLjC/xdeOUtUn/W1xvRtebX3Oxt0UUUgCiiigAooooAKKKKAObsf+Sp67/2BdN/9H31dJXN2P8AyVPXf+wLpv8A6Pvq6SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/yLtr/ANhrSv8A04W9dJXN+PP+Rdtf+w1pX/pwt6AOkooooAKKKKACub+I/wDySzxX/wBgW8/9EPXSVzfxH/5JZ4r/AOwLef8Aoh6ANy/tXvbCa2iu5rJ5F2i4gCF4/cb1Zc/UGuJtfhNbWml6Pp0PijX/ALLotyLqyRjanY4zjJ8jJHzNwf730x31FC0dw3Vjhrz4WWl9Y63az+Ida8vXLpLq7wbYHeuMBT5PA+VP++R6nLZfhXb3FrrsF14o16Ya+iJfM32UFwqhRjEAC/KNvA6e/Nd3RQBySfD62Ourql1rWqXb/wBm/wBmSQS+QI5YMchgsQOSfmyCOfbiqo+FtgF09m13XGn0y0ks7Sf7TGGiicAY2hArYCgfMpz3zgY7eij+vz/zf3h/X5f5L7jidP8AhjZ6fN4fZNe1iWPw/E0NpDL9nKMjDDK+IQWyuF6jgeuSdjQvCcPh8iKz1PUJNPiObbT5nQw23XhCEDlRnhWZgOwGBW9RTuxWRieIfDCeI7ae1udTv7e0uYxFcW8DR7Jo/myp3oxXduwSpVuBgjFY+q6LZeIPFGhQ29rdxjw/cGSSV4JYoygT5Y1dgBKC2xvlLAeXzziuzopLQb1MDWfCUGvTp/aGo37WYuEuXsQ0flO6bSnJQuACgbCsMknOQcVUk+HukynVd1xfBdSvBfFVmA+zXA2/vIiBkNlFPJbuOhIPVUUbf16f5L7gOR1bwD/bdjYwX/ibW2ks7lLpbhTbB3dDmPcPJ24U56KM5+bPFVr34YWl/F4hjufEGslPERU3oH2YYCgKAn7ngbQF78e/NdvRR/X9fcgMm+8OWeq+Fm0HV5Jr63eERSSyELI+MYfKBQGBAOQByK5+b4Y2lzcyXl14i16a+ewOnfa2uIg3kkkkFRGEY8kZZT6/e5rtqKHruC0VkciPh9B/wisPh19e1iTTktktJI2aDM0K7hsb91xkNtLLtbCrzkZqe68B6fNcXJtLy+063vY1jvrS0dBHdqECDeWQsp2gLlGUkdTXT0U223dhtsc5p3gq00zxVea3Bf3jfa7WOzaxcQ/Z0iTOxVAjDDGW6sevOeMZifCzSUGnw/2prBsdLu/tdjZC6CR2xww2KyqJCnzHgscdBgZB7aii7Fbp/XY5my8FR6ZDcWum61qttYybzBZo0JjtGbnMe6MtgEkhWLKP7uMCnaJ4NTw/4VtNC03W9USKzLeRcM0JlUEMNp/d7GA3Ejcp5AznFdJRSH1uZnh/QLTw3pX2GyaWQNK88ssxBeWR2LO5wAASSTgAAdgK06KKACiiigDm/iP/AMks8V/9gW8/9EPXSVzfxH/5JZ4r/wCwLef+iHrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+I//ACSzxX/2Bbz/ANEPWxq1g+qaXPZR3txYmZdpntghkUd8b1ZeRxyD19eax/iP/wAks8V/9gW8/wDRD1a8Y6ve6B4N1TV9Mt4Li4sbZ51juJGRGCjJ5AJ6A4Hc8ZHWplazuVFNySW5kS/Dm3m+Hq+DX17V/wCzlQQ+YPs/nGEDAiz5ONvA5xu/2qg1/QLfXRo/h+ZtSvZ9Mu4biS/ntzGPLAbcDIqJG+5f3ZVP73I61r6f400SXRUu9R1vS7eaG2hmvla7RBbGRQRvBbKAk4G7rV1fFGgNHZyLrmmlL/cbRhdx4uNv3vLOfmx3xnFaO6lr3/H+vvM42cdO35nEarZXOp/HDbBLrumQ/wBi/Zf7Qs7JvKMnm7ynmvE0f3e/Y8AhuK6R/AenRQaaujXV7o8+mwmCC6s3RpDGxBZX81XVwSM/MCc81r2XiDRtSvDaadq1jd3IjEphguUdwh6NtBzg+vSlh17SLi+ubKDVbKW6tBm5gS4RpIR6uoOV/GpWiS7f5v8AzKesm/T8kv0MqHwZFD4zi8Sf2vqT3EVq1qLdzEYmjY7mz+735LDdnd14GBxTbrwLp2p3qT63dXmqxxW8lvFb3ZjKRrIu1zlUDMSOPmY47YrQbxX4dW1luW17TFghCGSU3ke1A/3CTnA3dvXtU134g0bT7SK6v9Xsba3mfy4pprlESRs42hicE5HQUdLf1r/w4db/ANaGLP4FW68M3eh3XiLWpra5ha3V5HgMkMTcMinyucgY3OGbGcEHmoIfh1FDq9hqI8R60ZrCwOnxDdbqDEcZzthBzlVOQR90dsg9Ffa9o+mAnUtVsbMLF5x+0XKR4jyBv5P3ckDPTkUlzr+j2QtjearY24uwWt/NuUXzhjOUyfm4547U7u9/66r/AD/ELaW/rp/wDnNV+GdjrNlq0N7rGqmbWPLW7u0MCyNFGSUiGItoUFjzt3Huxq3L4Fgk1GfUF1nVIr2509LCedGhBlVd22Qjy9u8b26ALz93gYuav4m07QU1C91TVrGOzsbZZZYOPOjyT8xO7kNwFG0cg8nOBHp3i3S9W03TtTttZ0yO0uIGnkQzq5IC5bDhwBsIO7g9D0pbp/13QbNf12/4BTX4d6afh9B4Qnv9RnsrYIILlpES4h2MGTa6IoBXAwcZqzrXg231nUNFuhqd/YjRZfNtobTydhbaV+bfGxPykrgEcH15q3H4u8Ny2MV7F4h0p7Waf7PFOt7GUkl/55q27Bb/AGRzWbrfjzRvDNilzq+safItxqC2kPlyLGEyyghyWIygJZjwMdhTu7/P8RWVrBHouleErfUuNTvLfWLuSRrRIHuVSSXlwBGhKqT1ZzgZ6gcUzQvDV54e+G1to+mz3UF9HED5iSRvIrk5wWlVlKj7ucE7RxzitO08ZeGNQt7mew8R6TdQ2kfmXMkN9E6wp/echsKPc1audf0ez0dNWvNWsYNNkCsl5LcosLBvukOTtOe3PNLZfd/wB7u/qXYRIsEYnZWlCjeyjAJxyQKfWaviPQ3nt4E1nT2luoPtFvGLpC00WM+Yoz8y4BO4ccUWXiPRNTsJ77TdY0+7tLckTXEF0kkcWBk7mBwOPWhguxpUVnDxForaS+qLrFgdPQAvdi6TylBAIJfOBwQevemxeJdCnnt4Yda06SW6hM9vGl0haaIZy6jPzLweRxxQBp0Vx3iHxv8AZrHRL/wxNpmq2OoarDYTXMdz5ioHcKSmzIY9erDHv0q5r3jLTfC+i6vq2qapZSwWTBVhiIWRH2giJjuOXJ5HC4BHHGSdL/10/wA0Pd2/r+tDpaKy7DWrLU7hJNP1fT7q2ktvOWOCRXcjP+s3hsbO33evftU+nazpmroz6TqNpfKhwzW06yBeSOdpPcEfgaCb31Mix/5Knrv/AGBdN/8AR99XSVzdj/yVPXf+wLpv/o++rpKBhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfjz/AJF21/7DWlf+nC3rpK5vx5/yLtr/ANhrSv8A04W9AHSUUUUAFFFFABXN/Ef/AJJZ4r/7At5/6Ieukrm/iP8A8ks8V/8AYFvP/RD0AdJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/wCSWeK/+wLef+iHrpK5v4j/APJLPFf/AGBbz/0Q9dJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/5JZ4r/AOwLef8Aoh6T4i+Y3w31+KC3ubmaewlhihtbd5pHd1KqAqAnqRzjA6nil+I//JLPFf8A2Bbz/wBEPXSUpLmVioy5ZKXY8n0WCOfxt4btm0TUY7BvC72F0ZdJnihVyYyI3LIFHCv1+nUjLtD0qafQtb0HXrRbi08MW0+n25nUOlwrrvjbBzkrF5a5PctXqF3BJc2csMN1LaSOpCzwhC8Z9QHVlz9QR7VnP4ejPh+70yO+u4nvA3n3q+WZnZhhn5Qpkjj7uAOgGBTqNyi15P722/wuyYJRt5W/BJfjZHmPhG1l17w/8PU0Wwu7SfSLLzbm+ltHhjVHtiuxXIAk3uyt8hYDbk4OKi0rwrFJotn/AMJMPE15qGh2U0EthNpcbWzb4yr7WjtwbhWOCAHZs4JGQa9W8NaDF4Y8OWejW13c3cFlGIopLrYXCDhVJRVBwOOmfXNalXUalKVuv/B/zFG6S8jyTQPD0EXwp8Lzra6loes6fChNzBo7yTRSxo4KywlN7qd7jAHJbKkZzVdrTX7+8sr/AMUx6tpdpfadJZyDRNMSfDmZyxkheGV4xKhRuBwQQxzivY6KUnzSbfUForf13R47aaNY+HPiFaCLRdXntrLwzJZm9k0qWd5HBUorSRx4Z/LBHH+714qlo9vq+n/D/RL3TLbWLfXLXSksJdNvNEllgvcM+IXBUNHgg/PlVAZckivb6KXM/wCvVv8A9uY9P6+X+SPHtT0+5u/FHj2Kx0G8gn1Tw4kKsmnyJFPcqku9RLtCO3zoM556DOKsWgB8feAr0aFqkTw6TLa3dy2kzDZuRFjWR9nyjcH4YjbnJwDk+s0UJ2/r1/zE9V/Xl/kef+GtIvdN8Sah4fnsJV0Owu31OzuDF+7kE2SIR6lHaU4HQbPWuN02wuE8HmKx0HVLeGz8aJfLbf2VNCVtTPlXSMoCVC9lHHcCvcqKE7NPtb8Gn+g5aprv/k1+rZ5vr2n3dl48iXT7N1svGEC218oAHkyRfMXbB6tD5i5GeVWu61fSLXWdBu9Ju4wbW6gaB1x0UjHH0qODRxHqz6hc311eSfMIEm8sJbK2MqgRVz90csWPvya0qTs48o7tSujy+GHWr74baq+v+H572+srF9KWydGQ3gU4eVdpDFXAUgDBOzjrVLT9Jl1DWPFC6nFrS2+qWenNDdxaU0BVkZhlEZeNh2kq+5sZzkV67RTu3v8A1/TJtbb+tv8AI8jhm8SS6hpWsazpt1qWm6Xqkhe4i0t4Li6RoNiXD2pG8sjZXhckcquK0b/T7TTPE3hLWtF0XUItKiurxp1hsZmkRriPO8xYLopfIOVGCeQBzXpdFFx2/r7/APM8OKanZ+FrWC78O63E6+M2v9senvMTbi4LmTEQYgAEdcZ/hz1p9xps934T+J1lo+hajD9tvRc2cJ0uaATrsjDGMMg3EsrnA5PXHNe3UUJ2Vl/Xw/8AyKDrf+t2/wBTylI7a8+KGuTtoOrw2eo+HRbzzR6VNGZ5AWJG/aAX8sqBk56L1GB0HgVtYh1bUNPvTNfadZwxRWup3enNZzuQWBiYEKJAowQ6qFO49Tmu2ooTt/Xm3+ov6/BL9Dm7H/kqeu/9gXTf/R99XSVzdj/yVPXf+wLpv/o++rpKQwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/wAi7a/9hrSv/Thb10lc348/5F21/wCw1pX/AKcLegDpKKKKACiiigArm/iP/wAks8V/9gW8/wDRD10lc38R/wDklniv/sC3n/oh6AOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDpKK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDpKK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDpKK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDpKK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgA+I//ACSzxX/2Bbz/ANEPXSV534+8A+D7P4beJbqz8J6HBcQ6TdSRSxabCrxsIWIZSFyCCMgiug/4Vx4I/wChN8P/APgrg/8AiaAOkorm/wDhXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImgDpKK5v8A4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJoA6Siub/AOFceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8AiaAOkorm/wDhXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImgDpKK5v8A4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJoA6Siub/AOFceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8AiaAOkorm/wDhXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImgDpKK5v8A4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJoA6Siub/AOFceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8AiaAD4j/8ks8V/wDYFvP/AEQ9dJXnfj7wD4Ps/ht4lurPwnocFxDpN1JFLFpsKvGwhYhlIXIIIyCK6D/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgAsf+Sp67/2BdN/9H31dJXndn4B8Ht8SdZtW8J6GbePSbCRIjpsOxWaa8DMBtwCQignvtHoK6D/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Sub8ef8AIu2v/Ya0r/04W9H/AArjwR/0Jvh//wAFcH/xNYfizwV4V0jS7G+0rw1o9jdxa1pfl3FtYRRyJm/gBwyqCMgkfQ0AegUUUUAFFFFABXN/Ef8A5JZ4r/7At5/6Ieukrm/iP/ySzxX/ANgW8/8ARD0AbmoS3UGnzS6fBDcXKLmOKeYxIx9C4ViP++TXA2PxP1L+ydA1nW/DtvaaTrk8dvDNaakZ5YXkOE3xtEnGepVmx6V3mp3aWOl3FzKk8iRoSUt4Hmc/REBZj9BXi/hPRbnQvD3hvxImj61qB01Ps+o6TfW1w81s56T2sUo4K7sERjBUnHIojbm120/X+r9Bv4dNz2W91rS9Nu7e11HUrO0uLo7beGedUeY+ignLfhQda0tdUOmnUrMX6qGNqZ180A9DsznB+leX6vpDeI/EGsx6xP4ottJ16OE2ostKUhkVApjkMlu0kDhwWBYovzZBzmtMWOo6Z4rgt9KjvNQsdSuwdR0/UtNLxxAJsadLkAKD8oO1ixbPAFC8/wCv66/0xPTVf1/X9djuIvEeiT38djBrGny3cu7y7dLpDI+0kNhQcnBBB9MUi6xZwS3bXmr6d5Uc6whQ4QwsQMRuS5yxJyOF4IGD1PkHhWzXVPAumaDoulXMV5b+I5LpbmOzZILeKO8cs4lxszsBTYDu5xjFZ+tadbSP4hto/CmqOJPFNrfWgTw9clfJXyhNIpEWBnbJnu2e+apK7t/W8f8AN/cwel/67/5fie2S+LPDsENtLNr+lxx3blLd3vIwJmBwQhz8xzxgd6qHxvoY8cDwr/aFsNS+z+cY2nUNnIwgHdiMtgcgDPeuC+IelTTPr9jomgXFst3oTCKey055TeOWdzF0KREE5OV3uX4ORVq+0/WLvxXeSaZZ3sD6n4RWztLp7d0WKcM5w5I/dkbgcNg+gOKnpf1/J/5Dsu/b84/o/wAPu9EtPEGjX93c2tjq1jc3Fp/x8Qw3KO8P++Acr+NUbnx14Rs5FjvPFOi27su5Vl1GJSRnGQC3TIP5VwcmlxatD4WX+wr23Xw/aSR6rHPpkoVoTblGgUbcThnwcJvBxn0yvhHwVDq3wKtdNbS20zWY7YhJLmyaCaGdJDJGfmUNgOQcjg5PvTaSv5flrqhLW3S56dFq2nTanJp0N/ayX0cYle1SZTKiHoxTOQD64xVHxX4o07wf4butZ1eZI4YF+VWYKZX/AIUGe5NYnhTXTL4Xfxbr9pcWct/sDxLbtK8KINmCIwx27t756ANk4qf4oWV1qvwu1u20y3ku55bcGOKFSzPhgflA5JwOgoasENWrlO3+ItsfGd3aX17o9voCaZFfW+pC9BWXfIU5c4QcqwwCc8c9q6rUdd0nR7NLvVtUsrG2kICTXVwkaNnphmIBrzTULhbv4h6zqEuhau0DeGPskUj6NcNuk3uxRSEOSVZePwPIIEfhFb3Sx4d1bX9L1SWxXw3Hppi/syaSa2uFYeYrxBC4DAAbtu07euMZEtP6/vf5JfNC8/T8o/5t/I9Ou9f0ewVGvtWsbZXj81TNcom5Mgbhk8jJHPuKE1/R5NYOkx6tYvqSrvNmtyhmC+uzO7HvivH/AAp4PTTPHmhW2r+H5pIzYX6SO+mvLDEkswaCF5dhT5Y9wwThckdxm4lrft4q0WcaJqFjDZ+Jbh5baHTpWjjWSOVRO0pBL7iQcoQihsEcA07LTz/zsD2fl/lf+v6R6suuaS2sNpK6nZnUlTzGsxcJ5wX+8Uzux74qGLWbK30mfUNQ1jTmtIpXDXaOscUYDEbWYuRuXoTkcg8DpXE+E7C1i0+HSfFOgX0ur6ZfXF0Lg2UjxzF3f98JgNjbkflCxbttOBXN+FrW807SdCuxoGqLpuk67fy3Fj/ZksbxxymTyZUhKAuFDDhASM9OKSG9P69f6/z0PaLS8ttQs4ruwuIrq2mXdHNC4dHHqGHBFVbfxBo13qVxp9rq1jPe2ozPbR3KNJEPVlByv41D4etdOtNJf+xdPlsraaV7gRSxPEzM53M2x8MmSTwQMeleT2NtKdV0C71Tw7qUOnwQ6lBdacujTSx23mDOwkqzzbufnGUYngDpUvQaVz1228Q6Ne3yWVnq9hcXTxmVIIrlGdkBwWCg5IzxnpXPeK/HI0bXdG0vSp9Lup7vUobS9ge5zPbpJ0YRrzzg8kjHHBrz7wvb3Gn6R8M7aPQ9WtJ7G4uPtuNHuEEG+N0Bc+XgAsycnjv0Gam+y6nH4b8LaZL4Y1W41rRfECXF88dmdsvzSM86zNiNg+QSd3GcHHFXb3l6r8/8tyX8L9H99n/ke20UUVIwooooA5v4j/8AJLPFf/YFvP8A0Q9amu3t5puh3V7ptpDeXFvGZBBPcGFXA5PzhGwcZxx19OtZfxH/AOSWeK/+wLef+iHrb1K2a80q7tYyA00LxqT0BKkf1qZ35XbcqNuZXOds/FOr3fw2XxONGs0uZLQXkdkdQYqYiofmXyeG2542kZ4z3q9B4qsbXSYbnxPfaVo9y0aySwtqCskYY/L87hCc8fwjngZ61ymj6neRfDa38KT6Jqq65Fpw09ovsMog3iPZv+0bfK2d87s47Z4rPcaboPxf1lZtImuzceHrWOQWVg07TOXkX59ikjcFA3NxgDJHFaTspPl26fj+ehEb8ib36/ev82ek32vaPpib9S1Wxs18vzd1xcpGNmQN3J6ZI56cikvNf0fT9Nj1C/1WxtbKXHl3M9yiRvnphicHNeRaHp8fgvxp4TGt6dNLexeGZ47j7JZtdTKRLGFUiNWZgoOzIBA+lPsvDOr6MmmTakda07TJIb2NYtLsorySzE1wXWJ4jDKQpjwDsHBXB4oa2t5/g2vxt+I/+B+KX5Hrd5r2kaeFN/qtlaho/MUz3CJlMgbhk9Mkc+4qe71CzsI0kvruC2SRgiNNKEDMTgAEnkk9q8n03wjpWlfEXw1p6aJqF5Y2+i3NpJd3+mtKGDOpiSWURhPuBwAcbQcHBODu/Fiyt7m38Nk6PcahLbazbzbrbTpLkwQq4MhyiNtGAOOM474osrq3V2/G3/BF38l+l/8AgHXv4n0GKCzmk1vTUivm22kjXcYW4Pohz8x+mamk1vSotUGmy6nZpflQ4tWuFEpUnAOzOcE8Zx1rzfxJ4VSTxRqtjetrVjoesWcVvCuiabFNERl98cn7iRojuYtuyq/MTnIqw2n6joXiC1i0KPUL+K+ubdNQ0/UtPMsbBERGuFuQAiMqqDhidxU7QKUdX/X9f121G9P6/r+vuO8HiPRGv4bFdZ083c7MsVuLpPMkK/eCrnJI746ULq9pC97Jeavp/kQTLHw4Q25Kj5JGLkFiTkcLwQMHqfHtEsI9Q8FX/hrQ9IuI7z/hJ5pbeaGyZILZI7zPmeaBsXaqkBc7uwGKpeINLgn0bxnZReFdTk+0eIbe6sUTQLgqyjyhLImIsDO2XJHXPfcMi1t/X8v+b+71B6Nr+uv+X4ntM/izw7bW0Vxc6/pcME0rQxSyXkarJIDgoCTgsCCCBzVX/hN9D/4TdfCw1C1/tE2/nGMzqGySNqAfxMRlsDkAZ71xfjnTmmu7610XQbi3S+0GdY7u0015DO7ksYSMbIicBiXXc2cAgjk0qy1U+KIZrewv7c3vhCGzguJLV0WGdWbIkyBsI3A4bBPbNTrvb+rS/wAvx+8f9ffH9G/u+70W38QaNd39xY2urWM93ajNxbx3KNJCPVlByv41RufHXhGzkWO88U6Lbuy7lWXUYlJGcZALdMg/lXnTaL/aHh3wjp0+h3sdz4dT/ia+dpsjIYhAyyxodpE/mNj5Y9+e9WvCPgqHVvgVa6a2ltpmsx2xCSXNk0E0M6SGSM/MobAcg5HByfeqdlfsvxXdAtbef9WPTotW06bU5NOhv7WS+jjEr2qTKZUQ9GKZyAfXGKt1y3gK7udb0U+ItStGtLvUguYXA3RJGNu3jtuDsP8AfrqaGraCTurhRRRSGc38R/8Aklniv/sC3n/oh66Sub+I/wDySzxX/wBgW8/9EPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzdj/wAlT13/ALAum/8Ao++rpK5ux/5Knrv/AGBdN/8AR99XSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN+PP8AkXbX/sNaV/6cLeukrm/Hn/Iu2v8A2GtK/wDThb0AdJRRRQAUUUUAFc38R/8Aklniv/sC3n/oh66Sub+I/wDySzxX/wBgW8/9EPQB0lFZ3iG+utM8N6hf6fDDPc21u8scc7lEYqM8kAnt6VxOmeMvFF/deGbeQaRE3iPSmu4mEErC1kREY5G8eYpD/d+QjH3j1oWt/wCu/wDkw/r8v8z0emSoZIXRJGiZlIEiAblPqMgjI9wRXmtv8Tb+58PaSDAkOrX0l3G8kGm3N7Gn2eTy2cQw5chjtwCwxnknHNvTfG+ua9FpWkx6bHpOtX0dzLMdStJfLjihcJvELFHO/euASMAnOcYJZvRBtubPg7S9H8J6ONOsfEL6jDPeyiJrueFm85izvGpjVcnO5tvJHPYcdTXjPgDXNR8O2uj6RbWGnx2WpeJNRtJ/LLDySrSOFiQAAL8mMk8cDHcdIfHWsQ+OrHTLhdNa1vNRmsTawqzzQBY2dJHmVzGCwXPlFVYBupware39dv8AMHpfyv8Am/8AI9CqKW7t4JoIZ54o5bhikKO4DSsAWIUHqcAnjsDXmN9461jUPB/iNrfU9O0/V7GxuJ30+SylS6tNg44d8SDhv3gAXJXAPe7p/iHxHpC+CdJdNMvU1a0cNPiSFgyW5dF25fA4UF8nPOFFSv8AL9f8gen4/hb/ADPRqpanYTahAkcOpXWnhXDO1qI8yL3Ql0bAPquG9CK4DQPiD4hvrfwxf6pbaZHba1qM+nyQWyyF42Qy7XDs2MfusEbec5yPuixaeN9Xl8c2OjajHpj2mo3N1atawRvJJaiJWZS8wZo2LquTHhWG7vg0+V7Be2v9df8AJnZ21rpV5oyWVmYZ7CECEJDLuTCcbDg89MEH8at3V5bWMIlvbiG2i3BQ8rhFyTgDJ7k1xfwghitvA88FvGkUMWrX6RxooVUUXLgAAdAB2rlfHmq33ivwmNVSHThpFpr8FvbpLAzXIeO7WJphJu2rkhl27c7Tndzina8ku9vxt/mLZPyv+F/8j1+O6t5biaCKeN5oMebGrgtHkZG4dRkdM1LXn0/jnXYm8XRf2bbGTRLq3hh+zpLcfupAGMroMM+1W3FFx0IBPWpl8cT3dvo1ro2o6TqV3rVzJBb30MT+REscW92eLfu3BgRs3jqMmpWq0G9N/wCrHd02SRIo2klZURRlmY4AHqTXmF78RvE1lO2mHT9Ll1Cz1u20u7nLyJG6ThWSSNOSCVJyC3ykD71WtX1TxBren634euItEkn03T/M1MyQSSQ3BkDlY41LAp8qglm34JwAetKTtByX9aX/AFQ0ve5X/Wtj0K2uYLy1iubOaO4gmUPHLE4ZXU9CCOCPepa8a0Lx1qOleBNB0rQbV5ruz0C0unX+yrq8E5dCFiBgGIidh+dsjn7pwcdBpXjPxfrniifT7bSdOsIoLKzv2hvTL5+yUtvjYYGyQBWwMEAgZzn5dJx5ZOK6P+vyJT0v/XT/ADPRaK47wR4tuPEkkkd9d2C3kSFrnTFtpILmyYkbUdXY7wPm+cBQeMCuxqWrDCiiikAUUUUAFFFFAHN/Ef8A5JZ4r/7At5/6Ieukrm/iP/ySzxX/ANgW8/8ARD0/x9d3+n/D3XL3SLlLW7trGWWOV49+3apJwMjnA4PY84PSpk+WLZUY80lHudDXP2/hKO38c3PigarqD3FzbrbPav5PkCNSSoAEYfgknO7PPPHFcdpviHxpa3Hh7w5ZjQp5LzQ2u4ruZJkGUEYCsgY44cAkMc8nAxtNw+PdYtvGljp16umm2utQmsntYFeSa3CRs6yNMrFAWC58oqrAMOeDWjjyy+//ACM0+aN/67/1/mdLP4SjuPHNt4oOq6glxbW7WyWq+T5BjYgsCDHv5IBzuzx6cV0FcToPiDxV4hg07V7K207+xdUWQopRvOslwfLkclwJckAFFVSN33jgmmfCO51e+8DLea3fQ3kk13csrR25jYfv5A24l2ByemAuBgc4zSs0rPp/mU+53NRW11b3tutxZzx3EL52yROGVsHBwRx1FcXovjPUNV1DUrEz6ZFqlt5xTR7mGW3nRVJCMXJbzEY4JdEwAcDJFVbDx5rGq+D/AApeW8NlaX/iKZojNLG8lvbEK7fdDKWJ2YA3DJOfalv+H4h/wfwPQ6RwWRgGKEjAYYyPfmvL4/iR4nnXS/K0jR1jutdfRpLj7XK25kLBpFTywADsJHzt2HrieT4ga1baXqC3q2aT6brLadd6lFYzSW8MXliQTNCshcD5lU/PgE5JxxRa6/ry/wA0PVO39df8mdZ4T8JxeEbK6tbfU7/UEubl7pje+USsjks5HlonBJzg59sVvVnaXqJ1DQY7+G4tL8SI0kUtm/7qVcnbgknHGM88HNcLovj/AMQXmqz2E8WkXU7aPJqMKW/mRxwSI4UwNMDIsuN3LpjkdORQ97Pp+i/yQlqr9/1f/BPS6hmvbW2ngguLmGKW4YpDG8gVpWAJIUHqcAnjsK850b4jaw0Phm/16HT1sdc0ue8aO1jfzLdooxITuZiGUqTxtBB7ms+7uNT1jxx8Ode1ODTUjvp5pLdYISJ7dGtXYRvIWIfPU4CgEdD1quV81n/W/wDkK6tfyPXKp6nYTahAkcOpXen7XDO1qI8yL3Q70bAPquG9CKuUVIyK0tYbGzhtbWMRwQII40H8KgYAqWiijcAooooA5v4j/wDJLPFf/YFvP/RD10lc38R/+SWeK/8AsC3n/oh66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAObsf8Akqeu/wDYF03/ANH31dJXN2P/ACVPXf8AsC6b/wCj76ukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACub8ef8i7a/8AYa0r/wBOFvXSVzfjz/kXbX/sNaV/6cLegDpKKKKACiiigArm/iP/AMks8V/9gW8/9EPXSVzfxH/5JZ4r/wCwLef+iHoA1ta0wazot3prXVxaLdRmJ5rbZ5iqeDjerDkZHIPWuasvhtBY3mhXEXiLWWbQrV7W0V/sxHlsMEN+55OAoz/sjvkns6KP6/r72BxVh8MbHTdLt7W21vV1uLS6lurW/wB0AngaUkyKMRBGRiSSrKw+mBjS1HwZb6jJYXZ1PUbfVLAsYtSgeMTMGADqwKGMq2B8uzAwMAV0dFO4HCW/wn02zvbO5s9c1yFrTUJNRVDcRyK00mdxIeNsDDMMLjrk5PNW4vhvYQXVtLBquqxpaak+pW8IkiKRSPv3qMx5Kt5jdSSM8EV2FFF/6/r0D+vz/wA2ctc+ALDUZ5ZdY1DUNR3WElhGLh4x5MUihZNpRFYs2ASXLc9MVWufhzHO+iSR+Jdct5dEjKWskZtmOSmwsweFgTt4wAB3xnJrsqKX9f197G9dzhbT4V2lnZ6PaxeItbMWj3r31sGNtzIxJO4+TyPmfj/bPoMWbb4bWVnNYPa6zq0Y067murNN8JWEyhg6DMZ3L87H5sn3xxXY0U7sX9f195g+EvCkXhDTJrG21K+v4priS43XpiLK7sWfHlovBYk8568cVkah8LtJ1CK9tTqWrW2nXt0t7JYW1wqRLOHDl1O3euWGSAwHJIAPNdrRR1uByumeBI9K1bVNRtvEGstLqckckwkkhIUxgBMHysnCgL8xOR1yeabH8PNMityy3l9/aZvGvv7VDRi4E7JsL4CeXygC7dm09xnmusopAcdqHw3stQt4FbWNUhnjvk1Ga6iMHmXVwgAR5N0RX5QowqhV9qu6r4Js9T1mbU4tQ1DT7i6tvst59jkQLdRjOA4ZWwRuOGXa3PWukooeqt/Xb8tA8/67/mchp3w307RY7AaFqmq6dLZW62pmjnSVriFSSEk81HBAJOMAFQcDA4q5p/gyHTvFV7rseralJNeWyWrwSNEY1RM7MERh8gsxyWOdxznjHR0U229WFrGFYeFLe08Q/wBtXN/e6heJbfZYGujH+5iJBZRsRS2SoJLbj6EVu0UUXAKKKKQBRRRQAUUUUAc38R/+SWeK/wDsC3n/AKIetnVdNt9Z0e80y+DG2vIHglCtg7WBBwe3BrG+I/8AySzxX/2Bbz/0Q9dFLLHBE8szrHGgLM7nAUDqSe1J2a1Gm07o5TT/AIfwafr+lasuu6vPLpdmbOKKZoCjxnGQ2Igcnap4I+7x1OWRfDfT4Lq2lh1XVES01J9St4PMiKRSPv8AMXmPJVvMb7xJGeCK1ZfGnhaCyivJ/Eujx2sxxFO9/EEkPorFsH8KtTeItFt7uW1n1iwiuIUWSSF7pA6I3CsVJyAcjB71V3f+vUnRL+vT/gFDQvB9v4dkaPTdS1BdO3tJFpjSIYIGY5Ow7PMxkn5S5XnpU/hnwza+FdPksdPuLqW3aZ5US4cN5W92cquAOMseuT6k4FPk8WeHYoJp5df0tIoJvs80jXkYWOX+4xzw3seam1DxBo2kqW1XV7GyCoHJublI8LkDd8xHGSBn3FIfUy5vBkVzqUV9caxqUtxbQSQ2buYSbUuu1nU+XlmI/v7h7VyGueCrbRPDeh+GpJtevtBtpJJJLiOxhv3j4wkbwCBg65ZmDGNipXqOCOwvPHegWXirTvD82p2gvNQiMsQa4UDGQEA55Lk/KB1wcVqQa9pFzq0ul22q2M2oQjMtpHco0sY9WQHI/EUf19wf195xtl4HbV7XTPN1rWLew0i6S60xTaWtq5IXHzxCAbVGSAu1Dy2R901q6b4D/sm41S4s/EutLNqdybqVybY7JCmzKjycdAvDAj5QfXO0viPQ3uorZNZ09p5i4jiF0hZyhw+BnJ2459O9InibQpNIk1WPWtOfTomKyXi3aGFCDggvnAP407/193+SC3T+uv8AmyLS/DGnaR4ZbQrUSG0dZBIzv88hkJLsSMAElieAAM8AViW3w2trT7M0HiDWVltdPk02KUtASsDFSFwYtuV2jBxn1zVnxj41i8PeGJNS04R3heOTyJwyvAJF6ByrbsE8fKDz1xW1omrx65paX0MEsMcjEIJduWAONwwTweozg46gHije7/r+tWG1jl7P4W2No2gqdc1eeDQYHt7WCX7OUeNxtZXxCC2VwvUHA9ckyW3ww0y3l0ndquszW+izmbTrZ7sKtuCMbAyqHZcHGGY8cZwSK7Sii7vcVugUUUUhhRRRQAUUUUAc38R/+SWeK/8AsC3n/oh66Sub+I//ACSzxX/2Bbz/ANEPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzdj/yVPXf+wLpv/o++rpK5ux/5Knrv/YF03/0ffV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfjz/kXbX/sNaV/6cLeukrm/Hn/ACLtr/2GtK/9OFvQB0lFFFABRRRQAVzfxH/5JZ4r/wCwLef+iHrpK5v4j/8AJLPFf/YFvP8A0Q9AHSUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38R/+SWeK/8AsC3n/oh6v+J7CDVPDN9Y3QuTDcx+UxtF3SrkgblGDnHXoenQ1Q+I/wDySzxX/wBgW8/9EPXSUnqB5pBpGs+LfCev6Vq+ZXhdG0rV5tPaymllQbkd4mAOUcAbgFDAnAArC8VLN4r+ErazqXh+6udT1O8tWitIrBrmSBYnUNwittGBMc9w+O+K9c1Owm1CBI4dSu9P2uGdrUR5kXuh3o2AfVcN6EVPaWsNjZw2trGI4IEEcaD+FQMAVV+vp+H+egf8E8l1gifxN43nttE1Uw3nhuK2tXGi3IEsmJAUX931+eMY9v8AZOKfh66sNK8eaXd3miX3nSeEIoriNNJla4MiyCMh4wm/+HbuIxgDnGDXtdc+PCMY8eHxV/a2ofaDbfZPsn7nyPKznbjy9/3vmzuzn24pLf8ArtL/AOSB6x/rvH/5E4Dw/wCHtb0HWPCYnsLtNulX9uDHH5i2byzI8UbsvChVGMk4+XA7Ciy0W5uvDfhHRJdLvYNX8P3kc1/cvZSCMIobzisu3bL5mcbULE7uR1r1+inf+vm3+vzF3/rpY8EsLRbTwJpVnD4Z1WF4fFpu2gXQbgbLbz2bft8r7vlsB9OOxFbqWhvfEniwvDr+mN/bEN9Y30GjzOoMdsELhWjIkUlWXABJyCOxr16ii+n9f3f/AJFD/r8/8zitH0aTxh4G8rxfp0dreSm4jS4gtvs8ux2I85VfLQs64JU888+lddZ2Nrp8BhsbaK3jLs7LEgUMzHLMcdSTyT3NT0UNiCiiikMKKKKACiiigAooooA5v4j/APJLPFf/AGBbz/0Q9dJXN/Ef/klniv8A7At5/wCiHrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5ux/5Knrv/YF03/0ffV0lc3Y/wDJU9d/7Aum/wDo++rpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm/Hn/Iu2v8A2GtK/wDThb10lc348/5F21/7DWlf+nC3oA6SiiigAooooAK5v4j/APJLPFf/AGBbz/0Q9dJXN/Ef/klniv8A7At5/wCiHoAP+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfrevLuCwsp7u8kWK3t42klkboqqMkn8BWBZeNYrxrMNo2q2y6gxFi88Ue25AjaQEFXOzKqcCTaeenXAAv/AAgekf8AP54g/wDCj1D/AOP0f8IHpH/P54g/8KPUP/j9TeDfEx8W6AdSawfT2W5mt2t5JFdlMchQ5K8ZyvbI9z1rZia4aaYTxRJGrAQskpZnXAyWBUbTnIwC3ABzzgOwGB/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8ACj1D/wCP10lFIDm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfrpKx/Fmvt4X8Kahra2Mt+LGEzNBE6oSo6nLHGAOe544BPFJuw0m3ZFP8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfrdsbn7bp9vdbNnnxLJtznbkA4z+NT1TTTsyU01dHN/8ACB6R/wA/niD/AMKPUP8A4/R/wgekf8/niD/wo9Q/+P1L4x8UN4S0mC/GnS3yS3cNs2yRUEXmOEDMTyRkjgAnnsOa36XS4zm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfrpKpaxq1noWj3Wp6lKIrW1jMkjew7D1J6AetAbmR/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9dGrblDDoRmloA5v8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfrpKKAOb/AOED0j/n88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8AH66SigDm/wDhA9I/5/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/AB+tfWNXs9C0qbUNRk8uCLGT3Yk4Cj1JJAH1qwrXBvHVoohbBAUkEpLl8nIK7cAYxzuOcngY5AMD/hA9I/5/PEH/AIUeof8Ax+j/AIQPSP8An88Qf+FHqH/x+ukooA5v/hA9I/5/PEH/AIUeof8Ax+j/AIQPSP8An88Qf+FHqH/x+ukooA878feCtLtfht4luIrrXGeHSbp1Euv30iEiFiNyNMVYeoIIPQiug/4QPSP+fzxB/wCFHqH/AMfo+I//ACSzxX/2Bbz/ANEPWzql82maXcXqWc96YE3mC3KCRwOuN7KvTnkjpSbSV2NK7sY3/CB6R/z+eIP/AAo9Q/8Aj9H/AAgekf8AP54g/wDCj1D/AOP1R0j4lafqb6R9r0rVNJh1tQdOuL1IjHckruCgxyPtYjkB9pNdlVNNbk3Ob/4QPSP+fzxB/wCFHqH/AMfo/wCED0j/AJ/PEH/hR6h/8frpKila4WaEQRRPEzHzmeUqyLg4KgKdxzgYJXgk54wUMwP+ED0j/n88Qf8AhR6h/wDH6P8AhA9I/wCfzxB/4Ueof/H619L1ez1m3ln06USxRTyQFx0LI21sewII/CrtAHN/8IHpH/P54g/8KPUP/j9H/CB6R/z+eIP/AAo9Q/8Aj9dJRQBzf/CB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wAKPUP/AI/XSUUAc3/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8ACj1D/wCP10lFAHN/8IHpH/P54g/8KPUP/j9H/CB6R/z+eIP/AAo9Q/8Aj9dJRQBzf/CB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wAKPUP/AI/XSUUAc3/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8ACj1D/wCP10lFAHnfj7wVpdr8NvEtxFda4zw6TdOol1++kQkQsRuRpirD1BBB6EV0H/CB6R/z+eIP/Cj1D/4/R8R/+SWeK/8AsC3n/oh61ta1NtH0e41BbG5vxbpvaC12eYVHUjeyrwOevbjJ4pNpK7Gld2Rk/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0W3jFbrwL/wlMWh6p9naH7QlqfIE7xYzvA83bjbzgsDx0zxWzpV8+p6XBeSWVxYmZd3kXJQyKO2djMvI54J61TTTafQm90mY3/CB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P1o2mspq9jLcaF5N2IrlrcmSUohKPtkIYBs4w2OOSMZHWtOkM5v/AIQPSP8An88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8frpKbKZBC5gVXkCnYrttUnsCQDge+D9KAOd/4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfroojIYUMyqkhUb1RtwB7gHAyPfA+lOoA5v8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfrpKKAOb/AOED0j/n88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8AH66SigDm/wDhA9I/5/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/AB+ukooA5v8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfrpKKAOb/AOED0j/n88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8AH66SigDm/wDhA9I/5/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/AB+ukooA5v8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfrpKKAPO7PwVpbfEnWbc3WubI9JsHBGv3wclprwHL+duI+UYBOByQBuOeg/4QPSP+fzxB/wCFHqH/AMfosf8Akqeu/wDYF03/ANH31dGSFUljgAZJPagDnP8AhA9I/wCfzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/x+rPhXxbpnjHTZ77R2lMUFzJbOJVCtuU9cZPBBDA9wRW3QBzf/AAgekf8AP54g/wDCj1D/AOP0f8IHpH/P54g/8KPUP/j9dJUUbXBuJhLFGsIx5TrIWZ+Ody7QFwemCc+1AGB/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9dJRQBzf8Awgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9S2Xihrvx3qPhp9OlgNlaRXS3LyKRMrsR8qjJABUjnB46YwTv0dLh1sc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9Yfizwlp2maXY3dtc6w8setaXtW51u8uIzm/gHMckrKevcHB56ivQK5vx5/yLtr/2GtK/9OFvQB0lFFFABRRRQAVzfxH/AOSWeK/+wLef+iHrpK5v4j/8ks8V/wDYFvP/AEQ9AGp4gkgh8N6lLd2n22BLWVpLbGfOUKcp+I4/GvMNFlj8L+KtK03wp4iGs6K8pFxot6RJPoqeWzebvPzxKB8u2T1wK9fooWjuD1Vv6/r+mfPngfXvDs+qWsXixtJu9IfVb5tJuGkjkSG6Nw7Hzc/dLIUKHp+JU1W8Rap4eXQ/HdquvRh18S2zwKNVbe4IiD878so/e8HIXaem0Y+jKKadrf11T/QOr8/+D/mea+Cb/RIfi74r0vQbuyFvJaWlyLe1lUh5fnEkmAeWwY9x9xnrXM/E6602TXtcmzDDqeltYyJNePmaJPMUs1qoAMaYOHk3EE5BHAr3Cijqn2De9+p87+I77wxJb/E+8i1Szuri3mt5tOlkvvOaKYRg7otzHBEhYfL05XoMVoeLdQ0XV9I8av4klt7jUnsPN8PySENvtjbKd1se+X37ynOPvcV7xRS+zby/r8hp2dzlJxFq/wAK0jW9l01LrT44luJYHVoiQFBZDhsZ4I44/OvNdRmsrjwkJX0nRYI/D2vae7alo/Nk0YkXe8fH7vaMh1BOO5Ne60VXN7/N5p/c7kJWio/1tY8C137Bd6j48XRbVntZr/SbwyWlq/lSKrxtLIHVdp+9uJB5BLcjJrR1gRxXWuaj4BG7wxMlk2oPpXMUzfaD9oaLZ1byvvlOfXmvbKKSdreX/AWvloU9b/1/TPHPFmj+EF8AXuqeEHtbjT49Qsr4rZlZLWz2TKJHiCjbGdm7eAc9yBnnA8aromp3fxFl06zhure50qyu47iG0LwyOrMXlEgXYThx82ckZxnBx9BUUX/r7v8AJDX9ffc8D+IL+HnttVTRorK2l03SYJ7BpVwIVDs2+yjUKU/2pQ2Pu8EVB4kvvCt3e/Ey4Oq2V3ImmW0to0t/5uy4CvzHuY4ZXZQNv3S2BjOK+g6KL6feJaW+X4W/r5nhepD/AISzVZYtU8TaPpjXVrayaJe3Vm08zDyl3PaSidFEnmbgVVSx4zkECtDW4dPuLnxTB41kj/tnYp8PPL8lwQIFw1qM7g/m7shOc4B4xXslFD1vb+vNefmEdLeX9fceEX1vbaa/jC08Ww2q6jqvhW1neJ4gTd3MccvmOqgfO6sFJIGRwferMd5b6faaDrPlafqrNYWdidJv4ng1CFgAGNruGTnILIFGdud2K9uop82t/T8L/o7EtXSX9dP8jgfjTZWt38Mbp7y1inS3ubaUmWMMI1Eyb256DaWyfTPauZsZfDjfEDxlpOi6xDp1vcaDbpF9mmJ+zEeYGMceflCgodqgAAg8ZzXslFStL/10sXd/163PFoDaX2h3+j/8Uzp66bcQ5vbZN+kahtWVmhlTICEYdmXJwSpJPApNN1DSJfF3hTXtS0ux0e1vLbUdPlcMHt7li6lAkhA3o/zlBjkEgCvaqKd9b/1tZi6W/rufO+itG3hnR7G9fT9L8OJc6lHKdc0uR7NZTcBoQyl4gPkJ2sSVByPvdPaPA2nS6T4NsrGfVjrHkBlS9MRTzE3HbgFmJAGADuOQAa6CinzaW/r+v0B6u5zfxH/5JZ4r/wCwLef+iHrT8Q31rp3hy/utQuYbW3jgffLNIEVcjAyTx1IH41mfEf8A5JZ4r/7At5/6IeukrOS5otDi7NM8b8EeHE8VfDvwrqGv+J7O40XRbVJlt7GI25hkWLb++nErHKAn7oQg8nFczY6D4cvfgnB4mt4YL3UdO1IeZfGUzSQRLf72ySSRhDuyecMT0Jz9FUVq5Xk5LvclL3bP+kfPvjW+0B7r4kXFpMIbe+0a1mgu7UvFDczjzORKmFcnenGTu9Dg427m18I6N4/8BT6fe28Z1UyyTq2oM8c++2MavsZymWb5dwGWPGSa9noqU7f10G9f69P8j58ttJ0Kx+HrXcOm2NtdaT4uWW8nS2VHtolvTgswGQBGenZT6Vfnj0e/8X+MYtPu9PsbWe7s7xJL2zZtOvdsDPIJWACFW3bs7uThua90oovpb+un+Qdf67v/ADOa8AammreEIbqPTotOUzSjy4JDJC+HP7yJiBujb7ynAGDxxXS0UUN3YgooopDCiiigAooooAKKKKACiiigDm/iP/ySzxX/ANgW8/8ARD1s6rBJdaNe28IzJLbuiD1JUgVjfEf/AJJZ4r/7At5/6IeukqZLmTQ07O55honivSP+FT23h57uNdfj0kWL6PuH2sTCLZt8r73XvjGOc45rPXRfDes/G+80XV5Yr5hodu0llLeM4E6SZ4Td8pCqhwAODnHzHPr9FaOV5873/wCH/wAybWhyL+tV/kfOjJ4a0P4edbPS7+DxcBKEb7OSi3pIVwMBwsRJCtnauCAODXa20fh/WPFurReLLsW+uxaotxpE4k2TvbBUaMWx5LIQGDBM5yc16tRSTt/Xp/l+LB6/16/5/gjwvVb/AEj/AITyDVElt7S5tvFC215cXUv+mJGUZdpYbfKgJHyqSwbrkGqFhZ+FLj4U+N9XXUVluLK61GK1vRqkhdUYjyl378sGKJgEnd75NfQdFRb3XHyt+X+X4l83vqXnf8/8/wAD5/8AF+oaPq/hnEEtrPdW3hWK4tJ7mXzFVlDZa0RRnzQVIeQMNmF4PNe2aNrWnX9ta29vqNtcXRtI5zEk6tIUYcORnOCc81qVWNjG2prfOzvIkZjjUkbYwSC2B6nA5OenGOc6uV7+ev5majZJdv8Agf5FmiiioKCiiigAooooAKKKKACiiigAooooAKKKKAObsf8Akqeu/wDYF03/ANH31UfiL4hhstNt/D9ve2cOra7ILW2iuroQAofvndhivy5UEKfmZQAavWP/ACVPXf8AsC6b/wCj76uko9Rp2PHrTXYvAvxXubTxZLo2g2PiGwVxFb6oZEhlhGwMzNHEY96cA4wTH1zXK6LqfhrT9D8M6hb6rZfbo/F88S3Ml4JJhbGWQMC7MW2FGQnJwdyseTmvouimnZp9v87/APAJaumu/wDlb/gnhOrT6bd+M9Q06TUbK31ltdQjWX1eK0mjtcrutQBItwONyhVXa2Q27NPkvkGqfECx8N6g90y6pYtcJFeNNMtsNguSpLFsDLggdORx0r0m28LavAt5Yy69DcaRdySu8clh/pWJGJZfOEm0jkgZjzjHPGa6lVCIFUYVRgD0pR0il/XT/L8WN6tv+uv+fyPFdUjEFxrd18K5Lf8AsF9MiN0NLXzLdZvPG9o1jIBfyRJuCEMflzyRTDZtpvhfWNU8L6/Yajpd29p9stfDli0ENtEso891AlkKyNGTuAwcDOM17dRTTt/Xnez8gev9eR4HfXOm23ifxH/wrdYhbXGh2bo+l2zyQKguH84r5eBnZu+UMpJyB82aqeJrLRdP8D6nqNr4t0mewvbmzEVpoiPY20UolG84E75cxliy/wCzuIyM19D0UXt/XncHrv8A1pY8J1yXwe2v+PbWG50lrMaDFeRRCdDH9qxIPNAzgycxfN97JXnnnL8S6vpeu+FpbyO7t7nVLPw/ZzxXd3N5roy8u9qq4KuGBEkm7ggAjg19FUUJ2/D8L/5/gD1/r0/y/EitZo7i0imhkWWORAyupyGBHUHvUtFFJiWisFFFFAwooooAKKKKACiiigArm/Hn/Iu2v/Ya0r/04W9dJXN+PP8AkXbX/sNaV/6cLegDpKKKKACiiigArm/iP/ySzxX/ANgW8/8ARD10lc38R/8Aklniv/sC3n/oh6ANjV9VtdD0W81TUHKWtnC00rAZIVRk4Hc15w19qtx8YtAv7/R3tHl0e8kht4tQM3mqPLKqVYKkcnzEHGRyPnOOPRNc0e18Q6DfaRqAY217A0Mmw4IDDGQfWuUg8Ca7/bekareeK1mudItZraDZpqoJlcLgy5c7j8gzt2Z7beci3v8A1s/+AN7f13X/AASvpPxDtT4f0Oay0ey0o6xdXMaQXd2tvFGySsHy6owMjHLBQOTu+bvWxeeLNS/tE6Vo+ixXeqwWSXt5bzX3lJCrkgIrhG3OSrYGAOOSKzNL+H2qaf4IPhy41jS9Qh3TH/S9GLxN5j7/AJo/OySCXAIYD5hkHHNiw8AT6A1pN4a1gW91HYRafcS31sbkTxR5KHAdNrjccHJGOCDim7a/10F/X4/5Gfp/xVude1K1tPDvhe5ujc2BvUa4u44MhZVjkTHzcqxYc4yV44O6sj4ja/ceIfDaz2Gnt/ZNprdvbrfC+aN3lS5WN/3IGHjzuXLN1GdvRq6TQvh5N4e8WWOpWOqQmws9PexFo9mTLIHfzHkMokxuMnP3MYJGO9VNQ+GF5c6Ze6PY+IzZ6Pc366hHD9hWSa3l84SsFkLbShYEgFCQT1I4LVrxfn/7d/kD2a/rb/MTU/jBpGneIPsQawngW/GnyhdST7WspbbuFtjJjDcFtwPU4xzRbfFC+m0fUdXn8LS2mn6dcTWtxLPfR7opY3VRuCggJljlgTtCk8itzTPC2p6LfXS6brqjS7uZriS2ns98qSvy5SUOoUM2WIKHBJwRxiLwx4R1Tw/pGpWk2tWt1Lfag995qaeY1UyPukQq0rblPIHIIB7mpW2vb8dP+CN2vp3/AA1/4BuaHqNxqmni5uYbVA2DG9nd/aYpVKg7lfauRkkcgdM1o1zng/wkvhWLUD58Dy6hdG5kjs7b7NbxttC/u4tzbc4yfmOSSfaujpu3QkKKKKQwooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4j/8AJLPFf/YFvP8A0Q9dJXN/Ef8A5JZ4r/7At5/6IeukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4j/8ks8V/wDYFvP/AEQ9amva1a+HdBvNX1A4t7SIyPggZx2ySByeOTWX8R/+SWeK/wDsC3n/AKIetTXdHg8QaFd6XdtIkV1HsLxnDIeoYH1BAP4Une2g1ucPZ/GTS5rm/s5ksri7gWFrZdK1FLyK586QRonmBVCPuIDAjABzkiuhg17xLNBewv4Ygg1C1lRR5uoMLSWNlzvWfytxxjBHl5Bx25qK/wDCGpa74efTfEWvLPKjpJa3VlZ+Q0ToyukjBncMwZR02ggnim674Y8Sa/4Sm0m48TWsFxcFUmuLfTWRHiz8ybPO3AsOCwfpnABOap7ab/1/T/AS31/r+un4mNa/FZxob6lq+n6bp0M96bLTriTVsW12yqxaQyvEhSMbSA20knoDxlum/F+PVpNLh07Rvtc17qUumyyW99G9vFKiF8rJ1kUryCFHGe+FOq/gvWbi1sxPrlhBcaW6PpTWGltDFbFVZGDo0zmRWVtpG5cAcYPNP1fwjrur6poF/N4gskm0m6N06jTGKSsUMZCjzsou1m6ljk5zgYp6X/ry/wCCLW39ef8AwCgfiXew6fLeXmgRxR2Oqrpeo7L/AHmKRnVFaL92PMX51J3bCAe9W9X8f3Gj+JILK50YR2E2oxaclxNd+XNNJIAQ8UJTEkYJALBweG44rLufhlrdzo2r2LeJbEHU9Xj1VpBpD/u2VlbYB9o5GY059N3qCLV58N7+7vrm5bXrfzJtSt9RDtp251eIqfLLebkx/L8q8Fc9WojbTm8r/wDkt/8A24Jdbedvxt+hu+NPFcnhHS7W8j0qbUhcXkNqVilSPyzI4UMSx55IGADz1wOawNR+JV9pg1OO50GD7Tpeo2tpcRrqBKmK4KiOVW8rk5YZQgYwfmPGdzxv4YvvFekWtjZanb6eYbyG6d5bMz7zE4dQAJEwNyjPJ49OtYV98NdR1O78Rz3uv22dae2liEOnFfs0luwMTcynePl5HGexFKNuvf8ADT/gjfl/W/8AwB3iD4mXfh658TRT+HvtQ0OG3nQ296P30cxYAsGVdmCvIG/rxmrVz451eHVtT0uPw9Ab2zsU1GNZNR2pJASwIZhGSrgqRtAZenzCszXvhbq2uvrM8nitYrjWrWC1ulGmKYQsZyCi+YGByTjLnAY5zwRoyeCNdm8R32sSeINP8270gaYYxpThVxk7/wDj45+ZmOPTAzxkp/Dpvr+Wn4j0v935q/4XI7T4kXWralZWei+HZJTf6KNWglurxIYyp2/Idodh97GcdexHIXS/iPPqjeHJV0VYbLxFG4tJHvMyJMiM5V0CYCfKQGDE/wCyKp6F8N/EGh32n3KeJ9Om/s7RzpMKnRnGY+Crt/pHLBlXOMAjI4zkO0z4aavpln4Ttl8RWcieGppJEJ0tgbgOrKQf3/yna7c884OOMG3y30/rV/pYnW39dl+tyWz+JV7c6NoGoyaFDHHqmrvpU6C/LG3cSOgZf3Q8wHYx524469qHhLULjQLXxb/Z1jPqUv8Awk0kESSzuQgMcfzSSkMVjXu2Dgdqut8L7s2ttYxeJHt7Gy1ltWtVhsk81GZncozszBgGc4O0ccEHqGJ8NNXMN+tx4js5WutYXVwh0pvKL4wY5EMx3pwpAyCGXOT0Extdvv8A5x/ykOXl/Xxf/ahF8VpprHTJIPDzXEt9q0mkM1vfRvBHMpPIkwC6kAkEIOAc4OAe70y4vLrS7efU7IWF26AzWwmEoibuN4wG+uBXBt8M9WW6tWt/EdmsFtrj6yqSaUzMXYEbNwmA2/M3Qenpz6NQvh13/wCAv1uJ/Fpt/wAF/pYKKKKQwooooAKKKKAObsf+Sp67/wBgXTf/AEffV0lc3Y/8lT13/sC6b/6Pvq6SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/wAi7a/9hrSv/Thb10lc348/5F21/wCw1pX/AKcLegDpKKKKACiiigArm/iP/wAks8V/9gW8/wDRD10lc38R/wDklniv/sC3n/oh6AOkorm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkygDpKK5v7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMoA6Siub+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTKAOkorm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkygDpKK5v7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMoA6Siub+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTKAOkorm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkygDpKK5v7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMoA6Siub+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTKAOkorm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkygDpKK5v7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMoA6Siub+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTKAOkorm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkygA+I//ACSzxX/2Bbz/ANEPXSV534+s/GK/DbxK15ruhy240m6MscWizI7L5LZCsbpgpI6Eg49D0roPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygA+I//JLPFf8A2Bbz/wBEPXSV534+s/GK/DbxK15ruhy240m6MscWizI7L5LZCsbpgpI6Eg49D0roPsPjf/oYfD//AIIZ/wD5MoA6Siub+w+N/wDoYfD/AP4IZ/8A5Mo+w+N/+hh8P/8Aghn/APkygDpKK5v7D43/AOhh8P8A/ghn/wDkyj7D43/6GHw//wCCGf8A+TKAOkorm/sPjf8A6GHw/wD+CGf/AOTKPsPjf/oYfD//AIIZ/wD5MoA6Siub+w+N/wDoYfD/AP4IZ/8A5Mo+w+N/+hh8P/8Aghn/APkygDpKK5v7D43/AOhh8P8A/ghn/wDkyj7D43/6GHw//wCCGf8A+TKAOkorm/sPjf8A6GHw/wD+CGf/AOTKPsPjf/oYfD//AIIZ/wD5MoA6Siub+w+N/wDoYfD/AP4IZ/8A5Mo+w+N/+hh8P/8Aghn/APkygDpKK5v7D43/AOhh8P8A/ghn/wDkyj7D43/6GHw//wCCGf8A+TKAOkorm/sPjf8A6GHw/wD+CGf/AOTKPsPjf/oYfD//AIIZ/wD5MoA6Siub+w+N/wDoYfD/AP4IZ/8A5Mo+w+N/+hh8P/8Aghn/APkygDpKK5v7D43/AOhh8P8A/ghn/wDkyj7D43/6GHw//wCCGf8A+TKACx/5Knrv/YF03/0ffV0led2dn4x/4WTrKrruhi4Gk2BeQ6LMUZfOvNoC/asgghsnJzkcDBJ6D7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Sub8ef8i7a/8AYa0r/wBOFvR9h8b/APQw+H//AAQz/wDyZWH4stPFUWl2L6rrOj3NoNa0vzIrbSJYZG/0+DGHa5cDnB+6cjjjqAD0CiiigAooooAK5v4j/wDJLPFf/YFvP/RD10lc38R/+SWeK/8AsC3n/oh6AOkrMl8S6FBq66VPrWnR6i/3bN7tBM30Qnd2PbtVLx5e6jp3w/1280QMdQgsZXg2jJDBTyB6jrXOaLFp9p8C7efRNMs9XtpdNFxcw3U3li6JTdKXcI+XJ3dRye460m7Jvt+t/wDIaV2l3/4H+Z6EjrIivGwZWGVZTkEetLXklv4s8Sanpuk6Z4f02/s5f7Dhv4102a0uGAclYlka58sFcKN2xc5OAR1MkWu+OL7W73TtU1OPRpofDiag0FnbRSPBcbirDexdWGUPbo2BgjdVS91u/S/4X/yFG7/D8bf5o9XorygeNvE3iGx0i30W21Bb240KDU5ZNNW0OZZMgKwuXUeXlTnaN3I5HefSdV8dav40XSNU1W20Z00e3v5raCzjl8uXzdskZcswYHY/IIxuGORktxalyvz/AAv/AJMV9L+n42t+aPTZpo7eB5p3WOKNS7uxwFAGSSfSqmja1p3iHSo9S0W6S7s5SwjmQHa+1ipxnqMg8968/wDD/ijXZ/HGkQXGqvqFhqsd4X22qJaqYiNn2d9qyMMHktuU/wAJrY+EP/JNLP8A6+bv/wBKZKlbX/rqNnSax4h0nQPsn9sX0dqb24S2tlbJaWRjgKoHJ6/h1NXYrlJppokWUNAwVy8TIpJAPykgBhg9VyM5HUEV494h1HU/EvhbRvEM2pslrN4ltol0xYU8uJEu9indt3+Z8oJy23nAUda249f8XXFv4ugt5nvrjTNYjt4vsFvEkqWxjjdvLWQlWcBz98kE9ugppXjf+vs//JA97f11/wAj0uivOYfGE2tX2h6Lous3iHUpLoXF7NZJFdW3kKuYjG6bVkywyShGM4HINY03izxgmpWmkDVrdTb+JBo9xeGyUyXUbRCVX67FYDggLgnB46Es27f1ul+bDpf+tE3+h6pqmq2OiaXPqOrXUdpZ267pZpWwqDp/OpLK8g1GwgvbN/Mt7iNZYnwRuVhkHB5HB715hrl1r2p6F4w0mbxA4Ph/TPKldbSJTfu9uzs8gIO1cEABNvIJzjiqdv4h8WXOi22leELW/e40zRrGSL7MLMxyyvFnbN58it5ZwB+7APXntSXX5fjf/IHo153/AAt/mexUV5po+peNdY8Y61Zy6xb2Y06GzuY7KOzRlPmI5aFn3EnkAb1I6AgAZB1vA2v3d/dS6brt3qUeswwCW5sNRtIoyuTjfE8ahXjzwMFiONxzTtrYV+p2tFeZfEbxPrujXGqXGi6q6DS7OG4WztLZJQSXO43LSLhUKgbQjhz8xweKq6/4j8VW9547aHXUgi0GwgvrKOCyj6sjuUcvuLA7QCRg9Mbecrpcq2tkemapqtjomlz6jq11HaWduu6WaVsKg6fzqSyvINRsIL2zfzLe4jWWJ8EblYZBweRwe9eZa/reqeKtD8XRW2onTYNJ0oFreOFH+0vLbGRi5YEhMMANu05BOT0rufBf/Ih6D/2Drf8A9FrTtvfpb8b/AORN/ht1v+Fv8zbooopDCiiigAooooA5v4j/APJLPFf/AGBbz/0Q9beoalY6TYyXuq3lvZWseN89zKsaJk4GWYgDkgVifEf/AJJZ4r/7At5/6IetnVRnR73P/Pu//oJqZPli2VFXaQzStc0rXrZrjQ9Ts9SgR9jS2dwkyq2M4JUkA4I496nuruOzWMyrMwkkWJfJgeXBJwCdoO0erHAHcivJfD2pa1p3gv4W2Wj6hDZWmpxrb3S/ZQ7t+4Z8hicD7vp1IOcZBuQ+K/EqaPF/xNUlez8WDSLiea1TzLmAzKo+6AqthsEhee2DWrj7/Iu9vxS/VGfN7vM+36N/oz1WivMD4o8Zarrc134f06+ls7PVmspYWNkto0EcmyR2ZpPPEmAWGAF6DaetaWg33iXxV/xOrDWUtbdNTntJtMeFCiwRyNGWDbS/nfKGGTt5xt71C1V/66f5lPRtPp/wf8jtZr2CCFpCXkVZBGwgjaVgxIGCEBPcZPYcnA5qxXiWi6j4h0H4fDUrLxBcTtN4pa1nW8gikJja9MbbWCrhmzkk7hxhQtdDq3iXxBdab4u1vStUNivhm5lihsTbxtFdCKJHbzSyl/myQCjLjjrT6X/rp/mh2u7Lvb8/8j0yivKL/wATeKbvUfE3kayNOgsdAg1W0hhsoy8TssjFHaTduGUweBweNpGT2ranq+ofDmPVNHgR9VudOS4hi4wZGQNgbsDvxnjpmhppO/T/AIP+TJTTat1/4H+aN25uEtLdppVkZFxkRRNI3Jxwqgk/gKeJEMpiDqZFUMUzyAc4OPTg/lXlereNNUt/At3d6NrN4mo6fe2sF5b6xp0aXMQkdVKkKFTndkOFZSFIGeohvtS1Hw7458f61FqV5dGxsbMw2coiMRLh9oPyghVJJGGXqdxPYt/X3f5j6f13seuUVxfhC78XN4hvYNetL8aS8Cy21xqRsxMsucPGFtnIKYIIJGRyCTxXaUWFcKKKKQwooooAKKKKAOb+I/8AySzxX/2Bbz/0Q9dJXN/Ef/klniv/ALAt5/6IeukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm7H/AJKnrv8A2BdN/wDR99Wjq/ibQdAeJNe1vTtMaYExre3ccJcDqRuIzjIrOsf+Sp67/wBgXTf/AEffVj/Fkzro2gtZxRTXC+ILIxJLIY1ZvM4BYKxUe4B+ho6pd2l97sHRvyf4GxL8RPB0Wm3GoDxPpU1rbFRNJb3aTbC2dowhJycHA6nFdICGUEdDyK80+IZ1Wf4S+KLjxDptjZXgQRxGzmMwaHchH7wqpPzFuCq/TuU1PWteg1Tx1aW+t3EMem6PBf2BEEBNu5WUsozGdynywPmyeTgih2UW3/Wg0nJpL+tUv1PTCQASeAOprJ07xRo+saY+oaRefb7RJ/s5ltInlBfIBA2g5AJGWHA5JOAazdE8WxNo+iJqSalPfXtlbyvNBpVxJEWdRkmSOMxrznOSMd8CuBstX1bQ/CWo3mjXcVuW8bS284eASGSOS6VCFJOFPzdcH8OtVyvn5H/Tul+pCknBTX9Kzf6HqeneI9I1bVdQ03TL+K5u9NZVu448nyWbOFJ6Z+U8ZyO9adeQ6jrUlj8YPEWmW9/LpM2rf2dBHqYjRktyEkbb86su58bVBHJPXOKva1r3jKTVtU0zwpFqd/c6IIYkcLYCK7kaNXJuPMZGAIbH7pVA569BO6RXVnplxOlrayzyiRkiUuwijaRiAM8KoJY+wBJrLPizQl1G9sH1OBLqwtvtV3GxwbeLAO58/d4OcHmszx9q+raV8MdU1jSJ4rHULWzNwDJEJgpAyVAyBnsDyO+DWRYSNN8Y7qWQ5d/CtuzHHUmZ6Tuvx/Jv9B6ct/T80v1O20nVrHXNLg1LSbhbmzuAWimUEBxkjIz2yKuV4t4M1LXLbw38NtM0zVI7Ox1SK5juFW1V5cokjAh2JA7YG3qOcjir1l438RXljY6PG1/eX8t9qFu95YR2i3DpbS7VIWYrEGIYZ4PQ4HORclZtISvpf+v6set0V5e/iLxlp2ladd+LbfUtNtoVnF9cabb29y6lW/dvNGvmYQocnyuQe4FaF74mvrHxLbyalqN7baJdC2Wwv7a0ils7gvtz5rbS8bMchTlUww6mla4rnoFFFFIYUUUUAFFFFABRRRQAVzfjz/kXbX/sNaV/6cLeukrm/Hn/ACLtr/2GtK/9OFvQB0lFFFABRRRQAVzfxH/5JZ4r/wCwLef+iHrpK5v4j/8AJLPFf/YFvP8A0Q9AHSdetcy3w78MmWVobKe1jmYtNbWd9Pb28pJyd8MbiNs55ypz3zXQ3NzDZ2stzdypDBChkkkc4VFAyST6AVkaX4y0LWBefY71lNlGJbgXMEluUjIJEmJFUlCAcMODjrQPUW98H6HfrYCS0eBtOTy7SSzuJLZ4UwBsDRMp28D5c44HFVZ/h/4duNSur97e8W5urb7JM0WpXMYMP9wKsgAHU8AcknqTXOH4jw/8LKWJ9XSDw7Ho015MtzZPblGWSNRJvkALoQx2lQFP+126OD4h+GbryRbahJKbi1+126pZzE3EfrENmZCMjKrlh3AptXV31v8Aqvxsxbf16P8AyFj+H/hyHT9OtILW5hTTFKWckWoXCTQoeqCUOHKcD5S2OBxwKsWvg7RbPxG+u21vOmoPALdnN5MUMY6L5ZfZjv8Ad6knqSarL4z8PahNogtNfEb6nKxtIET5rraGDIyshZQpBz90gqAT1BbD8RvClzNsttXScC8Fi0sMUjxpOcYRpApVckgAkgE8A5GKNW/MNLf1/XS4W/w68M2jWzWtncQNamU25j1C4UwCQYdUxJ8qn+6MAHkAGtLw74Z0vwpph0/Q4ZoLUyNII5bqWfazcnBkZiMnnA4ySepNUovF+g+brE6a59qj0+VILmGNN4t5T8ojXYu53Y8bcsc4AA6Vn658SNN0m70eCO21CY6ld+Q2NNuC0QEfmHKBN27G35cZ5JxgGhXe3UH5+Zau/ht4Tv5bhrzSFmjuZxcy27TyeQ0oOd/k7tm49zt575qWy8BeH9OuLyezgu45L6Xzp2/tG4JMmCoYZk+UgHGVxxgdhUNv8S/B91JKtvrtvIsJlWSVVfy1MaB3Bkxt4U5684OM4OKWt/FHRbDwlq+r6d9quptNRQ9q9jPHIrOP3ZdHQMqH+9jGOhpdP6/rsPdmwfBWgnS47AWcixxzGdJkupVuBKeDJ54bzN5HBbdkjgmornwF4eu49PSa1uANOnNxbmO/njIlPWRirgu/+02TyeeTTtP8U6RqviCKytdVmW9FkbiTTJIDEyoWX95IroHQjOACRkMTg9QW/jvw3c3v2WPU1RmjaWOSaGSKKdFGWaOVlCSADklCcU9Vr/Wn/DE7r+uv/Dj9X8E+H9dv5LzUrFnnmtzbTNFcSwieI5+SQIwDgZON2cdsVGvgLw3D9j+x6cbH7FH5UP2G4ltvkyW2N5bLvXJJ2tkZJ9aTTPiB4Y1meyi0zUxcfb2kS1kWCTy5XTO5RIV27htJ25yRyMjmtTU9bsdIe3jvXl825bbDFBbyTO+Op2opOBkZbGBnkilsPco2fgzQ7DVdQ1G1t51udSi8m6LXszI6DgKELlVAHAwBgEgYFWtP8O6bpmoTX1rFKbqdQjTT3EkzBBzsUux2LnnauBntWfL4u0Q6xBBFrEklz9ge9GnW8JkaWHgiQqELgjsARnJ4OOKPh34j6XrPhC3125S7tluJHWOD7DO0j4JICIELS/KASUDAc+lAM0dW8DeHtcu7y41OxeWS+gFvchbmWNZkHTcqsFJGeGxkdjVOX4Z+GJ/7S8631CT+1I1ivd2r3Z89F6Kf3vQdMehI6Eiuh0vVbLWtNh1DS7lLm1mGUlTocHBHPIIIIIPIrOsfGegajq/9mWl/uuWV2j3QyJHME++Y5GUJJt77Ccd6NtAv1Klx8OvDF0qCawmbbafYmIvZwZoMYCSkPmUAHjfux2xW5pelWOiaZBp2k2sVpZ267YoYlwqjr/Osm38d+G7m9+yx6mqM0bSxyTQyRRTooyzRysoSQAckoTim6Z8QPDGsz2UWmamLj7e0iWsiwSeXK6Z3KJCu3cNpO3OSORkc09X/AF/XmG3yOjorz3xZ48MGu6BZeHtTUCfWY7K9H2J2SVSTuVJiPLypUhguWGf4cVPq3xK0bStCutV02+uNbjOqR2A8i2aVLeRigKAxoMgBs8liWO0EnACWqv8A10/zQPR2/rr/AJM7uiues/Feh3mqagIdbO6wtY5ru0mTy1tFOWDvuQMrEdVY8AD5Rzlsfj/wy6XbS6mLQWcPnzfbYJLY+VnAkUSKu9CeAy5Bz1o2A6Oiuf0/x14c1SRUs9SBD2f25HkhkjSSAYy6uyhWAyM4JK98Vf0rXbDWgxsGn+VQ+J7WWAlSSAwEiqSDtOCOD1p2YGZ8R/8Aklniv/sC3n/oh62tT0231fTZbG9MwgmGH8i4kgcj0DxsrD8DyOKxfiP/AMks8V/9gW8/9EPWvrGs6d4f0qbUtavIrKygAMk0rYVcnA/Ek4xUu1tRq99Dn7X4Y+FrOPTY7a2v0j0uUy2Sf2vdlbdsY+UGXAGOMdME+pzlXPgaC2vodK8P6TqFtatqsGq3eo3N+Z4pHjfewAklaTexABO0A9STgVvw+P8Aw3c2Ul1a38k8aMqBYbSZ5JCyBxsjCFnG05yoIxn0NPuPHXh230q11H+0Gnt7xWaD7LbyzyOE++fLjUvhf4sj5e+Kq7Tv2/4f9CdGrd/6/Un/AOET0f8AtyXV0t5Y7uYhphHcypFMwGAzxBgjsAByyk8D0oh8JaNbazNqdvayQ3Fw/mTJHcyrDK/HztCG8tn4HzFc8Dmob3xv4esdOtb6XUPNt7yH7RCbaCSctEACZNsasQgyMsQAM8ms5PiPpUvjQaLF5zWw04XxvhbSNCVY5VhIF2hNoY7yducAHORS2dv6/rQe6v8A12/Unu/hv4WvbSS2msJ1gku/trRw39xEPO3btw2OMfMS2BwGOcZ5q7deDdDvL43dxaSNIwUSqLqVY7jaAAZYw22UgAcuGPFVrPxnoK+H7bUo9Ym1O2u5ZRbSRWzSyz7XIYJHFHuYLjGQp4AJJ6lz/EHwpHaadcPrdsI9TkMVoMndK4OCu3G4EHgggYPB5p6rQN9Rt78P/D2o6hqV7dwXrT6pCLe7KancoJYx0TasgAHXgAdW9TnUtNA06x0GHRreKQWMCqkcb3EjsoU5Ub2YtxgY57YqjH440GbS/t0V1O8f2k2nkrZTGfzhyY/I2eZuABONvTnpzWL448cSaRo8L6Lh5bpX8t1GZ1Mciq2IGX5hyQSSMcdc0tlYOv8AX9dDSvfh34a1HTZ7G9tLqaG4nW4nZtRuPMmdfu75PM3sF7KSQMDAGBV3/hD9CN/PeSWPnT3FstpO00zyCaNQVAcMxDHDMNxBbBPNcr4j+IV3b+BU1HTktYru8S4WIw3IneJoyQCEKAPjHzg4289cV1vhnWz4g0Vb5o4oiZXjKRzeYV2sRhuBtbjlecHjJ607br+uwr9STRvDunaDGY9NS4CnhftF3LPsH91fMZti8D5VwPatOiikMKKKKACiiigAooooA5v4j/8AJLPFf/YFvP8A0Q9dJXN/Ef8A5JZ4r/7At5/6IeukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm7H/kqeu/8AYF03/wBH31WfEXhDR/FRtv7ajupRaSCWEQ389uFcHIfEbqCw7E8jtVax/wCSp67/ANgXTf8A0ffV0lAGTrnhjS/Emhf2PrMU9xYnbujF3LGX29NzKwZvXknJ5PNU7zwF4dv333tnNOxs/sMhe8mPnQ84WT5/3mMkgvkgnIOa6KigCpp2lWOkaXFpul2sdpZwrsjhhG1UHtj61zf/AAqzwodOksTa35tpLoXrodXu/mnznzM+bndnnPqAeorr6KOtw6WOTu/hn4Wv5dRkvbS8nbVFRbzzNUuiJQjBk48zA2kcEYxyBwTV5/BeiPeW92YboXNvCsAmW/nV5Y16LKQ+ZhyeJN3U+tb1FAGbrnh/TvEeiy6Rq0MkljMAskMU8kO5f7pKMpx7Zwayrf4eeHrXUHvoY9RF09r9jaY6vdlvJxgJky8YzkHqDyOea6eigDkrP4YeFtPbTms7W+i/sssbIDVrsrBu+9tBlxg5wR3HFSQfDfwxbaYbCGzuVh+1G8VzqNyZY5j1kSUyb0Y5OSrDOTnOa6mii4GLdeEdHvLQW1xFcmPYEfbfTo0qgk4kYODIDk53E5zzmkn8H6HczwyTWjlYZFkS3W4kWAsoUKTCG2NtCLjKnGARzW3RRsAUUUUAFFFFABRRRQAUUUUAFc348/5F21/7DWlf+nC3rpK5vx5/yLtr/wBhrSv/AE4W9AHSUUUUAFFFFABXN/Ef/klniv8A7At5/wCiHrpK5v4j/wDJLPFf/YFvP/RD0AaHiaG+ufCupwaTb21zeyWsiQQ3ahopHKkAMDwQfQ8V5pJ4J8R6ofEEbWV5anVtCt7eOfULqF8TxO5MbrGxCKQQMIu3BPQ5Fev0ULQd9Lf10/yPKdbsfF+ra9FrEXhCSIDQbnTprd7+3EnmSFcFMMVZcr/Ey8Z6EAFdG0vxLa6r4DkuPDF/HFouky2l632m1O12REGAJssMx5yOzL3yB6rRTTsrf11/+SYv6/L/ACR4vouieLLVfC0Fx4Q1FBpeuXV/cSG6syvlTGbbjE+SR5oyMdjjNPv9C8VXHh3xFbR+E7/z9Q8SxalApurQZhV42JJ87g/uiMerL749looUmnf+t0/0QPX+vX/NnmNroOp6lrvjA634V1BLDV7m1mt2F7BHIPKRV3K0cpKuGXcvTp1B4qNNB8ZSf8I/eX9vc6gNL1t54oryeAXaWrQNGvmsh8tmDMSdpJ246nivUqKE7beX4W/yB6nmWl6T4lXw144jPhzyLzU7+W6soL97eWOdHRV2kK7Ln5Dw+ByOvOMvUfBviPUNP8YxxaVe+ZrOmWgt2vr2F3aWItujba+1DyMBfk9xzXsNFCdvuS+4Ot/O/wCNzzm80vX9V+IiXUmh3dlYzaBNpzXouLdhDI7Bgdok3HAGDgH5umR81Q2vhzWp9M8Kabe6LNbnwo8cz3KTQst6Y4WQJD8+RuJGfMCAV6ZRRfS39bt/m2H9fgl+KX+R45pGgeKbXRPBtpP4Vvlk0vXJ7y7/ANKtSEicy4IxNz/rhwP7re2e48caPLqcVtNaWWqSXtosj211pN3HDPC52jbiRlRlYZJDZHydDxXV0UPUOt/66/5nm9rpvix/HPhq91rS3uWttGmtL/UIJYREJ5ChyFLhyBsOcL1IwMdMfTfBXiC08L+FlvtJvpH0NJ7W4srDVvss0yyMCJY5I5UBA2j5WcZDHOCAD7BRRf8Ar5t/qwWn9eVjA8P+HrXSvC0um6fZS6ZDcGV/JluWnkRpMlizlmy2SScMR7msDwzomqx+DrXwxrGifZrnTbJrKHVxJE8ZUxlBJFhjIGIxkMq9+T376ik9U0+v9fqC0tboeZ2vhzWp9M8Kabe6LNbnwo8cz3KTQst6Y4WQJD8+RuJGfMCAVjaX4f8AFVvoPg+ym8L30cuma3PeXZF1akRxOZcEfvuT++HA/ut7Z9loqnJttvrr8xW0svT5a/5s8hHhvxfB4b8OaBHoCTzeH9YiuPtz3sSQXUKlzvGCZAx3DcCnU8ZpJPDfie90PxFG3h25t5p/EsGr28UtzbkzwrJESoKyEBsRnhiByOeuPX6KSbTv/XR/+2octf69f82eU694W8ReJfEXiyP+yZtOt9W0aC0t7ySeFozLGzuVIVy+07wudvY8dM3de0fXPEF4msf8I9dWk+naVd2Udo1xbmS7kmVVG0iTaI1wTlip/wBmvSaKlq6t/Wt/8xp2d/66f5HkdloPiH7T4RS98I3ctvpvh+fT71JLq2CmR0RdvEpJU+WeQDw49wOq8FaVrekapqNtOdQTQI0RLGHVLiOedHBO4q6MxMWNuA7bs54ArsqKtybbfr+Lv+pKSSt/X9aHN/Ef/klniv8A7At5/wCiHqTx5a3t/wCANasdKspL68vLOS3hgjdEJZ1Kg5dlUAZyeeg4yeKj+I//ACSzxX/2Bbz/ANEPXSVElzKzLjJxaaPN9U8NardaX4Tvjpeou2l2jW13pdpqf2S4G5EXcskcqqSDH90uAQ3XIxTJvCd9p50q00DQbi10p0ujcCO9RryGSXB+eeRywRjuL+UxbIXGQDn0uiqk+Zu/W/4kx91JLoeU+EfD/iTwuNFvbnw/Ner/AGJFpV7ZR3EBlgeN2IcbpAjIwY5+bPTit2LR9U0r4j/2vZaGp01tCSzWK1miUQvHIzCMKSvVWAGPlz1IHNdzRRJtu/r+N/8ANh0a9Pwt/kjyLwh4c8TaFFoerXnh+7M+mC+tptNW5tjI63EwlWWNvN2HGNpDMp64zxmS58Ja7ZXGlXNrok9y0/ih9cu4oJ4ALSMqUCEvIu5uQTtyM7uemfWaKL6p9v8AO/56g9U13/ya/JnlNr4b1S6uPEj6t4Z1i3+0ay2o6fcWV/bR3Ef7kRhkIlxu+UghyFw4znkDstD0jUNS8Dw6d46Vby5fPnBiAWUPuj3lMLvAC7tvGQccV0lFF9Len4KwPV3Kup6baaxpdxp2pQie0uUMcsRJAZT1GRzVkAKoCjAAwBS0UgCiiigAooooAKKKKACiiigDm/iP/wAks8V/9gW8/wDRD10lc38R/wDklniv/sC3n/oh66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAObsf+Sp67/wBgXTf/AEffV0lc3Y/8lT13/sC6b/6Pvq6SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/wAi7a/9hrSv/Thb10lc348/5F21/wCw1pX/AKcLegDpKKKKACiiigArm/iP/wAks8V/9gW8/wDRD10lYnjXT7rV/APiDTdPi867vNMuYII9wXe7xMqjJIAySOScUAbdFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQAfEf/klniv/ALAt5/6IeukrhPFmp69r3gvW9Is/A+uJcahp89rE0txYBFZ42UFiLknGTzgGtf8A4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAD4j/APJLPFf/AGBbz/0Q9dJXCeLNT17XvBet6RZ+B9cS41DT57WJpbiwCKzxsoLEXJOMnnANa/8AwlGr/wDQieIP+/8Ap/8A8lUAdJRXN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVQB0lFc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVAHSUVzf/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lUAdJRXN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVQB0lFc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVAHSUVzf/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lUAdJRXN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVQB0lFc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVAHSUVzf/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lUAdJRXN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVQB0lFc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVABY/8lT13/sC6b/6Pvq6SuEttT16HxpqWrt4H1w291p9paoouLDeGikuGYkfacYxMuOex6cZ1/8AhKNX/wChE8Qf9/8AT/8A5KoA6Siub/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSqAOkorm/+Eo1f/oRPEH/f/T//AJKo/wCEo1f/AKETxB/3/wBP/wDkqgDpKK5v/hKNX/6ETxB/3/0//wCSqP8AhKNX/wChE8Qf9/8AT/8A5KoA6Siub/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSqAOkorm/+Eo1f/oRPEH/f/T//AJKo/wCEo1f/AKETxB/3/wBP/wDkqgDpKK5v/hKNX/6ETxB/3/0//wCSqP8AhKNX/wChE8Qf9/8AT/8A5KoA6Siub/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSqAOkorm/+Eo1f/oRPEH/f/T//AJKo/wCEo1f/AKETxB/3/wBP/wDkqgDpKK5v/hKNX/6ETxB/3/0//wCSqP8AhKNX/wChE8Qf9/8AT/8A5KoA6Siub/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSqAOkrm/Hn/Iu2v/Ya0r/04W9H/CUav/0IniD/AL/6f/8AJVZuu32t+ILSzsIvB2sWn/EzsZ3nuZ7Ly40iu4pXJ2XDN91G4AJzQB21FFFABRRRQAUUUUAFZHijXD4d0GTUViimZHRBHLN5e/cwXCnBy3PC9zgZGc1r0jAMpVgCCMEHvSd7aDW5y/w+8WT+MfDS6heW8NtOuxZI43O4MY1Y7kPMZ+bhctxg55rqaitraCytYrazgjt7eFQkcUSBURRwAAOAB6VKenrVSabuhIzY9YsoUle91fTyvnuiMriMJtG4o2XOWAyT047CnSeINGi0ZdXl1axTTGAZb1rlBCQTgEPnb+teUaX4W1e11vSmbwFPDBZeIrq/WQSWO2G2lR1UKBNkYYoxUD+HjJArR0PQ/Emn2+m6jP4buHaw1fUJ20xri2MjRXDMySxnzPL3KGwQzL1fHbIleKfkv0G1Zv5/r/kvvOqvPGX2Xxlp9m0unDQrvTJ746ibjp5ZTJzwgTDg7snPPTHO7a69pF7dRWtnqtlcXE1uLqOGK4R3eE8CQAHJQ/3ulcdLpepyeOdCuLLwvJY6ZBpd3byFJbdUtmmZCqlFfOf3Z3bQwywwW5Nc/aeEvF8+l6JYR6WumPZeHbvR5rua8jykjLGEkQJuLKTHxnaQCc4IAL0t9/8A7d/kvvDS/wB36f8ABOvg8brffEF9F0+70qfTU06W4a7hufNeOZJEQq4BCqBu6ZJPt32v+Ei0my02CfVdd0td0UbtceekUUm7ADqGc4Vj0+Y9eprz+48P67fX8dzL4LjS1j8OzaXNaPc27GRyVKBBkqy5XjcVwCSQCMHLsPDGvx6bdq/ge6iu38Jx6QJTNZbpbhQVPzCYnbgryccL06Ck9I+n46y/yX3oUfeeum3/ALb/AJv7j1fVvE2g6C0Q1zW9O00zAmIXl3HDvA6kbiM/hVptTsF0wai17brYmMSi6Mq+UUIyG35xjHfNeRappWqX08lkNJvHik0S0s9aSFrSWaIpubaGe5QRMAc7h5gO4HAIGey+INhL4r+FF3a6RpL6pNfW6G2t5PLVlJwQxMjAAjr1z6U2kvvFHVq/Y328V+HVVmbXtMAW4+ysTeR8Tf8APM8/f/2etTza9o9vq8OlXGq2MWozjMVm9yizSD1VCcnoegrzHxFoGvagnjAaf4OukbVdFtbO0PnWi/vEDblP77gDevt8hx/Dm3rukeK9YvrV7fw8bOK31DT70hJLYNchNvmea+4tvTkYXjAGGb7tFldK/wDX9f11C+l/6/roegR6taxPcm71bT2RLgxIFYIYjtB8tyXOX6n+HgjjucbW/GBt/wDhHrnQZNP1DTtV1FLOW6SfeFUhjlNvyt90jJPHoa4WHwtq0evAnwFMLdPFB1SORZLLZHAYgjEDzdwJYBsY5wD14q1Fo/idY7QHwtfAR+LZNVK/abX5Lc7sH/Xdfn6D0PtmVry/L/22/wCb+4ctE7ef/t1vyX3nocPi/wANXFn9qt/EOlS2xnFt5yXsbJ5p6R7g2Nx/u9av6hqdjpFk95qt7b2NqmN09zKsaLn1ZiAK5O00W4g+JN5BC8Z0dwmqvCOqXRDR4x02tt3/AO8pPerfi6w1Rta0HWNMsm1OLTJ5WnsEkRHcOmwSIXKruXJ4LDhjzmjov6/rW4dWv6/q1vmbNz4i0WzsYb271iwgtJ1LRTy3SLHIAM5VicEYBPHalXX9HfVE01NWsWv5IxKlqLlDKyHowTOSPfFecWXg7UtN8UeHNQi8OMypqt7ezmKSD/QIp1ZViyXBOGYOwTcM5xnjNmXwnrlytzod1ppdZNeGqxa4Jo9qx+cJNpXd5gkCgxgBSuMfNjiqSTa/rt/XnYT6/wBd/wDL8TvV8Q6NLfrYQ6tYSX0m7ZbC6TzGK/ewuc8d+OKx/B/jBddsUi1ebT7XWGuLqMWMFxlmWGZoyyhsMw+XrgfQVwfhjRbjU7GbStL0T7La2Piue9XUYjCscaxXBJjVQwcOQNn3du0/e7Vb0nRfEVs2gs/hG7he38RXt/csbi0+WKYShGJEpJOJlyBk/I3X5ckUnG7/AK2/z/DzKkrNrs/yv/kvvPSLbxJod7NdxWes6fcSWX/H0kV0jG3/AN8A/L0PXFV7bxl4YvdSTT7PxHpFxeyHCW0V9E0jcZ4UNk8c15jqXhXxVqS3M934UR0n0C504abE9okMEpkVo/LG7leNwZiD8ucKeD1Gr6dqVv4D8PX9lbCw13R/s6RQXDKclsRPEShYEMDkYJGQp7VK2/ru1+ifzE97Lz/Jf5v7jqh4r8OmyN4Ne0w2oDMZ/tkewBThjuzjgkA+hNSaj4k0PR7WC51fWdPsLe4/1Mt1dJEkvGflLEA8c8Vxeo+G7rT/ABvpV5Y+GptSis9EubWW+ja2VpJXKso+eRWJJV+cYBl68sRzEWja9FpGg6Qmj3H9o2/h9tP1S2BtLl44WYKMK1zGq52MVcM3TDJxw7aaf18X+S+8en9fL/P8Oh6yfFGgCKzlOuaaI784tHN3Hi5P/TM5+f8ADNSjXdIOs/2Quq2R1Pbv+xfaE87b67M7se+K80l8ILrOrR3U+i6rq+g3+l29mkcertbNbmIsCs6rMqyIcg7l38gkAggm7eaH4nuvGOmXUehx21npmsNOFglhEdxE1u0fnM5PmM+SAcgcdmxmnZXsRd2v5fpf/gf1Y6vwbr99r9jqUmqQW9vNZ6lPZ7LdmZcRkDOWAJJ+g+laNv4i0W61BbG11iwmvGDMtvHdI0hCnDHaDnggg+hFYPgCx1K1tdcj1rSJtP8AtWrXF1Es8kMnmRSNkf6t2x7g/rXE+CNGudS0fTLLTtEFpa6V4hvLxdQDRLHtSeZfKRQd4JyFOVC7e54FStUr9l+SuU9Oa3d2/Gx6nbeIdH1CS8g03WdPuLizB+0JFcJIbc8/fUNleR3x0qM+IdKsdLguNW1zTEDW6zNc+csUUinA8xdznCEkY+Y9QMmvNx4b8TXWoPeaj4WRreTQrnT20yJrVYY3Misixjd8ynGQWI6chOhTS/DmtWrafLN4KuPtNv4UbS5ZvNsyzTgABc+dkjCnB6fN25wbRv8A19r/ACX3g/it/XT/ADf3HrysroGRgysMgg5BFZOs+IbHTEktxqGnJqbJ/o1pdXaxGWQg7Fxy3JHYE9eKzPBN1eWWh6NoGq6ZdWt7a6XF5zySQuoZAEK5SRjnjIJGCD1yCBmJpeoWXxL8S6tbeGpzbXmlRRR3ML26/apk3kjBkDZIZVBYAfJyQAMlRWbSff8AAIO6Tfl+Nja8I+LbXxH4dsLma8sU1KawivLm0imBaAOoOSudwX3NXV1/TbLSobjVtc0wZg81rkSrDE6jALqGc4XJH8R6jmvN9G8O63aWvhu2vvBdzJBZeHLnT72LzbNleVyh24M2GDeUeenzjP8AFiPw94b1vTZ/DE934KuTPpnh6fT7mUS2ZYynbsUHzskfI4B6DzO2WxpNK75fP/27/JfeOK7/ANbf5v7j1K88QaNpy2rahq9jai8IFsZ7lE88noEyfmz7Ut1r2kWV7HZ3mq2VvdSlVjgluER3JzgBScnODj6V5d4d8MeJtK0RLfVPDMmoJe6DDpUls9zATZyR7wd2ZNpibeGyhZuPu5rT8MeE77QPFGpLeaBLe2b6Ba2Ml5m3I1CaJWD5UvuO4MqguAPl5IABMySTdun47/5fjoL+vy/zf3HQax45tLfU9Kg0a+0q9huL1be+ZbsM9srI7Btq9M+WwyxGMd+203iTQ00VdYfWtPXTGOFvTdIITzj/AFmdvXjrXnWleH9ctPA3grS5/ClwZdL1MTXcAmtSsSLvw3+tweZAQBk/KeBxmB/C3iC5MF3c+HtSWC21q9uX0+31RLaeaKc/JJHJFMBleQVZ1yGPWp7r+un+Y9NH/X2v8l96PTbzxHoenRW0moazp9rHdkC3ae6RBMT02En5vwrSryrxN4R1c+FZPDvhbw6LSzm0m4hjm+0RTTxuzlhC8kzEhG6nbv5OMqAGrvdA1Ka5V7C7sJrSeyjiV2eSN0clexRicjHIYA+mRgl6WJ1/r5FttZ0tNSfT21K0W9RA7WxnXzFUgkErnIGAefY0lprelX909tY6nZ3M6RrM0UNwjsqN0YgHIU9j0rh9b8Pauvii7n07SZr7TbxpJb2zuTay2837jy90e8iSOVuFwf3ZXOSM1ztp4O8TTaRoGlRaDcaS8Hhm70u4u/Pt9kM8gQKTslLEExk5AJ+cd84Fqr/1s/8AJL5/Iuyvb+tz1iz1/R9RhuZtP1axuorVitw8FyjrCR1DEH5SPeqz+MfDMWlR6pJ4j0lNPlkMUd219EInfn5Q+7BPB4z2rz5/AN5e+Db1LLQb/S9ZeG3im+267LP9qWGRX8qNxK5RGAYBvkIz0q3c6PqumaBKfCfhLVrS+1WcfbZ59Uiuru3XbteRWmuCpYqAq4f3IG0AjVv6/rT8iVrb+v6/U7m31/TdSa0uNK1zTLi0m8zmKVZfO2jnY6vgbcHPDfhVi01vSr+6a2sdTs7mdI1laKG4R2VG6MQDnB7Hoa8zvvD93/augzWHw6uxY2Njd2U0LTWLSPHIoCK+ZsNk72IyfvZ5JIqDSdF1XR7Tw2dW8OXGn2Gl+G7qy1Kc3VsiRuwQ5JSUnB8oncAcb198Glm/66/5L7xpX/r0/wCCelWPi3w5qmpHTtN1/S7y9Xdm2t72OSQbevyg547+la9eZfD21v7HWLJ/EGnXlrdtpiWVo/lW6RNDH82G8q4kLsM/fKovsCcH02m1YhO4UUUVJQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUEhVJY4A5JPaisjxRoZ8RaDLpwkiiLujB5YfM27WDZUZGG44bnacHBxik720Gty+l/ZyaeL+O6gezMfmi5WQGMpjO7d0xjnPSpkkSWNZImV0YBlZTkEHoQa80g+Fd5H8NT4fkv7Q3rESm5EJLiQQeX/ruu7PSXZkLxtrsfCXh+Twz4bj05pYriRCzmRU2bye7HJ3N6vgZPOB0qnZNi7GvbXdveRs9pPFOiO0bNE4YK6nDKcdwQQR2NS15xYeO/El/Doi/YNKhm1DV7zTJ282R1hMPm7SowC/8AqjkkrngYGciTSvG2ua2lhpVoNOttYnkvklupYHe3AtZhGSsQcNliynG/5Rnk4wSzG1Z/15/5Hem7theLaG4iFyyGRYd43lAQC23rgEgZ9xU1eZ6l/aFl8RYtQ8rTrfXP+EVuHmkSNpIWkSWMgHlGZRzjJBGasS/ELUNNt49Q1GK0ltH8NjV/JhiZJBKCgK7ixG0l/wC7kepoSulbz/8Abv8A5Fkt2dv6+z/8kjvJdQs4ZpIpruCOSOIzOjyAFIx1cjPC+/SpopY54UlhdZI5FDI6HIYHkEHuK8mubrWfD/jvxBrUlvpFzqaeGFuz5Eb28cgWVuHOXZiFGAe+BwvbVv8Axt4lEd2bO30qJbbw/HrAklEkhkJBLJsBXaDtYA7jjg89Km6td/18X+Q7Nysv6+H/AOSO1vfDuialfw32o6PYXd3B/qbie1R5I/8AdYjI/CtGvMfFXxE1qyWMaKdLtJ5dMhvbO21CJ5pNSkcnMMIWRPmUY/vE7hwBzXV+KPEV14W8Gf2lNAt7fAwwCOJRGrzSOqDAZ8KNzZwX/wCBd6pppfO3zEmmzo6K82bxd47s4tOh1bQ7GwlvtVSxW6uMfMjqWDiCKaTBBVgQZfQjqQLU3iPxTpusX+h6le6PJqMsMEmkyRadKkc26TY+9TOxO0kZAIwCDk9KW+39df1Htv8A1rY7q4uYLSEy3U0cEYIBeRwoyeByalrxvxBPrmpWPjCPWruw1CLS9XsY7OL7I0XlPugYMrF32jDkHgnknOPlroNS8d63pP8AalhJaWt9qUeqQWFkbaLYredEJBuWSUAlRkf6xQxA+7mjp/XW1vzHb+vTc7ux02x0yN49Nsre0SSQyOtvEsYZycliAOST1NWa88Pi3xrb/wBg2up6HY2F1qepSWUj3EgPyiJnSVY45HAztbKmQ4IxnnIbp3jbxC82jNqMemNDdaxcaPcLBFIrM8fmgTKS5Cg+V9whuv3qdv6/r1Qul/66/wCTPRaYksU/mLHIkmxtjhWB2nHQ+h5HHvXCaR45vz4sudM1efTbq2TTZdQEunQShYfLkCtH5jMVm4I5ULgjkcik0/UvEVp4osPD0S6dapdafJqlxPPHJPIZDMvmJtDIFH7wgHLdBxxgpK9vP/g/5MHpfy/4H+aOw0rQtI0KKSLRNLstNjlbfIlnbpEHb1IUDJ96sm7theLaG4iFyyGRYd43lAQC23rgEgZ9xXm+nfEfxHPZ3PiG58OMfDCW9xcLcKYleNYwxXkTsz7iuMeUm0nvjNZ19fa1pPjqXxDNb6Rcaj/witxdoIY3hVlWWNgkjZYuVGcNxn0Wjrr5/gm/0HZ7L+tUv1PX6rS6bYz6hDfzWVvJeQKUhuHiUyRqeoVsZAOBnFcBefETV9EW/bV7WzuWXSLfUbaK0DJteWTyvLZnbDDcQd2F4zkd6kPivxxZaLNPrPh/7IY7qNReLZifEJDF3NtBcSOdpAXiT+Ldjgint/XnYS1/ryueiVnal4e0XWpoZdY0iwv5Lc5he6tklMZ9VLA4/CuRuvHt3DcaVN9o0+PSr2BXGpfZppbaWVnK+X5qkCHAwf3gO4nHy4Nd/wDSl5gQ21xbXCuLSaKUQuYnETA+Ww6qcdCPSpiQoJJwBySe1eWX3i3xVqdjYfZp9P0q5/4Sg6VKqQvcIyJkjnehIJXn7uQccc56PStV1vxPNNPHHpTaEt1cWNxaTxOZ2WMtGz7txXll/wBWV+6c7u1LePMv60T/AFDZ2f8AWrX6M6uKa3vrUSQyRXFvICAyMHVx0PPQ1R0DTdC07TseF7PTrWymcv8A8S6JEjduhPyDBPGM+1cB4B1jWdO0LwvpcUOnva3ul3DW0WHRo5IiNu6TkbWDDgJlcdWq5pHjfxLrlv4bFta6VbPrVnczPNIZJBA8RwAIwRuHK/xAnnpTejdv63/yCz6no1FeYXPxJ1R/C+g3yS6RpD6nZzSvd6ijPA08eAIEUSIQzncRljwuMMa7nwtd6nf+FdNvNejji1C4t1lnijgaIRswzs2szEEZwcnqO3Snbf8Arv8A5C7GtRXH6/4rvtH8X21hN9nsdOnWJYrq6tZXjnkZ8MnnIdsTAAYDj5ywAIxXPXXj7xLpUhj1OTS3ey1wWWoLDp8i4tG8srOpM524Ei5J3DLDjjkWv9eaX6j/AK/C/wCh6jUD31pHcPBJdQpMkfmtG0gDKn94jqB79K8/1Hxp4pSSw0/RbC21PUb+Ce+ieC3UILdXVYwUkuUyWDAlg5x/cNU7i3/tDxlq0us6RBaXd74PV760YJKPM8xwVZhkPjGAeeAKiTaV/X8E3+asNLp6fi0v1uelQ6lY3EkCW97byvcQ+fCqSqxlj4+dQDyvzDkccj1qzXlvhrxTrOnaHoelWdlYyQL4RXUIGlmcM8kaxrtbC4Vfm7bifbvo6b43195IRfWVndPeeHjq9tbWaurCRduYizMQ24uMHC46c9a1nHlbXa/4c3/yLIi7pedv0/zR6DRXA+BvFuteJtfuFl1DRtQ0iKyimFxptpIu2Zycws7TMAyADI25+YZC9DueO9d1Dw14NvNW0m3tri4t9p2XTsqYLAE/KCSeenH1qWmtx3OiqK4u7ezRHu54oFd1jVpXChnY4VRnqSSAB3NcXL4o1+z1TWNIvZ9FjubaC3u7a9kjkjhSKWRkKum4lnUqcAMu/IHy1n2nxC1qbw7Z3gtrGaQ+IRpF1KY5YAUMoTzEibLAkHozcdeelCV2l/W6X5sb0V3/AFpf8j0mmCeJp2gWRDKihmjDDcoOcEj0OD+Rrz+08b+IWu7GXULbTIrWbXpdHkhg8yR+NwWQSEqBgpyNpyD1FQ+Ib3XIjpt/ol9DZPrOvx2xM9s0uYVDBBw6naTGWIzzv6julrbzt+Nv80wel0+l/wAL/wCTPSaK880Lxn4v17VvOsPDscmiNLcQC4keKMIYyyq5cTM7BmXBXyQVz1bHMOl/ETVxBo2oa7b2K2eqabdXZhtEcyQtAA33ycMGU9NoIPc0m0ld/wBb/wCQ0m3ZHojXdul2lq88S3Eil0hLgOyjqQOpAyKkdFkRkkUMrDDKwyCPSvHr3W7zTPGWmeMNat9PkZvDV7eKllCUkEa+S6xO7Md+Nxw3yj5j8o76Nz458eaf4cvdUv8Aw5Zwwqbdrae4dI12yOEK7Ippi5G5SGygIzwMYNOL6/1q1+grrdf1ov8AM9B0rw/o2hiUaJpNjpwmO6T7JbJFvPqdoGa0K891jxP4u0m91iyzokjabpJ1NbnyJQJQGb92Yt/y8IRu3nnnHO0Q3Hj7xPqOsGDwl4d+3xWsNtLdIzRAsZkD7Q7zoUwp67JMnjiktf69V+gPTf8ArZ/qj0iiuFi8Z6v/AG7qunT2sCXsKzvY6ZLbyxSXSoPkMcxJjl3cE7QCmcEHrWr4L8Ry+IbGc3Vzby3VsypNElnLaSwsRkiSGUll9uSDjINC1B6HS0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFIw3KQc4IxwcUtFAHKW3w08M2jWhgt79TZ3T3kGdXuzsmf7z8y8k5Oc9dzf3jmSH4deGrfT0s4LW7SOO5e6jkXUrnzo5X++yy+ZvXdzkBgDk56109FF2BgjwVoY1mLVTb3DXcNs1qrNezspib7yshfa2SckkEk8nnmq9p8O/Ctn5WzSI5jDbPaRm6le4KQtwYwZGbC44x2HA4rpqKP6/r7394HKH4Z+EzHIr6bK7SWpszM97O0ogJJMYkL7lXkjAI446cUp+G3hlllVoL9hNZCwfOrXZ3W46R/63p/ifU11VFG/wDX9dx3f9fL/Jfcjgb3wJdJrKHTId1ittFaxyL4hv7OaCNM4DCMnz8FiRuZSBx711s2i21/4d/sjWlGpQPAIp/PH+uwBlj75GfY1o0UbqzFs7o5uXwB4fnhsY5or6T7BMJ7d21S6Lq4+6S/mbmxkgBiQASBjJqy+kT3/im31LUrWzSPTRKtk8chkkfzFUFmyg2cAjaC2cg5GMVt0UAc5qngDw5rE17LfWUxe+kjluTDeTw+YyABT8jjB+VenXauc4GGyfD7w3P/AGl9os55/wC02R7rz76eTcyfcZdznYy4GGXBGBzXS0UBdnPXHgbQrp9Pe4ivHk02Xz7aQ6lc7xJgLvZvMzIdoxlyeMjoSKqp8M/C6JboLa+K21217EG1W7O2dvvPzLyTz19W9Tnq6KAOatPh74ZsXga305s20TQQh7qVxHGzBigDMQFyBgdB0GATV+TwzpkviiLxC8dx/acUJgSQXcoQRnqvlhthGeeV6gHqBWtRTuwMOz8GaDY3F1LbWO1btneaBppGgLOCHYQljGpYE5KqCcnPWs9/hh4Rki8uTS5HxA1sjtezl4om+9Gj79yKem1SBgkdCRXWUUg8zmo/h74bSd5Xsp5zJZDT3W5vp5ke3HRCjuVI75xnPOc1Yh8G6Nb6YtjFHdiJPuSNqFw0yYBACyl/MUAM2AG4ycVu0UAYUngvQZILeA2TiGBVVYkuJVRwpLASKGxIMsTh85Jyeav6Zpp05bkG5nnE87TASyu/l5/hXezED2BwM8ADir1FAHNRfD3w3DZSWq2dw8Ml6L9hLf3EhE4OfMDM5IJyc4IBzzmrB8GaJ/aFxeRwXEElzkzJBezxROxGN/lq4TfwMPjcCAQcgVu0UB1uctbfDjw3Z/YfssF/F/Z8UkNrt1W6/dI/3wP3nfP6D0FJafDbwzYfYvskF/F9gjkitdurXf7pZPvgfve/9B6CuqooA4C/+Hv2FtNg8NWYawsYZIo4X1++spYt7BmImj3s6navyHABGc10ek+H5tPmtZp9Su52ggaEo9zK6sC24Z3OQxUcByN5xy3atyindgZWoeGtL1S9jur6CSWRGR9onkWNyhyu9AwV8HkBgcHnrUd/4S0PU5tSlvtPSZ9UtRaXhLsPNiGcLweOp5GD054GNmikBj6n4U0bV/sJvLV1k0/i1mtriS3khGMFVeNlYAgDIzg4Gaq3HgPw/c6lPfSW90txcWn2KRotQuIwYf7gVXAA75ABySepzXRUUb7hscnH8M/C8Pk+Vb36eTZtYx41e7+WA9Yx+96f4D0GGXPw50eKzY6PHNFexac+nWz3N/cyxpCwxsKGQgj8OMD0FdfRQ7v+vX/N/ewVl/X9dkcTovg/UYbaeO8lm05ZIWh8qHxDfX6t0wwaQxtGRg8Jg8/e7Vd8c+HtR134f3Wg6Sbee4uI0iMl/OyKVBBLMyoxJOPTv1rqaKHqC0Oai8DaJLozWl9YyF53imnb7fPJIsqcrtnZhIAp+7grjsB0ptz8OvDN1btDJZXCK12L1jDf3ETGcdH3I4OQeevUk9Tmunoo/r+vuX3CtpY5SP4a+GYo4USDUCILw30e7V7tiJz1kyZeT9fU+prX1Dw1pOqaZaafe2m+2s5I5LdVkdDGyfdIZSD0468gkHOa1KKBmFB4L0K0vLu4tLSW3a8LNKkN3Mke9hgusYYKj/7agN3zVWy+HfhrT5tOktbS6B0xHjtFk1G5kSNX++u1pCGBzyCD29BXT0UAcxafDnwpZ3EE0WkJI9skkduLiWSZYEkGGRFdiEUjjaAAATgDJpJPhx4Zl0Q6Q9pdmx3qyw/2lc/JtIIVT5mVQEA7FIXIBxwK6iigDnL7wFoGpXdzc3sN7JLd2gsp2Gp3K74R/AQJAPqepyc9TlyeBPD0dza3EdnMstrbi1VxeTAyRDokvz/vVHYSbq6Gijb+v67sP6/r7l9xjN4S0V72S6ktXeSRJEKvcSNGokzvKoW2oWycsoBI4zVnS9DsNGa4exjkEly4eWSaeSZ3x0G52JwOy5wOwFaFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAf/Z" alt="" width="789" height="382" vspace="0" hspace="0" border="0" style="width:789px;height:382px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p>Description of selected adverse reactions<br />Local injection site reactions<br />Local injection site reactions, including erythema/redness, itching, swelling, and pain/tenderness, were reported in 6.1% of patients treated with alirocumab versus 4.1% in the control group (receiving placebo injections). Most injection site reactions were transient and of mild intensity. The discontinuation rate due to local injection site reactions was comparable between the two groups (0.2% in the alirocumab group versus 0.3% in the control group). In the cardiovascular outcomes study (ODYSSEY OUTCOMES), injection site reactions also occurred more frequently in alirocumab-treated patients than in placebo-treated patients (3.8% alirocumab versus 2.1% placebo).<br />General allergic reactions<br />General allergic reactions were reported more frequently in the alirocumab group (8.1% of patients) than in the control group (7.0% of patients), mainly due to a difference in the incidence of pruritus. The observed cases of pruritus were typically mild and transient. In addition, rare and sometimes serious allergic reactions such as hypersensitivity, nummular eczema, urticaria, and hypersensitivity vasculitis have been reported in controlled clinical studies (see section 4.4). In the cardiovascular outcomes study (ODYSSEYOUTCOMES), general allergic reactions were similar in alirocumab-treated patients and placebo-treated patients (7.9% alirocumab, 7.8% placebo). No difference was seen in the incidence of pruritus.<br />Special populations<br />Elderly<br />Although no safety issues were observed in patients over 75 years of age, data are limited in this age group.<br />In the phase 3 primary hypercholesterolemia and mixed dyslipidaemia controlled studies, 1,158 patients (34.7%) treated with alirocumab were &ge;65 years of age and 241 patients (7.2%) treated with alirocumab were &ge;75 years of age. In the cardiovascular outcomes controlled study, 2,505 patients (26.5%) treated with alirocumab were &ge;65 years of age and 493 patients (5.2%) treated with alirocumab were &ge;75 years of age. There were no significant differences observed in safety and efficacy with increasing age.<br />Every 4 week dosing study<br />The safety profile in patients treated with a 300 mg once every 4 week (monthly) dosing regimen was similar to the safety profile as described for the clinical studies program using a 2 week dosing regimen, except for a higher rate of local injection site reactions. Local injection site reactions were reported overall at a frequency of 16.6% in the 300 mg once every 4 weeks treatment group and 7.9% in the placebo group. Patients in the alirocumab 300 mg every 4 weeks treatment group received alternating placebo injections to maintain blinding in regard to injection frequency. Excluding injection site reactions (ISRs) that occurred after these placebo injections, the frequency of ISRs was 11.8%. The discontinuation rate due to injection site reactions was 0.7% in the 300 mg once every 4 weeks treatment group and 0% in the placebo group.<br />LDL-C values &lt;25 mg/dL (&lt;0.65 mmol/L)<br />In all clinical studies background lipid lowering therapies could not be adjusted by trial design. The percentage of patients who reached LDL-C values &lt;25 mg/dL (&lt;0.65 mmol/L) depended both on the baseline LDL-C and the dose of alirocumab.<br />In a pool of controlled studies using a 75 mg every 2 week (Q2W) starting dose and in which the dose was increased to 150 mg Q2W if the patient&rsquo;s LDL-C was not &lt;70 mg/dL or &lt; 100 mg/dL (1.81 mmol/L or 2.59 mmol/L), 29.3% of patients with baseline LDL-C &lt;100 mg/dL and 5.0% of patients with baseline LDL-C &ge;100 mg/dL treated with alirocumab had two consecutive values of LDL-C &lt;25 mg/dL (&lt;0.65 mmol/L). In the ODYSSEY OUTCOMES study, in which the starting alirocumab dose was 75 mg Q2W and the dose was increased to 150 mg Q2W if the patient&rsquo;s LDL-C was not &lt;50 mg/dL (1.29 mmol/L), 54.8% of patients with baseline LDL-C &lt;100 mg/dL and 24.2% of patients with baseline LDL-C &ge;100 mg/dL treated with alirocumab had two consecutive values of LDL-C &lt;25 mg/dL (&lt;0.65 mmol/L).<br />Although adverse consequences of very low LDL-C were not identified in alirocumab trials, the long-term effects of very low levels of LDL-C are unknown. In published genetic studies as well as clinical and observational trials with lipid lowering therapies an increased risk of new onset of diabetes has been associated with lower levels of LDL-C.<br />Immunogenicity/ Anti-drug-antibodies (ADA)<br />In the ODYSSEY OUTCOMES trial, 5.5% of patients treated with alirocumab 75 mg and/or 150 mg every 2 weeks (Q2W) had anti-drug antibodies (ADA) detected after initiating treatment compared with 1.6% of patients treated with placebo, most of these were transient responses. Persistent ADA responses were observed in 0.7% of patients treated with alirocumab and 0.4% of patients treated with placebo. Neutralising antibody (NAb) responses were observed in 0.5% of patients treated with alirocumab and in &lt;0.1% of patients treated with placebo.<br />Anti-drug antibody responses, including NAb, were low titer and did not appear to have a clinically meaningful impact on the efficacy or safety of alirocumab, except for a higher rate of injection site reactions</p><p>in patients with treatment emergent ADA compared to patients who were ADA negative (7.5% vs 3.6%). The long-term consequences of continuing alirocumab treatment in the presence of ADA are unknown.<br />In a pool of ten placebo-controlled and active-controlled trials of patients treated with alirocumab 75 mg and/or 150 mg Q2W as well as in a separate clinical study of patients treated with alirocumab 75 mg Q2W or 300 mg every 4 weeks (including some patients with dose adjustment to 150 mg Q2W), the incidence of detecting ADA and NAb was similar to the results from the ODYSSEY OUTCOMES trial described above.<br />Reporting of suspected adverse reactions<br />Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed below:<br /><strong>To report any side effect(s):<br />&bull; Saudi Arabia:<br />- The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-2356-2340.<br />o SFDA call center : 19999<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc<br />&bull; Sanofi- Pharmacovigilance: KSA_Pharmacovigilance@sanofi.com</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is no specific treatment for alirocumab overdose. In the event of an overdose, the patient should be treated symptomatically, and supportive measures instituted as required.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: lipid modifying agents, other lipid modifying agents, ATC code: C10AX14.<br />Mechanism of action<br />Alirocumab is a fully human IgG1 monoclonal antibody that binds with high affinity and specificity to proprotein convertase subtilisin kexin type 9 (PCSK9). PCSK9 binds to the low-density lipoprotein receptors (LDLR) on the surface of hepatocytes to promote LDLR degradation within the liver. LDLR is the primary receptor that clears circulating LDL, therefore the decrease in LDLR levels by PCSK9 results in higher blood levels of LDL-C. By inhibiting the binding of PCSK9 to LDLR, alirocumab increases the number of LDLRs available to clear LDL, thereby lowering LDL-C levels.<br />The LDLR also binds triglyceride-rich VLDL remnant lipoproteins and intermediate-density lipoprotein (IDL). Therefore, alirocumab treatment can produce reductions in these remnant lipoproteins as evidenced by its reductions in apolipoprotein B (Apo B), non-high-density lipoprotein cholesterol (non-HDL-C) and triglycerides (TG). Alirocumab also results in reductions in lipoprotein (a) [Lp(a)], which is a form of LDL that is bound to apolipoprotein (a). However, the LDLR has been shown to have a low affinity for Lp(a), therefore the exact mechanism by which alirocumab lowers Lp(a) is not fully understood.<br />In genetic studies in humans, PCSK9 variants with either loss-of-function or gain-of-function mutations have been identified. Individuals with single allele PCSK9 loss-of-function mutation have lower levels of LDL-C, which correlated with a significantly lower incidence of coronary heart disease. A few individuals have been reported, who carry PCSK9 loss-of-function mutations in two alleles and have profoundly low LDL-Clevels, with HDL-C and TG levels in the normal range. Conversely, gain-of-function mutations in the PCSK9 gene have been identified in patients with increased LDL-C levels and a clinical diagnosis of familial hypercholesterolaemia.<br />In a multicenter, double-blind, placebo-controlled, 14 week study, 13 patients with heterozygous familial hypercholesterolaemia (heFH) due to gain-of-function mutations in the PCSK9 gene were randomised to receive either alirocumab 150 mg Q2W or placebo. Mean baseline LDL-C was 151.5 mg/dL (3.90 mmol/L). At week 2, the mean reduction from baseline in LDL-C was 62.5% in the alirocumab-treated patients as compared to 8.8% in the placebo patients. At week 8, the mean reduction in LDL-C from baseline with all patients treated with alirocumab was 72.4%.<br />Pharmacodynamic effects<br />In in vitro assays, alirocumab did not induce Fc-mediated effector function activity (antibody-dependent cell-mediated toxicity and complement-dependent cytotoxicity) either in the presence or absence of PCSK9 and no soluble immune complexes capable of binding complement proteins were observed for alirocumab when bound to PCSK9.<br />Clinical efficacy and safety in primary hypercholesterolaemia and mixed dyslipidaemia<br />Summary of the Phase 3 Clinical Trials Program - 75 mg and/or 150 mg every 2 weeks (Q2W) dosing regimen<br />The efficacy of alirocumab was investigated in ten phase 3 trials (five placebo-controlled and five ezetimibe-controlled studies), involving 5,296 randomised patients with hypercholesterolaemia (heterozygous familial and non-familial) or mixed dyslipidaemia, with 3,188 patients randomised to alirocumab. In the phase 3 studies, 31% of patients had type 2 diabetes mellitus, and 64% of patients had a history of coronary heart disease. Three of the ten studies were conducted exclusively in patients with heterozygous familial hypercholesterolaemia (heFH). The majority of patients in the phase 3 program were taking background lipid-modifying therapy consisting of a maximally tolerated dose of statin, with or without other lipid-modifying therapies, and were at high or very high cardiovascular (CV) risk. Two studies were conducted in patients who were not concomitantly treated with a statin, including one study in patients with documented statin intolerance.<br />Two studies (LONG TERM and HIGH FH), involving a total of 2,416 patients, were performed with a 150 mg every 2 weeks (Q2W) dose only. Eight studies were performed with a dose of 75 mg Q2W, and criteria-based up-titration to 150 mg Q2W at week 12 in patients who did not achieve their pre-defined target LDL-C based on their level of CV risk at week 8.<br />The primary efficacy endpoint in all of the phase 3 studies was the mean percent reduction from baseline in LDL-C at week 24 as compared to placebo or ezetimibe. All of the studies met their primary endpoint. In general, administration of alirocumab also resulted in a statistically significant greater percent reduction in total cholesterol (Total-C), non-high-density lipoprotein cholesterol (non-HDL-C), apolipoprotein B (Apo B), and lipoprotein (a) [Lp(a)] as compared to placebo/ ezetimibe, whether or not patients were concomitantly being treated with a statin. Alirocumab also reduced triglycerides (TG), and increased high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A-1 (Apo A-1) as compared to placebo. For detailed results see Table 2 below. Reduction in LDL-C was seen across age, gender, body mass index (BMI), race, baseline LDL-C levels, patients with heFH and non-heFH, patients with mixed dyslipidaemia, and diabetic patients. Although similar efficacy was observed in patients over 75 years, data are limited in this age group. LDL-C reduction was consistent regardless of concomitantly used statins and doses. A significantly higher proportion of patients achieved an LDL-C of ˂70 mg/dL (˂1.81 mmol/L) in the alirocumab group as compared to placebo or ezetimibe at week 12 and week 24. In studies using the criteria-based up-titration regimen, a majority of patients achieved the pre-defined target LDL-C (based on their level of CV risk) on the 75 mg Q2W dose, and a majority of patients maintained treatment on the 75 mg Q2W dose. The lipid-lowering effect of alirocumab was observed within 15 days after the first dose reaching maximum effect at approximately 4 weeks. With long-term treatment, efficacy was sustained over the&nbsp;duration of the studies (up to 2 years). Following discontinuation of alirocumab, no rebound in LDL-C was observed, and LDL-C levels gradually returned to baseline levels.<br />In pre-specified analyses before possible up-titration at week 12 in the 8 studies in which patients started with the 75 mg every 2 weeks dosing regimen, mean reductions in LDL-C ranging from 44.5% to 49.2% were achieved. In the 2 studies in which patients were started and maintained on 150 mg every 2 weeks, the achieved mean reduction of LDL-C at week 12 was 62.6%. In analyses of pooled phase 3 studies that allowed up-titration, among the subgroup of patients up-titrated, an increase from 75 mg Q2W to 150 mg Q2W alirocumab at week 12 resulted in an additional 14% mean reduction in LDL-C in patients on a background statin. In patients not on a background statin, up-titration of alirocumab resulted in an additional 3% mean reduction in LDL-C, with the majority of the effect seen in approximately 25% of patients who achieved at least an additional 10% LDL-C lowering after up-titration. Patients up-titrated to 150 mg Q2W had a higher mean baseline LDL-C.<br />Evaluation of cardiovascular (CV) events<br />In pre-specified analyses of pooled phase 3 studies, treatment-emergent CV events confirmed by adjudication, consisting of coronary heart disease (CHD) death, myocardial infarction, ischemic stroke, unstable angina requiring hospitalisation, congestive heart failure hospitalisation, and revascularisation, were reported in 110 (3.5%) patients in the alirocumab group and 53 (3.0%) patients in the control group (placebo or active control) with HR=1.08 (95% CI, 0.78 to 1.50). Major adverse cardiovascular events (&ldquo;MACE-plus&rdquo;, i.e.: CHD death, myocardial infarction, ischemic stroke, and unstable angina requiring hospitalisation) confirmed by adjudication were reported in 52 of 3,182 (1.6%) patients in the alirocumab group and 33 of 1,792 (1.8%) patients in the control group (placebo or active control); HR=0.81 (95% CI, 0.52 to 1.25).<br />In pre-specified final analyses of the LONG TERM study, treatment-emergent CV events confirmed by adjudication occurred in 72 of 1,550 (4.6%) patients in the alirocumab group and in 40 of 788 (5.1%) patients in the placebo group; MACE-plus confirmed by adjudication were reported in 27 of 1,550 (1.7%) patients in the alirocumab group and 26 of 788 (3.3%) patients in the placebo group. Hazard ratios were calculated post-hoc; for all CV events, HR=0.91 (95% CI, 0.62 to 1.34); for MACE-plus, HR=0.52 (95% CI, 0.31 to 0.90).<br />All-cause mortality<br />All-cause mortality in phase 3 studies was 0.6% (20 of 3,182 patients) in the alirocumab group and 0.9% (17 of 1,792 patients) in the control group. The primary cause of death in the majority of these patients was CV events.<br />Combination therapy with a statin<br />Placebo-controlled phase 3 studies (on background statin) in patients with primary hypercholesterolaemia or mixed dyslipidaemia<br />LONG TERM study<br />This multicenter, double-blind, placebo-controlled, 18-month study included 2,310 patients with primary hypercholesterolaemia at high or very high CV risk and on a maximally tolerated dose of statin, with or without other lipid-modifying therapy. Patients received either alirocumab at a dose of 150 mg Q2W or placebo in addition to their existing lipid-modifying therapy. The LONG TERM study included 17.7% heFH patients, 34.6% with type 2 diabetes mellitus, and 68.6% with a history of coronary heart disease. At week 24, the mean treatment difference from placebo in LDL-C percent change from baseline was -61.9% (95% CI: -64.3%, -59.4%; p-value: ˂0.0001). For detailed results see Table 2. At week 12, 82.1% of patients in the alirocumab group reached an LDL-C ˂70 mg/dL (˂1.81 mmol/L) compared to 7.2% of patients in the placebo group. Difference versus placebo was statistically significant at week 24 for all lipids/lipoproteins.</p><p>COMBO I study<br />A multicenter, double-blind, placebo-controlled, 52 week study included 311 patients categorised as very high CV risk and not at their pre-defined target LDL-C on a maximally tolerated dose of statin, with or without other lipid-modifying therapy. Patients received either 75 mg alirocumab Q2W or placebo in addition to their existing lipid-modifying therapy. Dose up-titration of alirocumab to 150 mg Q2W occurred at week 12 in patients with LDL-C &ge;70 mg/dL (&ge;1.81 mmol/L). At week 24, the mean treatment difference from placebo in LDL-C percent change from baseline was -45.9% (95% CI: -52.5%, -39.3%; p-value: ˂0.0001). For detailed results see Table 4. At week 12 (before up-titration), 76.0% of patients in the alirocumab group reached an LDL-C of ˂70 mg/dL (˂ 1.81 mmol/L) as compared to 11.3% in the placebo group. The dose was up-titrated to 150 mg Q2W in 32 (16.8%) patients treated beyond 12 weeks. Among the subgroup of patients up-titrated at week 12, an additional 22.8% mean reduction in LDL-C was achieved at week 24. The difference versus placebo was statistically significant at week 24 for all lipids/ lipoproteins except TG and Apo A-1.<br />Placebo-controlled phase 3 studies (on background statin) in patients with heterozygous familial hypercholesterolaemia (heFH)<br />FH I and FH II studies<br />Two multicenter, placebo-controlled, double-blind 18-month studies included 732 patients with heFH receiving a maximally tolerated dose of statin, with or without other lipid-modifying therapy. Patients received either alirocumab 75 mg Q2W or placebo in addition to their existing lipid-modifying therapy. Dose up-titration of alirocumab to 150 mg Q2W occurred at week 12 in patients with LDL-C &ge;70 mg/dL (&ge;1.81 mmol/L). At week 24, the mean treatment difference from placebo in LDL-C percent change from baseline was -55.8% (95% CI: -60.0%, -51.6%; p-value: ˂ 0.0001). For detailed results see Table 2. At week 12 (before up-titration), 50.2% of patients reached an LDL-C of ˂70 mg/dL (˂1.81 mmol/L) as compared to 0.6% in the placebo group. Among the subgroup of patients up-titrated at week 12, an additional 15.7% mean reduction in LDL-C was achieved at week 24. Difference versus placebo was statistically significant at week 24 for all lipids/ lipoproteins.<br />HIGH FH study<br />A third multicenter, double-blind, placebo-controlled 18-month study included 106 heFH patients on a maximally tolerated dose of statin, with or without other lipid-modifying therapies, and a baseline LDL-C &ge;160 mg/dL (&ge;4.14 mmol/L). Patients received either alirocumab at a dose of 150 mg Q2W or placebo in addition to their existing lipid-modifying therapy. At week 24, the mean treatment difference from placebo in LDL-C percent change from baseline was -39.1% (95% CI: -51.1%, -27.1%; p-value: ˂0.0001). For detailed results see Table 2. Mean changes for all other lipids/ lipoproteins were similar to the FH I and FH II studies, however statistical significance was not reached for TG, HDL-C and Apo A-1.<br />Ezetimibe-controlled phase 3 study (on background statin) in patients with primary hypercholesterolaemia or mixed dyslipidaemia<br />COMBO II study<br />A multicenter, double-blind, ezetimibe-controlled 2 year study included 707 patients categorised as very high CV risk and not at their pre-defined target LDL-C on a maximally tolerated dose of statin. Patients received either alirocumab 75 mg Q2W or ezetimibe 10 mg once daily in addition to their existing statin therapy. Dose up-titration of alirocumab to 150 mg Q2W occurred at week 12 in patients with LDL-C &ge;70 mg/dL (&ge;1.81 mmol/L). At week 24, the mean treatment difference from ezetimibe in LDL-C percent change from baseline was -29.8% (95% CI: -34.4%, -25.3%; p-value: ˂0.0001). For detailed results see Table 2. At week 12 (before up-titration), 77.2% of patients reached an LDL-C of ˂70 mg/dL (˂1.81 mmol/L) as compared to 46.2% in the ezetimibe group. Among the subgroup of patients up-titrated at week 12, an additional 10.5% mean reduction in LDL-C was achieved at week 24. Difference versus ezetimibe was statistically significant at week 24 for all lipids/ lipoproteins except for TG, and Apo A-1.</p><p>Monotherapy or as add-on to non-statin lipid-modifying therapy<br />Ezetimibe-controlled phase 3 trials in patients with primary hypercholesterolaemia (without a background statin)<br />ALTERNATIVE study<br />A multicentre, double-blind, ezetimibe-controlled, 24 week study included 248 patients with documented statin intolerance due to skeletal muscle-related symptoms. Patients received either alirocumab 75 mg Q2W or ezetimibe 10 mg once daily, or atorvastatin 20 mg once daily (as a re-challenge arm). Dose up-titration of alirocumab to 150 mg Q2W occurred at week 12 in patients with LDL-C &ge;70 mg/dL (&ge;1.81 mmol/L) or &ge;100 mg/dL (&ge;2.59 mmol/L), depending on their level of CV risk. At week 24, the mean treatment difference from ezetimibe in LDL-C percent change from baseline was -30.4% (95% CI: -36.6%, -24.2%; p-value: ˂0.0001). For detailed results see Table 2. At week 12 (before up-titration), 34.9% of patients reached an LDL-C of ˂70 mg/dL (˂1.81 mmol/L) as compared to 0% in the ezetimibe group. Among the subgroup of patients up-titrated at week 12, an additional 3.6% mean reduction in LDL-C was achieved at week 24. Difference versus ezetimibe was statistically significant at week 24 for LDL-C, Total-C, Non-HDL-C, Apo B, and Lp(a).<br />This trial evaluated patients who did not tolerate at least two statins (at least one at the lowest approved dose), In these patients, musculo-skeletal adverse events occurred at a lower rate in the alirocumab group (32.5%) as compared to the atorvastatin group (46.0%) (HR= 0.61 [95% CI, 0.38 to 0.99]), and a lower percentage of patients in the alirocumab group (15.9%) discontinued study treatment due to musculo-skeletal adverse events as compared to the atorvastatin group (22.2%). In the five placebo-controlled trials in patients on a maximally tolerated dose of statin (n=3752), the discontinuation rate due to musculo-skeletal adverse events was 0.4% in the alirocumab group and 0.5% in the placebo group.<br />MONO study<br />A multicenter, double-blind, ezetimibe-controlled, 24-week study included 103 patients with a moderate CV risk, not taking statins or other lipid-modifying therapies, and a baseline LDL-C between 100 mg/dL (2.59 mmol/L) to 190 mg/dL (4.91 mmol/L). Patients received either alirocumab 75 mg Q2W or ezetimibe 10 mg once daily. Dose up-titration of alirocumab to 150 mg Q2W occurred at week 12 in patients with LDL-C &ge;70 mg/dL (&ge;1.81 mmol/L). At week 24, the mean treatment difference from ezetimibe in LDL-C percent change from baseline was -31.6% (95% CI: -40.2%, -23.0%; p-value: ˂0.0001). For detailed results see Table 2. At week 12 (before up-titration), 57.7% of patients reached an LDL-C of ˂70 mg/dL (˂1.81 mmol/L) as compared to 0% in the ezetimibe group. The dose was up-titrated to 150 mg Q2W in 14 (30.4%) patients treated beyond 12 weeks. Among the subgroup of patients up-titrated at week 12, an additional 1.4 % mean reduction in LDL-C was achieved at week 24. The difference versus ezetimibe was statistically significant at week 24 for LDL-C, Total-C, Non-HDL-C and Apo B.</p><p><img src="data:image/jpeg;base64,/9j/4AAQSkZJRgABAQEAYABgAAD/4RESRXhpZgAATU0AKgAAAAgABAE7AAIAAAAYAAAISodpAAQAAAABAAAIYpydAAEAAAAwAAAQ2uocAAcAAAgMAAAAPgAAAAAc6gAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAE11aGFtbWVkLCBVc21hbiAvU0EvRVhUAAAFkAMAAgAAABQAABCwkAQAAgAAABQAABDEkpEAAgAAAAM4MgAAkpIAAgAAAAM4MgAA6hwABwAACAwAAAikAAAAABzqAAAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAMjAyMTowMToxMSAwOTo0MTozMwAyMDIxOjAxOjExIDA5OjQxOjMzAAAATQB1AGgAYQBtAG0AZQBkACwAIABVAHMAbQBhAG4AIAAvAFMAQQAvAEUAWABUAAAA/+ELKmh0dHA6Ly9ucy5hZG9iZS5jb20veGFwLzEuMC8APD94cGFja2V0IGJlZ2luPSfvu78nIGlkPSdXNU0wTXBDZWhpSHpyZVN6TlRjemtjOWQnPz4NCjx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iPjxyZGY6UkRGIHhtbG5zOnJkZj0iaHR0cDovL3d3dy53My5vcmcvMTk5OS8wMi8yMi1yZGYtc3ludGF4LW5zIyI+PHJkZjpEZXNjcmlwdGlvbiByZGY6YWJvdXQ9InV1aWQ6ZmFmNWJkZDUtYmEzZC0xMWRhLWFkMzEtZDMzZDc1MTgyZjFiIiB4bWxuczpkYz0iaHR0cDovL3B1cmwub3JnL2RjL2VsZW1lbnRzLzEuMS8iLz48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOnhtcD0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wLyI+PHhtcDpDcmVhdGVEYXRlPjIwMjEtMDEtMTFUMDk6NDE6MzMuODIxPC94bXA6Q3JlYXRlRGF0ZT48L3JkZjpEZXNjcmlwdGlvbj48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOmRjPSJodHRwOi8vcHVybC5vcmcvZGMvZWxlbWVudHMvMS4xLyI+PGRjOmNyZWF0b3I+PHJkZjpTZXEgeG1sbnM6cmRmPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5LzAyLzIyLXJkZi1zeW50YXgtbnMjIj48cmRmOmxpPk11aGFtbWVkLCBVc21hbiAvU0EvRVhUPC9yZGY6bGk+PC9yZGY6U2VxPg0KCQkJPC9kYzpjcmVhdG9yPjwvcmRmOkRlc2NyaXB0aW9uPjwvcmRmOlJERj48L3g6eG1wbWV0YT4NCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgPD94cGFja2V0IGVuZD0ndyc/Pv/bAEMABwUFBgUEBwYFBggHBwgKEQsKCQkKFQ8QDBEYFRoZGBUYFxseJyEbHSUdFxgiLiIlKCkrLCsaIC8zLyoyJyorKv/bAEMBBwgICgkKFAsLFCocGBwqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKv/AABEIAX4DFQMBIgACEQEDEQH/xAAfAAABBQEBAQEBAQAAAAAAAAAAAQIDBAUGBwgJCgv/xAC1EAACAQMDAgQDBQUEBAAAAX0BAgMABBEFEiExQQYTUWEHInEUMoGRoQgjQrHBFVLR8CQzYnKCCQoWFxgZGiUmJygpKjQ1Njc4OTpDREVGR0hJSlNUVVZXWFlaY2RlZmdoaWpzdHV2d3h5eoOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4eLj5OXm5+jp6vHy8/T19vf4+fr/xAAfAQADAQEBAQEBAQEBAAAAAAAAAQIDBAUGBwgJCgv/xAC1EQACAQIEBAMEBwUEBAABAncAAQIDEQQFITEGEkFRB2FxEyIygQgUQpGhscEJIzNS8BVictEKFiQ04SXxFxgZGiYnKCkqNTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqCg4SFhoeIiYqSk5SVlpeYmZqio6Slpqeoqaqys7S1tre4ubrCw8TFxsfIycrS09TV1tfY2dri4+Tl5ufo6ery8/T19vf4+fr/2gAMAwEAAhEDEQA/APpGiiigAooqhrGh6b4gs0tNas4b21WQSmCdA8bkZxuU8Ec5x7UAX6K8P+Fvg3w5qHi7x6lzolgfsGu4s3W2QNahSSBGcfIAQOBxXQX3xK1zTfG2m6beWeni1vdXbTGtoyZJYhjKSmZXK5YEHyiisPpg0R961utvxt/mD05m+l/wv/keoUV4No+r6j4PvPihrOhwWBt9N1hZ57WWJh5ybfmCMpARuSckNz271p3mrWdl+0AniEwFIf8AhDWvZQFAdgH3c++AB+FJNNJ+V/8AyXm/QaTbaX9apfqezUV558P/AIhar4tvLX7XpUyWd9ZG7juI9OuIYrY5AELSyDbKSDkOmBwRjvVX422yjQdHvUknSZdZs4vkuHVCjScgoDtOfcdh6VVmmk+rt+Nibqza6f5XPTaKhu7u2sLOW7vriK2toVLyzTOERFHUljwB7msSD4geDbm4jgtvFuhTTSsEjjj1KFmdicAABskk9qW+gzoaKoa5q1toei3OoXtxDbxQr/rJ5AiKScLljwBkjk15f8GfFEf/AAknirwlLrMGs/Zbx7+zvYJVkWeKU7mwVJHDNzz1Y+lC1bXlf+vzB6K56/RXgXjTXrrxx4P0zxHNa6elhH4mht9PHkt9pjRZtjOZCcfOV+6FXGBya7o+LfE1v8RtZ8MX0mlRD+z/ALZo0ospCZsvtxJ++5KkgEDGc5yvShar7/yT/UbVnb+t2vzPQ6K8r1L4o6xaeKtQ0ax0x9Sl0RbZb2Oz0u5ma8eQAv5bRllgCg5HmFt3I4xmtWLxV4ovviL4h8M6eulBbC1t7q0lngkHEh5STD8nAOCAMeh6U7Xt5iem539Fec2vxEvYvEuuWuuSWdgulR3E39lyWkiXM0EYJWaOYvslDAZICjbnBPHL/h/8QtV8W3lr9r0qZLO+sjdx3EenXEMVscgCFpZBtlJByHTA4Ix3pLXb+t/8n+W4PTf+v6v+ux6HRXEeKvFmtaN8R/C2haeli9nrguFkM0TmSJo03BgwcDHI4254PPPGJrvxK1/R9ebw/Fp8V7q1hpq3t2tlp1zcrdOxIEUQjyYs4+/JkDIGD1o7ef6f8MNq39fI9Soryvx58T9d8KW9xqEGnWcVpbQ204tbpS89ysrBXztcG3KE4y6MGPA54ran8Xa5rHjPUfD/AITXTI5tKtbe4uDqKyMJjLz5alCNmFGd2H5IG2nZi8zuqK8zXVfE918b9X0yHVLGOzsdHSaKCWyeRRvbnkSr825Rlj1AwAOtc/4D8e3i+C/CWn6Vp+nWF74g1C8iDBJZILfYzOz7Gk3sSe28Dn8KUfeV1/WrX6B38v8AK57ZRXkOq/FrWoPDSXWn22n/AG+18Sf2FepNHIY5DnHmR4cFMjBwd2M45xmtGL4ieITa+NLddNt77UPDl5HFEbS3ciSJ8EuYt5Zii5JUMN2OMUef9dP80DunZ/1v/kz02isDwXrh8ReG49R/tOw1NZHYLcWEDwoR6NG7MyOOhBNb9Nqwk7hRRRSGFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABVbUtQtdI0q71LUJfJtLOF555NpbYiKWY4AJOADwBmrNc38R/8Aklniv/sC3n/oh6AD/hPNI/58/EH/AITmof8Aximv470lkYC18QoSMBh4bv8AI9+YK6aigDy3wlF4f8H6xqmo2l/41vZNVlM93HeeHLkpJKf4/ks1IPXgEDnp0rPTw54KiuLeaJ/GiNbaw2sxf8SK9IWZvvLza8qcDrk+/WvYqKa0aa6f1+gPW9+v9fqeUXWmeDbufUiyeL47fV7j7RqdomgX3l3rA5UPm2LKB0whXI65qe6g8K3njhfE0o8WeaLE6cbIeHLv7O0BByhX7Lu6nPDfpxXqFFLpb+trfloO7/r7/wAzzvwpfaB4Q04afp8vjC4sYifs1tdaBeutspOdikWwYqM8bi2Kr+MpNC8bQ20F9e+M7K3tpknWGy8OXIDSocq5L2jNkemceor0yih6u7Ftocta+NtLt7SKKVPEl06IFaeXw3fB5CP4jttwuT7AD2qX/hPNI/58/EH/AITmof8AxiukooA4bVfEOm6nqOn3SXni+yWyk8z7PbeG7ry5z0w++1YkYyOCOueuCMXVLfw9qfj228XC/wDGtnqFrGIY0tfDtysZj7owNmWYHn7xOM8Y4r1OijYDyOfQvBFzZTafLH4y/syS/wD7QSwj0XUI44ZuSShW3DgEnOCxAPTFb97qfha/8SaVrtxY+JDe6VHLHbt/wj2oYIkAB3ZgyenHPWu9oo2/r5fkD13PN2l8NJ4ym8S2B8XWF5dxLFexW3h+9EV2qjC7w1sSCBwGUqfejT5/D2neO9R8VRzeMJbvUYVhmt5fD14YQq427QLUMMc/xdznNekUULQHqeeXV74a1DVor3U4/FN6kCSLDaz+Hb1o4zICrkH7NvOVYrgsVA6AUnhS+0Dwhpw0/T5fGFxYxE/Zra60C9dbZSc7FItgxUZ43FsV6JRRsG55trc3h7XfF+i+Ip5vGFvc6KWNtDB4duxE2/h9wa1JORxwRx0weadqE/hu98XQeJbY+LdN1OOH7PLJaeHr3bcxZzskV7ZgRnuMEetej0UbW8geu55Brvh7wT4huNdlvR4zT+3EgW6WLQ77AMP3GXdbEg8c5JB9K05P+EZ/4SmDxDaP4vstRS2W0uJLfw/egXkQ6CUG2IJGPvLtI9a9Moo2B67nnE1x4bfxXceIbf8A4S60vrmy+xS+T4fvirKDlWw1sfmU9Ox7g1kaPofhDRPDtjpNpN4zb+zbtrywu5PD12ZrWRgQ20i0CkHLcMrdfpj16ihabf1rf8w/r8LfkePXnh7wfd6Cml+f40hUas2ryXEfh6682W5JJ3MTaEYGeAAOgzmtLRl8PaJrOt6nbXfjSS41qZJ7jzPD92Ajr90rttRgY4wcgjrmvT6KNv69P8l9wPXf+v6uzgtK8TeGPCel3ssn/CQ7ZJHvL6+u/D14hdto3SOVt1RQFUZwAABWz/wnmkf8+fiD/wAJzUP/AIxR8R/+SWeK/wDsC3n/AKIeukoA5v8A4TzSP+fPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/wAYrpKKAOb/AOE80j/nz8Qf+E5qH/xij/hPNI/58/EH/hOah/8AGK6SigDm/wDhPNI/58/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/ABiukooA5v8A4TzSP+fPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/wAYrpKKAOb/AOE80j/nz8Qf+E5qH/xij/hPNI/58/EH/hOah/8AGK6SigDm/wDhPNI/58/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/ABiukooA5v8A4TzSP+fPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/wAYrpKKAOb/AOE80j/nz8Qf+E5qH/xij/hPNI/58/EH/hOah/8AGK6SigDm/wDhPNI/58/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/ABiukooA5a5+Iug2drLdXkWuQW8KGSWWXw9fqkagZLMTDgAAZJNS/wDCeaR/z5+IP/Cc1D/4xR8R/wDklniv/sC3n/oh66SgDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDll+IugtdSWqxa4biNFkeIeHr/eqsWCsR5OQCUYA99p9DUv/AAnmkf8APn4g/wDCc1D/AOMUWP8AyVPXf+wLpv8A6Pvq6SgDm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xiukooA5v/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YrpKKAOb/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GK6SigDm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xiukooA5v/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YrpKKAOb/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GK6SigDm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xiukooA5v/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YrpKKAOb/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GK6SigDm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xiukooA5v/AITzSP8Anz8Qf+E5qH/xigePdE86COWPWLfz5o4EkudCvYY98jhEBd4Qq5ZlGSQMmukrm/Hn/Iu2v/Ya0r/04W9AHSUUUUAFFFFABXN/Ef8A5JZ4r/7At5/6Ieukrm/iP/ySzxX/ANgW8/8ARD0AbOrX/wDZei3t+IHuPssDzeTH96TapO0e5xXI+DvGl54osLPU7S+0fVLO4ObmKwV1m08eWW2uCzGRtwC5xH1zg11+pm9GlXR0pY2vfKb7OspwhfHy7j2GetednwH53xF0rXtH8OHw3eWk5fUr2C4jEF9EVO6NURtzksR8zonTPPFEfi1/4YH8P3nUab8Q/Der6ZNqGm3N5cW0N0tnIy6bc5WYnATaY89SATjAJGcVag8Y6NdanNYWs1zNNCZFZo7Kdoi0f31WUJsZh0KqxOQRjIrB0fwpcaX8WNcv7WdBpGoQw3ktrjJF386bh6AqMnrk4PGKbp3hjUNK+Ij32iQXenaZeGWXU4HuEktJ3OdrxJnekpOC3yhSO5NHT5fj/wAPf8Ael/60/q34ljwz8T9E8Q+HLzXJPtFhY287RiS6tZYw43lF2sVw7MR91SSCQCM1fvfiH4Y07S7fUL7UXgtri6FmrSWkwKTH/lnIuzMZ/wB8LXmY+G3ih/g5F4fNkI9S0rWTfxRreKgvUErPhJFOUyG4J2kEdutafizwVfSeDbSLwr4V1EXdzrNvqN9Bdaok0w8vG5mklmYEkKAMMffFNW0+X6Xf5+lhy0bt5/rb9PvOuuvit4Lsnu47vWfJmspfLuYHtZhLF0+Zk2bgnI+fG3kc811T3dvFYteSTxrbLH5rTFgFCYzuz6Y5zXiXiDwf4r1Gf4mPbeFrkt4ijto9Pdrm1BYRgK27978o/i+g9eK9Ml0G51n4VtoFyrWF1c6T9jdXKsYXMW3kqSDg+hNS/gbW9l+X6BpzpdNf0/r5FnT/ABtoGqeZ9hvJJGS3N0qG1lVpoQM+ZEpUGVeRym4ZOKg0z4heF9YsYLyw1Tfa3EM0yTvBLGmyI4kJZlAXHocHHI4ri9G8L+JY9f8ACt1eaPNbxeG9CnspdtzCRdzFVRVjw/3Tt3Avt7ZxTPC3hq90X9nXUtB8XaPcW80cF351vHcw7pVYs4KOrFR94D5u46Y61KyUmun+bX+TFHWyfdflf89DtNN+I/hjVdQeys72481Lf7UzTafcQxrDgkSGR4woQ4OGzg9s1Np3jzw7qtzc21jfSPcW1v8Aamha0mR3h/56RqyAyKezJuB4x1ryvwjeSXWsXEtzoutp4jk0NtM0qLW9FNjaTpGpYRt+8cOxxlidoI6KK0PCvg3xVpfjmz13UdFKx/8ACLmymjgngAjuQ27y0QMFVeyhflHcjmnJJXt2f/t1vyXzYo67+X6X/N/cd7o/xK8J69Np0Wl6qZW1TzBZl7aaNZjH99QzIBuH90nPfFbmraxYaFp7Xuq3At4FYIDtLMzE4VVUAlmJ4CgEnsK8P8LeBPGGl2fw5gvPDlwjaDf3Ut8wurYhElb5WGJctwckDng+2fRvih4c1jXtJ0m58PKk97o+qQ6itm7hBdBM5TceAeeCeKJJJ6d7fLTUfX5f56fgvvM/xL8THt7jwvN4Xktbqy1TWl0q9S7tZUmiYnkAEqUYYPDKeo/Hpp/Hnhu31qPSptSC3Mtx9lRvJkMJn/55edt8sSf7G7d7VyfxE0vxH4lm8G3eneHLpv7P1iK/uoWubcPDGg5BzJtLZJwFLDjqM4rnvEPgrxlrOtJetoVtGtp4shv40tJoYlltEGPNIyN8h7l/m4wOKIpOyff8Pd/zbE77+X/yX/APVP8AhLtG/t46OtxM92snlOUtJmhR9u/Y0wXy1bbztLA8j1FO0XxXpHiCd4tJmnm2J5gke0mijkTON0buoWRc91JFc3d+GdQt/iHBrHh+3u7FbqUnVv8ASI2s7yILtG6MncJuFwyrjGcntTvBfhnUPDniS9isYryx8OtDuWwurhJo47gkEm3IJZY8bgVbbz0GKUddxy02/r+v67HdUUUUgCiiigAooooAKKKKAOb+I/8AySzxX/2Bbz/0Q9dJXN/Ef/klniv/ALAt5/6IeukoAKKKKACiiigCO4uIrW1luLhwkUSF3Y9FUDJNcT4T8VeIPHdiNd0VdP07Q2ldLZLuCSae7VSV35V0EQJBwMPXY6jYxappd1YXOTDdQvDJj+6wIP6GuB+H2l+I/h94fi8K3eiTatbWsr/ZNSsriFUMbOWHmpI6upBPO0PQt3f5fqD2VvmdK/i+10u2to/Eo+x6nOJG+xWkct0+xGILgIhYpjB3FQOe1F3498NWU+kxTampOsgnT3ihkkS4wM4V1Urn2JyaxNZ0DWoviFpniy3svt5TTJdPubS2lRTGWcMrqZCoZRyCcg9CB2rjtI8DeKtF0z4bWz6NNdto13Pdai0dzB/o/mE4QbnG7G7+HI44zTWtr9/1f6WYPRO39af56HfQfFbwVcPAkWuIXmuPs2xreVWil3bQkoK5iJIIG/bnBxmrWofEPwzpWrahpl9fTR3um24urmEWU7lYuPnG1DuUZ5K5xznoa8jufA3jCXwdq9lH4TuVu73xZ/ayj7Xac2+7dyfN+8MYx7/Wuo8Q+H/Et38Q/FGp2nhy6ms7/wANHTbaUXNuN8xyehkBA+bGT6Htipe1/wCvhT/PQf2rdNP/AEqz/DU7bSviF4V1vVoNN0nWYbq5uImmh8tH2SquC22TGxiMjKg5HcCptP8AG3h7VL+OzsdREskzOkLmF1jnZM7ljkKhJCMHIUkjFeX6F4M8Twa98OWufDdxa22habPa6hL9otiI3kQpkBZCWGRuJA6MO+QLOjeAfEdhaeC/D8ti62/hzWJbubUlni8uaL94ybV3b8neFIKjHPUc1o4xva/9Xav91n5kXdn/AF0/z0O4tfij4Qu5FSHVXBa+/s4mWznjCXP/ADzYsgCn0zjPNdbXz3N4D8ZtoGo26eGLozT+MhrUafa7Xm369fNxu46e9fQYOVBIIJHQ9qn7N/62T/NtfIuWkrL+tX+lhaKKKQgooooA5v4j/wDJLPFf/YFvP/RD10lc38R/+SWeK/8AsC3n/oh66SgAooooAKKKKACiiigAooooA4X4ueLdb8DeCX1/QfsDm3lRJYb23eTzA7BRgrIu3Gc8g59qgi8X+JNL+IWi+HNYTT9Wh1e2efz9OtJLd7MIM5kVpJAVJIAOV59aj+N2ha34p+Hcuh+HNIm1G6upo3JWaGNIgjhjuMjr17YB98VkaZ4V1/wR4wtdc8GeHZv7F1eILq+grPbxNaSqMCWMeZ5f1Ct/9Zwt17/p/n1Ce2nb9f60O8Hjvw4dbi0kakPtU8zW8TeTJ5Ukq/ejWbb5Zcd1DZHpUcXj/wANzXt5Zx30v2iyu47K4jazmUxyyNtQHKdCcfN93kc8ivNrrwb4yv8AxFpepXOgwQiy8VNetFaTQxx/ZcACUKGG5zyWLfOTjtwOs8DaLrOn/EbxtqWqaPLZ2mrXMMlpcPNC/mLGmzojlhnqMgcHseKI6q7/AK+H/N/NCk2np/W/+S+86iHxdodxrjaRDfB7xZDFgRv5ZkAyYxJjYXA5KA7gOcVs15N4J+HM+j+IbyPxDpN5di31aXUtN1JNVcWw3nIzbiQYkAZhnyyDnrXrNL7KYfaaCiiigYUUUUAFFFFABRRRQBzdj/yVPXf+wLpv/o++rpK5ux/5Knrv/YF03/0ffV0lABRRRQAUUUUAFebeOfHXiTwL4hjvbmys9R8KKYzevb27rdWauSoYnzCrgFST8q9QPevSa59kn1DxNqVjqGg3DaXPZpCbuZ4WhmwXLLsDl+Q+OVHQ+2VrfQeltSKDX5BcXWsXWs6UfC62Ud1DKsDK4Vs/M0pkKlflPRB94enM9v410O6s724t7idzYw/aJoGtJUm8vBIcRModlODhgCDjg1wa/CC8sPA3i/wnpmos2n6iEfSRPIT9nGS5iPU7d/f0b1zVyw8M6/qfjy61q902XS7ceGhpSJPPE3mzFySf3bN8owME4PzdOopy2du2n3N/noEfPv8Aql+V2dZ4H8X2/jfwzDrFpb3NukpJCT27x8ZO3DMAH4xkqSM5Ga5zw38S5JJPEx8VCNIdI1k6bA+n2M8jSA/d3IvmNknjIwM49a1/hdpOp6B8OdK0fW7M2l3YxGF181XD4Y/MCpIwQRjPPqBXm9v4L8aaZr+u+JdM0a+Gop4gN/Y2bX0AhvbeQFJFYebhW2kkMRkZGM8gU7Ko0tv+Cv0uTG7p3e//AAH+tj0y/wDiX4V0y+vbK/v7iG5sbZbu5ibT7jdHCcfPgR8gZGcdOc4wavXvjPQbCOzeW+Mv26H7RbJawSXDyRYB8wJGrNtGRlsYGa8y8R+GvFes+K/FmqQeF7xItX8MjTrdXurXPnnBKn97wBkjP+yfbN/QvCHiDRbjwlrb6TNNPYeHzo95p6Tw+ZE+QVkBLhCuQc4bOMcHkVP2b/19r/JfePr/AF/d/wA39x3D+PvDaarpenLqDS3Grx+bYeRbSypcLzkrIqleMc88d+tM0v4geHdagjm0y4vLhJLtrIFdNuRiZRllIMfy4AOScAYPNcFZfDXxBbfCjwjYxbYfEOjalHe/NIrCFXlbzFznBARzkA87eK6vwt4QuvDfjbxBPEi/2LdNHdWcYYZE7Jsl47fcByeu8+9U0k38/wBP+D80J+X9b/8AAfoWrD4oeENSktUtNVcm7vGsYjJZzxr9oAyYmLIAregbGe2a62vnyHwJ4yXQNLt28MXQmt/GJ1mRTd2vFvnPXzfvc9PY+1fQdKy5U+v/AAE/zbXyDr/Xdr8rBRRRSGFFFFABXN+PP+Rdtf8AsNaV/wCnC3rpK5vx5/yLtr/2GtK/9OFvQB0lFFFABRRRQAVzfxH/AOSWeK/+wLef+iHrpK5v4j/8ks8V/wDYFvP/AEQ9AHSUEZBB6GiigCho2iaf4f08WWkwNDbhiwVpWkwSc9WJOPQdB0FX6KKACiiigAooooAKgvbK21Gyls76BJ7eZSkkUgyrA9jU9FAGRpnhjTNJuftFst1LMAQkl5fT3RjB6hDK7bAcdFxWvRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38R/+SWeK/wDsC3n/AKIeukrm/iP/AMks8V/9gW8/9EPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38R/+SWeK/8AsC3n/oh66Sub+I//ACSzxX/2Bbz/ANEPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzdj/yVPXf+wLpv/o++rpK5ux/5Knrv/YF03/0ffV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfjz/kXbX/sNaV/6cLeukrm/Hn/ACLtr/2GtK/9OFvQB0lFFFABRRRQAVzfxH/5JZ4r/wCwLef+iHrpK5v4j/8AJLPFf/YFvP8A0Q9AHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AdJRXN/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHQB0lFc39u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdAHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AdJRXN/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHQB0lFc39u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdAHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AdJRXN/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHQB0lFc39u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdAHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AdJRXN/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHQB0lFc39u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdAHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AHxH/5JZ4r/wCwLef+iHrpK878fXnjFvht4lW80LQ4rc6TdCWSLWpndV8lslVNqoYgdASM+o610H27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAB8R/wDklniv/sC3n/oh66SvO/H154xb4beJVvNC0OK3Ok3Qlki1qZ3VfJbJVTaqGIHQEjPqOtdB9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQAWP8AyVPXf+wLpv8A6Pvq6SvO7O88Y/8ACydZZdC0M3B0mwDxnWpgir515tIb7LkkktkYGMDk5IHQfbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJXN+PP+Rdtf+w1pX/pwt6Pt3jf/AKF7w/8A+D6f/wCQ6w/Fl34ql0uxTVdG0e2tDrWl+ZLbavLNIv8Ap8GMI1sgPOB94YHPPQgHoFFFFABRRRQAVzfxH/5JZ4r/AOwLef8Aoh66Sub+I/8AySzxX/2Bbz/0Q9AHSUVV1OytdR0u4tNQtobq2ljIkhnjDo49Cp4NeQeB9QuPCHw18DJ4b0nTF/t68FvezSlkcsxchsKvzHCkZJ4wBjHQWrt6fiD2v6/ge00V5he+PvEunaTr13Oukyt4d1OO1uQlvKv2uN/LIKAyHymAlHJLgkHgU7VfH3iezXxnNFaaTFD4YeOQI3mytcxFPMK5yoRipHOGAORg9aP6/L/MOtj02ivOtT8aeIbC91mzH9lmWHQTrNm/2eQrGAxBikHmAvnHDDZ/u0r+NvEQ1DQkgh0yZNW0GXUBC6SRFJ40RseYGb5D5nTYSMdTmjpf+uv/AMiw62/rp/8AJI9Eorzfw98QNau5PCtxrUOnraeIdOmufLtY3DwPGgfO5mIZSpPG0EHuad4Y+Ier67r2lD+yriXStWhaQSJpF3B9g+Xcu+eQeXKGHG5duDjG4HNVyu9v66/5CurXPRqK47xX4uuNB8QWtnJc2Wl2c0BdL7ULaR4ZZskCIyKyrEfunLZznAGapz+KfEGmeJ9c03VZ9L8qPTTfaQ0NpJum+YqVbMvzFTsBC7d28HK9Klar7/wK2/D8TvaK4RfF2rWfimDRNdvdK0+4ZIVj86zmSO/dsF/JlMm1SPmURncxIByAawNJ8V63oY8VXuqXcOoFvEP9n28cOnzMyOVjAbajOzKE/gVckg/Nzwdf67pfqLpf+tr/AKHrVFeVt8RvFcNvEjaLCWOs22ni9vLK6sI7mKYjDxwyguCDuU5YgYB5ziptU8d+JtMsPFcrDSJH8LzI0pFvKBdwuiuFA8z92wDY3ZcEj7op2v8A16f5oOtv66/5Hp1QNf2iXRtXuoFuFjMpiMgDhBwWx1xyOelZfibxGvh3wpNq/kec4EawwltoeSRgiKW7Dcwyewrz2d9b0P4razqUsGkXOpp4XNwGgie2jm2zdH5diQFwDnnA4XtLdnr5/gmw3V15fi0v1PWbe4hu7aK4tJo54JkDxyxMGV1IyCCOCCO9SV5y/wAQr9LHw9cX02n6RDqmlx3TXl5bStbSTuv+pEgcCHBIOXLZBwBmrWp+L9dnfxDN4cj05oPDhC3EN1G7PeMIllZUdWAjwrYBKvk9hVSXK3fpf8NAj71rdf1O8qGe8traSFLm4ihed9kSyOFMjeig9T7CvPdM8e+Ite8QzxadaaVbaZDp9nqge4eR5Xt5ixYHGAr7VOOoyByc8Y2p6hqHiHWPh74mvYdOSzvNT8yzSOBvtNvE0EjBWlLENuABICrggD5utPlaevf+v1+4V002u1/wuew0V5hp/wASde1a9spdI0d7yy1FZPKV9LvIFtcKTG8l0yGN0YgA7F4zxupLDx74sufAlj4nvLbTILO+CAvb2s9y1ll3DSPGrAumAn3SpBJJOBUj62PUKKzdA1JdX0WG+ivbK/jmLGO4sSTFIu4gEZJwcdRk4Oa0qbVmG4UUUUgOb+I//JLPFf8A2Bbz/wBEPXSVzfxH/wCSWeK/+wLef+iHrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+I/wDySzxX/wBgW8/9EPXSVzfxH/5JZ4r/AOwLef8Aoh60vEVhZ6n4cv7XUrWG7t3gYtDPGHQkDIJB44IB+oqZPlTY4q7saVFfPt4sB/ZkjtP+EDukgGlx3Ivyll5Qm2DNxgTeZk/3tm7npXodtq9/4X8UWuiTDSLHw3Jpclxp4gsmjZHjALxsfM28Al+FGRnpjJ0lHlbXb9CVqk+//A/zO/orznT/ABJ45u/EaeHrldBtrx9IGoi5+zzMu4uFCNF5gIxyD859f9mq/wDwtC/v9K05LCz+y6lcWs00+NMutQSN4pTEUCQDdhmVsOSMADgk4qdv69f8mP8Ar77W/M9OorzLTvHPjTXNcsNNttE0/SZbvSTfmLUvO8xHWVEdGXClRy2OvBUn+6bEPxJe3h1ufVprOK40uOeeTRjbSw3Sxx5CsGZiJVbAO9VCjOOcU2rfj+DsC1/D8T0WivLpfiN4mtrPWpRowu0s9NfUILqfS7zT4UKn5oHMykuwXkMuA2Oi9auw+OPEcF6kF1YWV9LeeH21a0trKN1YSJtBiLFjvBLjBCqR0wetFv6+/wDyYf1+X+aO/urq3sbWS5vZ47e3iUtJLK4REHqSeAKkyNu7IxjOa82vviHqUHw61LX9IvNF1i4sAgmQQzWpgYkhleFmZwwyuFJXPzcjilbUvEyfFPxF9lvLCe3stGgngs54HQHcZSF8wOdp3LktsbIwABjNJ6b/ANaXBa7f1rY9Etbq3vbWO5sp47i3lUNHLE4dXB6EEcEUTXdvbSQpcTxRPO/lwrI4UyPgnauepwCcDsDXn+meNfEN5H4J1O5OmQaV4giVboC1kMkU5jLqqv5mArYwMqcEd88Tt4s8SWmreHobldKuLLXNRngSeKKSN0iVHaM7C7BiQmS24dQNveqcWnb5CurX8rnfUV4zYeIPHOmeFPEevw6lpF5HY63cJdJPpkpcRRuEd1K3AGFQZCY6D71el6VqN9qOv32y4s5dIgjiSIxwsJGlZQ7HfvKldrLjC/xdeOUtUn/W1xvRtebX3Oxt0UUUgCiiigAooooAKKKKAObsf+Sp67/2BdN/9H31dJXN2P8AyVPXf+wLpv8A6Pvq6SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/yLtr/ANhrSv8A04W9dJXN+PP+Rdtf+w1pX/pwt6AOkooooAKKKKACub+I/wDySzxX/wBgW8/9EPXSVzfxH/5JZ4r/AOwLef8Aoh6ANy/tXvbCa2iu5rJ5F2i4gCF4/cb1Zc/UGuJtfhNbWml6Pp0PijX/ALLotyLqyRjanY4zjJ8jJHzNwf730x31FC0dw3Vjhrz4WWl9Y63az+Ida8vXLpLq7wbYHeuMBT5PA+VP++R6nLZfhXb3FrrsF14o16Ya+iJfM32UFwqhRjEAC/KNvA6e/Nd3RQBySfD62Ourql1rWqXb/wBm/wBmSQS+QI5YMchgsQOSfmyCOfbiqo+FtgF09m13XGn0y0ks7Sf7TGGiicAY2hArYCgfMpz3zgY7eij+vz/zf3h/X5f5L7jidP8AhjZ6fN4fZNe1iWPw/E0NpDL9nKMjDDK+IQWyuF6jgeuSdjQvCcPh8iKz1PUJNPiObbT5nQw23XhCEDlRnhWZgOwGBW9RTuxWRieIfDCeI7ae1udTv7e0uYxFcW8DR7Jo/myp3oxXduwSpVuBgjFY+q6LZeIPFGhQ29rdxjw/cGSSV4JYoygT5Y1dgBKC2xvlLAeXzziuzopLQb1MDWfCUGvTp/aGo37WYuEuXsQ0flO6bSnJQuACgbCsMknOQcVUk+HukynVd1xfBdSvBfFVmA+zXA2/vIiBkNlFPJbuOhIPVUUbf16f5L7gOR1bwD/bdjYwX/ibW2ks7lLpbhTbB3dDmPcPJ24U56KM5+bPFVr34YWl/F4hjufEGslPERU3oH2YYCgKAn7ngbQF78e/NdvRR/X9fcgMm+8OWeq+Fm0HV5Jr63eERSSyELI+MYfKBQGBAOQByK5+b4Y2lzcyXl14i16a+ewOnfa2uIg3kkkkFRGEY8kZZT6/e5rtqKHruC0VkciPh9B/wisPh19e1iTTktktJI2aDM0K7hsb91xkNtLLtbCrzkZqe68B6fNcXJtLy+063vY1jvrS0dBHdqECDeWQsp2gLlGUkdTXT0U223dhtsc5p3gq00zxVea3Bf3jfa7WOzaxcQ/Z0iTOxVAjDDGW6sevOeMZifCzSUGnw/2prBsdLu/tdjZC6CR2xww2KyqJCnzHgscdBgZB7aii7Fbp/XY5my8FR6ZDcWum61qttYybzBZo0JjtGbnMe6MtgEkhWLKP7uMCnaJ4NTw/4VtNC03W9USKzLeRcM0JlUEMNp/d7GA3Ejcp5AznFdJRSH1uZnh/QLTw3pX2GyaWQNK88ssxBeWR2LO5wAASSTgAAdgK06KKACiiigDm/iP/AMks8V/9gW8/9EPXSVzfxH/5JZ4r/wCwLef+iHrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+I//ACSzxX/2Bbz/ANEPWxq1g+qaXPZR3txYmZdpntghkUd8b1ZeRxyD19eax/iP/wAks8V/9gW8/wDRD1a8Y6ve6B4N1TV9Mt4Li4sbZ51juJGRGCjJ5AJ6A4Hc8ZHWplazuVFNySW5kS/Dm3m+Hq+DX17V/wCzlQQ+YPs/nGEDAiz5ONvA5xu/2qg1/QLfXRo/h+ZtSvZ9Mu4biS/ntzGPLAbcDIqJG+5f3ZVP73I61r6f400SXRUu9R1vS7eaG2hmvla7RBbGRQRvBbKAk4G7rV1fFGgNHZyLrmmlL/cbRhdx4uNv3vLOfmx3xnFaO6lr3/H+vvM42cdO35nEarZXOp/HDbBLrumQ/wBi/Zf7Qs7JvKMnm7ynmvE0f3e/Y8AhuK6R/AenRQaaujXV7o8+mwmCC6s3RpDGxBZX81XVwSM/MCc81r2XiDRtSvDaadq1jd3IjEphguUdwh6NtBzg+vSlh17SLi+ubKDVbKW6tBm5gS4RpIR6uoOV/GpWiS7f5v8AzKesm/T8kv0MqHwZFD4zi8Sf2vqT3EVq1qLdzEYmjY7mz+735LDdnd14GBxTbrwLp2p3qT63dXmqxxW8lvFb3ZjKRrIu1zlUDMSOPmY47YrQbxX4dW1luW17TFghCGSU3ke1A/3CTnA3dvXtU134g0bT7SK6v9Xsba3mfy4pprlESRs42hicE5HQUdLf1r/w4db/ANaGLP4FW68M3eh3XiLWpra5ha3V5HgMkMTcMinyucgY3OGbGcEHmoIfh1FDq9hqI8R60ZrCwOnxDdbqDEcZzthBzlVOQR90dsg9Ffa9o+mAnUtVsbMLF5x+0XKR4jyBv5P3ckDPTkUlzr+j2QtjearY24uwWt/NuUXzhjOUyfm4547U7u9/66r/AD/ELaW/rp/wDnNV+GdjrNlq0N7rGqmbWPLW7u0MCyNFGSUiGItoUFjzt3Huxq3L4Fgk1GfUF1nVIr2509LCedGhBlVd22Qjy9u8b26ALz93gYuav4m07QU1C91TVrGOzsbZZZYOPOjyT8xO7kNwFG0cg8nOBHp3i3S9W03TtTttZ0yO0uIGnkQzq5IC5bDhwBsIO7g9D0pbp/13QbNf12/4BTX4d6afh9B4Qnv9RnsrYIILlpES4h2MGTa6IoBXAwcZqzrXg231nUNFuhqd/YjRZfNtobTydhbaV+bfGxPykrgEcH15q3H4u8Ny2MV7F4h0p7Waf7PFOt7GUkl/55q27Bb/AGRzWbrfjzRvDNilzq+safItxqC2kPlyLGEyyghyWIygJZjwMdhTu7/P8RWVrBHouleErfUuNTvLfWLuSRrRIHuVSSXlwBGhKqT1ZzgZ6gcUzQvDV54e+G1to+mz3UF9HED5iSRvIrk5wWlVlKj7ucE7RxzitO08ZeGNQt7mew8R6TdQ2kfmXMkN9E6wp/echsKPc1audf0ez0dNWvNWsYNNkCsl5LcosLBvukOTtOe3PNLZfd/wB7u/qXYRIsEYnZWlCjeyjAJxyQKfWaviPQ3nt4E1nT2luoPtFvGLpC00WM+Yoz8y4BO4ccUWXiPRNTsJ77TdY0+7tLckTXEF0kkcWBk7mBwOPWhguxpUVnDxForaS+qLrFgdPQAvdi6TylBAIJfOBwQevemxeJdCnnt4Yda06SW6hM9vGl0haaIZy6jPzLweRxxQBp0Vx3iHxv8AZrHRL/wxNpmq2OoarDYTXMdz5ioHcKSmzIY9erDHv0q5r3jLTfC+i6vq2qapZSwWTBVhiIWRH2giJjuOXJ5HC4BHHGSdL/10/wA0Pd2/r+tDpaKy7DWrLU7hJNP1fT7q2ktvOWOCRXcjP+s3hsbO33evftU+nazpmroz6TqNpfKhwzW06yBeSOdpPcEfgaCb31Mix/5Knrv/AGBdN/8AR99XSVzdj/yVPXf+wLpv/o++rpKBhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfjz/AJF21/7DWlf+nC3rpK5vx5/yLtr/ANhrSv8A04W9AHSUUUUAFFFFABXN/Ef/AJJZ4r/7At5/6Ieukrm/iP8A8ks8V/8AYFvP/RD0AdJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/wCSWeK/+wLef+iHrpK5v4j/APJLPFf/AGBbz/0Q9dJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/5JZ4r/AOwLef8Aoh6T4i+Y3w31+KC3ubmaewlhihtbd5pHd1KqAqAnqRzjA6nil+I//JLPFf8A2Bbz/wBEPXSUpLmVioy5ZKXY8n0WCOfxt4btm0TUY7BvC72F0ZdJnihVyYyI3LIFHCv1+nUjLtD0qafQtb0HXrRbi08MW0+n25nUOlwrrvjbBzkrF5a5PctXqF3BJc2csMN1LaSOpCzwhC8Z9QHVlz9QR7VnP4ejPh+70yO+u4nvA3n3q+WZnZhhn5Qpkjj7uAOgGBTqNyi15P722/wuyYJRt5W/BJfjZHmPhG1l17w/8PU0Wwu7SfSLLzbm+ltHhjVHtiuxXIAk3uyt8hYDbk4OKi0rwrFJotn/AMJMPE15qGh2U0EthNpcbWzb4yr7WjtwbhWOCAHZs4JGQa9W8NaDF4Y8OWejW13c3cFlGIopLrYXCDhVJRVBwOOmfXNalXUalKVuv/B/zFG6S8jyTQPD0EXwp8Lzra6loes6fChNzBo7yTRSxo4KywlN7qd7jAHJbKkZzVdrTX7+8sr/AMUx6tpdpfadJZyDRNMSfDmZyxkheGV4xKhRuBwQQxzivY6KUnzSbfUForf13R47aaNY+HPiFaCLRdXntrLwzJZm9k0qWd5HBUorSRx4Z/LBHH+714qlo9vq+n/D/RL3TLbWLfXLXSksJdNvNEllgvcM+IXBUNHgg/PlVAZckivb6KXM/wCvVv8A9uY9P6+X+SPHtT0+5u/FHj2Kx0G8gn1Tw4kKsmnyJFPcqku9RLtCO3zoM556DOKsWgB8feAr0aFqkTw6TLa3dy2kzDZuRFjWR9nyjcH4YjbnJwDk+s0UJ2/r1/zE9V/Xl/kef+GtIvdN8Sah4fnsJV0Owu31OzuDF+7kE2SIR6lHaU4HQbPWuN02wuE8HmKx0HVLeGz8aJfLbf2VNCVtTPlXSMoCVC9lHHcCvcqKE7NPtb8Gn+g5aprv/k1+rZ5vr2n3dl48iXT7N1svGEC218oAHkyRfMXbB6tD5i5GeVWu61fSLXWdBu9Ju4wbW6gaB1x0UjHH0qODRxHqz6hc311eSfMIEm8sJbK2MqgRVz90csWPvya0qTs48o7tSujy+GHWr74baq+v+H572+srF9KWydGQ3gU4eVdpDFXAUgDBOzjrVLT9Jl1DWPFC6nFrS2+qWenNDdxaU0BVkZhlEZeNh2kq+5sZzkV67RTu3v8A1/TJtbb+tv8AI8jhm8SS6hpWsazpt1qWm6Xqkhe4i0t4Li6RoNiXD2pG8sjZXhckcquK0b/T7TTPE3hLWtF0XUItKiurxp1hsZmkRriPO8xYLopfIOVGCeQBzXpdFFx2/r7/APM8OKanZ+FrWC78O63E6+M2v9senvMTbi4LmTEQYgAEdcZ/hz1p9xps934T+J1lo+hajD9tvRc2cJ0uaATrsjDGMMg3EsrnA5PXHNe3UUJ2Vl/Xw/8AyKDrf+t2/wBTylI7a8+KGuTtoOrw2eo+HRbzzR6VNGZ5AWJG/aAX8sqBk56L1GB0HgVtYh1bUNPvTNfadZwxRWup3enNZzuQWBiYEKJAowQ6qFO49Tmu2ooTt/Xm3+ov6/BL9Dm7H/kqeu/9gXTf/R99XSVzdj/yVPXf+wLpv/o++rpKQwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/wAi7a/9hrSv/Thb10lc348/5F21/wCw1pX/AKcLegDpKKKKACiiigArm/iP/wAks8V/9gW8/wDRD10lc38R/wDklniv/sC3n/oh6AOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDpKK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDpKK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDpKK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDpKK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgA+I//ACSzxX/2Bbz/ANEPXSV534+8A+D7P4beJbqz8J6HBcQ6TdSRSxabCrxsIWIZSFyCCMgiug/4Vx4I/wChN8P/APgrg/8AiaAOkorm/wDhXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImgDpKK5v8A4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJoA6Siub/AOFceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8AiaAOkorm/wDhXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImgDpKK5v8A4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJoA6Siub/AOFceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8AiaAOkorm/wDhXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImgDpKK5v8A4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJoA6Siub/AOFceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8AiaAD4j/8ks8V/wDYFvP/AEQ9dJXnfj7wD4Ps/ht4lurPwnocFxDpN1JFLFpsKvGwhYhlIXIIIyCK6D/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgAsf+Sp67/2BdN/9H31dJXndn4B8Ht8SdZtW8J6GbePSbCRIjpsOxWaa8DMBtwCQignvtHoK6D/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Sub8ef8AIu2v/Ya0r/04W9H/AArjwR/0Jvh//wAFcH/xNYfizwV4V0jS7G+0rw1o9jdxa1pfl3FtYRRyJm/gBwyqCMgkfQ0AegUUUUAFFFFABXN/Ef8A5JZ4r/7At5/6Ieukrm/iP/ySzxX/ANgW8/8ARD0AbmoS3UGnzS6fBDcXKLmOKeYxIx9C4ViP++TXA2PxP1L+ydA1nW/DtvaaTrk8dvDNaakZ5YXkOE3xtEnGepVmx6V3mp3aWOl3FzKk8iRoSUt4Hmc/REBZj9BXi/hPRbnQvD3hvxImj61qB01Ps+o6TfW1w81s56T2sUo4K7sERjBUnHIojbm120/X+r9Bv4dNz2W91rS9Nu7e11HUrO0uLo7beGedUeY+ignLfhQda0tdUOmnUrMX6qGNqZ180A9DsznB+leX6vpDeI/EGsx6xP4ottJ16OE2ostKUhkVApjkMlu0kDhwWBYovzZBzmtMWOo6Z4rgt9KjvNQsdSuwdR0/UtNLxxAJsadLkAKD8oO1ixbPAFC8/wCv66/0xPTVf1/X9djuIvEeiT38djBrGny3cu7y7dLpDI+0kNhQcnBBB9MUi6xZwS3bXmr6d5Uc6whQ4QwsQMRuS5yxJyOF4IGD1PkHhWzXVPAumaDoulXMV5b+I5LpbmOzZILeKO8cs4lxszsBTYDu5xjFZ+tadbSP4hto/CmqOJPFNrfWgTw9clfJXyhNIpEWBnbJnu2e+apK7t/W8f8AN/cwel/67/5fie2S+LPDsENtLNr+lxx3blLd3vIwJmBwQhz8xzxgd6qHxvoY8cDwr/aFsNS+z+cY2nUNnIwgHdiMtgcgDPeuC+IelTTPr9jomgXFst3oTCKey055TeOWdzF0KREE5OV3uX4ORVq+0/WLvxXeSaZZ3sD6n4RWztLp7d0WKcM5w5I/dkbgcNg+gOKnpf1/J/5Dsu/b84/o/wAPu9EtPEGjX93c2tjq1jc3Fp/x8Qw3KO8P++Acr+NUbnx14Rs5FjvPFOi27su5Vl1GJSRnGQC3TIP5VwcmlxatD4WX+wr23Xw/aSR6rHPpkoVoTblGgUbcThnwcJvBxn0yvhHwVDq3wKtdNbS20zWY7YhJLmyaCaGdJDJGfmUNgOQcjg5PvTaSv5flrqhLW3S56dFq2nTanJp0N/ayX0cYle1SZTKiHoxTOQD64xVHxX4o07wf4butZ1eZI4YF+VWYKZX/AIUGe5NYnhTXTL4Xfxbr9pcWct/sDxLbtK8KINmCIwx27t756ANk4qf4oWV1qvwu1u20y3ku55bcGOKFSzPhgflA5JwOgoasENWrlO3+ItsfGd3aX17o9voCaZFfW+pC9BWXfIU5c4QcqwwCc8c9q6rUdd0nR7NLvVtUsrG2kICTXVwkaNnphmIBrzTULhbv4h6zqEuhau0DeGPskUj6NcNuk3uxRSEOSVZePwPIIEfhFb3Sx4d1bX9L1SWxXw3Hppi/syaSa2uFYeYrxBC4DAAbtu07euMZEtP6/vf5JfNC8/T8o/5t/I9Ou9f0ewVGvtWsbZXj81TNcom5Mgbhk8jJHPuKE1/R5NYOkx6tYvqSrvNmtyhmC+uzO7HvivH/AAp4PTTPHmhW2r+H5pIzYX6SO+mvLDEkswaCF5dhT5Y9wwThckdxm4lrft4q0WcaJqFjDZ+Jbh5baHTpWjjWSOVRO0pBL7iQcoQihsEcA07LTz/zsD2fl/lf+v6R6suuaS2sNpK6nZnUlTzGsxcJ5wX+8Uzux74qGLWbK30mfUNQ1jTmtIpXDXaOscUYDEbWYuRuXoTkcg8DpXE+E7C1i0+HSfFOgX0ur6ZfXF0Lg2UjxzF3f98JgNjbkflCxbttOBXN+FrW807SdCuxoGqLpuk67fy3Fj/ZksbxxymTyZUhKAuFDDhASM9OKSG9P69f6/z0PaLS8ttQs4ruwuIrq2mXdHNC4dHHqGHBFVbfxBo13qVxp9rq1jPe2ozPbR3KNJEPVlByv41D4etdOtNJf+xdPlsraaV7gRSxPEzM53M2x8MmSTwQMeleT2NtKdV0C71Tw7qUOnwQ6lBdacujTSx23mDOwkqzzbufnGUYngDpUvQaVz1228Q6Ne3yWVnq9hcXTxmVIIrlGdkBwWCg5IzxnpXPeK/HI0bXdG0vSp9Lup7vUobS9ge5zPbpJ0YRrzzg8kjHHBrz7wvb3Gn6R8M7aPQ9WtJ7G4uPtuNHuEEG+N0Bc+XgAsycnjv0Gam+y6nH4b8LaZL4Y1W41rRfECXF88dmdsvzSM86zNiNg+QSd3GcHHFXb3l6r8/8tyX8L9H99n/ke20UUVIwooooA5v4j/8AJLPFf/YFvP8A0Q9amu3t5puh3V7ptpDeXFvGZBBPcGFXA5PzhGwcZxx19OtZfxH/AOSWeK/+wLef+iHrb1K2a80q7tYyA00LxqT0BKkf1qZ35XbcqNuZXOds/FOr3fw2XxONGs0uZLQXkdkdQYqYiofmXyeG2542kZ4z3q9B4qsbXSYbnxPfaVo9y0aySwtqCskYY/L87hCc8fwjngZ61ymj6neRfDa38KT6Jqq65Fpw09ovsMog3iPZv+0bfK2d87s47Z4rPcaboPxf1lZtImuzceHrWOQWVg07TOXkX59ikjcFA3NxgDJHFaTspPl26fj+ehEb8ib36/ev82ek32vaPpib9S1Wxs18vzd1xcpGNmQN3J6ZI56cikvNf0fT9Nj1C/1WxtbKXHl3M9yiRvnphicHNeRaHp8fgvxp4TGt6dNLexeGZ47j7JZtdTKRLGFUiNWZgoOzIBA+lPsvDOr6MmmTakda07TJIb2NYtLsorySzE1wXWJ4jDKQpjwDsHBXB4oa2t5/g2vxt+I/+B+KX5Hrd5r2kaeFN/qtlaho/MUz3CJlMgbhk9Mkc+4qe71CzsI0kvruC2SRgiNNKEDMTgAEnkk9q8n03wjpWlfEXw1p6aJqF5Y2+i3NpJd3+mtKGDOpiSWURhPuBwAcbQcHBODu/Fiyt7m38Nk6PcahLbazbzbrbTpLkwQq4MhyiNtGAOOM474osrq3V2/G3/BF38l+l/8AgHXv4n0GKCzmk1vTUivm22kjXcYW4Pohz8x+mamk1vSotUGmy6nZpflQ4tWuFEpUnAOzOcE8Zx1rzfxJ4VSTxRqtjetrVjoesWcVvCuiabFNERl98cn7iRojuYtuyq/MTnIqw2n6joXiC1i0KPUL+K+ubdNQ0/UtPMsbBERGuFuQAiMqqDhidxU7QKUdX/X9f121G9P6/r+vuO8HiPRGv4bFdZ083c7MsVuLpPMkK/eCrnJI746ULq9pC97Jeavp/kQTLHw4Q25Kj5JGLkFiTkcLwQMHqfHtEsI9Q8FX/hrQ9IuI7z/hJ5pbeaGyZILZI7zPmeaBsXaqkBc7uwGKpeINLgn0bxnZReFdTk+0eIbe6sUTQLgqyjyhLImIsDO2XJHXPfcMi1t/X8v+b+71B6Nr+uv+X4ntM/izw7bW0Vxc6/pcME0rQxSyXkarJIDgoCTgsCCCBzVX/hN9D/4TdfCw1C1/tE2/nGMzqGySNqAfxMRlsDkAZ71xfjnTmmu7610XQbi3S+0GdY7u0015DO7ksYSMbIicBiXXc2cAgjk0qy1U+KIZrewv7c3vhCGzguJLV0WGdWbIkyBsI3A4bBPbNTrvb+rS/wAvx+8f9ffH9G/u+70W38QaNd39xY2urWM93ajNxbx3KNJCPVlByv41RufHXhGzkWO88U6Lbuy7lWXUYlJGcZALdMg/lXnTaL/aHh3wjp0+h3sdz4dT/ia+dpsjIYhAyyxodpE/mNj5Y9+e9WvCPgqHVvgVa6a2ltpmsx2xCSXNk0E0M6SGSM/MobAcg5HByfeqdlfsvxXdAtbef9WPTotW06bU5NOhv7WS+jjEr2qTKZUQ9GKZyAfXGKt1y3gK7udb0U+ItStGtLvUguYXA3RJGNu3jtuDsP8AfrqaGraCTurhRRRSGc38R/8Aklniv/sC3n/oh66Sub+I/wDySzxX/wBgW8/9EPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzdj/wAlT13/ALAum/8Ao++rpK5ux/5Knrv/AGBdN/8AR99XSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN+PP8AkXbX/sNaV/6cLeukrm/Hn/Iu2v8A2GtK/wDThb0AdJRRRQAUUUUAFc38R/8Aklniv/sC3n/oh66Sub+I/wDySzxX/wBgW8/9EPQB0lFZ3iG+utM8N6hf6fDDPc21u8scc7lEYqM8kAnt6VxOmeMvFF/deGbeQaRE3iPSmu4mEErC1kREY5G8eYpD/d+QjH3j1oWt/wCu/wDkw/r8v8z0emSoZIXRJGiZlIEiAblPqMgjI9wRXmtv8Tb+58PaSDAkOrX0l3G8kGm3N7Gn2eTy2cQw5chjtwCwxnknHNvTfG+ua9FpWkx6bHpOtX0dzLMdStJfLjihcJvELFHO/euASMAnOcYJZvRBtubPg7S9H8J6ONOsfEL6jDPeyiJrueFm85izvGpjVcnO5tvJHPYcdTXjPgDXNR8O2uj6RbWGnx2WpeJNRtJ/LLDySrSOFiQAAL8mMk8cDHcdIfHWsQ+OrHTLhdNa1vNRmsTawqzzQBY2dJHmVzGCwXPlFVYBupware39dv8AMHpfyv8Am/8AI9CqKW7t4JoIZ54o5bhikKO4DSsAWIUHqcAnjsDXmN9461jUPB/iNrfU9O0/V7GxuJ30+SylS6tNg44d8SDhv3gAXJXAPe7p/iHxHpC+CdJdNMvU1a0cNPiSFgyW5dF25fA4UF8nPOFFSv8AL9f8gen4/hb/ADPRqpanYTahAkcOpXWnhXDO1qI8yL3Ql0bAPquG9CK4DQPiD4hvrfwxf6pbaZHba1qM+nyQWyyF42Qy7XDs2MfusEbec5yPuixaeN9Xl8c2OjajHpj2mo3N1atawRvJJaiJWZS8wZo2LquTHhWG7vg0+V7Be2v9df8AJnZ21rpV5oyWVmYZ7CECEJDLuTCcbDg89MEH8at3V5bWMIlvbiG2i3BQ8rhFyTgDJ7k1xfwghitvA88FvGkUMWrX6RxooVUUXLgAAdAB2rlfHmq33ivwmNVSHThpFpr8FvbpLAzXIeO7WJphJu2rkhl27c7Tndzina8ku9vxt/mLZPyv+F/8j1+O6t5biaCKeN5oMebGrgtHkZG4dRkdM1LXn0/jnXYm8XRf2bbGTRLq3hh+zpLcfupAGMroMM+1W3FFx0IBPWpl8cT3dvo1ro2o6TqV3rVzJBb30MT+REscW92eLfu3BgRs3jqMmpWq0G9N/wCrHd02SRIo2klZURRlmY4AHqTXmF78RvE1lO2mHT9Ll1Cz1u20u7nLyJG6ThWSSNOSCVJyC3ykD71WtX1TxBren634euItEkn03T/M1MyQSSQ3BkDlY41LAp8qglm34JwAetKTtByX9aX/AFQ0ve5X/Wtj0K2uYLy1iubOaO4gmUPHLE4ZXU9CCOCPepa8a0Lx1qOleBNB0rQbV5ruz0C0unX+yrq8E5dCFiBgGIidh+dsjn7pwcdBpXjPxfrniifT7bSdOsIoLKzv2hvTL5+yUtvjYYGyQBWwMEAgZzn5dJx5ZOK6P+vyJT0v/XT/ADPRaK47wR4tuPEkkkd9d2C3kSFrnTFtpILmyYkbUdXY7wPm+cBQeMCuxqWrDCiiikAUUUUAFFFFAHN/Ef8A5JZ4r/7At5/6Ieukrm/iP/ySzxX/ANgW8/8ARD0/x9d3+n/D3XL3SLlLW7trGWWOV49+3apJwMjnA4PY84PSpk+WLZUY80lHudDXP2/hKO38c3PigarqD3FzbrbPav5PkCNSSoAEYfgknO7PPPHFcdpviHxpa3Hh7w5ZjQp5LzQ2u4ruZJkGUEYCsgY44cAkMc8nAxtNw+PdYtvGljp16umm2utQmsntYFeSa3CRs6yNMrFAWC58oqrAMOeDWjjyy+//ACM0+aN/67/1/mdLP4SjuPHNt4oOq6glxbW7WyWq+T5BjYgsCDHv5IBzuzx6cV0FcToPiDxV4hg07V7K207+xdUWQopRvOslwfLkclwJckAFFVSN33jgmmfCO51e+8DLea3fQ3kk13csrR25jYfv5A24l2ByemAuBgc4zSs0rPp/mU+53NRW11b3tutxZzx3EL52yROGVsHBwRx1FcXovjPUNV1DUrEz6ZFqlt5xTR7mGW3nRVJCMXJbzEY4JdEwAcDJFVbDx5rGq+D/AApeW8NlaX/iKZojNLG8lvbEK7fdDKWJ2YA3DJOfalv+H4h/wfwPQ6RwWRgGKEjAYYyPfmvL4/iR4nnXS/K0jR1jutdfRpLj7XK25kLBpFTywADsJHzt2HrieT4ga1baXqC3q2aT6brLadd6lFYzSW8MXliQTNCshcD5lU/PgE5JxxRa6/ry/wA0PVO39df8mdZ4T8JxeEbK6tbfU7/UEubl7pje+USsjks5HlonBJzg59sVvVnaXqJ1DQY7+G4tL8SI0kUtm/7qVcnbgknHGM88HNcLovj/AMQXmqz2E8WkXU7aPJqMKW/mRxwSI4UwNMDIsuN3LpjkdORQ97Pp+i/yQlqr9/1f/BPS6hmvbW2ngguLmGKW4YpDG8gVpWAJIUHqcAnjsK850b4jaw0Phm/16HT1sdc0ue8aO1jfzLdooxITuZiGUqTxtBB7ms+7uNT1jxx8Ode1ODTUjvp5pLdYISJ7dGtXYRvIWIfPU4CgEdD1quV81n/W/wDkK6tfyPXKp6nYTahAkcOpXen7XDO1qI8yL3Q70bAPquG9CKuUVIyK0tYbGzhtbWMRwQII40H8KgYAqWiijcAooooA5v4j/wDJLPFf/YFvP/RD10lc38R/+SWeK/8AsC3n/oh66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAObsf8Akqeu/wDYF03/ANH31dJXN2P/ACVPXf8AsC6b/wCj76ukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACub8ef8i7a/8AYa0r/wBOFvXSVzfjz/kXbX/sNaV/6cLegDpKKKKACiiigArm/iP/AMks8V/9gW8/9EPXSVzfxH/5JZ4r/wCwLef+iHoA1ta0wazot3prXVxaLdRmJ5rbZ5iqeDjerDkZHIPWuasvhtBY3mhXEXiLWWbQrV7W0V/sxHlsMEN+55OAoz/sjvkns6KP6/r72BxVh8MbHTdLt7W21vV1uLS6lurW/wB0AngaUkyKMRBGRiSSrKw+mBjS1HwZb6jJYXZ1PUbfVLAsYtSgeMTMGADqwKGMq2B8uzAwMAV0dFO4HCW/wn02zvbO5s9c1yFrTUJNRVDcRyK00mdxIeNsDDMMLjrk5PNW4vhvYQXVtLBquqxpaak+pW8IkiKRSPv3qMx5Kt5jdSSM8EV2FFF/6/r0D+vz/wA2ctc+ALDUZ5ZdY1DUNR3WElhGLh4x5MUihZNpRFYs2ASXLc9MVWufhzHO+iSR+Jdct5dEjKWskZtmOSmwsweFgTt4wAB3xnJrsqKX9f197G9dzhbT4V2lnZ6PaxeItbMWj3r31sGNtzIxJO4+TyPmfj/bPoMWbb4bWVnNYPa6zq0Y067murNN8JWEyhg6DMZ3L87H5sn3xxXY0U7sX9f195g+EvCkXhDTJrG21K+v4priS43XpiLK7sWfHlovBYk8568cVkah8LtJ1CK9tTqWrW2nXt0t7JYW1wqRLOHDl1O3euWGSAwHJIAPNdrRR1uByumeBI9K1bVNRtvEGstLqckckwkkhIUxgBMHysnCgL8xOR1yeabH8PNMityy3l9/aZvGvv7VDRi4E7JsL4CeXygC7dm09xnmusopAcdqHw3stQt4FbWNUhnjvk1Ga6iMHmXVwgAR5N0RX5QowqhV9qu6r4Js9T1mbU4tQ1DT7i6tvst59jkQLdRjOA4ZWwRuOGXa3PWukooeqt/Xb8tA8/67/mchp3w307RY7AaFqmq6dLZW62pmjnSVriFSSEk81HBAJOMAFQcDA4q5p/gyHTvFV7rseralJNeWyWrwSNEY1RM7MERh8gsxyWOdxznjHR0U229WFrGFYeFLe08Q/wBtXN/e6heJbfZYGujH+5iJBZRsRS2SoJLbj6EVu0UUXAKKKKQBRRRQAUUUUAc38R/+SWeK/wDsC3n/AKIetnVdNt9Z0e80y+DG2vIHglCtg7WBBwe3BrG+I/8AySzxX/2Bbz/0Q9dFLLHBE8szrHGgLM7nAUDqSe1J2a1Gm07o5TT/AIfwafr+lasuu6vPLpdmbOKKZoCjxnGQ2Igcnap4I+7x1OWRfDfT4Lq2lh1XVES01J9St4PMiKRSPv8AMXmPJVvMb7xJGeCK1ZfGnhaCyivJ/Eujx2sxxFO9/EEkPorFsH8KtTeItFt7uW1n1iwiuIUWSSF7pA6I3CsVJyAcjB71V3f+vUnRL+vT/gFDQvB9v4dkaPTdS1BdO3tJFpjSIYIGY5Ow7PMxkn5S5XnpU/hnwza+FdPksdPuLqW3aZ5US4cN5W92cquAOMseuT6k4FPk8WeHYoJp5df0tIoJvs80jXkYWOX+4xzw3seam1DxBo2kqW1XV7GyCoHJublI8LkDd8xHGSBn3FIfUy5vBkVzqUV9caxqUtxbQSQ2buYSbUuu1nU+XlmI/v7h7VyGueCrbRPDeh+GpJtevtBtpJJJLiOxhv3j4wkbwCBg65ZmDGNipXqOCOwvPHegWXirTvD82p2gvNQiMsQa4UDGQEA55Lk/KB1wcVqQa9pFzq0ul22q2M2oQjMtpHco0sY9WQHI/EUf19wf195xtl4HbV7XTPN1rWLew0i6S60xTaWtq5IXHzxCAbVGSAu1Dy2R901q6b4D/sm41S4s/EutLNqdybqVybY7JCmzKjycdAvDAj5QfXO0viPQ3uorZNZ09p5i4jiF0hZyhw+BnJ2459O9InibQpNIk1WPWtOfTomKyXi3aGFCDggvnAP407/193+SC3T+uv8AmyLS/DGnaR4ZbQrUSG0dZBIzv88hkJLsSMAElieAAM8AViW3w2trT7M0HiDWVltdPk02KUtASsDFSFwYtuV2jBxn1zVnxj41i8PeGJNS04R3heOTyJwyvAJF6ByrbsE8fKDz1xW1omrx65paX0MEsMcjEIJduWAONwwTweozg46gHije7/r+tWG1jl7P4W2No2gqdc1eeDQYHt7WCX7OUeNxtZXxCC2VwvUHA9ckyW3ww0y3l0ndquszW+izmbTrZ7sKtuCMbAyqHZcHGGY8cZwSK7Sii7vcVugUUUUhhRRRQAUUUUAc38R/+SWeK/8AsC3n/oh66Sub+I//ACSzxX/2Bbz/ANEPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzdj/yVPXf+wLpv/o++rpK5ux/5Knrv/YF03/0ffV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfjz/kXbX/sNaV/6cLeukrm/Hn/ACLtr/2GtK/9OFvQB0lFFFABRRRQAVzfxH/5JZ4r/wCwLef+iHrpK5v4j/8AJLPFf/YFvP8A0Q9AHSUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38R/+SWeK/8AsC3n/oh6v+J7CDVPDN9Y3QuTDcx+UxtF3SrkgblGDnHXoenQ1Q+I/wDySzxX/wBgW8/9EPXSUnqB5pBpGs+LfCev6Vq+ZXhdG0rV5tPaymllQbkd4mAOUcAbgFDAnAArC8VLN4r+ErazqXh+6udT1O8tWitIrBrmSBYnUNwittGBMc9w+O+K9c1Owm1CBI4dSu9P2uGdrUR5kXuh3o2AfVcN6EVPaWsNjZw2trGI4IEEcaD+FQMAVV+vp+H+egf8E8l1gifxN43nttE1Uw3nhuK2tXGi3IEsmJAUX931+eMY9v8AZOKfh66sNK8eaXd3miX3nSeEIoriNNJla4MiyCMh4wm/+HbuIxgDnGDXtdc+PCMY8eHxV/a2ofaDbfZPsn7nyPKznbjy9/3vmzuzn24pLf8ArtL/AOSB6x/rvH/5E4Dw/wCHtb0HWPCYnsLtNulX9uDHH5i2byzI8UbsvChVGMk4+XA7Ciy0W5uvDfhHRJdLvYNX8P3kc1/cvZSCMIobzisu3bL5mcbULE7uR1r1+inf+vm3+vzF3/rpY8EsLRbTwJpVnD4Z1WF4fFpu2gXQbgbLbz2bft8r7vlsB9OOxFbqWhvfEniwvDr+mN/bEN9Y30GjzOoMdsELhWjIkUlWXABJyCOxr16ii+n9f3f/AJFD/r8/8zitH0aTxh4G8rxfp0dreSm4jS4gtvs8ux2I85VfLQs64JU888+lddZ2Nrp8BhsbaK3jLs7LEgUMzHLMcdSTyT3NT0UNiCiiikMKKKKACiiigAooooA5v4j/APJLPFf/AGBbz/0Q9dJXN/Ef/klniv8A7At5/wCiHrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5ux/5Knrv/YF03/0ffV0lc3Y/wDJU9d/7Aum/wDo++rpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm/Hn/Iu2v8A2GtK/wDThb10lc348/5F21/7DWlf+nC3oA6SiiigAooooAK5v4j/APJLPFf/AGBbz/0Q9dJXN/Ef/klniv8A7At5/wCiHoAP+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfrevLuCwsp7u8kWK3t42klkboqqMkn8BWBZeNYrxrMNo2q2y6gxFi88Ue25AjaQEFXOzKqcCTaeenXAAv/AAgekf8AP54g/wDCj1D/AOP0f8IHpH/P54g/8KPUP/j9TeDfEx8W6AdSawfT2W5mt2t5JFdlMchQ5K8ZyvbI9z1rZia4aaYTxRJGrAQskpZnXAyWBUbTnIwC3ABzzgOwGB/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8ACj1D/wCP10lFIDm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfrpKx/Fmvt4X8Kahra2Mt+LGEzNBE6oSo6nLHGAOe544BPFJuw0m3ZFP8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfrdsbn7bp9vdbNnnxLJtznbkA4z+NT1TTTsyU01dHN/8ACB6R/wA/niD/AMKPUP8A4/R/wgekf8/niD/wo9Q/+P1L4x8UN4S0mC/GnS3yS3cNs2yRUEXmOEDMTyRkjgAnnsOa36XS4zm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfrpKpaxq1noWj3Wp6lKIrW1jMkjew7D1J6AetAbmR/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9dGrblDDoRmloA5v8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfrpKKAOb/AOED0j/n88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8AH66SigDm/wDhA9I/5/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/AB+tfWNXs9C0qbUNRk8uCLGT3Yk4Cj1JJAH1qwrXBvHVoohbBAUkEpLl8nIK7cAYxzuOcngY5AMD/hA9I/5/PEH/AIUeof8Ax+j/AIQPSP8An88Qf+FHqH/x+ukooA5v/hA9I/5/PEH/AIUeof8Ax+j/AIQPSP8An88Qf+FHqH/x+ukooA878feCtLtfht4luIrrXGeHSbp1Euv30iEiFiNyNMVYeoIIPQiug/4QPSP+fzxB/wCFHqH/AMfo+I//ACSzxX/2Bbz/ANEPWzql82maXcXqWc96YE3mC3KCRwOuN7KvTnkjpSbSV2NK7sY3/CB6R/z+eIP/AAo9Q/8Aj9H/AAgekf8AP54g/wDCj1D/AOP1R0j4lafqb6R9r0rVNJh1tQdOuL1IjHckruCgxyPtYjkB9pNdlVNNbk3Ob/4QPSP+fzxB/wCFHqH/AMfo/wCED0j/AJ/PEH/hR6h/8frpKila4WaEQRRPEzHzmeUqyLg4KgKdxzgYJXgk54wUMwP+ED0j/n88Qf8AhR6h/wDH6P8AhA9I/wCfzxB/4Ueof/H619L1ez1m3ln06USxRTyQFx0LI21sewII/CrtAHN/8IHpH/P54g/8KPUP/j9H/CB6R/z+eIP/AAo9Q/8Aj9dJRQBzf/CB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wAKPUP/AI/XSUUAc3/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8ACj1D/wCP10lFAHN/8IHpH/P54g/8KPUP/j9H/CB6R/z+eIP/AAo9Q/8Aj9dJRQBzf/CB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wAKPUP/AI/XSUUAc3/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8ACj1D/wCP10lFAHnfj7wVpdr8NvEtxFda4zw6TdOol1++kQkQsRuRpirD1BBB6EV0H/CB6R/z+eIP/Cj1D/4/R8R/+SWeK/8AsC3n/oh61ta1NtH0e41BbG5vxbpvaC12eYVHUjeyrwOevbjJ4pNpK7Gld2Rk/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0W3jFbrwL/wlMWh6p9naH7QlqfIE7xYzvA83bjbzgsDx0zxWzpV8+p6XBeSWVxYmZd3kXJQyKO2djMvI54J61TTTafQm90mY3/CB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P1o2mspq9jLcaF5N2IrlrcmSUohKPtkIYBs4w2OOSMZHWtOkM5v/AIQPSP8An88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8frpKbKZBC5gVXkCnYrttUnsCQDge+D9KAOd/4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfroojIYUMyqkhUb1RtwB7gHAyPfA+lOoA5v8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfrpKKAOb/AOED0j/n88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8AH66SigDm/wDhA9I/5/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/AB+ukooA5v8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfrpKKAOb/AOED0j/n88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8AH66SigDm/wDhA9I/5/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/AB+ukooA5v8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfrpKKAPO7PwVpbfEnWbc3WubI9JsHBGv3wclprwHL+duI+UYBOByQBuOeg/4QPSP+fzxB/wCFHqH/AMfosf8Akqeu/wDYF03/ANH31dGSFUljgAZJPagDnP8AhA9I/wCfzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/x+rPhXxbpnjHTZ77R2lMUFzJbOJVCtuU9cZPBBDA9wRW3QBzf/AAgekf8AP54g/wDCj1D/AOP0f8IHpH/P54g/8KPUP/j9dJUUbXBuJhLFGsIx5TrIWZ+Ody7QFwemCc+1AGB/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9dJRQBzf8Awgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9S2Xihrvx3qPhp9OlgNlaRXS3LyKRMrsR8qjJABUjnB46YwTv0dLh1sc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9Yfizwlp2maXY3dtc6w8setaXtW51u8uIzm/gHMckrKevcHB56ivQK5vx5/yLtr/2GtK/9OFvQB0lFFFABRRRQAVzfxH/AOSWeK/+wLef+iHrpK5v4j/8ks8V/wDYFvP/AEQ9AGp4gkgh8N6lLd2n22BLWVpLbGfOUKcp+I4/GvMNFlj8L+KtK03wp4iGs6K8pFxot6RJPoqeWzebvPzxKB8u2T1wK9fooWjuD1Vv6/r+mfPngfXvDs+qWsXixtJu9IfVb5tJuGkjkSG6Nw7Hzc/dLIUKHp+JU1W8Rap4eXQ/HdquvRh18S2zwKNVbe4IiD878so/e8HIXaem0Y+jKKadrf11T/QOr8/+D/mea+Cb/RIfi74r0vQbuyFvJaWlyLe1lUh5fnEkmAeWwY9x9xnrXM/E6602TXtcmzDDqeltYyJNePmaJPMUs1qoAMaYOHk3EE5BHAr3Cijqn2De9+p87+I77wxJb/E+8i1Szuri3mt5tOlkvvOaKYRg7otzHBEhYfL05XoMVoeLdQ0XV9I8av4klt7jUnsPN8PySENvtjbKd1se+X37ynOPvcV7xRS+zby/r8hp2dzlJxFq/wAK0jW9l01LrT44luJYHVoiQFBZDhsZ4I44/OvNdRmsrjwkJX0nRYI/D2vae7alo/Nk0YkXe8fH7vaMh1BOO5Ne60VXN7/N5p/c7kJWio/1tY8C137Bd6j48XRbVntZr/SbwyWlq/lSKrxtLIHVdp+9uJB5BLcjJrR1gRxXWuaj4BG7wxMlk2oPpXMUzfaD9oaLZ1byvvlOfXmvbKKSdreX/AWvloU9b/1/TPHPFmj+EF8AXuqeEHtbjT49Qsr4rZlZLWz2TKJHiCjbGdm7eAc9yBnnA8aromp3fxFl06zhure50qyu47iG0LwyOrMXlEgXYThx82ckZxnBx9BUUX/r7v8AJDX9ffc8D+IL+HnttVTRorK2l03SYJ7BpVwIVDs2+yjUKU/2pQ2Pu8EVB4kvvCt3e/Ey4Oq2V3ImmW0to0t/5uy4CvzHuY4ZXZQNv3S2BjOK+g6KL6feJaW+X4W/r5nhepD/AISzVZYtU8TaPpjXVrayaJe3Vm08zDyl3PaSidFEnmbgVVSx4zkECtDW4dPuLnxTB41kj/tnYp8PPL8lwQIFw1qM7g/m7shOc4B4xXslFD1vb+vNefmEdLeX9fceEX1vbaa/jC08Ww2q6jqvhW1neJ4gTd3MccvmOqgfO6sFJIGRwferMd5b6faaDrPlafqrNYWdidJv4ng1CFgAGNruGTnILIFGdud2K9uop82t/T8L/o7EtXSX9dP8jgfjTZWt38Mbp7y1inS3ubaUmWMMI1Eyb256DaWyfTPauZsZfDjfEDxlpOi6xDp1vcaDbpF9mmJ+zEeYGMceflCgodqgAAg8ZzXslFStL/10sXd/163PFoDaX2h3+j/8Uzp66bcQ5vbZN+kahtWVmhlTICEYdmXJwSpJPApNN1DSJfF3hTXtS0ux0e1vLbUdPlcMHt7li6lAkhA3o/zlBjkEgCvaqKd9b/1tZi6W/rufO+itG3hnR7G9fT9L8OJc6lHKdc0uR7NZTcBoQyl4gPkJ2sSVByPvdPaPA2nS6T4NsrGfVjrHkBlS9MRTzE3HbgFmJAGADuOQAa6CinzaW/r+v0B6u5zfxH/5JZ4r/wCwLef+iHrT8Q31rp3hy/utQuYbW3jgffLNIEVcjAyTx1IH41mfEf8A5JZ4r/7At5/6IeukrOS5otDi7NM8b8EeHE8VfDvwrqGv+J7O40XRbVJlt7GI25hkWLb++nErHKAn7oQg8nFczY6D4cvfgnB4mt4YL3UdO1IeZfGUzSQRLf72ySSRhDuyecMT0Jz9FUVq5Xk5LvclL3bP+kfPvjW+0B7r4kXFpMIbe+0a1mgu7UvFDczjzORKmFcnenGTu9Dg427m18I6N4/8BT6fe28Z1UyyTq2oM8c++2MavsZymWb5dwGWPGSa9noqU7f10G9f69P8j58ttJ0Kx+HrXcOm2NtdaT4uWW8nS2VHtolvTgswGQBGenZT6Vfnj0e/8X+MYtPu9PsbWe7s7xJL2zZtOvdsDPIJWACFW3bs7uThua90oovpb+un+Qdf67v/ADOa8AammreEIbqPTotOUzSjy4JDJC+HP7yJiBujb7ynAGDxxXS0UUN3YgooopDCiiigAooooAKKKKACiiigDm/iP/ySzxX/ANgW8/8ARD1s6rBJdaNe28IzJLbuiD1JUgVjfEf/AJJZ4r/7At5/6IeukqZLmTQ07O55honivSP+FT23h57uNdfj0kWL6PuH2sTCLZt8r73XvjGOc45rPXRfDes/G+80XV5Yr5hodu0llLeM4E6SZ4Td8pCqhwAODnHzHPr9FaOV5873/wCH/wAybWhyL+tV/kfOjJ4a0P4edbPS7+DxcBKEb7OSi3pIVwMBwsRJCtnauCAODXa20fh/WPFurReLLsW+uxaotxpE4k2TvbBUaMWx5LIQGDBM5yc16tRSTt/Xp/l+LB6/16/5/gjwvVb/AEj/AITyDVElt7S5tvFC215cXUv+mJGUZdpYbfKgJHyqSwbrkGqFhZ+FLj4U+N9XXUVluLK61GK1vRqkhdUYjyl378sGKJgEnd75NfQdFRb3XHyt+X+X4l83vqXnf8/8/wAD5/8AF+oaPq/hnEEtrPdW3hWK4tJ7mXzFVlDZa0RRnzQVIeQMNmF4PNe2aNrWnX9ta29vqNtcXRtI5zEk6tIUYcORnOCc81qVWNjG2prfOzvIkZjjUkbYwSC2B6nA5OenGOc6uV7+ev5majZJdv8Agf5FmiiioKCiiigAooooAKKKKACiiigAooooAKKKKAObsf8Akqeu/wDYF03/ANH31UfiL4hhstNt/D9ve2cOra7ILW2iuroQAofvndhivy5UEKfmZQAavWP/ACVPXf8AsC6b/wCj76uko9Rp2PHrTXYvAvxXubTxZLo2g2PiGwVxFb6oZEhlhGwMzNHEY96cA4wTH1zXK6LqfhrT9D8M6hb6rZfbo/F88S3Ml4JJhbGWQMC7MW2FGQnJwdyseTmvouimnZp9v87/APAJaumu/wDlb/gnhOrT6bd+M9Q06TUbK31ltdQjWX1eK0mjtcrutQBItwONyhVXa2Q27NPkvkGqfECx8N6g90y6pYtcJFeNNMtsNguSpLFsDLggdORx0r0m28LavAt5Yy69DcaRdySu8clh/pWJGJZfOEm0jkgZjzjHPGa6lVCIFUYVRgD0pR0il/XT/L8WN6tv+uv+fyPFdUjEFxrd18K5Lf8AsF9MiN0NLXzLdZvPG9o1jIBfyRJuCEMflzyRTDZtpvhfWNU8L6/Yajpd29p9stfDli0ENtEso891AlkKyNGTuAwcDOM17dRTTt/Xnez8gev9eR4HfXOm23ifxH/wrdYhbXGh2bo+l2zyQKguH84r5eBnZu+UMpJyB82aqeJrLRdP8D6nqNr4t0mewvbmzEVpoiPY20UolG84E75cxliy/wCzuIyM19D0UXt/XncHrv8A1pY8J1yXwe2v+PbWG50lrMaDFeRRCdDH9qxIPNAzgycxfN97JXnnnL8S6vpeu+FpbyO7t7nVLPw/ZzxXd3N5roy8u9qq4KuGBEkm7ggAjg19FUUJ2/D8L/5/gD1/r0/y/EitZo7i0imhkWWORAyupyGBHUHvUtFFJiWisFFFFAwooooAKKKKACiiigArm/Hn/Iu2v/Ya0r/04W9dJXN+PP8AkXbX/sNaV/6cLegDpKKKKACiiigArm/iP/ySzxX/ANgW8/8ARD10lc38R/8Aklniv/sC3n/oh6ANjV9VtdD0W81TUHKWtnC00rAZIVRk4Hc15w19qtx8YtAv7/R3tHl0e8kht4tQM3mqPLKqVYKkcnzEHGRyPnOOPRNc0e18Q6DfaRqAY217A0Mmw4IDDGQfWuUg8Ca7/bekareeK1mudItZraDZpqoJlcLgy5c7j8gzt2Z7beci3v8A1s/+AN7f13X/AASvpPxDtT4f0Oay0ey0o6xdXMaQXd2tvFGySsHy6owMjHLBQOTu+bvWxeeLNS/tE6Vo+ixXeqwWSXt5bzX3lJCrkgIrhG3OSrYGAOOSKzNL+H2qaf4IPhy41jS9Qh3TH/S9GLxN5j7/AJo/OySCXAIYD5hkHHNiw8AT6A1pN4a1gW91HYRafcS31sbkTxR5KHAdNrjccHJGOCDim7a/10F/X4/5Gfp/xVude1K1tPDvhe5ujc2BvUa4u44MhZVjkTHzcqxYc4yV44O6sj4ja/ceIfDaz2Gnt/ZNprdvbrfC+aN3lS5WN/3IGHjzuXLN1GdvRq6TQvh5N4e8WWOpWOqQmws9PexFo9mTLIHfzHkMokxuMnP3MYJGO9VNQ+GF5c6Ze6PY+IzZ6Pc366hHD9hWSa3l84SsFkLbShYEgFCQT1I4LVrxfn/7d/kD2a/rb/MTU/jBpGneIPsQawngW/GnyhdST7WspbbuFtjJjDcFtwPU4xzRbfFC+m0fUdXn8LS2mn6dcTWtxLPfR7opY3VRuCggJljlgTtCk8itzTPC2p6LfXS6brqjS7uZriS2ns98qSvy5SUOoUM2WIKHBJwRxiLwx4R1Tw/pGpWk2tWt1Lfag995qaeY1UyPukQq0rblPIHIIB7mpW2vb8dP+CN2vp3/AA1/4BuaHqNxqmni5uYbVA2DG9nd/aYpVKg7lfauRkkcgdM1o1zng/wkvhWLUD58Dy6hdG5kjs7b7NbxttC/u4tzbc4yfmOSSfaujpu3QkKKKKQwooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4j/8AJLPFf/YFvP8A0Q9dJXN/Ef8A5JZ4r/7At5/6IeukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4j/8ks8V/wDYFvP/AEQ9amva1a+HdBvNX1A4t7SIyPggZx2ySByeOTWX8R/+SWeK/wDsC3n/AKIetTXdHg8QaFd6XdtIkV1HsLxnDIeoYH1BAP4Une2g1ucPZ/GTS5rm/s5ksri7gWFrZdK1FLyK586QRonmBVCPuIDAjABzkiuhg17xLNBewv4Ygg1C1lRR5uoMLSWNlzvWfytxxjBHl5Bx25qK/wDCGpa74efTfEWvLPKjpJa3VlZ+Q0ToyukjBncMwZR02ggnim674Y8Sa/4Sm0m48TWsFxcFUmuLfTWRHiz8ybPO3AsOCwfpnABOap7ab/1/T/AS31/r+un4mNa/FZxob6lq+n6bp0M96bLTriTVsW12yqxaQyvEhSMbSA20knoDxlum/F+PVpNLh07Rvtc17qUumyyW99G9vFKiF8rJ1kUryCFHGe+FOq/gvWbi1sxPrlhBcaW6PpTWGltDFbFVZGDo0zmRWVtpG5cAcYPNP1fwjrur6poF/N4gskm0m6N06jTGKSsUMZCjzsou1m6ljk5zgYp6X/ry/wCCLW39ef8AwCgfiXew6fLeXmgRxR2Oqrpeo7L/AHmKRnVFaL92PMX51J3bCAe9W9X8f3Gj+JILK50YR2E2oxaclxNd+XNNJIAQ8UJTEkYJALBweG44rLufhlrdzo2r2LeJbEHU9Xj1VpBpD/u2VlbYB9o5GY059N3qCLV58N7+7vrm5bXrfzJtSt9RDtp251eIqfLLebkx/L8q8Fc9WojbTm8r/wDkt/8A24Jdbedvxt+hu+NPFcnhHS7W8j0qbUhcXkNqVilSPyzI4UMSx55IGADz1wOawNR+JV9pg1OO50GD7Tpeo2tpcRrqBKmK4KiOVW8rk5YZQgYwfmPGdzxv4YvvFekWtjZanb6eYbyG6d5bMz7zE4dQAJEwNyjPJ49OtYV98NdR1O78Rz3uv22dae2liEOnFfs0luwMTcynePl5HGexFKNuvf8ADT/gjfl/W/8AwB3iD4mXfh658TRT+HvtQ0OG3nQ296P30cxYAsGVdmCvIG/rxmrVz451eHVtT0uPw9Ab2zsU1GNZNR2pJASwIZhGSrgqRtAZenzCszXvhbq2uvrM8nitYrjWrWC1ulGmKYQsZyCi+YGByTjLnAY5zwRoyeCNdm8R32sSeINP8270gaYYxpThVxk7/wDj45+ZmOPTAzxkp/Dpvr+Wn4j0v935q/4XI7T4kXWralZWei+HZJTf6KNWglurxIYyp2/Idodh97GcdexHIXS/iPPqjeHJV0VYbLxFG4tJHvMyJMiM5V0CYCfKQGDE/wCyKp6F8N/EGh32n3KeJ9Om/s7RzpMKnRnGY+Crt/pHLBlXOMAjI4zkO0z4aavpln4Ttl8RWcieGppJEJ0tgbgOrKQf3/yna7c884OOMG3y30/rV/pYnW39dl+tyWz+JV7c6NoGoyaFDHHqmrvpU6C/LG3cSOgZf3Q8wHYx524469qHhLULjQLXxb/Z1jPqUv8Awk0kESSzuQgMcfzSSkMVjXu2Dgdqut8L7s2ttYxeJHt7Gy1ltWtVhsk81GZncozszBgGc4O0ccEHqGJ8NNXMN+tx4js5WutYXVwh0pvKL4wY5EMx3pwpAyCGXOT0Extdvv8A5x/ykOXl/Xxf/ahF8VpprHTJIPDzXEt9q0mkM1vfRvBHMpPIkwC6kAkEIOAc4OAe70y4vLrS7efU7IWF26AzWwmEoibuN4wG+uBXBt8M9WW6tWt/EdmsFtrj6yqSaUzMXYEbNwmA2/M3Qenpz6NQvh13/wCAv1uJ/Fpt/wAF/pYKKKKQwooooAKKKKAObsf+Sp67/wBgXTf/AEffV0lc3Y/8lT13/sC6b/6Pvq6SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/wAi7a/9hrSv/Thb10lc348/5F21/wCw1pX/AKcLegDpKKKKACiiigArm/iP/wAks8V/9gW8/wDRD10lc38R/wDklniv/sC3n/oh6AOkorm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkygDpKK5v7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMoA6Siub+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTKAOkorm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkygDpKK5v7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMoA6Siub+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTKAOkorm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkygDpKK5v7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMoA6Siub+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTKAOkorm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkygDpKK5v7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMoA6Siub+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTKAOkorm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkygA+I//ACSzxX/2Bbz/ANEPXSV534+s/GK/DbxK15ruhy240m6MscWizI7L5LZCsbpgpI6Eg49D0roPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygA+I//JLPFf8A2Bbz/wBEPXSV534+s/GK/DbxK15ruhy240m6MscWizI7L5LZCsbpgpI6Eg49D0roPsPjf/oYfD//AIIZ/wD5MoA6Siub+w+N/wDoYfD/AP4IZ/8A5Mo+w+N/+hh8P/8Aghn/APkygDpKK5v7D43/AOhh8P8A/ghn/wDkyj7D43/6GHw//wCCGf8A+TKAOkorm/sPjf8A6GHw/wD+CGf/AOTKPsPjf/oYfD//AIIZ/wD5MoA6Siub+w+N/wDoYfD/AP4IZ/8A5Mo+w+N/+hh8P/8Aghn/APkygDpKK5v7D43/AOhh8P8A/ghn/wDkyj7D43/6GHw//wCCGf8A+TKAOkorm/sPjf8A6GHw/wD+CGf/AOTKPsPjf/oYfD//AIIZ/wD5MoA6Siub+w+N/wDoYfD/AP4IZ/8A5Mo+w+N/+hh8P/8Aghn/APkygDpKK5v7D43/AOhh8P8A/ghn/wDkyj7D43/6GHw//wCCGf8A+TKAOkorm/sPjf8A6GHw/wD+CGf/AOTKPsPjf/oYfD//AIIZ/wD5MoA6Siub+w+N/wDoYfD/AP4IZ/8A5Mo+w+N/+hh8P/8Aghn/APkygDpKK5v7D43/AOhh8P8A/ghn/wDkyj7D43/6GHw//wCCGf8A+TKACx/5Knrv/YF03/0ffV0led2dn4x/4WTrKrruhi4Gk2BeQ6LMUZfOvNoC/asgghsnJzkcDBJ6D7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Sub8ef8i7a/8AYa0r/wBOFvR9h8b/APQw+H//AAQz/wDyZWH4stPFUWl2L6rrOj3NoNa0vzIrbSJYZG/0+DGHa5cDnB+6cjjjqAD0CiiigAooooAK5v4j/wDJLPFf/YFvP/RD10lc38R/+SWeK/8AsC3n/oh6AOkrMl8S6FBq66VPrWnR6i/3bN7tBM30Qnd2PbtVLx5e6jp3w/1280QMdQgsZXg2jJDBTyB6jrXOaLFp9p8C7efRNMs9XtpdNFxcw3U3li6JTdKXcI+XJ3dRye460m7Jvt+t/wDIaV2l3/4H+Z6EjrIivGwZWGVZTkEetLXklv4s8Sanpuk6Z4f02/s5f7Dhv4102a0uGAclYlka58sFcKN2xc5OAR1MkWu+OL7W73TtU1OPRpofDiag0FnbRSPBcbirDexdWGUPbo2BgjdVS91u/S/4X/yFG7/D8bf5o9XorygeNvE3iGx0i30W21Bb240KDU5ZNNW0OZZMgKwuXUeXlTnaN3I5HefSdV8dav40XSNU1W20Z00e3v5raCzjl8uXzdskZcswYHY/IIxuGORktxalyvz/AAv/AJMV9L+n42t+aPTZpo7eB5p3WOKNS7uxwFAGSSfSqmja1p3iHSo9S0W6S7s5SwjmQHa+1ipxnqMg8968/wDD/ijXZ/HGkQXGqvqFhqsd4X22qJaqYiNn2d9qyMMHktuU/wAJrY+EP/JNLP8A6+bv/wBKZKlbX/rqNnSax4h0nQPsn9sX0dqb24S2tlbJaWRjgKoHJ6/h1NXYrlJppokWUNAwVy8TIpJAPykgBhg9VyM5HUEV494h1HU/EvhbRvEM2pslrN4ltol0xYU8uJEu9indt3+Z8oJy23nAUda249f8XXFv4ugt5nvrjTNYjt4vsFvEkqWxjjdvLWQlWcBz98kE9ugppXjf+vs//JA97f11/wAj0uivOYfGE2tX2h6Lous3iHUpLoXF7NZJFdW3kKuYjG6bVkywyShGM4HINY03izxgmpWmkDVrdTb+JBo9xeGyUyXUbRCVX67FYDggLgnB46Es27f1ul+bDpf+tE3+h6pqmq2OiaXPqOrXUdpZ267pZpWwqDp/OpLK8g1GwgvbN/Mt7iNZYnwRuVhkHB5HB715hrl1r2p6F4w0mbxA4Ph/TPKldbSJTfu9uzs8gIO1cEABNvIJzjiqdv4h8WXOi22leELW/e40zRrGSL7MLMxyyvFnbN58it5ZwB+7APXntSXX5fjf/IHo153/AAt/mexUV5po+peNdY8Y61Zy6xb2Y06GzuY7KOzRlPmI5aFn3EnkAb1I6AgAZB1vA2v3d/dS6brt3qUeswwCW5sNRtIoyuTjfE8ahXjzwMFiONxzTtrYV+p2tFeZfEbxPrujXGqXGi6q6DS7OG4WztLZJQSXO43LSLhUKgbQjhz8xweKq6/4j8VW9547aHXUgi0GwgvrKOCyj6sjuUcvuLA7QCRg9Mbecrpcq2tkemapqtjomlz6jq11HaWduu6WaVsKg6fzqSyvINRsIL2zfzLe4jWWJ8EblYZBweRwe9eZa/reqeKtD8XRW2onTYNJ0oFreOFH+0vLbGRi5YEhMMANu05BOT0rufBf/Ih6D/2Drf8A9FrTtvfpb8b/AORN/ht1v+Fv8zbooopDCiiigAooooA5v4j/APJLPFf/AGBbz/0Q9beoalY6TYyXuq3lvZWseN89zKsaJk4GWYgDkgVifEf/AJJZ4r/7At5/6IetnVRnR73P/Pu//oJqZPli2VFXaQzStc0rXrZrjQ9Ts9SgR9jS2dwkyq2M4JUkA4I496nuruOzWMyrMwkkWJfJgeXBJwCdoO0erHAHcivJfD2pa1p3gv4W2Wj6hDZWmpxrb3S/ZQ7t+4Z8hicD7vp1IOcZBuQ+K/EqaPF/xNUlez8WDSLiea1TzLmAzKo+6AqthsEhee2DWrj7/Iu9vxS/VGfN7vM+36N/oz1WivMD4o8Zarrc134f06+ls7PVmspYWNkto0EcmyR2ZpPPEmAWGAF6DaetaWg33iXxV/xOrDWUtbdNTntJtMeFCiwRyNGWDbS/nfKGGTt5xt71C1V/66f5lPRtPp/wf8jtZr2CCFpCXkVZBGwgjaVgxIGCEBPcZPYcnA5qxXiWi6j4h0H4fDUrLxBcTtN4pa1nW8gikJja9MbbWCrhmzkk7hxhQtdDq3iXxBdab4u1vStUNivhm5lihsTbxtFdCKJHbzSyl/myQCjLjjrT6X/rp/mh2u7Lvb8/8j0yivKL/wATeKbvUfE3kayNOgsdAg1W0hhsoy8TssjFHaTduGUweBweNpGT2ranq+ofDmPVNHgR9VudOS4hi4wZGQNgbsDvxnjpmhppO/T/AIP+TJTTat1/4H+aN25uEtLdppVkZFxkRRNI3Jxwqgk/gKeJEMpiDqZFUMUzyAc4OPTg/lXlereNNUt/At3d6NrN4mo6fe2sF5b6xp0aXMQkdVKkKFTndkOFZSFIGeohvtS1Hw7458f61FqV5dGxsbMw2coiMRLh9oPyghVJJGGXqdxPYt/X3f5j6f13seuUVxfhC78XN4hvYNetL8aS8Cy21xqRsxMsucPGFtnIKYIIJGRyCTxXaUWFcKKKKQwooooAKKKKAOb+I/8AySzxX/2Bbz/0Q9dJXN/Ef/klniv/ALAt5/6IeukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm7H/AJKnrv8A2BdN/wDR99Wjq/ibQdAeJNe1vTtMaYExre3ccJcDqRuIzjIrOsf+Sp67/wBgXTf/AEffVj/Fkzro2gtZxRTXC+ILIxJLIY1ZvM4BYKxUe4B+ho6pd2l97sHRvyf4GxL8RPB0Wm3GoDxPpU1rbFRNJb3aTbC2dowhJycHA6nFdICGUEdDyK80+IZ1Wf4S+KLjxDptjZXgQRxGzmMwaHchH7wqpPzFuCq/TuU1PWteg1Tx1aW+t3EMem6PBf2BEEBNu5WUsozGdynywPmyeTgih2UW3/Wg0nJpL+tUv1PTCQASeAOprJ07xRo+saY+oaRefb7RJ/s5ltInlBfIBA2g5AJGWHA5JOAazdE8WxNo+iJqSalPfXtlbyvNBpVxJEWdRkmSOMxrznOSMd8CuBstX1bQ/CWo3mjXcVuW8bS284eASGSOS6VCFJOFPzdcH8OtVyvn5H/Tul+pCknBTX9Kzf6HqeneI9I1bVdQ03TL+K5u9NZVu448nyWbOFJ6Z+U8ZyO9adeQ6jrUlj8YPEWmW9/LpM2rf2dBHqYjRktyEkbb86su58bVBHJPXOKva1r3jKTVtU0zwpFqd/c6IIYkcLYCK7kaNXJuPMZGAIbH7pVA569BO6RXVnplxOlrayzyiRkiUuwijaRiAM8KoJY+wBJrLPizQl1G9sH1OBLqwtvtV3GxwbeLAO58/d4OcHmszx9q+raV8MdU1jSJ4rHULWzNwDJEJgpAyVAyBnsDyO+DWRYSNN8Y7qWQ5d/CtuzHHUmZ6Tuvx/Jv9B6ct/T80v1O20nVrHXNLg1LSbhbmzuAWimUEBxkjIz2yKuV4t4M1LXLbw38NtM0zVI7Ox1SK5juFW1V5cokjAh2JA7YG3qOcjir1l438RXljY6PG1/eX8t9qFu95YR2i3DpbS7VIWYrEGIYZ4PQ4HORclZtISvpf+v6set0V5e/iLxlp2ladd+LbfUtNtoVnF9cabb29y6lW/dvNGvmYQocnyuQe4FaF74mvrHxLbyalqN7baJdC2Wwv7a0ils7gvtz5rbS8bMchTlUww6mla4rnoFFFFIYUUUUAFFFFABRRRQAVzfjz/kXbX/sNaV/6cLeukrm/Hn/ACLtr/2GtK/9OFvQB0lFFFABRRRQAVzfxH/5JZ4r/wCwLef+iHrpK5v4j/8AJLPFf/YFvP8A0Q9AHSdetcy3w78MmWVobKe1jmYtNbWd9Pb28pJyd8MbiNs55ypz3zXQ3NzDZ2stzdypDBChkkkc4VFAyST6AVkaX4y0LWBefY71lNlGJbgXMEluUjIJEmJFUlCAcMODjrQPUW98H6HfrYCS0eBtOTy7SSzuJLZ4UwBsDRMp28D5c44HFVZ/h/4duNSur97e8W5urb7JM0WpXMYMP9wKsgAHU8AcknqTXOH4jw/8LKWJ9XSDw7Ho015MtzZPblGWSNRJvkALoQx2lQFP+126OD4h+GbryRbahJKbi1+126pZzE3EfrENmZCMjKrlh3AptXV31v8Aqvxsxbf16P8AyFj+H/hyHT9OtILW5hTTFKWckWoXCTQoeqCUOHKcD5S2OBxwKsWvg7RbPxG+u21vOmoPALdnN5MUMY6L5ZfZjv8Ad6knqSarL4z8PahNogtNfEb6nKxtIET5rraGDIyshZQpBz90gqAT1BbD8RvClzNsttXScC8Fi0sMUjxpOcYRpApVckgAkgE8A5GKNW/MNLf1/XS4W/w68M2jWzWtncQNamU25j1C4UwCQYdUxJ8qn+6MAHkAGtLw74Z0vwpph0/Q4ZoLUyNII5bqWfazcnBkZiMnnA4ySepNUovF+g+brE6a59qj0+VILmGNN4t5T8ojXYu53Y8bcsc4AA6Vn658SNN0m70eCO21CY6ld+Q2NNuC0QEfmHKBN27G35cZ5JxgGhXe3UH5+Zau/ht4Tv5bhrzSFmjuZxcy27TyeQ0oOd/k7tm49zt575qWy8BeH9OuLyezgu45L6Xzp2/tG4JMmCoYZk+UgHGVxxgdhUNv8S/B91JKtvrtvIsJlWSVVfy1MaB3Bkxt4U5684OM4OKWt/FHRbDwlq+r6d9quptNRQ9q9jPHIrOP3ZdHQMqH+9jGOhpdP6/rsPdmwfBWgnS47AWcixxzGdJkupVuBKeDJ54bzN5HBbdkjgmornwF4eu49PSa1uANOnNxbmO/njIlPWRirgu/+02TyeeTTtP8U6RqviCKytdVmW9FkbiTTJIDEyoWX95IroHQjOACRkMTg9QW/jvw3c3v2WPU1RmjaWOSaGSKKdFGWaOVlCSADklCcU9Vr/Wn/DE7r+uv/Dj9X8E+H9dv5LzUrFnnmtzbTNFcSwieI5+SQIwDgZON2cdsVGvgLw3D9j+x6cbH7FH5UP2G4ltvkyW2N5bLvXJJ2tkZJ9aTTPiB4Y1meyi0zUxcfb2kS1kWCTy5XTO5RIV27htJ25yRyMjmtTU9bsdIe3jvXl825bbDFBbyTO+Op2opOBkZbGBnkilsPco2fgzQ7DVdQ1G1t51udSi8m6LXszI6DgKELlVAHAwBgEgYFWtP8O6bpmoTX1rFKbqdQjTT3EkzBBzsUux2LnnauBntWfL4u0Q6xBBFrEklz9ge9GnW8JkaWHgiQqELgjsARnJ4OOKPh34j6XrPhC3125S7tluJHWOD7DO0j4JICIELS/KASUDAc+lAM0dW8DeHtcu7y41OxeWS+gFvchbmWNZkHTcqsFJGeGxkdjVOX4Z+GJ/7S8631CT+1I1ivd2r3Z89F6Kf3vQdMehI6Eiuh0vVbLWtNh1DS7lLm1mGUlTocHBHPIIIIIPIrOsfGegajq/9mWl/uuWV2j3QyJHME++Y5GUJJt77Ccd6NtAv1Klx8OvDF0qCawmbbafYmIvZwZoMYCSkPmUAHjfux2xW5pelWOiaZBp2k2sVpZ267YoYlwqjr/Osm38d+G7m9+yx6mqM0bSxyTQyRRTooyzRysoSQAckoTim6Z8QPDGsz2UWmamLj7e0iWsiwSeXK6Z3KJCu3cNpO3OSORkc09X/AF/XmG3yOjorz3xZ48MGu6BZeHtTUCfWY7K9H2J2SVSTuVJiPLypUhguWGf4cVPq3xK0bStCutV02+uNbjOqR2A8i2aVLeRigKAxoMgBs8liWO0EnACWqv8A10/zQPR2/rr/AJM7uiues/Feh3mqagIdbO6wtY5ru0mTy1tFOWDvuQMrEdVY8AD5Rzlsfj/wy6XbS6mLQWcPnzfbYJLY+VnAkUSKu9CeAy5Bz1o2A6Oiuf0/x14c1SRUs9SBD2f25HkhkjSSAYy6uyhWAyM4JK98Vf0rXbDWgxsGn+VQ+J7WWAlSSAwEiqSDtOCOD1p2YGZ8R/8Aklniv/sC3n/oh62tT0231fTZbG9MwgmGH8i4kgcj0DxsrD8DyOKxfiP/AMks8V/9gW8/9EPWvrGs6d4f0qbUtavIrKygAMk0rYVcnA/Ek4xUu1tRq99Dn7X4Y+FrOPTY7a2v0j0uUy2Sf2vdlbdsY+UGXAGOMdME+pzlXPgaC2vodK8P6TqFtatqsGq3eo3N+Z4pHjfewAklaTexABO0A9STgVvw+P8Aw3c2Ul1a38k8aMqBYbSZ5JCyBxsjCFnG05yoIxn0NPuPHXh230q11H+0Gnt7xWaD7LbyzyOE++fLjUvhf4sj5e+Kq7Tv2/4f9CdGrd/6/Un/AOET0f8AtyXV0t5Y7uYhphHcypFMwGAzxBgjsAByyk8D0oh8JaNbazNqdvayQ3Fw/mTJHcyrDK/HztCG8tn4HzFc8Dmob3xv4esdOtb6XUPNt7yH7RCbaCSctEACZNsasQgyMsQAM8ms5PiPpUvjQaLF5zWw04XxvhbSNCVY5VhIF2hNoY7yducAHORS2dv6/rQe6v8A12/Unu/hv4WvbSS2msJ1gku/trRw39xEPO3btw2OMfMS2BwGOcZ5q7deDdDvL43dxaSNIwUSqLqVY7jaAAZYw22UgAcuGPFVrPxnoK+H7bUo9Ym1O2u5ZRbSRWzSyz7XIYJHFHuYLjGQp4AJJ6lz/EHwpHaadcPrdsI9TkMVoMndK4OCu3G4EHgggYPB5p6rQN9Rt78P/D2o6hqV7dwXrT6pCLe7KancoJYx0TasgAHXgAdW9TnUtNA06x0GHRreKQWMCqkcb3EjsoU5Ub2YtxgY57YqjH440GbS/t0V1O8f2k2nkrZTGfzhyY/I2eZuABONvTnpzWL448cSaRo8L6Lh5bpX8t1GZ1Mciq2IGX5hyQSSMcdc0tlYOv8AX9dDSvfh34a1HTZ7G9tLqaG4nW4nZtRuPMmdfu75PM3sF7KSQMDAGBV3/hD9CN/PeSWPnT3FstpO00zyCaNQVAcMxDHDMNxBbBPNcr4j+IV3b+BU1HTktYru8S4WIw3IneJoyQCEKAPjHzg4289cV1vhnWz4g0Vb5o4oiZXjKRzeYV2sRhuBtbjlecHjJ607br+uwr9STRvDunaDGY9NS4CnhftF3LPsH91fMZti8D5VwPatOiikMKKKKACiiigAooooA5v4j/8AJLPFf/YFvP8A0Q9dJXN/Ef8A5JZ4r/7At5/6IeukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm7H/kqeu/8AYF03/wBH31WfEXhDR/FRtv7ajupRaSCWEQ389uFcHIfEbqCw7E8jtVax/wCSp67/ANgXTf8A0ffV0lAGTrnhjS/Emhf2PrMU9xYnbujF3LGX29NzKwZvXknJ5PNU7zwF4dv333tnNOxs/sMhe8mPnQ84WT5/3mMkgvkgnIOa6KigCpp2lWOkaXFpul2sdpZwrsjhhG1UHtj61zf/AAqzwodOksTa35tpLoXrodXu/mnznzM+bndnnPqAeorr6KOtw6WOTu/hn4Wv5dRkvbS8nbVFRbzzNUuiJQjBk48zA2kcEYxyBwTV5/BeiPeW92YboXNvCsAmW/nV5Y16LKQ+ZhyeJN3U+tb1FAGbrnh/TvEeiy6Rq0MkljMAskMU8kO5f7pKMpx7Zwayrf4eeHrXUHvoY9RF09r9jaY6vdlvJxgJky8YzkHqDyOea6eigDkrP4YeFtPbTms7W+i/sssbIDVrsrBu+9tBlxg5wR3HFSQfDfwxbaYbCGzuVh+1G8VzqNyZY5j1kSUyb0Y5OSrDOTnOa6mii4GLdeEdHvLQW1xFcmPYEfbfTo0qgk4kYODIDk53E5zzmkn8H6HczwyTWjlYZFkS3W4kWAsoUKTCG2NtCLjKnGARzW3RRsAUUUUAFFFFABRRRQAUUUUAFc348/5F21/7DWlf+nC3rpK5vx5/yLtr/wBhrSv/AE4W9AHSUUUUAFFFFABXN/Ef/klniv8A7At5/wCiHrpK5v4j/wDJLPFf/YFvP/RD0AaHiaG+ufCupwaTb21zeyWsiQQ3ahopHKkAMDwQfQ8V5pJ4J8R6ofEEbWV5anVtCt7eOfULqF8TxO5MbrGxCKQQMIu3BPQ5Fev0ULQd9Lf10/yPKdbsfF+ra9FrEXhCSIDQbnTprd7+3EnmSFcFMMVZcr/Ey8Z6EAFdG0vxLa6r4DkuPDF/HFouky2l632m1O12REGAJssMx5yOzL3yB6rRTTsrf11/+SYv6/L/ACR4vouieLLVfC0Fx4Q1FBpeuXV/cSG6syvlTGbbjE+SR5oyMdjjNPv9C8VXHh3xFbR+E7/z9Q8SxalApurQZhV42JJ87g/uiMerL749looUmnf+t0/0QPX+vX/NnmNroOp6lrvjA634V1BLDV7m1mt2F7BHIPKRV3K0cpKuGXcvTp1B4qNNB8ZSf8I/eX9vc6gNL1t54oryeAXaWrQNGvmsh8tmDMSdpJ246nivUqKE7beX4W/yB6nmWl6T4lXw144jPhzyLzU7+W6soL97eWOdHRV2kK7Ln5Dw+ByOvOMvUfBviPUNP8YxxaVe+ZrOmWgt2vr2F3aWItujba+1DyMBfk9xzXsNFCdvuS+4Ot/O/wCNzzm80vX9V+IiXUmh3dlYzaBNpzXouLdhDI7Bgdok3HAGDgH5umR81Q2vhzWp9M8Kabe6LNbnwo8cz3KTQst6Y4WQJD8+RuJGfMCAV6ZRRfS39bt/m2H9fgl+KX+R45pGgeKbXRPBtpP4Vvlk0vXJ7y7/ANKtSEicy4IxNz/rhwP7re2e48caPLqcVtNaWWqSXtosj211pN3HDPC52jbiRlRlYZJDZHydDxXV0UPUOt/66/5nm9rpvix/HPhq91rS3uWttGmtL/UIJYREJ5ChyFLhyBsOcL1IwMdMfTfBXiC08L+FlvtJvpH0NJ7W4srDVvss0yyMCJY5I5UBA2j5WcZDHOCAD7BRRf8Ar5t/qwWn9eVjA8P+HrXSvC0um6fZS6ZDcGV/JluWnkRpMlizlmy2SScMR7msDwzomqx+DrXwxrGifZrnTbJrKHVxJE8ZUxlBJFhjIGIxkMq9+T376ik9U0+v9fqC0tboeZ2vhzWp9M8Kabe6LNbnwo8cz3KTQst6Y4WQJD8+RuJGfMCAVjaX4f8AFVvoPg+ym8L30cuma3PeXZF1akRxOZcEfvuT++HA/ut7Z9loqnJttvrr8xW0svT5a/5s8hHhvxfB4b8OaBHoCTzeH9YiuPtz3sSQXUKlzvGCZAx3DcCnU8ZpJPDfie90PxFG3h25t5p/EsGr28UtzbkzwrJESoKyEBsRnhiByOeuPX6KSbTv/XR/+2octf69f82eU694W8ReJfEXiyP+yZtOt9W0aC0t7ySeFozLGzuVIVy+07wudvY8dM3de0fXPEF4msf8I9dWk+naVd2Udo1xbmS7kmVVG0iTaI1wTlip/wBmvSaKlq6t/Wt/8xp2d/66f5HkdloPiH7T4RS98I3ctvpvh+fT71JLq2CmR0RdvEpJU+WeQDw49wOq8FaVrekapqNtOdQTQI0RLGHVLiOedHBO4q6MxMWNuA7bs54ArsqKtybbfr+Lv+pKSSt/X9aHN/Ef/klniv8A7At5/wCiHqTx5a3t/wCANasdKspL68vLOS3hgjdEJZ1Kg5dlUAZyeeg4yeKj+I//ACSzxX/2Bbz/ANEPXSVElzKzLjJxaaPN9U8NardaX4Tvjpeou2l2jW13pdpqf2S4G5EXcskcqqSDH90uAQ3XIxTJvCd9p50q00DQbi10p0ujcCO9RryGSXB+eeRywRjuL+UxbIXGQDn0uiqk+Zu/W/4kx91JLoeU+EfD/iTwuNFvbnw/Ner/AGJFpV7ZR3EBlgeN2IcbpAjIwY5+bPTit2LR9U0r4j/2vZaGp01tCSzWK1miUQvHIzCMKSvVWAGPlz1IHNdzRRJtu/r+N/8ANh0a9Pwt/kjyLwh4c8TaFFoerXnh+7M+mC+tptNW5tjI63EwlWWNvN2HGNpDMp64zxmS58Ja7ZXGlXNrok9y0/ih9cu4oJ4ALSMqUCEvIu5uQTtyM7uemfWaKL6p9v8AO/56g9U13/ya/JnlNr4b1S6uPEj6t4Z1i3+0ay2o6fcWV/bR3Ef7kRhkIlxu+UghyFw4znkDstD0jUNS8Dw6d46Vby5fPnBiAWUPuj3lMLvAC7tvGQccV0lFF9Len4KwPV3Kup6baaxpdxp2pQie0uUMcsRJAZT1GRzVkAKoCjAAwBS0UgCiiigAooooAKKKKACiiigDm/iP/wAks8V/9gW8/wDRD10lc38R/wDklniv/sC3n/oh66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAObsf+Sp67/wBgXTf/AEffV0lc3Y/8lT13/sC6b/6Pvq6SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/wAi7a/9hrSv/Thb10lc348/5F21/wCw1pX/AKcLegDpKKKKACiiigArm/iP/wAks8V/9gW8/wDRD10lYnjXT7rV/APiDTdPi867vNMuYII9wXe7xMqjJIAySOScUAbdFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQAfEf/klniv/ALAt5/6IeukrhPFmp69r3gvW9Is/A+uJcahp89rE0txYBFZ42UFiLknGTzgGtf8A4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAD4j/APJLPFf/AGBbz/0Q9dJXCeLNT17XvBet6RZ+B9cS41DT57WJpbiwCKzxsoLEXJOMnnANa/8AwlGr/wDQieIP+/8Ap/8A8lUAdJRXN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVQB0lFc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVAHSUVzf/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lUAdJRXN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVQB0lFc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVAHSUVzf/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lUAdJRXN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVQB0lFc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVAHSUVzf/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lUAdJRXN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVQB0lFc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVABY/8lT13/sC6b/6Pvq6SuEttT16HxpqWrt4H1w291p9paoouLDeGikuGYkfacYxMuOex6cZ1/8AhKNX/wChE8Qf9/8AT/8A5KoA6Siub/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSqAOkorm/+Eo1f/oRPEH/f/T//AJKo/wCEo1f/AKETxB/3/wBP/wDkqgDpKK5v/hKNX/6ETxB/3/0//wCSqP8AhKNX/wChE8Qf9/8AT/8A5KoA6Siub/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSqAOkorm/+Eo1f/oRPEH/f/T//AJKo/wCEo1f/AKETxB/3/wBP/wDkqgDpKK5v/hKNX/6ETxB/3/0//wCSqP8AhKNX/wChE8Qf9/8AT/8A5KoA6Siub/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSqAOkorm/+Eo1f/oRPEH/f/T//AJKo/wCEo1f/AKETxB/3/wBP/wDkqgDpKK5v/hKNX/6ETxB/3/0//wCSqP8AhKNX/wChE8Qf9/8AT/8A5KoA6Siub/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSqAOkrm/Hn/Iu2v/Ya0r/04W9H/CUav/0IniD/AL/6f/8AJVZuu32t+ILSzsIvB2sWn/EzsZ3nuZ7Ly40iu4pXJ2XDN91G4AJzQB21FFFABRRRQAUUUUAFZHijXD4d0GTUViimZHRBHLN5e/cwXCnBy3PC9zgZGc1r0jAMpVgCCMEHvSd7aDW5y/w+8WT+MfDS6heW8NtOuxZI43O4MY1Y7kPMZ+bhctxg55rqaitraCytYrazgjt7eFQkcUSBURRwAAOAB6VKenrVSabuhIzY9YsoUle91fTyvnuiMriMJtG4o2XOWAyT047CnSeINGi0ZdXl1axTTGAZb1rlBCQTgEPnb+teUaX4W1e11vSmbwFPDBZeIrq/WQSWO2G2lR1UKBNkYYoxUD+HjJArR0PQ/Emn2+m6jP4buHaw1fUJ20xri2MjRXDMySxnzPL3KGwQzL1fHbIleKfkv0G1Zv5/r/kvvOqvPGX2Xxlp9m0unDQrvTJ746ibjp5ZTJzwgTDg7snPPTHO7a69pF7dRWtnqtlcXE1uLqOGK4R3eE8CQAHJQ/3ulcdLpepyeOdCuLLwvJY6ZBpd3byFJbdUtmmZCqlFfOf3Z3bQwywwW5Nc/aeEvF8+l6JYR6WumPZeHbvR5rua8jykjLGEkQJuLKTHxnaQCc4IAL0t9/8A7d/kvvDS/wB36f8ABOvg8brffEF9F0+70qfTU06W4a7hufNeOZJEQq4BCqBu6ZJPt32v+Ei0my02CfVdd0td0UbtceekUUm7ADqGc4Vj0+Y9eprz+48P67fX8dzL4LjS1j8OzaXNaPc27GRyVKBBkqy5XjcVwCSQCMHLsPDGvx6bdq/ge6iu38Jx6QJTNZbpbhQVPzCYnbgryccL06Ck9I+n46y/yX3oUfeeum3/ALb/AJv7j1fVvE2g6C0Q1zW9O00zAmIXl3HDvA6kbiM/hVptTsF0wai17brYmMSi6Mq+UUIyG35xjHfNeRappWqX08lkNJvHik0S0s9aSFrSWaIpubaGe5QRMAc7h5gO4HAIGey+INhL4r+FF3a6RpL6pNfW6G2t5PLVlJwQxMjAAjr1z6U2kvvFHVq/Y328V+HVVmbXtMAW4+ysTeR8Tf8APM8/f/2etTza9o9vq8OlXGq2MWozjMVm9yizSD1VCcnoegrzHxFoGvagnjAaf4OukbVdFtbO0PnWi/vEDblP77gDevt8hx/Dm3rukeK9YvrV7fw8bOK31DT70hJLYNchNvmea+4tvTkYXjAGGb7tFldK/wDX9f11C+l/6/roegR6taxPcm71bT2RLgxIFYIYjtB8tyXOX6n+HgjjucbW/GBt/wDhHrnQZNP1DTtV1FLOW6SfeFUhjlNvyt90jJPHoa4WHwtq0evAnwFMLdPFB1SORZLLZHAYgjEDzdwJYBsY5wD14q1Fo/idY7QHwtfAR+LZNVK/abX5Lc7sH/Xdfn6D0PtmVry/L/22/wCb+4ctE7ef/t1vyX3nocPi/wANXFn9qt/EOlS2xnFt5yXsbJ5p6R7g2Nx/u9av6hqdjpFk95qt7b2NqmN09zKsaLn1ZiAK5O00W4g+JN5BC8Z0dwmqvCOqXRDR4x02tt3/AO8pPerfi6w1Rta0HWNMsm1OLTJ5WnsEkRHcOmwSIXKruXJ4LDhjzmjov6/rW4dWv6/q1vmbNz4i0WzsYb271iwgtJ1LRTy3SLHIAM5VicEYBPHalXX9HfVE01NWsWv5IxKlqLlDKyHowTOSPfFecWXg7UtN8UeHNQi8OMypqt7ezmKSD/QIp1ZViyXBOGYOwTcM5xnjNmXwnrlytzod1ppdZNeGqxa4Jo9qx+cJNpXd5gkCgxgBSuMfNjiqSTa/rt/XnYT6/wBd/wDL8TvV8Q6NLfrYQ6tYSX0m7ZbC6TzGK/ewuc8d+OKx/B/jBddsUi1ebT7XWGuLqMWMFxlmWGZoyyhsMw+XrgfQVwfhjRbjU7GbStL0T7La2Piue9XUYjCscaxXBJjVQwcOQNn3du0/e7Vb0nRfEVs2gs/hG7he38RXt/csbi0+WKYShGJEpJOJlyBk/I3X5ckUnG7/AK2/z/DzKkrNrs/yv/kvvPSLbxJod7NdxWes6fcSWX/H0kV0jG3/AN8A/L0PXFV7bxl4YvdSTT7PxHpFxeyHCW0V9E0jcZ4UNk8c15jqXhXxVqS3M934UR0n0C504abE9okMEpkVo/LG7leNwZiD8ucKeD1Gr6dqVv4D8PX9lbCw13R/s6RQXDKclsRPEShYEMDkYJGQp7VK2/ru1+ifzE97Lz/Jf5v7jqh4r8OmyN4Ne0w2oDMZ/tkewBThjuzjgkA+hNSaj4k0PR7WC51fWdPsLe4/1Mt1dJEkvGflLEA8c8Vxeo+G7rT/ABvpV5Y+GptSis9EubWW+ja2VpJXKso+eRWJJV+cYBl68sRzEWja9FpGg6Qmj3H9o2/h9tP1S2BtLl44WYKMK1zGq52MVcM3TDJxw7aaf18X+S+8en9fL/P8Oh6yfFGgCKzlOuaaI784tHN3Hi5P/TM5+f8ADNSjXdIOs/2Quq2R1Pbv+xfaE87b67M7se+K80l8ILrOrR3U+i6rq+g3+l29mkcertbNbmIsCs6rMqyIcg7l38gkAggm7eaH4nuvGOmXUehx21npmsNOFglhEdxE1u0fnM5PmM+SAcgcdmxmnZXsRd2v5fpf/gf1Y6vwbr99r9jqUmqQW9vNZ6lPZ7LdmZcRkDOWAJJ+g+laNv4i0W61BbG11iwmvGDMtvHdI0hCnDHaDnggg+hFYPgCx1K1tdcj1rSJtP8AtWrXF1Es8kMnmRSNkf6t2x7g/rXE+CNGudS0fTLLTtEFpa6V4hvLxdQDRLHtSeZfKRQd4JyFOVC7e54FStUr9l+SuU9Oa3d2/Gx6nbeIdH1CS8g03WdPuLizB+0JFcJIbc8/fUNleR3x0qM+IdKsdLguNW1zTEDW6zNc+csUUinA8xdznCEkY+Y9QMmvNx4b8TXWoPeaj4WRreTQrnT20yJrVYY3Misixjd8ynGQWI6chOhTS/DmtWrafLN4KuPtNv4UbS5ZvNsyzTgABc+dkjCnB6fN25wbRv8A19r/ACX3g/it/XT/ADf3HrysroGRgysMgg5BFZOs+IbHTEktxqGnJqbJ/o1pdXaxGWQg7Fxy3JHYE9eKzPBN1eWWh6NoGq6ZdWt7a6XF5zySQuoZAEK5SRjnjIJGCD1yCBmJpeoWXxL8S6tbeGpzbXmlRRR3ML26/apk3kjBkDZIZVBYAfJyQAMlRWbSff8AAIO6Tfl+Nja8I+LbXxH4dsLma8sU1KawivLm0imBaAOoOSudwX3NXV1/TbLSobjVtc0wZg81rkSrDE6jALqGc4XJH8R6jmvN9G8O63aWvhu2vvBdzJBZeHLnT72LzbNleVyh24M2GDeUeenzjP8AFiPw94b1vTZ/DE934KuTPpnh6fT7mUS2ZYynbsUHzskfI4B6DzO2WxpNK75fP/27/JfeOK7/ANbf5v7j1K88QaNpy2rahq9jai8IFsZ7lE88noEyfmz7Ut1r2kWV7HZ3mq2VvdSlVjgluER3JzgBScnODj6V5d4d8MeJtK0RLfVPDMmoJe6DDpUls9zATZyR7wd2ZNpibeGyhZuPu5rT8MeE77QPFGpLeaBLe2b6Ba2Ml5m3I1CaJWD5UvuO4MqguAPl5IABMySTdun47/5fjoL+vy/zf3HQax45tLfU9Kg0a+0q9huL1be+ZbsM9srI7Btq9M+WwyxGMd+203iTQ00VdYfWtPXTGOFvTdIITzj/AFmdvXjrXnWleH9ctPA3grS5/ClwZdL1MTXcAmtSsSLvw3+tweZAQBk/KeBxmB/C3iC5MF3c+HtSWC21q9uX0+31RLaeaKc/JJHJFMBleQVZ1yGPWp7r+un+Y9NH/X2v8l96PTbzxHoenRW0moazp9rHdkC3ae6RBMT02En5vwrSryrxN4R1c+FZPDvhbw6LSzm0m4hjm+0RTTxuzlhC8kzEhG6nbv5OMqAGrvdA1Ka5V7C7sJrSeyjiV2eSN0clexRicjHIYA+mRgl6WJ1/r5FttZ0tNSfT21K0W9RA7WxnXzFUgkErnIGAefY0lprelX909tY6nZ3M6RrM0UNwjsqN0YgHIU9j0rh9b8Pauvii7n07SZr7TbxpJb2zuTay2837jy90e8iSOVuFwf3ZXOSM1ztp4O8TTaRoGlRaDcaS8Hhm70u4u/Pt9kM8gQKTslLEExk5AJ+cd84Fqr/1s/8AJL5/Iuyvb+tz1iz1/R9RhuZtP1axuorVitw8FyjrCR1DEH5SPeqz+MfDMWlR6pJ4j0lNPlkMUd219EInfn5Q+7BPB4z2rz5/AN5e+Db1LLQb/S9ZeG3im+267LP9qWGRX8qNxK5RGAYBvkIz0q3c6PqumaBKfCfhLVrS+1WcfbZ59Uiuru3XbteRWmuCpYqAq4f3IG0AjVv6/rT8iVrb+v6/U7m31/TdSa0uNK1zTLi0m8zmKVZfO2jnY6vgbcHPDfhVi01vSr+6a2sdTs7mdI1laKG4R2VG6MQDnB7Hoa8zvvD93/augzWHw6uxY2Njd2U0LTWLSPHIoCK+ZsNk72IyfvZ5JIqDSdF1XR7Tw2dW8OXGn2Gl+G7qy1Kc3VsiRuwQ5JSUnB8oncAcb198Glm/66/5L7xpX/r0/wCCelWPi3w5qmpHTtN1/S7y9Xdm2t72OSQbevyg547+la9eZfD21v7HWLJ/EGnXlrdtpiWVo/lW6RNDH82G8q4kLsM/fKovsCcH02m1YhO4UUUVJQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUEhVJY4A5JPaisjxRoZ8RaDLpwkiiLujB5YfM27WDZUZGG44bnacHBxik720Gty+l/ZyaeL+O6gezMfmi5WQGMpjO7d0xjnPSpkkSWNZImV0YBlZTkEHoQa80g+Fd5H8NT4fkv7Q3rESm5EJLiQQeX/ruu7PSXZkLxtrsfCXh+Twz4bj05pYriRCzmRU2bye7HJ3N6vgZPOB0qnZNi7GvbXdveRs9pPFOiO0bNE4YK6nDKcdwQQR2NS15xYeO/El/Doi/YNKhm1DV7zTJ282R1hMPm7SowC/8AqjkkrngYGciTSvG2ua2lhpVoNOttYnkvklupYHe3AtZhGSsQcNliynG/5Rnk4wSzG1Z/15/5Hem7theLaG4iFyyGRYd43lAQC23rgEgZ9xU1eZ6l/aFl8RYtQ8rTrfXP+EVuHmkSNpIWkSWMgHlGZRzjJBGasS/ELUNNt49Q1GK0ltH8NjV/JhiZJBKCgK7ixG0l/wC7kepoSulbz/8Abv8A5Fkt2dv6+z/8kjvJdQs4ZpIpruCOSOIzOjyAFIx1cjPC+/SpopY54UlhdZI5FDI6HIYHkEHuK8mubrWfD/jvxBrUlvpFzqaeGFuz5Eb28cgWVuHOXZiFGAe+BwvbVv8Axt4lEd2bO30qJbbw/HrAklEkhkJBLJsBXaDtYA7jjg89Km6td/18X+Q7Nysv6+H/AOSO1vfDuialfw32o6PYXd3B/qbie1R5I/8AdYjI/CtGvMfFXxE1qyWMaKdLtJ5dMhvbO21CJ5pNSkcnMMIWRPmUY/vE7hwBzXV+KPEV14W8Gf2lNAt7fAwwCOJRGrzSOqDAZ8KNzZwX/wCBd6pppfO3zEmmzo6K82bxd47s4tOh1bQ7GwlvtVSxW6uMfMjqWDiCKaTBBVgQZfQjqQLU3iPxTpusX+h6le6PJqMsMEmkyRadKkc26TY+9TOxO0kZAIwCDk9KW+39df1Htv8A1rY7q4uYLSEy3U0cEYIBeRwoyeByalrxvxBPrmpWPjCPWruw1CLS9XsY7OL7I0XlPugYMrF32jDkHgnknOPlroNS8d63pP8AalhJaWt9qUeqQWFkbaLYredEJBuWSUAlRkf6xQxA+7mjp/XW1vzHb+vTc7ux02x0yN49Nsre0SSQyOtvEsYZycliAOST1NWa88Pi3xrb/wBg2up6HY2F1qepSWUj3EgPyiJnSVY45HAztbKmQ4IxnnIbp3jbxC82jNqMemNDdaxcaPcLBFIrM8fmgTKS5Cg+V9whuv3qdv6/r1Qul/66/wCTPRaYksU/mLHIkmxtjhWB2nHQ+h5HHvXCaR45vz4sudM1efTbq2TTZdQEunQShYfLkCtH5jMVm4I5ULgjkcik0/UvEVp4osPD0S6dapdafJqlxPPHJPIZDMvmJtDIFH7wgHLdBxxgpK9vP/g/5MHpfy/4H+aOw0rQtI0KKSLRNLstNjlbfIlnbpEHb1IUDJ96sm7theLaG4iFyyGRYd43lAQC23rgEgZ9xXm+nfEfxHPZ3PiG58OMfDCW9xcLcKYleNYwxXkTsz7iuMeUm0nvjNZ19fa1pPjqXxDNb6Rcaj/witxdoIY3hVlWWNgkjZYuVGcNxn0Wjrr5/gm/0HZ7L+tUv1PX6rS6bYz6hDfzWVvJeQKUhuHiUyRqeoVsZAOBnFcBefETV9EW/bV7WzuWXSLfUbaK0DJteWTyvLZnbDDcQd2F4zkd6kPivxxZaLNPrPh/7IY7qNReLZifEJDF3NtBcSOdpAXiT+Ldjgint/XnYS1/ryueiVnal4e0XWpoZdY0iwv5Lc5he6tklMZ9VLA4/CuRuvHt3DcaVN9o0+PSr2BXGpfZppbaWVnK+X5qkCHAwf3gO4nHy4Nd/wDSl5gQ21xbXCuLSaKUQuYnETA+Ww6qcdCPSpiQoJJwBySe1eWX3i3xVqdjYfZp9P0q5/4Sg6VKqQvcIyJkjnehIJXn7uQccc56PStV1vxPNNPHHpTaEt1cWNxaTxOZ2WMtGz7txXll/wBWV+6c7u1LePMv60T/AFDZ2f8AWrX6M6uKa3vrUSQyRXFvICAyMHVx0PPQ1R0DTdC07TseF7PTrWymcv8A8S6JEjduhPyDBPGM+1cB4B1jWdO0LwvpcUOnva3ul3DW0WHRo5IiNu6TkbWDDgJlcdWq5pHjfxLrlv4bFta6VbPrVnczPNIZJBA8RwAIwRuHK/xAnnpTejdv63/yCz6no1FeYXPxJ1R/C+g3yS6RpD6nZzSvd6ijPA08eAIEUSIQzncRljwuMMa7nwtd6nf+FdNvNejji1C4t1lnijgaIRswzs2szEEZwcnqO3Snbf8Arv8A5C7GtRXH6/4rvtH8X21hN9nsdOnWJYrq6tZXjnkZ8MnnIdsTAAYDj5ywAIxXPXXj7xLpUhj1OTS3ey1wWWoLDp8i4tG8srOpM524Ei5J3DLDjjkWv9eaX6j/AK/C/wCh6jUD31pHcPBJdQpMkfmtG0gDKn94jqB79K8/1Hxp4pSSw0/RbC21PUb+Ce+ieC3UILdXVYwUkuUyWDAlg5x/cNU7i3/tDxlq0us6RBaXd74PV760YJKPM8xwVZhkPjGAeeAKiTaV/X8E3+asNLp6fi0v1uelQ6lY3EkCW97byvcQ+fCqSqxlj4+dQDyvzDkccj1qzXlvhrxTrOnaHoelWdlYyQL4RXUIGlmcM8kaxrtbC4Vfm7bifbvo6b43195IRfWVndPeeHjq9tbWaurCRduYizMQ24uMHC46c9a1nHlbXa/4c3/yLIi7pedv0/zR6DRXA+BvFuteJtfuFl1DRtQ0iKyimFxptpIu2Zycws7TMAyADI25+YZC9DueO9d1Dw14NvNW0m3tri4t9p2XTsqYLAE/KCSeenH1qWmtx3OiqK4u7ezRHu54oFd1jVpXChnY4VRnqSSAB3NcXL4o1+z1TWNIvZ9FjubaC3u7a9kjkjhSKWRkKum4lnUqcAMu/IHy1n2nxC1qbw7Z3gtrGaQ+IRpF1KY5YAUMoTzEibLAkHozcdeelCV2l/W6X5sb0V3/AFpf8j0mmCeJp2gWRDKihmjDDcoOcEj0OD+Rrz+08b+IWu7GXULbTIrWbXpdHkhg8yR+NwWQSEqBgpyNpyD1FQ+Ib3XIjpt/ol9DZPrOvx2xM9s0uYVDBBw6naTGWIzzv6julrbzt+Nv80wel0+l/wAL/wCTPSaK880Lxn4v17VvOsPDscmiNLcQC4keKMIYyyq5cTM7BmXBXyQVz1bHMOl/ETVxBo2oa7b2K2eqabdXZhtEcyQtAA33ycMGU9NoIPc0m0ld/wBb/wCQ0m3ZHojXdul2lq88S3Eil0hLgOyjqQOpAyKkdFkRkkUMrDDKwyCPSvHr3W7zTPGWmeMNat9PkZvDV7eKllCUkEa+S6xO7Md+Nxw3yj5j8o76Nz458eaf4cvdUv8Aw5Zwwqbdrae4dI12yOEK7Ippi5G5SGygIzwMYNOL6/1q1+grrdf1ov8AM9B0rw/o2hiUaJpNjpwmO6T7JbJFvPqdoGa0K891jxP4u0m91iyzokjabpJ1NbnyJQJQGb92Yt/y8IRu3nnnHO0Q3Hj7xPqOsGDwl4d+3xWsNtLdIzRAsZkD7Q7zoUwp67JMnjiktf69V+gPTf8ArZ/qj0iiuFi8Z6v/AG7qunT2sCXsKzvY6ZLbyxSXSoPkMcxJjl3cE7QCmcEHrWr4L8Ry+IbGc3Vzby3VsypNElnLaSwsRkiSGUll9uSDjINC1B6HS0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFIw3KQc4IxwcUtFAHKW3w08M2jWhgt79TZ3T3kGdXuzsmf7z8y8k5Oc9dzf3jmSH4deGrfT0s4LW7SOO5e6jkXUrnzo5X++yy+ZvXdzkBgDk56109FF2BgjwVoY1mLVTb3DXcNs1qrNezspib7yshfa2SckkEk8nnmq9p8O/Ctn5WzSI5jDbPaRm6le4KQtwYwZGbC44x2HA4rpqKP6/r7394HKH4Z+EzHIr6bK7SWpszM97O0ogJJMYkL7lXkjAI446cUp+G3hlllVoL9hNZCwfOrXZ3W46R/63p/ifU11VFG/wDX9dx3f9fL/Jfcjgb3wJdJrKHTId1ittFaxyL4hv7OaCNM4DCMnz8FiRuZSBx711s2i21/4d/sjWlGpQPAIp/PH+uwBlj75GfY1o0UbqzFs7o5uXwB4fnhsY5or6T7BMJ7d21S6Lq4+6S/mbmxkgBiQASBjJqy+kT3/im31LUrWzSPTRKtk8chkkfzFUFmyg2cAjaC2cg5GMVt0UAc5qngDw5rE17LfWUxe+kjluTDeTw+YyABT8jjB+VenXauc4GGyfD7w3P/AGl9os55/wC02R7rz76eTcyfcZdznYy4GGXBGBzXS0UBdnPXHgbQrp9Pe4ivHk02Xz7aQ6lc7xJgLvZvMzIdoxlyeMjoSKqp8M/C6JboLa+K21217EG1W7O2dvvPzLyTz19W9Tnq6KAOatPh74ZsXga305s20TQQh7qVxHGzBigDMQFyBgdB0GATV+TwzpkviiLxC8dx/acUJgSQXcoQRnqvlhthGeeV6gHqBWtRTuwMOz8GaDY3F1LbWO1btneaBppGgLOCHYQljGpYE5KqCcnPWs9/hh4Rki8uTS5HxA1sjtezl4om+9Gj79yKem1SBgkdCRXWUUg8zmo/h74bSd5Xsp5zJZDT3W5vp5ke3HRCjuVI75xnPOc1Yh8G6Nb6YtjFHdiJPuSNqFw0yYBACyl/MUAM2AG4ycVu0UAYUngvQZILeA2TiGBVVYkuJVRwpLASKGxIMsTh85Jyeav6Zpp05bkG5nnE87TASyu/l5/hXezED2BwM8ADir1FAHNRfD3w3DZSWq2dw8Ml6L9hLf3EhE4OfMDM5IJyc4IBzzmrB8GaJ/aFxeRwXEElzkzJBezxROxGN/lq4TfwMPjcCAQcgVu0UB1uctbfDjw3Z/YfssF/F/Z8UkNrt1W6/dI/3wP3nfP6D0FJafDbwzYfYvskF/F9gjkitdurXf7pZPvgfve/9B6CuqooA4C/+Hv2FtNg8NWYawsYZIo4X1++spYt7BmImj3s6navyHABGc10ek+H5tPmtZp9Su52ggaEo9zK6sC24Z3OQxUcByN5xy3atyindgZWoeGtL1S9jur6CSWRGR9onkWNyhyu9AwV8HkBgcHnrUd/4S0PU5tSlvtPSZ9UtRaXhLsPNiGcLweOp5GD054GNmikBj6n4U0bV/sJvLV1k0/i1mtriS3khGMFVeNlYAgDIzg4Gaq3HgPw/c6lPfSW90txcWn2KRotQuIwYf7gVXAA75ABySepzXRUUb7hscnH8M/C8Pk+Vb36eTZtYx41e7+WA9Yx+96f4D0GGXPw50eKzY6PHNFexac+nWz3N/cyxpCwxsKGQgj8OMD0FdfRQ7v+vX/N/ewVl/X9dkcTovg/UYbaeO8lm05ZIWh8qHxDfX6t0wwaQxtGRg8Jg8/e7Vd8c+HtR134f3Wg6Sbee4uI0iMl/OyKVBBLMyoxJOPTv1rqaKHqC0Oai8DaJLozWl9YyF53imnb7fPJIsqcrtnZhIAp+7grjsB0ptz8OvDN1btDJZXCK12L1jDf3ETGcdH3I4OQeevUk9Tmunoo/r+vuX3CtpY5SP4a+GYo4USDUCILw30e7V7tiJz1kyZeT9fU+prX1Dw1pOqaZaafe2m+2s5I5LdVkdDGyfdIZSD0468gkHOa1KKBmFB4L0K0vLu4tLSW3a8LNKkN3Mke9hgusYYKj/7agN3zVWy+HfhrT5tOktbS6B0xHjtFk1G5kSNX++u1pCGBzyCD29BXT0UAcxafDnwpZ3EE0WkJI9skkduLiWSZYEkGGRFdiEUjjaAAATgDJpJPhx4Zl0Q6Q9pdmx3qyw/2lc/JtIIVT5mVQEA7FIXIBxwK6iigDnL7wFoGpXdzc3sN7JLd2gsp2Gp3K74R/AQJAPqepyc9TlyeBPD0dza3EdnMstrbi1VxeTAyRDokvz/vVHYSbq6Gijb+v67sP6/r7l9xjN4S0V72S6ktXeSRJEKvcSNGokzvKoW2oWycsoBI4zVnS9DsNGa4exjkEly4eWSaeSZ3x0G52JwOy5wOwFaFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAf/Z" alt="" width="423" height="837" vspace="0" hspace="0" border="0" style="width:423px;height:837px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p>Every 4 week (Q4W) dosing regimen<br />CHOICE I study<br />A multicenter, double-blind, placebo-controlled, 48 week study included 540 patients on a maximally tolerated dose of a statin, with or without other lipid-modifying therapy (308 in the alirocumab 300 mg Q4W group, 76 in the alirocumab 75 mg Q2W group, and 156 in the placebo group), and 252 patients not treated with a statin (144 in the alirocumab 300 mg Q4W group, 37 in the alirocumab 75 mg Q2W group, and 71 in the placebo group). Patients received either alirocumab 300 mg Q4W, alirocumab 75 mg Q2W, or placebo in addition to their existing lipid-modifying therapy (statin, non-statin therapy or diet alone). Patients in the alirocumab 300 mg every 4 weeks treatment group received alternating placebo injections to maintain blinding in regard to injection frequency. Overall, 71.6% of patients were categorized at high or very high CV risk and not at their LDL-C target. Dose adjustment in the alirocumab groups to 150 mg Q2W occurred at week 12 in patients with LDL-C &ge;70 mg/dL or &ge;100 mg/dL, depending on their level of CV risk, or in patients who did not have at least a 30% reduction of LDL-C from baseline.<br />In the cohort of patients on background statin, the mean baseline LDL-C was 112.7 mg/dL. At week 12, the mean percent change from baseline with alirocumab 300 mg Q4W in LDL-C (ITT analysis) was -55.3% compared to +1.1% for placebo. At week 12 (before dose adjustment), 77.3% of patients treated with alirocumab 300 mg Q4W reached an LDL-C of ˂70 mg/dL as compared to 9.3% in the placebo group. At week 24, the mean percent change from baseline with alirocumab 300 mg Q4W/150 mg Q2W in LDL-C (ITT analysis) was -58.8% compared to -0.1% for placebo. At week 24, the mean treatment difference for alirocumab 300 mg Q4W/150 mg Q2W from placebo in LDL-C percent change from baseline was -58.7% (97.5% CI: -65.0%, -52.4%; p-value: ˂ 0.0001). In patients treated beyond 12 weeks, the dose was adjusted to 150 mg Q2W in 56 (19.3%) of 290 patients in the alirocumab 300 mg Q4W arm. Among the subgroup of patients dose adjusted to 150 mg Q2W at week 12, an additional 25.4% reduction in LDL-C was achieved at week 24.<br />In the cohort of patients not treated with a concomitant statin, the mean baseline LDL-C was 142.1 mg/dL. At week 12, the mean percent change from baseline with alirocumab 300 mg Q4W in LDL-C (ITT analysis) was -58.4% compared to +0.3% for placebo. At week 12 (before dose adjustment), 65.2% of patients treated with alirocumab 300 mg Q4W reached an LDL-C of ˂70 mg/dL as compared to 2.8% in the placebo group. At week 24, the mean percent change from baseline with alirocumab 300 mg Q4W/150 mg Q2W in LDL-C (ITT analysis) was -52.7% compared to -0.3% for placebo. At week 24, the mean treatment difference for alirocumab 300 mg Q4W/150 mg Q2W from placebo in LDL-C percent change from baseline was -52.4% (97.5% CI: -59.8%, -45.0%; p-value: ˂ 0.0001). In patients treated beyond 12 weeks, the dose was adjusted to 150 mg Q2W in 19 (14.7%) of 129 patients in the alirocumab 300 mg Q4W arm. Among the subgroup of patients dose adjusted to 150 mg Q2W at week 12, an additional 7.3% mean reduction in LDL-C was achieved at week 24.<br />In both cohorts, the difference vs placebo was statistically significant at week 24 for all lipid parameters, except for Apo A-1 in the subgroup of patients on background statin.</p><p>Clinical efficacy and safety in prevention of cardiovascular events<br />ODYSSEY OUTCOMES study<br />A multicentre, double-blind, placebo-controlled trial included 18,924 adult patients (9,462 alirocumab; 9,462 placebo) followed for up to 5 years. Patients had experienced an acute coronary syndrome (ACS) event 4 to 52 weeks prior to randomization and were treated with a lipid-modifying-therapy (LMT) regimen that was statin-intensive (defined as atorvastatin 40 or 80 mg, or rosuvastatin 20 or 40 mg) or at maximally tolerated dose of those statins, with or without other LMT. Patients were randomized 1:1 to receive either alirocumab 75 mg once every two weeks (Q2W) or placebo Q2W. At month 2, if additional LDL-C lowering was required based on pre-specified LDL-C criteria (LDL-C &ge;50 mg/dL or 1.29 mmol/L), alirocumab was adjusted to 150 mg Q2W. For patients who had their dose adjusted to 150 mg Q2W and who had two consecutive LDL-C values below 25 mg/dL (0.65 mmol/L), down-titration from 150 mg Q2W to 75 mg Q2W was performed. Patients on 75 mg Q2W who had two consecutive LDL-C values below 15 mg/dL (0.39 mmol/L) were switched to placebo in a blinded fashion. Approximately 2,615 (27.7%) of 9,451 patients treated with alirocumab required dose adjustment to 150 mg Q2W. Of these 2615 patients, 805 (30.8%) were down-titrated to 75 mg Q2W. Overall, 730 (7.7%) of 9,451 patients switched to placebo. A total of 99.5% of patients were followed for survival until the end of the trial. The median follow-up duration was 33 months.<br />The index ACS event was a myocardial infarction in 83.2% of patients (34.6% STEMI, 48.6% NSTEMI) and an episode of unstable angina in 16.8% of patients. Most patients (88.8%) were receiving high intensity statin therapy with or without other LMT at randomization. The mean LDL-C value at baseline was 92.4 mg/dL (2.39 mmol/L).<br />Alirocumab significantly reduced the risk for the primary composite endpoint of the time to first occurrence of Major Adverse Cardiovascular Events (MACE-plus) consisting of coronary heart disease (CHD) death, non-fatal myocardial infarction (MI), fatal and non-fatal ischemic stroke, or unstable angina (UA) requiring hospitalization (HR 0.85, 95% CI: 0.78, 0.93; p-value=0.0003). Alirocumab also significantly reduced the following composite endpoints: risk of CHD event; major CHD event; cardiovascular event; and the composite of all-cause mortality, non-fatal MI, and non-fatal ischemic stroke. A reduction of all-cause mortality was also observed, with only nominal statistical significance by hierarchical testing (HR 0.85, 95% CI: 0.73, 0.98). The results are presented in Table 3.</p><p><img src="data:image/jpeg;base64,/9j/4AAQSkZJRgABAQEAYABgAAD/4RESRXhpZgAATU0AKgAAAAgABAE7AAIAAAAYAAAISodpAAQAAAABAAAIYpydAAEAAAAwAAAQ2uocAAcAAAgMAAAAPgAAAAAc6gAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAE11aGFtbWVkLCBVc21hbiAvU0EvRVhUAAAFkAMAAgAAABQAABCwkAQAAgAAABQAABDEkpEAAgAAAAM4MgAAkpIAAgAAAAM4MgAA6hwABwAACAwAAAikAAAAABzqAAAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAMjAyMTowMToxMSAwOTo0MTozMwAyMDIxOjAxOjExIDA5OjQxOjMzAAAATQB1AGgAYQBtAG0AZQBkACwAIABVAHMAbQBhAG4AIAAvAFMAQQAvAEUAWABUAAAA/+ELKmh0dHA6Ly9ucy5hZG9iZS5jb20veGFwLzEuMC8APD94cGFja2V0IGJlZ2luPSfvu78nIGlkPSdXNU0wTXBDZWhpSHpyZVN6TlRjemtjOWQnPz4NCjx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iPjxyZGY6UkRGIHhtbG5zOnJkZj0iaHR0cDovL3d3dy53My5vcmcvMTk5OS8wMi8yMi1yZGYtc3ludGF4LW5zIyI+PHJkZjpEZXNjcmlwdGlvbiByZGY6YWJvdXQ9InV1aWQ6ZmFmNWJkZDUtYmEzZC0xMWRhLWFkMzEtZDMzZDc1MTgyZjFiIiB4bWxuczpkYz0iaHR0cDovL3B1cmwub3JnL2RjL2VsZW1lbnRzLzEuMS8iLz48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOnhtcD0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wLyI+PHhtcDpDcmVhdGVEYXRlPjIwMjEtMDEtMTFUMDk6NDE6MzMuODIxPC94bXA6Q3JlYXRlRGF0ZT48L3JkZjpEZXNjcmlwdGlvbj48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOmRjPSJodHRwOi8vcHVybC5vcmcvZGMvZWxlbWVudHMvMS4xLyI+PGRjOmNyZWF0b3I+PHJkZjpTZXEgeG1sbnM6cmRmPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5LzAyLzIyLXJkZi1zeW50YXgtbnMjIj48cmRmOmxpPk11aGFtbWVkLCBVc21hbiAvU0EvRVhUPC9yZGY6bGk+PC9yZGY6U2VxPg0KCQkJPC9kYzpjcmVhdG9yPjwvcmRmOkRlc2NyaXB0aW9uPjwvcmRmOlJERj48L3g6eG1wbWV0YT4NCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgPD94cGFja2V0IGVuZD0ndyc/Pv/bAEMABwUFBgUEBwYFBggHBwgKEQsKCQkKFQ8QDBEYFRoZGBUYFxseJyEbHSUdFxgiLiIlKCkrLCsaIC8zLyoyJyorKv/bAEMBBwgICgkKFAsLFCocGBwqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKv/AABEIAX4DFQMBIgACEQEDEQH/xAAfAAABBQEBAQEBAQAAAAAAAAAAAQIDBAUGBwgJCgv/xAC1EAACAQMDAgQDBQUEBAAAAX0BAgMABBEFEiExQQYTUWEHInEUMoGRoQgjQrHBFVLR8CQzYnKCCQoWFxgZGiUmJygpKjQ1Njc4OTpDREVGR0hJSlNUVVZXWFlaY2RlZmdoaWpzdHV2d3h5eoOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4eLj5OXm5+jp6vHy8/T19vf4+fr/xAAfAQADAQEBAQEBAQEBAAAAAAAAAQIDBAUGBwgJCgv/xAC1EQACAQIEBAMEBwUEBAABAncAAQIDEQQFITEGEkFRB2FxEyIygQgUQpGhscEJIzNS8BVictEKFiQ04SXxFxgZGiYnKCkqNTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqCg4SFhoeIiYqSk5SVlpeYmZqio6Slpqeoqaqys7S1tre4ubrCw8TFxsfIycrS09TV1tfY2dri4+Tl5ufo6ery8/T19vf4+fr/2gAMAwEAAhEDEQA/APpGiiigAooqhrGh6b4gs0tNas4b21WQSmCdA8bkZxuU8Ec5x7UAX6K8P+Fvg3w5qHi7x6lzolgfsGu4s3W2QNahSSBGcfIAQOBxXQX3xK1zTfG2m6beWeni1vdXbTGtoyZJYhjKSmZXK5YEHyiisPpg0R961utvxt/mD05m+l/wv/keoUV4No+r6j4PvPihrOhwWBt9N1hZ57WWJh5ybfmCMpARuSckNz271p3mrWdl+0AniEwFIf8AhDWvZQFAdgH3c++AB+FJNNJ+V/8AyXm/QaTbaX9apfqezUV558P/AIhar4tvLX7XpUyWd9ZG7juI9OuIYrY5AELSyDbKSDkOmBwRjvVX422yjQdHvUknSZdZs4vkuHVCjScgoDtOfcdh6VVmmk+rt+Nibqza6f5XPTaKhu7u2sLOW7vriK2toVLyzTOERFHUljwB7msSD4geDbm4jgtvFuhTTSsEjjj1KFmdicAABskk9qW+gzoaKoa5q1toei3OoXtxDbxQr/rJ5AiKScLljwBkjk15f8GfFEf/AAknirwlLrMGs/Zbx7+zvYJVkWeKU7mwVJHDNzz1Y+lC1bXlf+vzB6K56/RXgXjTXrrxx4P0zxHNa6elhH4mht9PHkt9pjRZtjOZCcfOV+6FXGBya7o+LfE1v8RtZ8MX0mlRD+z/ALZo0ospCZsvtxJ++5KkgEDGc5yvShar7/yT/UbVnb+t2vzPQ6K8r1L4o6xaeKtQ0ax0x9Sl0RbZb2Oz0u5ma8eQAv5bRllgCg5HmFt3I4xmtWLxV4ovviL4h8M6eulBbC1t7q0lngkHEh5STD8nAOCAMeh6U7Xt5iem539Fec2vxEvYvEuuWuuSWdgulR3E39lyWkiXM0EYJWaOYvslDAZICjbnBPHL/h/8QtV8W3lr9r0qZLO+sjdx3EenXEMVscgCFpZBtlJByHTA4Ix3pLXb+t/8n+W4PTf+v6v+ux6HRXEeKvFmtaN8R/C2haeli9nrguFkM0TmSJo03BgwcDHI4254PPPGJrvxK1/R9ebw/Fp8V7q1hpq3t2tlp1zcrdOxIEUQjyYs4+/JkDIGD1o7ef6f8MNq39fI9Soryvx58T9d8KW9xqEGnWcVpbQ204tbpS89ysrBXztcG3KE4y6MGPA54ran8Xa5rHjPUfD/AITXTI5tKtbe4uDqKyMJjLz5alCNmFGd2H5IG2nZi8zuqK8zXVfE918b9X0yHVLGOzsdHSaKCWyeRRvbnkSr825Rlj1AwAOtc/4D8e3i+C/CWn6Vp+nWF74g1C8iDBJZILfYzOz7Gk3sSe28Dn8KUfeV1/WrX6B38v8AK57ZRXkOq/FrWoPDSXWn22n/AG+18Sf2FepNHIY5DnHmR4cFMjBwd2M45xmtGL4ieITa+NLddNt77UPDl5HFEbS3ciSJ8EuYt5Zii5JUMN2OMUef9dP80DunZ/1v/kz02isDwXrh8ReG49R/tOw1NZHYLcWEDwoR6NG7MyOOhBNb9Nqwk7hRRRSGFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABVbUtQtdI0q71LUJfJtLOF555NpbYiKWY4AJOADwBmrNc38R/8Aklniv/sC3n/oh6AD/hPNI/58/EH/AITmof8Aximv470lkYC18QoSMBh4bv8AI9+YK6aigDy3wlF4f8H6xqmo2l/41vZNVlM93HeeHLkpJKf4/ks1IPXgEDnp0rPTw54KiuLeaJ/GiNbaw2sxf8SK9IWZvvLza8qcDrk+/WvYqKa0aa6f1+gPW9+v9fqeUXWmeDbufUiyeL47fV7j7RqdomgX3l3rA5UPm2LKB0whXI65qe6g8K3njhfE0o8WeaLE6cbIeHLv7O0BByhX7Lu6nPDfpxXqFFLpb+trfloO7/r7/wAzzvwpfaB4Q04afp8vjC4sYifs1tdaBeutspOdikWwYqM8bi2Kr+MpNC8bQ20F9e+M7K3tpknWGy8OXIDSocq5L2jNkemceor0yih6u7Ftocta+NtLt7SKKVPEl06IFaeXw3fB5CP4jttwuT7AD2qX/hPNI/58/EH/AITmof8AxiukooA4bVfEOm6nqOn3SXni+yWyk8z7PbeG7ry5z0w++1YkYyOCOueuCMXVLfw9qfj228XC/wDGtnqFrGIY0tfDtysZj7owNmWYHn7xOM8Y4r1OijYDyOfQvBFzZTafLH4y/syS/wD7QSwj0XUI44ZuSShW3DgEnOCxAPTFb97qfha/8SaVrtxY+JDe6VHLHbt/wj2oYIkAB3ZgyenHPWu9oo2/r5fkD13PN2l8NJ4ym8S2B8XWF5dxLFexW3h+9EV2qjC7w1sSCBwGUqfejT5/D2neO9R8VRzeMJbvUYVhmt5fD14YQq427QLUMMc/xdznNekUULQHqeeXV74a1DVor3U4/FN6kCSLDaz+Hb1o4zICrkH7NvOVYrgsVA6AUnhS+0Dwhpw0/T5fGFxYxE/Zra60C9dbZSc7FItgxUZ43FsV6JRRsG55trc3h7XfF+i+Ip5vGFvc6KWNtDB4duxE2/h9wa1JORxwRx0weadqE/hu98XQeJbY+LdN1OOH7PLJaeHr3bcxZzskV7ZgRnuMEetej0UbW8geu55Brvh7wT4huNdlvR4zT+3EgW6WLQ77AMP3GXdbEg8c5JB9K05P+EZ/4SmDxDaP4vstRS2W0uJLfw/egXkQ6CUG2IJGPvLtI9a9Moo2B67nnE1x4bfxXceIbf8A4S60vrmy+xS+T4fvirKDlWw1sfmU9Ox7g1kaPofhDRPDtjpNpN4zb+zbtrywu5PD12ZrWRgQ20i0CkHLcMrdfpj16ihabf1rf8w/r8LfkePXnh7wfd6Cml+f40hUas2ryXEfh6682W5JJ3MTaEYGeAAOgzmtLRl8PaJrOt6nbXfjSS41qZJ7jzPD92Ajr90rttRgY4wcgjrmvT6KNv69P8l9wPXf+v6uzgtK8TeGPCel3ssn/CQ7ZJHvL6+u/D14hdto3SOVt1RQFUZwAABWz/wnmkf8+fiD/wAJzUP/AIxR8R/+SWeK/wDsC3n/AKIeukoA5v8A4TzSP+fPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/wAYrpKKAOb/AOE80j/nz8Qf+E5qH/xij/hPNI/58/EH/hOah/8AGK6SigDm/wDhPNI/58/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/ABiukooA5v8A4TzSP+fPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/wAYrpKKAOb/AOE80j/nz8Qf+E5qH/xij/hPNI/58/EH/hOah/8AGK6SigDm/wDhPNI/58/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/ABiukooA5v8A4TzSP+fPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/wAYrpKKAOb/AOE80j/nz8Qf+E5qH/xij/hPNI/58/EH/hOah/8AGK6SigDm/wDhPNI/58/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/ABiukooA5a5+Iug2drLdXkWuQW8KGSWWXw9fqkagZLMTDgAAZJNS/wDCeaR/z5+IP/Cc1D/4xR8R/wDklniv/sC3n/oh66SgDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDll+IugtdSWqxa4biNFkeIeHr/eqsWCsR5OQCUYA99p9DUv/AAnmkf8APn4g/wDCc1D/AOMUWP8AyVPXf+wLpv8A6Pvq6SgDm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xiukooA5v/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YrpKKAOb/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GK6SigDm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xiukooA5v/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YrpKKAOb/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GK6SigDm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xiukooA5v/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YrpKKAOb/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GK6SigDm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xiukooA5v/AITzSP8Anz8Qf+E5qH/xigePdE86COWPWLfz5o4EkudCvYY98jhEBd4Qq5ZlGSQMmukrm/Hn/Iu2v/Ya0r/04W9AHSUUUUAFFFFABXN/Ef8A5JZ4r/7At5/6Ieukrm/iP/ySzxX/ANgW8/8ARD0AbOrX/wDZei3t+IHuPssDzeTH96TapO0e5xXI+DvGl54osLPU7S+0fVLO4ObmKwV1m08eWW2uCzGRtwC5xH1zg11+pm9GlXR0pY2vfKb7OspwhfHy7j2GetednwH53xF0rXtH8OHw3eWk5fUr2C4jEF9EVO6NURtzksR8zonTPPFEfi1/4YH8P3nUab8Q/Der6ZNqGm3N5cW0N0tnIy6bc5WYnATaY89SATjAJGcVag8Y6NdanNYWs1zNNCZFZo7Kdoi0f31WUJsZh0KqxOQRjIrB0fwpcaX8WNcv7WdBpGoQw3ktrjJF386bh6AqMnrk4PGKbp3hjUNK+Ij32iQXenaZeGWXU4HuEktJ3OdrxJnekpOC3yhSO5NHT5fj/wAPf8Ael/60/q34ljwz8T9E8Q+HLzXJPtFhY287RiS6tZYw43lF2sVw7MR91SSCQCM1fvfiH4Y07S7fUL7UXgtri6FmrSWkwKTH/lnIuzMZ/wB8LXmY+G3ih/g5F4fNkI9S0rWTfxRreKgvUErPhJFOUyG4J2kEdutafizwVfSeDbSLwr4V1EXdzrNvqN9Bdaok0w8vG5mklmYEkKAMMffFNW0+X6Xf5+lhy0bt5/rb9PvOuuvit4Lsnu47vWfJmspfLuYHtZhLF0+Zk2bgnI+fG3kc811T3dvFYteSTxrbLH5rTFgFCYzuz6Y5zXiXiDwf4r1Gf4mPbeFrkt4ijto9Pdrm1BYRgK27978o/i+g9eK9Ml0G51n4VtoFyrWF1c6T9jdXKsYXMW3kqSDg+hNS/gbW9l+X6BpzpdNf0/r5FnT/ABtoGqeZ9hvJJGS3N0qG1lVpoQM+ZEpUGVeRym4ZOKg0z4heF9YsYLyw1Tfa3EM0yTvBLGmyI4kJZlAXHocHHI4ri9G8L+JY9f8ACt1eaPNbxeG9CnspdtzCRdzFVRVjw/3Tt3Avt7ZxTPC3hq90X9nXUtB8XaPcW80cF351vHcw7pVYs4KOrFR94D5u46Y61KyUmun+bX+TFHWyfdflf89DtNN+I/hjVdQeys72481Lf7UzTafcQxrDgkSGR4woQ4OGzg9s1Np3jzw7qtzc21jfSPcW1v8Aamha0mR3h/56RqyAyKezJuB4x1ryvwjeSXWsXEtzoutp4jk0NtM0qLW9FNjaTpGpYRt+8cOxxlidoI6KK0PCvg3xVpfjmz13UdFKx/8ACLmymjgngAjuQ27y0QMFVeyhflHcjmnJJXt2f/t1vyXzYo67+X6X/N/cd7o/xK8J69Np0Wl6qZW1TzBZl7aaNZjH99QzIBuH90nPfFbmraxYaFp7Xuq3At4FYIDtLMzE4VVUAlmJ4CgEnsK8P8LeBPGGl2fw5gvPDlwjaDf3Ut8wurYhElb5WGJctwckDng+2fRvih4c1jXtJ0m58PKk97o+qQ6itm7hBdBM5TceAeeCeKJJJ6d7fLTUfX5f56fgvvM/xL8THt7jwvN4Xktbqy1TWl0q9S7tZUmiYnkAEqUYYPDKeo/Hpp/Hnhu31qPSptSC3Mtx9lRvJkMJn/55edt8sSf7G7d7VyfxE0vxH4lm8G3eneHLpv7P1iK/uoWubcPDGg5BzJtLZJwFLDjqM4rnvEPgrxlrOtJetoVtGtp4shv40tJoYlltEGPNIyN8h7l/m4wOKIpOyff8Pd/zbE77+X/yX/APVP8AhLtG/t46OtxM92snlOUtJmhR9u/Y0wXy1bbztLA8j1FO0XxXpHiCd4tJmnm2J5gke0mijkTON0buoWRc91JFc3d+GdQt/iHBrHh+3u7FbqUnVv8ASI2s7yILtG6MncJuFwyrjGcntTvBfhnUPDniS9isYryx8OtDuWwurhJo47gkEm3IJZY8bgVbbz0GKUddxy02/r+v67HdUUUUgCiiigAooooAKKKKAOb+I/8AySzxX/2Bbz/0Q9dJXN/Ef/klniv/ALAt5/6IeukoAKKKKACiiigCO4uIrW1luLhwkUSF3Y9FUDJNcT4T8VeIPHdiNd0VdP07Q2ldLZLuCSae7VSV35V0EQJBwMPXY6jYxappd1YXOTDdQvDJj+6wIP6GuB+H2l+I/h94fi8K3eiTatbWsr/ZNSsriFUMbOWHmpI6upBPO0PQt3f5fqD2VvmdK/i+10u2to/Eo+x6nOJG+xWkct0+xGILgIhYpjB3FQOe1F3498NWU+kxTampOsgnT3ihkkS4wM4V1Urn2JyaxNZ0DWoviFpniy3svt5TTJdPubS2lRTGWcMrqZCoZRyCcg9CB2rjtI8DeKtF0z4bWz6NNdto13Pdai0dzB/o/mE4QbnG7G7+HI44zTWtr9/1f6WYPRO39af56HfQfFbwVcPAkWuIXmuPs2xreVWil3bQkoK5iJIIG/bnBxmrWofEPwzpWrahpl9fTR3um24urmEWU7lYuPnG1DuUZ5K5xznoa8jufA3jCXwdq9lH4TuVu73xZ/ayj7Xac2+7dyfN+8MYx7/Wuo8Q+H/Et38Q/FGp2nhy6ms7/wANHTbaUXNuN8xyehkBA+bGT6Htipe1/wCvhT/PQf2rdNP/AEqz/DU7bSviF4V1vVoNN0nWYbq5uImmh8tH2SquC22TGxiMjKg5HcCptP8AG3h7VL+OzsdREskzOkLmF1jnZM7ljkKhJCMHIUkjFeX6F4M8Twa98OWufDdxa22habPa6hL9otiI3kQpkBZCWGRuJA6MO+QLOjeAfEdhaeC/D8ti62/hzWJbubUlni8uaL94ybV3b8neFIKjHPUc1o4xva/9Xav91n5kXdn/AF0/z0O4tfij4Qu5FSHVXBa+/s4mWznjCXP/ADzYsgCn0zjPNdbXz3N4D8ZtoGo26eGLozT+MhrUafa7Xm369fNxu46e9fQYOVBIIJHQ9qn7N/62T/NtfIuWkrL+tX+lhaKKKQgooooA5v4j/wDJLPFf/YFvP/RD10lc38R/+SWeK/8AsC3n/oh66SgAooooAKKKKACiiigAooooA4X4ueLdb8DeCX1/QfsDm3lRJYb23eTzA7BRgrIu3Gc8g59qgi8X+JNL+IWi+HNYTT9Wh1e2efz9OtJLd7MIM5kVpJAVJIAOV59aj+N2ha34p+Hcuh+HNIm1G6upo3JWaGNIgjhjuMjr17YB98VkaZ4V1/wR4wtdc8GeHZv7F1eILq+grPbxNaSqMCWMeZ5f1Ct/9Zwt17/p/n1Ce2nb9f60O8Hjvw4dbi0kakPtU8zW8TeTJ5Ukq/ejWbb5Zcd1DZHpUcXj/wANzXt5Zx30v2iyu47K4jazmUxyyNtQHKdCcfN93kc8ivNrrwb4yv8AxFpepXOgwQiy8VNetFaTQxx/ZcACUKGG5zyWLfOTjtwOs8DaLrOn/EbxtqWqaPLZ2mrXMMlpcPNC/mLGmzojlhnqMgcHseKI6q7/AK+H/N/NCk2np/W/+S+86iHxdodxrjaRDfB7xZDFgRv5ZkAyYxJjYXA5KA7gOcVs15N4J+HM+j+IbyPxDpN5di31aXUtN1JNVcWw3nIzbiQYkAZhnyyDnrXrNL7KYfaaCiiigYUUUUAFFFFABRRRQBzdj/yVPXf+wLpv/o++rpK5ux/5Knrv/YF03/0ffV0lABRRRQAUUUUAFebeOfHXiTwL4hjvbmys9R8KKYzevb27rdWauSoYnzCrgFST8q9QPevSa59kn1DxNqVjqGg3DaXPZpCbuZ4WhmwXLLsDl+Q+OVHQ+2VrfQeltSKDX5BcXWsXWs6UfC62Ud1DKsDK4Vs/M0pkKlflPRB94enM9v410O6s724t7idzYw/aJoGtJUm8vBIcRModlODhgCDjg1wa/CC8sPA3i/wnpmos2n6iEfSRPIT9nGS5iPU7d/f0b1zVyw8M6/qfjy61q902XS7ceGhpSJPPE3mzFySf3bN8owME4PzdOopy2du2n3N/noEfPv8Aql+V2dZ4H8X2/jfwzDrFpb3NukpJCT27x8ZO3DMAH4xkqSM5Ga5zw38S5JJPEx8VCNIdI1k6bA+n2M8jSA/d3IvmNknjIwM49a1/hdpOp6B8OdK0fW7M2l3YxGF181XD4Y/MCpIwQRjPPqBXm9v4L8aaZr+u+JdM0a+Gop4gN/Y2bX0AhvbeQFJFYebhW2kkMRkZGM8gU7Ko0tv+Cv0uTG7p3e//AAH+tj0y/wDiX4V0y+vbK/v7iG5sbZbu5ibT7jdHCcfPgR8gZGcdOc4wavXvjPQbCOzeW+Mv26H7RbJawSXDyRYB8wJGrNtGRlsYGa8y8R+GvFes+K/FmqQeF7xItX8MjTrdXurXPnnBKn97wBkjP+yfbN/QvCHiDRbjwlrb6TNNPYeHzo95p6Tw+ZE+QVkBLhCuQc4bOMcHkVP2b/19r/JfePr/AF/d/wA39x3D+PvDaarpenLqDS3Grx+bYeRbSypcLzkrIqleMc88d+tM0v4geHdagjm0y4vLhJLtrIFdNuRiZRllIMfy4AOScAYPNcFZfDXxBbfCjwjYxbYfEOjalHe/NIrCFXlbzFznBARzkA87eK6vwt4QuvDfjbxBPEi/2LdNHdWcYYZE7Jsl47fcByeu8+9U0k38/wBP+D80J+X9b/8AAfoWrD4oeENSktUtNVcm7vGsYjJZzxr9oAyYmLIAregbGe2a62vnyHwJ4yXQNLt28MXQmt/GJ1mRTd2vFvnPXzfvc9PY+1fQdKy5U+v/AAE/zbXyDr/Xdr8rBRRRSGFFFFABXN+PP+Rdtf8AsNaV/wCnC3rpK5vx5/yLtr/2GtK/9OFvQB0lFFFABRRRQAVzfxH/AOSWeK/+wLef+iHrpK5v4j/8ks8V/wDYFvP/AEQ9AHSUEZBB6GiigCho2iaf4f08WWkwNDbhiwVpWkwSc9WJOPQdB0FX6KKACiiigAooooAKgvbK21Gyls76BJ7eZSkkUgyrA9jU9FAGRpnhjTNJuftFst1LMAQkl5fT3RjB6hDK7bAcdFxWvRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38R/+SWeK/wDsC3n/AKIeukrm/iP/AMks8V/9gW8/9EPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38R/+SWeK/8AsC3n/oh66Sub+I//ACSzxX/2Bbz/ANEPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzdj/yVPXf+wLpv/o++rpK5ux/5Knrv/YF03/0ffV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfjz/kXbX/sNaV/6cLeukrm/Hn/ACLtr/2GtK/9OFvQB0lFFFABRRRQAVzfxH/5JZ4r/wCwLef+iHrpK5v4j/8AJLPFf/YFvP8A0Q9AHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AdJRXN/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHQB0lFc39u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdAHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AdJRXN/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHQB0lFc39u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdAHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AdJRXN/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHQB0lFc39u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdAHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AdJRXN/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHQB0lFc39u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdAHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AHxH/5JZ4r/wCwLef+iHrpK878fXnjFvht4lW80LQ4rc6TdCWSLWpndV8lslVNqoYgdASM+o610H27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAB8R/wDklniv/sC3n/oh66SvO/H154xb4beJVvNC0OK3Ok3Qlki1qZ3VfJbJVTaqGIHQEjPqOtdB9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQAWP8AyVPXf+wLpv8A6Pvq6SvO7O88Y/8ACydZZdC0M3B0mwDxnWpgir515tIb7LkkktkYGMDk5IHQfbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJXN+PP+Rdtf+w1pX/pwt6Pt3jf/AKF7w/8A+D6f/wCQ6w/Fl34ql0uxTVdG0e2tDrWl+ZLbavLNIv8Ap8GMI1sgPOB94YHPPQgHoFFFFABRRRQAVzfxH/5JZ4r/AOwLef8Aoh66Sub+I/8AySzxX/2Bbz/0Q9AHSUVV1OytdR0u4tNQtobq2ljIkhnjDo49Cp4NeQeB9QuPCHw18DJ4b0nTF/t68FvezSlkcsxchsKvzHCkZJ4wBjHQWrt6fiD2v6/ge00V5he+PvEunaTr13Oukyt4d1OO1uQlvKv2uN/LIKAyHymAlHJLgkHgU7VfH3iezXxnNFaaTFD4YeOQI3mytcxFPMK5yoRipHOGAORg9aP6/L/MOtj02ivOtT8aeIbC91mzH9lmWHQTrNm/2eQrGAxBikHmAvnHDDZ/u0r+NvEQ1DQkgh0yZNW0GXUBC6SRFJ40RseYGb5D5nTYSMdTmjpf+uv/AMiw62/rp/8AJI9Eorzfw98QNau5PCtxrUOnraeIdOmufLtY3DwPGgfO5mIZSpPG0EHuad4Y+Ier67r2lD+yriXStWhaQSJpF3B9g+Xcu+eQeXKGHG5duDjG4HNVyu9v66/5CurXPRqK47xX4uuNB8QWtnJc2Wl2c0BdL7ULaR4ZZskCIyKyrEfunLZznAGapz+KfEGmeJ9c03VZ9L8qPTTfaQ0NpJum+YqVbMvzFTsBC7d28HK9Klar7/wK2/D8TvaK4RfF2rWfimDRNdvdK0+4ZIVj86zmSO/dsF/JlMm1SPmURncxIByAawNJ8V63oY8VXuqXcOoFvEP9n28cOnzMyOVjAbajOzKE/gVckg/Nzwdf67pfqLpf+tr/AKHrVFeVt8RvFcNvEjaLCWOs22ni9vLK6sI7mKYjDxwyguCDuU5YgYB5ziptU8d+JtMsPFcrDSJH8LzI0pFvKBdwuiuFA8z92wDY3ZcEj7op2v8A16f5oOtv66/5Hp1QNf2iXRtXuoFuFjMpiMgDhBwWx1xyOelZfibxGvh3wpNq/kec4EawwltoeSRgiKW7Dcwyewrz2d9b0P4razqUsGkXOpp4XNwGgie2jm2zdH5diQFwDnnA4XtLdnr5/gmw3V15fi0v1PWbe4hu7aK4tJo54JkDxyxMGV1IyCCOCCO9SV5y/wAQr9LHw9cX02n6RDqmlx3TXl5bStbSTuv+pEgcCHBIOXLZBwBmrWp+L9dnfxDN4cj05oPDhC3EN1G7PeMIllZUdWAjwrYBKvk9hVSXK3fpf8NAj71rdf1O8qGe8traSFLm4ihed9kSyOFMjeig9T7CvPdM8e+Ite8QzxadaaVbaZDp9nqge4eR5Xt5ixYHGAr7VOOoyByc8Y2p6hqHiHWPh74mvYdOSzvNT8yzSOBvtNvE0EjBWlLENuABICrggD5utPlaevf+v1+4V002u1/wuew0V5hp/wASde1a9spdI0d7yy1FZPKV9LvIFtcKTG8l0yGN0YgA7F4zxupLDx74sufAlj4nvLbTILO+CAvb2s9y1ll3DSPGrAumAn3SpBJJOBUj62PUKKzdA1JdX0WG+ivbK/jmLGO4sSTFIu4gEZJwcdRk4Oa0qbVmG4UUUUgOb+I//JLPFf8A2Bbz/wBEPXSVzfxH/wCSWeK/+wLef+iHrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+I/wDySzxX/wBgW8/9EPXSVzfxH/5JZ4r/AOwLef8Aoh60vEVhZ6n4cv7XUrWG7t3gYtDPGHQkDIJB44IB+oqZPlTY4q7saVFfPt4sB/ZkjtP+EDukgGlx3Ivyll5Qm2DNxgTeZk/3tm7npXodtq9/4X8UWuiTDSLHw3Jpclxp4gsmjZHjALxsfM28Al+FGRnpjJ0lHlbXb9CVqk+//A/zO/orznT/ABJ45u/EaeHrldBtrx9IGoi5+zzMu4uFCNF5gIxyD859f9mq/wDwtC/v9K05LCz+y6lcWs00+NMutQSN4pTEUCQDdhmVsOSMADgk4qdv69f8mP8Ar77W/M9OorzLTvHPjTXNcsNNttE0/SZbvSTfmLUvO8xHWVEdGXClRy2OvBUn+6bEPxJe3h1ufVprOK40uOeeTRjbSw3Sxx5CsGZiJVbAO9VCjOOcU2rfj+DsC1/D8T0WivLpfiN4mtrPWpRowu0s9NfUILqfS7zT4UKn5oHMykuwXkMuA2Oi9auw+OPEcF6kF1YWV9LeeH21a0trKN1YSJtBiLFjvBLjBCqR0wetFv6+/wDyYf1+X+aO/urq3sbWS5vZ47e3iUtJLK4REHqSeAKkyNu7IxjOa82vviHqUHw61LX9IvNF1i4sAgmQQzWpgYkhleFmZwwyuFJXPzcjilbUvEyfFPxF9lvLCe3stGgngs54HQHcZSF8wOdp3LktsbIwABjNJ6b/ANaXBa7f1rY9Etbq3vbWO5sp47i3lUNHLE4dXB6EEcEUTXdvbSQpcTxRPO/lwrI4UyPgnauepwCcDsDXn+meNfEN5H4J1O5OmQaV4giVboC1kMkU5jLqqv5mArYwMqcEd88Tt4s8SWmreHobldKuLLXNRngSeKKSN0iVHaM7C7BiQmS24dQNveqcWnb5CurX8rnfUV4zYeIPHOmeFPEevw6lpF5HY63cJdJPpkpcRRuEd1K3AGFQZCY6D71el6VqN9qOv32y4s5dIgjiSIxwsJGlZQ7HfvKldrLjC/xdeOUtUn/W1xvRtebX3Oxt0UUUgCiiigAooooAKKKKAObsf+Sp67/2BdN/9H31dJXN2P8AyVPXf+wLpv8A6Pvq6SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/yLtr/ANhrSv8A04W9dJXN+PP+Rdtf+w1pX/pwt6AOkooooAKKKKACub+I/wDySzxX/wBgW8/9EPXSVzfxH/5JZ4r/AOwLef8Aoh6ANy/tXvbCa2iu5rJ5F2i4gCF4/cb1Zc/UGuJtfhNbWml6Pp0PijX/ALLotyLqyRjanY4zjJ8jJHzNwf730x31FC0dw3Vjhrz4WWl9Y63az+Ida8vXLpLq7wbYHeuMBT5PA+VP++R6nLZfhXb3FrrsF14o16Ya+iJfM32UFwqhRjEAC/KNvA6e/Nd3RQBySfD62Ourql1rWqXb/wBm/wBmSQS+QI5YMchgsQOSfmyCOfbiqo+FtgF09m13XGn0y0ks7Sf7TGGiicAY2hArYCgfMpz3zgY7eij+vz/zf3h/X5f5L7jidP8AhjZ6fN4fZNe1iWPw/E0NpDL9nKMjDDK+IQWyuF6jgeuSdjQvCcPh8iKz1PUJNPiObbT5nQw23XhCEDlRnhWZgOwGBW9RTuxWRieIfDCeI7ae1udTv7e0uYxFcW8DR7Jo/myp3oxXduwSpVuBgjFY+q6LZeIPFGhQ29rdxjw/cGSSV4JYoygT5Y1dgBKC2xvlLAeXzziuzopLQb1MDWfCUGvTp/aGo37WYuEuXsQ0flO6bSnJQuACgbCsMknOQcVUk+HukynVd1xfBdSvBfFVmA+zXA2/vIiBkNlFPJbuOhIPVUUbf16f5L7gOR1bwD/bdjYwX/ibW2ks7lLpbhTbB3dDmPcPJ24U56KM5+bPFVr34YWl/F4hjufEGslPERU3oH2YYCgKAn7ngbQF78e/NdvRR/X9fcgMm+8OWeq+Fm0HV5Jr63eERSSyELI+MYfKBQGBAOQByK5+b4Y2lzcyXl14i16a+ewOnfa2uIg3kkkkFRGEY8kZZT6/e5rtqKHruC0VkciPh9B/wisPh19e1iTTktktJI2aDM0K7hsb91xkNtLLtbCrzkZqe68B6fNcXJtLy+063vY1jvrS0dBHdqECDeWQsp2gLlGUkdTXT0U223dhtsc5p3gq00zxVea3Bf3jfa7WOzaxcQ/Z0iTOxVAjDDGW6sevOeMZifCzSUGnw/2prBsdLu/tdjZC6CR2xww2KyqJCnzHgscdBgZB7aii7Fbp/XY5my8FR6ZDcWum61qttYybzBZo0JjtGbnMe6MtgEkhWLKP7uMCnaJ4NTw/4VtNC03W9USKzLeRcM0JlUEMNp/d7GA3Ejcp5AznFdJRSH1uZnh/QLTw3pX2GyaWQNK88ssxBeWR2LO5wAASSTgAAdgK06KKACiiigDm/iP/AMks8V/9gW8/9EPXSVzfxH/5JZ4r/wCwLef+iHrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+I//ACSzxX/2Bbz/ANEPWxq1g+qaXPZR3txYmZdpntghkUd8b1ZeRxyD19eax/iP/wAks8V/9gW8/wDRD1a8Y6ve6B4N1TV9Mt4Li4sbZ51juJGRGCjJ5AJ6A4Hc8ZHWplazuVFNySW5kS/Dm3m+Hq+DX17V/wCzlQQ+YPs/nGEDAiz5ONvA5xu/2qg1/QLfXRo/h+ZtSvZ9Mu4biS/ntzGPLAbcDIqJG+5f3ZVP73I61r6f400SXRUu9R1vS7eaG2hmvla7RBbGRQRvBbKAk4G7rV1fFGgNHZyLrmmlL/cbRhdx4uNv3vLOfmx3xnFaO6lr3/H+vvM42cdO35nEarZXOp/HDbBLrumQ/wBi/Zf7Qs7JvKMnm7ynmvE0f3e/Y8AhuK6R/AenRQaaujXV7o8+mwmCC6s3RpDGxBZX81XVwSM/MCc81r2XiDRtSvDaadq1jd3IjEphguUdwh6NtBzg+vSlh17SLi+ubKDVbKW6tBm5gS4RpIR6uoOV/GpWiS7f5v8AzKesm/T8kv0MqHwZFD4zi8Sf2vqT3EVq1qLdzEYmjY7mz+735LDdnd14GBxTbrwLp2p3qT63dXmqxxW8lvFb3ZjKRrIu1zlUDMSOPmY47YrQbxX4dW1luW17TFghCGSU3ke1A/3CTnA3dvXtU134g0bT7SK6v9Xsba3mfy4pprlESRs42hicE5HQUdLf1r/w4db/ANaGLP4FW68M3eh3XiLWpra5ha3V5HgMkMTcMinyucgY3OGbGcEHmoIfh1FDq9hqI8R60ZrCwOnxDdbqDEcZzthBzlVOQR90dsg9Ffa9o+mAnUtVsbMLF5x+0XKR4jyBv5P3ckDPTkUlzr+j2QtjearY24uwWt/NuUXzhjOUyfm4547U7u9/66r/AD/ELaW/rp/wDnNV+GdjrNlq0N7rGqmbWPLW7u0MCyNFGSUiGItoUFjzt3Huxq3L4Fgk1GfUF1nVIr2509LCedGhBlVd22Qjy9u8b26ALz93gYuav4m07QU1C91TVrGOzsbZZZYOPOjyT8xO7kNwFG0cg8nOBHp3i3S9W03TtTttZ0yO0uIGnkQzq5IC5bDhwBsIO7g9D0pbp/13QbNf12/4BTX4d6afh9B4Qnv9RnsrYIILlpES4h2MGTa6IoBXAwcZqzrXg231nUNFuhqd/YjRZfNtobTydhbaV+bfGxPykrgEcH15q3H4u8Ny2MV7F4h0p7Waf7PFOt7GUkl/55q27Bb/AGRzWbrfjzRvDNilzq+safItxqC2kPlyLGEyyghyWIygJZjwMdhTu7/P8RWVrBHouleErfUuNTvLfWLuSRrRIHuVSSXlwBGhKqT1ZzgZ6gcUzQvDV54e+G1to+mz3UF9HED5iSRvIrk5wWlVlKj7ucE7RxzitO08ZeGNQt7mew8R6TdQ2kfmXMkN9E6wp/echsKPc1audf0ez0dNWvNWsYNNkCsl5LcosLBvukOTtOe3PNLZfd/wB7u/qXYRIsEYnZWlCjeyjAJxyQKfWaviPQ3nt4E1nT2luoPtFvGLpC00WM+Yoz8y4BO4ccUWXiPRNTsJ77TdY0+7tLckTXEF0kkcWBk7mBwOPWhguxpUVnDxForaS+qLrFgdPQAvdi6TylBAIJfOBwQevemxeJdCnnt4Yda06SW6hM9vGl0haaIZy6jPzLweRxxQBp0Vx3iHxv8AZrHRL/wxNpmq2OoarDYTXMdz5ioHcKSmzIY9erDHv0q5r3jLTfC+i6vq2qapZSwWTBVhiIWRH2giJjuOXJ5HC4BHHGSdL/10/wA0Pd2/r+tDpaKy7DWrLU7hJNP1fT7q2ktvOWOCRXcjP+s3hsbO33evftU+nazpmroz6TqNpfKhwzW06yBeSOdpPcEfgaCb31Mix/5Knrv/AGBdN/8AR99XSVzdj/yVPXf+wLpv/o++rpKBhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfjz/AJF21/7DWlf+nC3rpK5vx5/yLtr/ANhrSv8A04W9AHSUUUUAFFFFABXN/Ef/AJJZ4r/7At5/6Ieukrm/iP8A8ks8V/8AYFvP/RD0AdJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/wCSWeK/+wLef+iHrpK5v4j/APJLPFf/AGBbz/0Q9dJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/5JZ4r/AOwLef8Aoh6T4i+Y3w31+KC3ubmaewlhihtbd5pHd1KqAqAnqRzjA6nil+I//JLPFf8A2Bbz/wBEPXSUpLmVioy5ZKXY8n0WCOfxt4btm0TUY7BvC72F0ZdJnihVyYyI3LIFHCv1+nUjLtD0qafQtb0HXrRbi08MW0+n25nUOlwrrvjbBzkrF5a5PctXqF3BJc2csMN1LaSOpCzwhC8Z9QHVlz9QR7VnP4ejPh+70yO+u4nvA3n3q+WZnZhhn5Qpkjj7uAOgGBTqNyi15P722/wuyYJRt5W/BJfjZHmPhG1l17w/8PU0Wwu7SfSLLzbm+ltHhjVHtiuxXIAk3uyt8hYDbk4OKi0rwrFJotn/AMJMPE15qGh2U0EthNpcbWzb4yr7WjtwbhWOCAHZs4JGQa9W8NaDF4Y8OWejW13c3cFlGIopLrYXCDhVJRVBwOOmfXNalXUalKVuv/B/zFG6S8jyTQPD0EXwp8Lzra6loes6fChNzBo7yTRSxo4KywlN7qd7jAHJbKkZzVdrTX7+8sr/AMUx6tpdpfadJZyDRNMSfDmZyxkheGV4xKhRuBwQQxzivY6KUnzSbfUForf13R47aaNY+HPiFaCLRdXntrLwzJZm9k0qWd5HBUorSRx4Z/LBHH+714qlo9vq+n/D/RL3TLbWLfXLXSksJdNvNEllgvcM+IXBUNHgg/PlVAZckivb6KXM/wCvVv8A9uY9P6+X+SPHtT0+5u/FHj2Kx0G8gn1Tw4kKsmnyJFPcqku9RLtCO3zoM556DOKsWgB8feAr0aFqkTw6TLa3dy2kzDZuRFjWR9nyjcH4YjbnJwDk+s0UJ2/r1/zE9V/Xl/kef+GtIvdN8Sah4fnsJV0Owu31OzuDF+7kE2SIR6lHaU4HQbPWuN02wuE8HmKx0HVLeGz8aJfLbf2VNCVtTPlXSMoCVC9lHHcCvcqKE7NPtb8Gn+g5aprv/k1+rZ5vr2n3dl48iXT7N1svGEC218oAHkyRfMXbB6tD5i5GeVWu61fSLXWdBu9Ju4wbW6gaB1x0UjHH0qODRxHqz6hc311eSfMIEm8sJbK2MqgRVz90csWPvya0qTs48o7tSujy+GHWr74baq+v+H572+srF9KWydGQ3gU4eVdpDFXAUgDBOzjrVLT9Jl1DWPFC6nFrS2+qWenNDdxaU0BVkZhlEZeNh2kq+5sZzkV67RTu3v8A1/TJtbb+tv8AI8jhm8SS6hpWsazpt1qWm6Xqkhe4i0t4Li6RoNiXD2pG8sjZXhckcquK0b/T7TTPE3hLWtF0XUItKiurxp1hsZmkRriPO8xYLopfIOVGCeQBzXpdFFx2/r7/APM8OKanZ+FrWC78O63E6+M2v9senvMTbi4LmTEQYgAEdcZ/hz1p9xps934T+J1lo+hajD9tvRc2cJ0uaATrsjDGMMg3EsrnA5PXHNe3UUJ2Vl/Xw/8AyKDrf+t2/wBTylI7a8+KGuTtoOrw2eo+HRbzzR6VNGZ5AWJG/aAX8sqBk56L1GB0HgVtYh1bUNPvTNfadZwxRWup3enNZzuQWBiYEKJAowQ6qFO49Tmu2ooTt/Xm3+ov6/BL9Dm7H/kqeu/9gXTf/R99XSVzdj/yVPXf+wLpv/o++rpKQwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/wAi7a/9hrSv/Thb10lc348/5F21/wCw1pX/AKcLegDpKKKKACiiigArm/iP/wAks8V/9gW8/wDRD10lc38R/wDklniv/sC3n/oh6AOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDpKK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDpKK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDpKK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDpKK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgA+I//ACSzxX/2Bbz/ANEPXSV534+8A+D7P4beJbqz8J6HBcQ6TdSRSxabCrxsIWIZSFyCCMgiug/4Vx4I/wChN8P/APgrg/8AiaAOkorm/wDhXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImgDpKK5v8A4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJoA6Siub/AOFceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8AiaAOkorm/wDhXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImgDpKK5v8A4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJoA6Siub/AOFceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8AiaAOkorm/wDhXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImgDpKK5v8A4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJoA6Siub/AOFceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8AiaAD4j/8ks8V/wDYFvP/AEQ9dJXnfj7wD4Ps/ht4lurPwnocFxDpN1JFLFpsKvGwhYhlIXIIIyCK6D/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgAsf+Sp67/2BdN/9H31dJXndn4B8Ht8SdZtW8J6GbePSbCRIjpsOxWaa8DMBtwCQignvtHoK6D/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Sub8ef8AIu2v/Ya0r/04W9H/AArjwR/0Jvh//wAFcH/xNYfizwV4V0jS7G+0rw1o9jdxa1pfl3FtYRRyJm/gBwyqCMgkfQ0AegUUUUAFFFFABXN/Ef8A5JZ4r/7At5/6Ieukrm/iP/ySzxX/ANgW8/8ARD0AbmoS3UGnzS6fBDcXKLmOKeYxIx9C4ViP++TXA2PxP1L+ydA1nW/DtvaaTrk8dvDNaakZ5YXkOE3xtEnGepVmx6V3mp3aWOl3FzKk8iRoSUt4Hmc/REBZj9BXi/hPRbnQvD3hvxImj61qB01Ps+o6TfW1w81s56T2sUo4K7sERjBUnHIojbm120/X+r9Bv4dNz2W91rS9Nu7e11HUrO0uLo7beGedUeY+ignLfhQda0tdUOmnUrMX6qGNqZ180A9DsznB+leX6vpDeI/EGsx6xP4ottJ16OE2ostKUhkVApjkMlu0kDhwWBYovzZBzmtMWOo6Z4rgt9KjvNQsdSuwdR0/UtNLxxAJsadLkAKD8oO1ixbPAFC8/wCv66/0xPTVf1/X9djuIvEeiT38djBrGny3cu7y7dLpDI+0kNhQcnBBB9MUi6xZwS3bXmr6d5Uc6whQ4QwsQMRuS5yxJyOF4IGD1PkHhWzXVPAumaDoulXMV5b+I5LpbmOzZILeKO8cs4lxszsBTYDu5xjFZ+tadbSP4hto/CmqOJPFNrfWgTw9clfJXyhNIpEWBnbJnu2e+apK7t/W8f8AN/cwel/67/5fie2S+LPDsENtLNr+lxx3blLd3vIwJmBwQhz8xzxgd6qHxvoY8cDwr/aFsNS+z+cY2nUNnIwgHdiMtgcgDPeuC+IelTTPr9jomgXFst3oTCKey055TeOWdzF0KREE5OV3uX4ORVq+0/WLvxXeSaZZ3sD6n4RWztLp7d0WKcM5w5I/dkbgcNg+gOKnpf1/J/5Dsu/b84/o/wAPu9EtPEGjX93c2tjq1jc3Fp/x8Qw3KO8P++Acr+NUbnx14Rs5FjvPFOi27su5Vl1GJSRnGQC3TIP5VwcmlxatD4WX+wr23Xw/aSR6rHPpkoVoTblGgUbcThnwcJvBxn0yvhHwVDq3wKtdNbS20zWY7YhJLmyaCaGdJDJGfmUNgOQcjg5PvTaSv5flrqhLW3S56dFq2nTanJp0N/ayX0cYle1SZTKiHoxTOQD64xVHxX4o07wf4butZ1eZI4YF+VWYKZX/AIUGe5NYnhTXTL4Xfxbr9pcWct/sDxLbtK8KINmCIwx27t756ANk4qf4oWV1qvwu1u20y3ku55bcGOKFSzPhgflA5JwOgoasENWrlO3+ItsfGd3aX17o9voCaZFfW+pC9BWXfIU5c4QcqwwCc8c9q6rUdd0nR7NLvVtUsrG2kICTXVwkaNnphmIBrzTULhbv4h6zqEuhau0DeGPskUj6NcNuk3uxRSEOSVZePwPIIEfhFb3Sx4d1bX9L1SWxXw3Hppi/syaSa2uFYeYrxBC4DAAbtu07euMZEtP6/vf5JfNC8/T8o/5t/I9Ou9f0ewVGvtWsbZXj81TNcom5Mgbhk8jJHPuKE1/R5NYOkx6tYvqSrvNmtyhmC+uzO7HvivH/AAp4PTTPHmhW2r+H5pIzYX6SO+mvLDEkswaCF5dhT5Y9wwThckdxm4lrft4q0WcaJqFjDZ+Jbh5baHTpWjjWSOVRO0pBL7iQcoQihsEcA07LTz/zsD2fl/lf+v6R6suuaS2sNpK6nZnUlTzGsxcJ5wX+8Uzux74qGLWbK30mfUNQ1jTmtIpXDXaOscUYDEbWYuRuXoTkcg8DpXE+E7C1i0+HSfFOgX0ur6ZfXF0Lg2UjxzF3f98JgNjbkflCxbttOBXN+FrW807SdCuxoGqLpuk67fy3Fj/ZksbxxymTyZUhKAuFDDhASM9OKSG9P69f6/z0PaLS8ttQs4ruwuIrq2mXdHNC4dHHqGHBFVbfxBo13qVxp9rq1jPe2ozPbR3KNJEPVlByv41D4etdOtNJf+xdPlsraaV7gRSxPEzM53M2x8MmSTwQMeleT2NtKdV0C71Tw7qUOnwQ6lBdacujTSx23mDOwkqzzbufnGUYngDpUvQaVz1228Q6Ne3yWVnq9hcXTxmVIIrlGdkBwWCg5IzxnpXPeK/HI0bXdG0vSp9Lup7vUobS9ge5zPbpJ0YRrzzg8kjHHBrz7wvb3Gn6R8M7aPQ9WtJ7G4uPtuNHuEEG+N0Bc+XgAsycnjv0Gam+y6nH4b8LaZL4Y1W41rRfECXF88dmdsvzSM86zNiNg+QSd3GcHHFXb3l6r8/8tyX8L9H99n/ke20UUVIwooooA5v4j/8AJLPFf/YFvP8A0Q9amu3t5puh3V7ptpDeXFvGZBBPcGFXA5PzhGwcZxx19OtZfxH/AOSWeK/+wLef+iHrb1K2a80q7tYyA00LxqT0BKkf1qZ35XbcqNuZXOds/FOr3fw2XxONGs0uZLQXkdkdQYqYiofmXyeG2542kZ4z3q9B4qsbXSYbnxPfaVo9y0aySwtqCskYY/L87hCc8fwjngZ61ymj6neRfDa38KT6Jqq65Fpw09ovsMog3iPZv+0bfK2d87s47Z4rPcaboPxf1lZtImuzceHrWOQWVg07TOXkX59ikjcFA3NxgDJHFaTspPl26fj+ehEb8ib36/ev82ek32vaPpib9S1Wxs18vzd1xcpGNmQN3J6ZI56cikvNf0fT9Nj1C/1WxtbKXHl3M9yiRvnphicHNeRaHp8fgvxp4TGt6dNLexeGZ47j7JZtdTKRLGFUiNWZgoOzIBA+lPsvDOr6MmmTakda07TJIb2NYtLsorySzE1wXWJ4jDKQpjwDsHBXB4oa2t5/g2vxt+I/+B+KX5Hrd5r2kaeFN/qtlaho/MUz3CJlMgbhk9Mkc+4qe71CzsI0kvruC2SRgiNNKEDMTgAEnkk9q8n03wjpWlfEXw1p6aJqF5Y2+i3NpJd3+mtKGDOpiSWURhPuBwAcbQcHBODu/Fiyt7m38Nk6PcahLbazbzbrbTpLkwQq4MhyiNtGAOOM474osrq3V2/G3/BF38l+l/8AgHXv4n0GKCzmk1vTUivm22kjXcYW4Pohz8x+mamk1vSotUGmy6nZpflQ4tWuFEpUnAOzOcE8Zx1rzfxJ4VSTxRqtjetrVjoesWcVvCuiabFNERl98cn7iRojuYtuyq/MTnIqw2n6joXiC1i0KPUL+K+ubdNQ0/UtPMsbBERGuFuQAiMqqDhidxU7QKUdX/X9f121G9P6/r+vuO8HiPRGv4bFdZ083c7MsVuLpPMkK/eCrnJI746ULq9pC97Jeavp/kQTLHw4Q25Kj5JGLkFiTkcLwQMHqfHtEsI9Q8FX/hrQ9IuI7z/hJ5pbeaGyZILZI7zPmeaBsXaqkBc7uwGKpeINLgn0bxnZReFdTk+0eIbe6sUTQLgqyjyhLImIsDO2XJHXPfcMi1t/X8v+b+71B6Nr+uv+X4ntM/izw7bW0Vxc6/pcME0rQxSyXkarJIDgoCTgsCCCBzVX/hN9D/4TdfCw1C1/tE2/nGMzqGySNqAfxMRlsDkAZ71xfjnTmmu7610XQbi3S+0GdY7u0015DO7ksYSMbIicBiXXc2cAgjk0qy1U+KIZrewv7c3vhCGzguJLV0WGdWbIkyBsI3A4bBPbNTrvb+rS/wAvx+8f9ffH9G/u+70W38QaNd39xY2urWM93ajNxbx3KNJCPVlByv41RufHXhGzkWO88U6Lbuy7lWXUYlJGcZALdMg/lXnTaL/aHh3wjp0+h3sdz4dT/ia+dpsjIYhAyyxodpE/mNj5Y9+e9WvCPgqHVvgVa6a2ltpmsx2xCSXNk0E0M6SGSM/MobAcg5HByfeqdlfsvxXdAtbef9WPTotW06bU5NOhv7WS+jjEr2qTKZUQ9GKZyAfXGKt1y3gK7udb0U+ItStGtLvUguYXA3RJGNu3jtuDsP8AfrqaGraCTurhRRRSGc38R/8Aklniv/sC3n/oh66Sub+I/wDySzxX/wBgW8/9EPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzdj/wAlT13/ALAum/8Ao++rpK5ux/5Knrv/AGBdN/8AR99XSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN+PP8AkXbX/sNaV/6cLeukrm/Hn/Iu2v8A2GtK/wDThb0AdJRRRQAUUUUAFc38R/8Aklniv/sC3n/oh66Sub+I/wDySzxX/wBgW8/9EPQB0lFZ3iG+utM8N6hf6fDDPc21u8scc7lEYqM8kAnt6VxOmeMvFF/deGbeQaRE3iPSmu4mEErC1kREY5G8eYpD/d+QjH3j1oWt/wCu/wDkw/r8v8z0emSoZIXRJGiZlIEiAblPqMgjI9wRXmtv8Tb+58PaSDAkOrX0l3G8kGm3N7Gn2eTy2cQw5chjtwCwxnknHNvTfG+ua9FpWkx6bHpOtX0dzLMdStJfLjihcJvELFHO/euASMAnOcYJZvRBtubPg7S9H8J6ONOsfEL6jDPeyiJrueFm85izvGpjVcnO5tvJHPYcdTXjPgDXNR8O2uj6RbWGnx2WpeJNRtJ/LLDySrSOFiQAAL8mMk8cDHcdIfHWsQ+OrHTLhdNa1vNRmsTawqzzQBY2dJHmVzGCwXPlFVYBupware39dv8AMHpfyv8Am/8AI9CqKW7t4JoIZ54o5bhikKO4DSsAWIUHqcAnjsDXmN9461jUPB/iNrfU9O0/V7GxuJ30+SylS6tNg44d8SDhv3gAXJXAPe7p/iHxHpC+CdJdNMvU1a0cNPiSFgyW5dF25fA4UF8nPOFFSv8AL9f8gen4/hb/ADPRqpanYTahAkcOpXWnhXDO1qI8yL3Ql0bAPquG9CK4DQPiD4hvrfwxf6pbaZHba1qM+nyQWyyF42Qy7XDs2MfusEbec5yPuixaeN9Xl8c2OjajHpj2mo3N1atawRvJJaiJWZS8wZo2LquTHhWG7vg0+V7Be2v9df8AJnZ21rpV5oyWVmYZ7CECEJDLuTCcbDg89MEH8at3V5bWMIlvbiG2i3BQ8rhFyTgDJ7k1xfwghitvA88FvGkUMWrX6RxooVUUXLgAAdAB2rlfHmq33ivwmNVSHThpFpr8FvbpLAzXIeO7WJphJu2rkhl27c7Tndzina8ku9vxt/mLZPyv+F/8j1+O6t5biaCKeN5oMebGrgtHkZG4dRkdM1LXn0/jnXYm8XRf2bbGTRLq3hh+zpLcfupAGMroMM+1W3FFx0IBPWpl8cT3dvo1ro2o6TqV3rVzJBb30MT+REscW92eLfu3BgRs3jqMmpWq0G9N/wCrHd02SRIo2klZURRlmY4AHqTXmF78RvE1lO2mHT9Ll1Cz1u20u7nLyJG6ThWSSNOSCVJyC3ykD71WtX1TxBren634euItEkn03T/M1MyQSSQ3BkDlY41LAp8qglm34JwAetKTtByX9aX/AFQ0ve5X/Wtj0K2uYLy1iubOaO4gmUPHLE4ZXU9CCOCPepa8a0Lx1qOleBNB0rQbV5ruz0C0unX+yrq8E5dCFiBgGIidh+dsjn7pwcdBpXjPxfrniifT7bSdOsIoLKzv2hvTL5+yUtvjYYGyQBWwMEAgZzn5dJx5ZOK6P+vyJT0v/XT/ADPRaK47wR4tuPEkkkd9d2C3kSFrnTFtpILmyYkbUdXY7wPm+cBQeMCuxqWrDCiiikAUUUUAFFFFAHN/Ef8A5JZ4r/7At5/6Ieukrm/iP/ySzxX/ANgW8/8ARD0/x9d3+n/D3XL3SLlLW7trGWWOV49+3apJwMjnA4PY84PSpk+WLZUY80lHudDXP2/hKO38c3PigarqD3FzbrbPav5PkCNSSoAEYfgknO7PPPHFcdpviHxpa3Hh7w5ZjQp5LzQ2u4ruZJkGUEYCsgY44cAkMc8nAxtNw+PdYtvGljp16umm2utQmsntYFeSa3CRs6yNMrFAWC58oqrAMOeDWjjyy+//ACM0+aN/67/1/mdLP4SjuPHNt4oOq6glxbW7WyWq+T5BjYgsCDHv5IBzuzx6cV0FcToPiDxV4hg07V7K207+xdUWQopRvOslwfLkclwJckAFFVSN33jgmmfCO51e+8DLea3fQ3kk13csrR25jYfv5A24l2ByemAuBgc4zSs0rPp/mU+53NRW11b3tutxZzx3EL52yROGVsHBwRx1FcXovjPUNV1DUrEz6ZFqlt5xTR7mGW3nRVJCMXJbzEY4JdEwAcDJFVbDx5rGq+D/AApeW8NlaX/iKZojNLG8lvbEK7fdDKWJ2YA3DJOfalv+H4h/wfwPQ6RwWRgGKEjAYYyPfmvL4/iR4nnXS/K0jR1jutdfRpLj7XK25kLBpFTywADsJHzt2HrieT4ga1baXqC3q2aT6brLadd6lFYzSW8MXliQTNCshcD5lU/PgE5JxxRa6/ry/wA0PVO39df8mdZ4T8JxeEbK6tbfU7/UEubl7pje+USsjks5HlonBJzg59sVvVnaXqJ1DQY7+G4tL8SI0kUtm/7qVcnbgknHGM88HNcLovj/AMQXmqz2E8WkXU7aPJqMKW/mRxwSI4UwNMDIsuN3LpjkdORQ97Pp+i/yQlqr9/1f/BPS6hmvbW2ngguLmGKW4YpDG8gVpWAJIUHqcAnjsK850b4jaw0Phm/16HT1sdc0ue8aO1jfzLdooxITuZiGUqTxtBB7ms+7uNT1jxx8Ode1ODTUjvp5pLdYISJ7dGtXYRvIWIfPU4CgEdD1quV81n/W/wDkK6tfyPXKp6nYTahAkcOpXen7XDO1qI8yL3Q70bAPquG9CKuUVIyK0tYbGzhtbWMRwQII40H8KgYAqWiijcAooooA5v4j/wDJLPFf/YFvP/RD10lc38R/+SWeK/8AsC3n/oh66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAObsf8Akqeu/wDYF03/ANH31dJXN2P/ACVPXf8AsC6b/wCj76ukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACub8ef8i7a/8AYa0r/wBOFvXSVzfjz/kXbX/sNaV/6cLegDpKKKKACiiigArm/iP/AMks8V/9gW8/9EPXSVzfxH/5JZ4r/wCwLef+iHoA1ta0wazot3prXVxaLdRmJ5rbZ5iqeDjerDkZHIPWuasvhtBY3mhXEXiLWWbQrV7W0V/sxHlsMEN+55OAoz/sjvkns6KP6/r72BxVh8MbHTdLt7W21vV1uLS6lurW/wB0AngaUkyKMRBGRiSSrKw+mBjS1HwZb6jJYXZ1PUbfVLAsYtSgeMTMGADqwKGMq2B8uzAwMAV0dFO4HCW/wn02zvbO5s9c1yFrTUJNRVDcRyK00mdxIeNsDDMMLjrk5PNW4vhvYQXVtLBquqxpaak+pW8IkiKRSPv3qMx5Kt5jdSSM8EV2FFF/6/r0D+vz/wA2ctc+ALDUZ5ZdY1DUNR3WElhGLh4x5MUihZNpRFYs2ASXLc9MVWufhzHO+iSR+Jdct5dEjKWskZtmOSmwsweFgTt4wAB3xnJrsqKX9f197G9dzhbT4V2lnZ6PaxeItbMWj3r31sGNtzIxJO4+TyPmfj/bPoMWbb4bWVnNYPa6zq0Y067murNN8JWEyhg6DMZ3L87H5sn3xxXY0U7sX9f195g+EvCkXhDTJrG21K+v4priS43XpiLK7sWfHlovBYk8568cVkah8LtJ1CK9tTqWrW2nXt0t7JYW1wqRLOHDl1O3euWGSAwHJIAPNdrRR1uByumeBI9K1bVNRtvEGstLqckckwkkhIUxgBMHysnCgL8xOR1yeabH8PNMityy3l9/aZvGvv7VDRi4E7JsL4CeXygC7dm09xnmusopAcdqHw3stQt4FbWNUhnjvk1Ga6iMHmXVwgAR5N0RX5QowqhV9qu6r4Js9T1mbU4tQ1DT7i6tvst59jkQLdRjOA4ZWwRuOGXa3PWukooeqt/Xb8tA8/67/mchp3w307RY7AaFqmq6dLZW62pmjnSVriFSSEk81HBAJOMAFQcDA4q5p/gyHTvFV7rseralJNeWyWrwSNEY1RM7MERh8gsxyWOdxznjHR0U229WFrGFYeFLe08Q/wBtXN/e6heJbfZYGujH+5iJBZRsRS2SoJLbj6EVu0UUXAKKKKQBRRRQAUUUUAc38R/+SWeK/wDsC3n/AKIetnVdNt9Z0e80y+DG2vIHglCtg7WBBwe3BrG+I/8AySzxX/2Bbz/0Q9dFLLHBE8szrHGgLM7nAUDqSe1J2a1Gm07o5TT/AIfwafr+lasuu6vPLpdmbOKKZoCjxnGQ2Igcnap4I+7x1OWRfDfT4Lq2lh1XVES01J9St4PMiKRSPv8AMXmPJVvMb7xJGeCK1ZfGnhaCyivJ/Eujx2sxxFO9/EEkPorFsH8KtTeItFt7uW1n1iwiuIUWSSF7pA6I3CsVJyAcjB71V3f+vUnRL+vT/gFDQvB9v4dkaPTdS1BdO3tJFpjSIYIGY5Ow7PMxkn5S5XnpU/hnwza+FdPksdPuLqW3aZ5US4cN5W92cquAOMseuT6k4FPk8WeHYoJp5df0tIoJvs80jXkYWOX+4xzw3seam1DxBo2kqW1XV7GyCoHJublI8LkDd8xHGSBn3FIfUy5vBkVzqUV9caxqUtxbQSQ2buYSbUuu1nU+XlmI/v7h7VyGueCrbRPDeh+GpJtevtBtpJJJLiOxhv3j4wkbwCBg65ZmDGNipXqOCOwvPHegWXirTvD82p2gvNQiMsQa4UDGQEA55Lk/KB1wcVqQa9pFzq0ul22q2M2oQjMtpHco0sY9WQHI/EUf19wf195xtl4HbV7XTPN1rWLew0i6S60xTaWtq5IXHzxCAbVGSAu1Dy2R901q6b4D/sm41S4s/EutLNqdybqVybY7JCmzKjycdAvDAj5QfXO0viPQ3uorZNZ09p5i4jiF0hZyhw+BnJ2459O9InibQpNIk1WPWtOfTomKyXi3aGFCDggvnAP407/193+SC3T+uv8AmyLS/DGnaR4ZbQrUSG0dZBIzv88hkJLsSMAElieAAM8AViW3w2trT7M0HiDWVltdPk02KUtASsDFSFwYtuV2jBxn1zVnxj41i8PeGJNS04R3heOTyJwyvAJF6ByrbsE8fKDz1xW1omrx65paX0MEsMcjEIJduWAONwwTweozg46gHije7/r+tWG1jl7P4W2No2gqdc1eeDQYHt7WCX7OUeNxtZXxCC2VwvUHA9ckyW3ww0y3l0ndquszW+izmbTrZ7sKtuCMbAyqHZcHGGY8cZwSK7Sii7vcVugUUUUhhRRRQAUUUUAc38R/+SWeK/8AsC3n/oh66Sub+I//ACSzxX/2Bbz/ANEPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzdj/yVPXf+wLpv/o++rpK5ux/5Knrv/YF03/0ffV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfjz/kXbX/sNaV/6cLeukrm/Hn/ACLtr/2GtK/9OFvQB0lFFFABRRRQAVzfxH/5JZ4r/wCwLef+iHrpK5v4j/8AJLPFf/YFvP8A0Q9AHSUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38R/+SWeK/8AsC3n/oh6v+J7CDVPDN9Y3QuTDcx+UxtF3SrkgblGDnHXoenQ1Q+I/wDySzxX/wBgW8/9EPXSUnqB5pBpGs+LfCev6Vq+ZXhdG0rV5tPaymllQbkd4mAOUcAbgFDAnAArC8VLN4r+ErazqXh+6udT1O8tWitIrBrmSBYnUNwittGBMc9w+O+K9c1Owm1CBI4dSu9P2uGdrUR5kXuh3o2AfVcN6EVPaWsNjZw2trGI4IEEcaD+FQMAVV+vp+H+egf8E8l1gifxN43nttE1Uw3nhuK2tXGi3IEsmJAUX931+eMY9v8AZOKfh66sNK8eaXd3miX3nSeEIoriNNJla4MiyCMh4wm/+HbuIxgDnGDXtdc+PCMY8eHxV/a2ofaDbfZPsn7nyPKznbjy9/3vmzuzn24pLf8ArtL/AOSB6x/rvH/5E4Dw/wCHtb0HWPCYnsLtNulX9uDHH5i2byzI8UbsvChVGMk4+XA7Ciy0W5uvDfhHRJdLvYNX8P3kc1/cvZSCMIobzisu3bL5mcbULE7uR1r1+inf+vm3+vzF3/rpY8EsLRbTwJpVnD4Z1WF4fFpu2gXQbgbLbz2bft8r7vlsB9OOxFbqWhvfEniwvDr+mN/bEN9Y30GjzOoMdsELhWjIkUlWXABJyCOxr16ii+n9f3f/AJFD/r8/8zitH0aTxh4G8rxfp0dreSm4jS4gtvs8ux2I85VfLQs64JU888+lddZ2Nrp8BhsbaK3jLs7LEgUMzHLMcdSTyT3NT0UNiCiiikMKKKKACiiigAooooA5v4j/APJLPFf/AGBbz/0Q9dJXN/Ef/klniv8A7At5/wCiHrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5ux/5Knrv/YF03/0ffV0lc3Y/wDJU9d/7Aum/wDo++rpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm/Hn/Iu2v8A2GtK/wDThb10lc348/5F21/7DWlf+nC3oA6SiiigAooooAK5v4j/APJLPFf/AGBbz/0Q9dJXN/Ef/klniv8A7At5/wCiHoAP+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfrevLuCwsp7u8kWK3t42klkboqqMkn8BWBZeNYrxrMNo2q2y6gxFi88Ue25AjaQEFXOzKqcCTaeenXAAv/AAgekf8AP54g/wDCj1D/AOP0f8IHpH/P54g/8KPUP/j9TeDfEx8W6AdSawfT2W5mt2t5JFdlMchQ5K8ZyvbI9z1rZia4aaYTxRJGrAQskpZnXAyWBUbTnIwC3ABzzgOwGB/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8ACj1D/wCP10lFIDm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfrpKx/Fmvt4X8Kahra2Mt+LGEzNBE6oSo6nLHGAOe544BPFJuw0m3ZFP8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfrdsbn7bp9vdbNnnxLJtznbkA4z+NT1TTTsyU01dHN/8ACB6R/wA/niD/AMKPUP8A4/R/wgekf8/niD/wo9Q/+P1L4x8UN4S0mC/GnS3yS3cNs2yRUEXmOEDMTyRkjgAnnsOa36XS4zm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfrpKpaxq1noWj3Wp6lKIrW1jMkjew7D1J6AetAbmR/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9dGrblDDoRmloA5v8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfrpKKAOb/AOED0j/n88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8AH66SigDm/wDhA9I/5/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/AB+tfWNXs9C0qbUNRk8uCLGT3Yk4Cj1JJAH1qwrXBvHVoohbBAUkEpLl8nIK7cAYxzuOcngY5AMD/hA9I/5/PEH/AIUeof8Ax+j/AIQPSP8An88Qf+FHqH/x+ukooA5v/hA9I/5/PEH/AIUeof8Ax+j/AIQPSP8An88Qf+FHqH/x+ukooA878feCtLtfht4luIrrXGeHSbp1Euv30iEiFiNyNMVYeoIIPQiug/4QPSP+fzxB/wCFHqH/AMfo+I//ACSzxX/2Bbz/ANEPWzql82maXcXqWc96YE3mC3KCRwOuN7KvTnkjpSbSV2NK7sY3/CB6R/z+eIP/AAo9Q/8Aj9H/AAgekf8AP54g/wDCj1D/AOP1R0j4lafqb6R9r0rVNJh1tQdOuL1IjHckruCgxyPtYjkB9pNdlVNNbk3Ob/4QPSP+fzxB/wCFHqH/AMfo/wCED0j/AJ/PEH/hR6h/8frpKila4WaEQRRPEzHzmeUqyLg4KgKdxzgYJXgk54wUMwP+ED0j/n88Qf8AhR6h/wDH6P8AhA9I/wCfzxB/4Ueof/H619L1ez1m3ln06USxRTyQFx0LI21sewII/CrtAHN/8IHpH/P54g/8KPUP/j9H/CB6R/z+eIP/AAo9Q/8Aj9dJRQBzf/CB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wAKPUP/AI/XSUUAc3/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8ACj1D/wCP10lFAHN/8IHpH/P54g/8KPUP/j9H/CB6R/z+eIP/AAo9Q/8Aj9dJRQBzf/CB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wAKPUP/AI/XSUUAc3/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8ACj1D/wCP10lFAHnfj7wVpdr8NvEtxFda4zw6TdOol1++kQkQsRuRpirD1BBB6EV0H/CB6R/z+eIP/Cj1D/4/R8R/+SWeK/8AsC3n/oh61ta1NtH0e41BbG5vxbpvaC12eYVHUjeyrwOevbjJ4pNpK7Gld2Rk/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0W3jFbrwL/wlMWh6p9naH7QlqfIE7xYzvA83bjbzgsDx0zxWzpV8+p6XBeSWVxYmZd3kXJQyKO2djMvI54J61TTTafQm90mY3/CB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P1o2mspq9jLcaF5N2IrlrcmSUohKPtkIYBs4w2OOSMZHWtOkM5v/AIQPSP8An88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8frpKbKZBC5gVXkCnYrttUnsCQDge+D9KAOd/4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfroojIYUMyqkhUb1RtwB7gHAyPfA+lOoA5v8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfrpKKAOb/AOED0j/n88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8AH66SigDm/wDhA9I/5/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/AB+ukooA5v8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfrpKKAOb/AOED0j/n88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8AH66SigDm/wDhA9I/5/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/AB+ukooA5v8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfrpKKAPO7PwVpbfEnWbc3WubI9JsHBGv3wclprwHL+duI+UYBOByQBuOeg/4QPSP+fzxB/wCFHqH/AMfosf8Akqeu/wDYF03/ANH31dGSFUljgAZJPagDnP8AhA9I/wCfzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/x+rPhXxbpnjHTZ77R2lMUFzJbOJVCtuU9cZPBBDA9wRW3QBzf/AAgekf8AP54g/wDCj1D/AOP0f8IHpH/P54g/8KPUP/j9dJUUbXBuJhLFGsIx5TrIWZ+Ody7QFwemCc+1AGB/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9dJRQBzf8Awgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9S2Xihrvx3qPhp9OlgNlaRXS3LyKRMrsR8qjJABUjnB46YwTv0dLh1sc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9Yfizwlp2maXY3dtc6w8setaXtW51u8uIzm/gHMckrKevcHB56ivQK5vx5/yLtr/2GtK/9OFvQB0lFFFABRRRQAVzfxH/AOSWeK/+wLef+iHrpK5v4j/8ks8V/wDYFvP/AEQ9AGp4gkgh8N6lLd2n22BLWVpLbGfOUKcp+I4/GvMNFlj8L+KtK03wp4iGs6K8pFxot6RJPoqeWzebvPzxKB8u2T1wK9fooWjuD1Vv6/r+mfPngfXvDs+qWsXixtJu9IfVb5tJuGkjkSG6Nw7Hzc/dLIUKHp+JU1W8Rap4eXQ/HdquvRh18S2zwKNVbe4IiD878so/e8HIXaem0Y+jKKadrf11T/QOr8/+D/mea+Cb/RIfi74r0vQbuyFvJaWlyLe1lUh5fnEkmAeWwY9x9xnrXM/E6602TXtcmzDDqeltYyJNePmaJPMUs1qoAMaYOHk3EE5BHAr3Cijqn2De9+p87+I77wxJb/E+8i1Szuri3mt5tOlkvvOaKYRg7otzHBEhYfL05XoMVoeLdQ0XV9I8av4klt7jUnsPN8PySENvtjbKd1se+X37ynOPvcV7xRS+zby/r8hp2dzlJxFq/wAK0jW9l01LrT44luJYHVoiQFBZDhsZ4I44/OvNdRmsrjwkJX0nRYI/D2vae7alo/Nk0YkXe8fH7vaMh1BOO5Ne60VXN7/N5p/c7kJWio/1tY8C137Bd6j48XRbVntZr/SbwyWlq/lSKrxtLIHVdp+9uJB5BLcjJrR1gRxXWuaj4BG7wxMlk2oPpXMUzfaD9oaLZ1byvvlOfXmvbKKSdreX/AWvloU9b/1/TPHPFmj+EF8AXuqeEHtbjT49Qsr4rZlZLWz2TKJHiCjbGdm7eAc9yBnnA8aromp3fxFl06zhure50qyu47iG0LwyOrMXlEgXYThx82ckZxnBx9BUUX/r7v8AJDX9ffc8D+IL+HnttVTRorK2l03SYJ7BpVwIVDs2+yjUKU/2pQ2Pu8EVB4kvvCt3e/Ey4Oq2V3ImmW0to0t/5uy4CvzHuY4ZXZQNv3S2BjOK+g6KL6feJaW+X4W/r5nhepD/AISzVZYtU8TaPpjXVrayaJe3Vm08zDyl3PaSidFEnmbgVVSx4zkECtDW4dPuLnxTB41kj/tnYp8PPL8lwQIFw1qM7g/m7shOc4B4xXslFD1vb+vNefmEdLeX9fceEX1vbaa/jC08Ww2q6jqvhW1neJ4gTd3MccvmOqgfO6sFJIGRwferMd5b6faaDrPlafqrNYWdidJv4ng1CFgAGNruGTnILIFGdud2K9uop82t/T8L/o7EtXSX9dP8jgfjTZWt38Mbp7y1inS3ubaUmWMMI1Eyb256DaWyfTPauZsZfDjfEDxlpOi6xDp1vcaDbpF9mmJ+zEeYGMceflCgodqgAAg8ZzXslFStL/10sXd/163PFoDaX2h3+j/8Uzp66bcQ5vbZN+kahtWVmhlTICEYdmXJwSpJPApNN1DSJfF3hTXtS0ux0e1vLbUdPlcMHt7li6lAkhA3o/zlBjkEgCvaqKd9b/1tZi6W/rufO+itG3hnR7G9fT9L8OJc6lHKdc0uR7NZTcBoQyl4gPkJ2sSVByPvdPaPA2nS6T4NsrGfVjrHkBlS9MRTzE3HbgFmJAGADuOQAa6CinzaW/r+v0B6u5zfxH/5JZ4r/wCwLef+iHrT8Q31rp3hy/utQuYbW3jgffLNIEVcjAyTx1IH41mfEf8A5JZ4r/7At5/6IeukrOS5otDi7NM8b8EeHE8VfDvwrqGv+J7O40XRbVJlt7GI25hkWLb++nErHKAn7oQg8nFczY6D4cvfgnB4mt4YL3UdO1IeZfGUzSQRLf72ySSRhDuyecMT0Jz9FUVq5Xk5LvclL3bP+kfPvjW+0B7r4kXFpMIbe+0a1mgu7UvFDczjzORKmFcnenGTu9Dg427m18I6N4/8BT6fe28Z1UyyTq2oM8c++2MavsZymWb5dwGWPGSa9noqU7f10G9f69P8j58ttJ0Kx+HrXcOm2NtdaT4uWW8nS2VHtolvTgswGQBGenZT6Vfnj0e/8X+MYtPu9PsbWe7s7xJL2zZtOvdsDPIJWACFW3bs7uThua90oovpb+un+Qdf67v/ADOa8AammreEIbqPTotOUzSjy4JDJC+HP7yJiBujb7ynAGDxxXS0UUN3YgooopDCiiigAooooAKKKKACiiigDm/iP/ySzxX/ANgW8/8ARD1s6rBJdaNe28IzJLbuiD1JUgVjfEf/AJJZ4r/7At5/6IeukqZLmTQ07O55honivSP+FT23h57uNdfj0kWL6PuH2sTCLZt8r73XvjGOc45rPXRfDes/G+80XV5Yr5hodu0llLeM4E6SZ4Td8pCqhwAODnHzHPr9FaOV5873/wCH/wAybWhyL+tV/kfOjJ4a0P4edbPS7+DxcBKEb7OSi3pIVwMBwsRJCtnauCAODXa20fh/WPFurReLLsW+uxaotxpE4k2TvbBUaMWx5LIQGDBM5yc16tRSTt/Xp/l+LB6/16/5/gjwvVb/AEj/AITyDVElt7S5tvFC215cXUv+mJGUZdpYbfKgJHyqSwbrkGqFhZ+FLj4U+N9XXUVluLK61GK1vRqkhdUYjyl378sGKJgEnd75NfQdFRb3XHyt+X+X4l83vqXnf8/8/wAD5/8AF+oaPq/hnEEtrPdW3hWK4tJ7mXzFVlDZa0RRnzQVIeQMNmF4PNe2aNrWnX9ta29vqNtcXRtI5zEk6tIUYcORnOCc81qVWNjG2prfOzvIkZjjUkbYwSC2B6nA5OenGOc6uV7+ev5majZJdv8Agf5FmiiioKCiiigAooooAKKKKACiiigAooooAKKKKAObsf8Akqeu/wDYF03/ANH31UfiL4hhstNt/D9ve2cOra7ILW2iuroQAofvndhivy5UEKfmZQAavWP/ACVPXf8AsC6b/wCj76uko9Rp2PHrTXYvAvxXubTxZLo2g2PiGwVxFb6oZEhlhGwMzNHEY96cA4wTH1zXK6LqfhrT9D8M6hb6rZfbo/F88S3Ml4JJhbGWQMC7MW2FGQnJwdyseTmvouimnZp9v87/APAJaumu/wDlb/gnhOrT6bd+M9Q06TUbK31ltdQjWX1eK0mjtcrutQBItwONyhVXa2Q27NPkvkGqfECx8N6g90y6pYtcJFeNNMtsNguSpLFsDLggdORx0r0m28LavAt5Yy69DcaRdySu8clh/pWJGJZfOEm0jkgZjzjHPGa6lVCIFUYVRgD0pR0il/XT/L8WN6tv+uv+fyPFdUjEFxrd18K5Lf8AsF9MiN0NLXzLdZvPG9o1jIBfyRJuCEMflzyRTDZtpvhfWNU8L6/Yajpd29p9stfDli0ENtEso891AlkKyNGTuAwcDOM17dRTTt/Xnez8gev9eR4HfXOm23ifxH/wrdYhbXGh2bo+l2zyQKguH84r5eBnZu+UMpJyB82aqeJrLRdP8D6nqNr4t0mewvbmzEVpoiPY20UolG84E75cxliy/wCzuIyM19D0UXt/XncHrv8A1pY8J1yXwe2v+PbWG50lrMaDFeRRCdDH9qxIPNAzgycxfN97JXnnnL8S6vpeu+FpbyO7t7nVLPw/ZzxXd3N5roy8u9qq4KuGBEkm7ggAjg19FUUJ2/D8L/5/gD1/r0/y/EitZo7i0imhkWWORAyupyGBHUHvUtFFJiWisFFFFAwooooAKKKKACiiigArm/Hn/Iu2v/Ya0r/04W9dJXN+PP8AkXbX/sNaV/6cLegDpKKKKACiiigArm/iP/ySzxX/ANgW8/8ARD10lc38R/8Aklniv/sC3n/oh6ANjV9VtdD0W81TUHKWtnC00rAZIVRk4Hc15w19qtx8YtAv7/R3tHl0e8kht4tQM3mqPLKqVYKkcnzEHGRyPnOOPRNc0e18Q6DfaRqAY217A0Mmw4IDDGQfWuUg8Ca7/bekareeK1mudItZraDZpqoJlcLgy5c7j8gzt2Z7beci3v8A1s/+AN7f13X/AASvpPxDtT4f0Oay0ey0o6xdXMaQXd2tvFGySsHy6owMjHLBQOTu+bvWxeeLNS/tE6Vo+ixXeqwWSXt5bzX3lJCrkgIrhG3OSrYGAOOSKzNL+H2qaf4IPhy41jS9Qh3TH/S9GLxN5j7/AJo/OySCXAIYD5hkHHNiw8AT6A1pN4a1gW91HYRafcS31sbkTxR5KHAdNrjccHJGOCDim7a/10F/X4/5Gfp/xVude1K1tPDvhe5ujc2BvUa4u44MhZVjkTHzcqxYc4yV44O6sj4ja/ceIfDaz2Gnt/ZNprdvbrfC+aN3lS5WN/3IGHjzuXLN1GdvRq6TQvh5N4e8WWOpWOqQmws9PexFo9mTLIHfzHkMokxuMnP3MYJGO9VNQ+GF5c6Ze6PY+IzZ6Pc366hHD9hWSa3l84SsFkLbShYEgFCQT1I4LVrxfn/7d/kD2a/rb/MTU/jBpGneIPsQawngW/GnyhdST7WspbbuFtjJjDcFtwPU4xzRbfFC+m0fUdXn8LS2mn6dcTWtxLPfR7opY3VRuCggJljlgTtCk8itzTPC2p6LfXS6brqjS7uZriS2ns98qSvy5SUOoUM2WIKHBJwRxiLwx4R1Tw/pGpWk2tWt1Lfag995qaeY1UyPukQq0rblPIHIIB7mpW2vb8dP+CN2vp3/AA1/4BuaHqNxqmni5uYbVA2DG9nd/aYpVKg7lfauRkkcgdM1o1zng/wkvhWLUD58Dy6hdG5kjs7b7NbxttC/u4tzbc4yfmOSSfaujpu3QkKKKKQwooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4j/8AJLPFf/YFvP8A0Q9dJXN/Ef8A5JZ4r/7At5/6IeukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4j/8ks8V/wDYFvP/AEQ9amva1a+HdBvNX1A4t7SIyPggZx2ySByeOTWX8R/+SWeK/wDsC3n/AKIetTXdHg8QaFd6XdtIkV1HsLxnDIeoYH1BAP4Une2g1ucPZ/GTS5rm/s5ksri7gWFrZdK1FLyK586QRonmBVCPuIDAjABzkiuhg17xLNBewv4Ygg1C1lRR5uoMLSWNlzvWfytxxjBHl5Bx25qK/wDCGpa74efTfEWvLPKjpJa3VlZ+Q0ToyukjBncMwZR02ggnim674Y8Sa/4Sm0m48TWsFxcFUmuLfTWRHiz8ybPO3AsOCwfpnABOap7ab/1/T/AS31/r+un4mNa/FZxob6lq+n6bp0M96bLTriTVsW12yqxaQyvEhSMbSA20knoDxlum/F+PVpNLh07Rvtc17qUumyyW99G9vFKiF8rJ1kUryCFHGe+FOq/gvWbi1sxPrlhBcaW6PpTWGltDFbFVZGDo0zmRWVtpG5cAcYPNP1fwjrur6poF/N4gskm0m6N06jTGKSsUMZCjzsou1m6ljk5zgYp6X/ry/wCCLW39ef8AwCgfiXew6fLeXmgRxR2Oqrpeo7L/AHmKRnVFaL92PMX51J3bCAe9W9X8f3Gj+JILK50YR2E2oxaclxNd+XNNJIAQ8UJTEkYJALBweG44rLufhlrdzo2r2LeJbEHU9Xj1VpBpD/u2VlbYB9o5GY059N3qCLV58N7+7vrm5bXrfzJtSt9RDtp251eIqfLLebkx/L8q8Fc9WojbTm8r/wDkt/8A24Jdbedvxt+hu+NPFcnhHS7W8j0qbUhcXkNqVilSPyzI4UMSx55IGADz1wOawNR+JV9pg1OO50GD7Tpeo2tpcRrqBKmK4KiOVW8rk5YZQgYwfmPGdzxv4YvvFekWtjZanb6eYbyG6d5bMz7zE4dQAJEwNyjPJ49OtYV98NdR1O78Rz3uv22dae2liEOnFfs0luwMTcynePl5HGexFKNuvf8ADT/gjfl/W/8AwB3iD4mXfh658TRT+HvtQ0OG3nQ296P30cxYAsGVdmCvIG/rxmrVz451eHVtT0uPw9Ab2zsU1GNZNR2pJASwIZhGSrgqRtAZenzCszXvhbq2uvrM8nitYrjWrWC1ulGmKYQsZyCi+YGByTjLnAY5zwRoyeCNdm8R32sSeINP8270gaYYxpThVxk7/wDj45+ZmOPTAzxkp/Dpvr+Wn4j0v935q/4XI7T4kXWralZWei+HZJTf6KNWglurxIYyp2/Idodh97GcdexHIXS/iPPqjeHJV0VYbLxFG4tJHvMyJMiM5V0CYCfKQGDE/wCyKp6F8N/EGh32n3KeJ9Om/s7RzpMKnRnGY+Crt/pHLBlXOMAjI4zkO0z4aavpln4Ttl8RWcieGppJEJ0tgbgOrKQf3/yna7c884OOMG3y30/rV/pYnW39dl+tyWz+JV7c6NoGoyaFDHHqmrvpU6C/LG3cSOgZf3Q8wHYx524469qHhLULjQLXxb/Z1jPqUv8Awk0kESSzuQgMcfzSSkMVjXu2Dgdqut8L7s2ttYxeJHt7Gy1ltWtVhsk81GZncozszBgGc4O0ccEHqGJ8NNXMN+tx4js5WutYXVwh0pvKL4wY5EMx3pwpAyCGXOT0Extdvv8A5x/ykOXl/Xxf/ahF8VpprHTJIPDzXEt9q0mkM1vfRvBHMpPIkwC6kAkEIOAc4OAe70y4vLrS7efU7IWF26AzWwmEoibuN4wG+uBXBt8M9WW6tWt/EdmsFtrj6yqSaUzMXYEbNwmA2/M3Qenpz6NQvh13/wCAv1uJ/Fpt/wAF/pYKKKKQwooooAKKKKAObsf+Sp67/wBgXTf/AEffV0lc3Y/8lT13/sC6b/6Pvq6SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/wAi7a/9hrSv/Thb10lc348/5F21/wCw1pX/AKcLegDpKKKKACiiigArm/iP/wAks8V/9gW8/wDRD10lc38R/wDklniv/sC3n/oh6AOkorm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkygDpKK5v7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMoA6Siub+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTKAOkorm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkygDpKK5v7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMoA6Siub+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTKAOkorm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkygDpKK5v7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMoA6Siub+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTKAOkorm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkygDpKK5v7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMoA6Siub+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTKAOkorm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkygA+I//ACSzxX/2Bbz/ANEPXSV534+s/GK/DbxK15ruhy240m6MscWizI7L5LZCsbpgpI6Eg49D0roPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygA+I//JLPFf8A2Bbz/wBEPXSV534+s/GK/DbxK15ruhy240m6MscWizI7L5LZCsbpgpI6Eg49D0roPsPjf/oYfD//AIIZ/wD5MoA6Siub+w+N/wDoYfD/AP4IZ/8A5Mo+w+N/+hh8P/8Aghn/APkygDpKK5v7D43/AOhh8P8A/ghn/wDkyj7D43/6GHw//wCCGf8A+TKAOkorm/sPjf8A6GHw/wD+CGf/AOTKPsPjf/oYfD//AIIZ/wD5MoA6Siub+w+N/wDoYfD/AP4IZ/8A5Mo+w+N/+hh8P/8Aghn/APkygDpKK5v7D43/AOhh8P8A/ghn/wDkyj7D43/6GHw//wCCGf8A+TKAOkorm/sPjf8A6GHw/wD+CGf/AOTKPsPjf/oYfD//AIIZ/wD5MoA6Siub+w+N/wDoYfD/AP4IZ/8A5Mo+w+N/+hh8P/8Aghn/APkygDpKK5v7D43/AOhh8P8A/ghn/wDkyj7D43/6GHw//wCCGf8A+TKAOkorm/sPjf8A6GHw/wD+CGf/AOTKPsPjf/oYfD//AIIZ/wD5MoA6Siub+w+N/wDoYfD/AP4IZ/8A5Mo+w+N/+hh8P/8Aghn/APkygDpKK5v7D43/AOhh8P8A/ghn/wDkyj7D43/6GHw//wCCGf8A+TKACx/5Knrv/YF03/0ffV0led2dn4x/4WTrKrruhi4Gk2BeQ6LMUZfOvNoC/asgghsnJzkcDBJ6D7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Sub8ef8i7a/8AYa0r/wBOFvR9h8b/APQw+H//AAQz/wDyZWH4stPFUWl2L6rrOj3NoNa0vzIrbSJYZG/0+DGHa5cDnB+6cjjjqAD0CiiigAooooAK5v4j/wDJLPFf/YFvP/RD10lc38R/+SWeK/8AsC3n/oh6AOkrMl8S6FBq66VPrWnR6i/3bN7tBM30Qnd2PbtVLx5e6jp3w/1280QMdQgsZXg2jJDBTyB6jrXOaLFp9p8C7efRNMs9XtpdNFxcw3U3li6JTdKXcI+XJ3dRye460m7Jvt+t/wDIaV2l3/4H+Z6EjrIivGwZWGVZTkEetLXklv4s8Sanpuk6Z4f02/s5f7Dhv4102a0uGAclYlka58sFcKN2xc5OAR1MkWu+OL7W73TtU1OPRpofDiag0FnbRSPBcbirDexdWGUPbo2BgjdVS91u/S/4X/yFG7/D8bf5o9XorygeNvE3iGx0i30W21Bb240KDU5ZNNW0OZZMgKwuXUeXlTnaN3I5HefSdV8dav40XSNU1W20Z00e3v5raCzjl8uXzdskZcswYHY/IIxuGORktxalyvz/AAv/AJMV9L+n42t+aPTZpo7eB5p3WOKNS7uxwFAGSSfSqmja1p3iHSo9S0W6S7s5SwjmQHa+1ipxnqMg8968/wDD/ijXZ/HGkQXGqvqFhqsd4X22qJaqYiNn2d9qyMMHktuU/wAJrY+EP/JNLP8A6+bv/wBKZKlbX/rqNnSax4h0nQPsn9sX0dqb24S2tlbJaWRjgKoHJ6/h1NXYrlJppokWUNAwVy8TIpJAPykgBhg9VyM5HUEV494h1HU/EvhbRvEM2pslrN4ltol0xYU8uJEu9indt3+Z8oJy23nAUda249f8XXFv4ugt5nvrjTNYjt4vsFvEkqWxjjdvLWQlWcBz98kE9ugppXjf+vs//JA97f11/wAj0uivOYfGE2tX2h6Lous3iHUpLoXF7NZJFdW3kKuYjG6bVkywyShGM4HINY03izxgmpWmkDVrdTb+JBo9xeGyUyXUbRCVX67FYDggLgnB46Es27f1ul+bDpf+tE3+h6pqmq2OiaXPqOrXUdpZ267pZpWwqDp/OpLK8g1GwgvbN/Mt7iNZYnwRuVhkHB5HB715hrl1r2p6F4w0mbxA4Ph/TPKldbSJTfu9uzs8gIO1cEABNvIJzjiqdv4h8WXOi22leELW/e40zRrGSL7MLMxyyvFnbN58it5ZwB+7APXntSXX5fjf/IHo153/AAt/mexUV5po+peNdY8Y61Zy6xb2Y06GzuY7KOzRlPmI5aFn3EnkAb1I6AgAZB1vA2v3d/dS6brt3qUeswwCW5sNRtIoyuTjfE8ahXjzwMFiONxzTtrYV+p2tFeZfEbxPrujXGqXGi6q6DS7OG4WztLZJQSXO43LSLhUKgbQjhz8xweKq6/4j8VW9547aHXUgi0GwgvrKOCyj6sjuUcvuLA7QCRg9Mbecrpcq2tkemapqtjomlz6jq11HaWduu6WaVsKg6fzqSyvINRsIL2zfzLe4jWWJ8EblYZBweRwe9eZa/reqeKtD8XRW2onTYNJ0oFreOFH+0vLbGRi5YEhMMANu05BOT0rufBf/Ih6D/2Drf8A9FrTtvfpb8b/AORN/ht1v+Fv8zbooopDCiiigAooooA5v4j/APJLPFf/AGBbz/0Q9beoalY6TYyXuq3lvZWseN89zKsaJk4GWYgDkgVifEf/AJJZ4r/7At5/6IetnVRnR73P/Pu//oJqZPli2VFXaQzStc0rXrZrjQ9Ts9SgR9jS2dwkyq2M4JUkA4I496nuruOzWMyrMwkkWJfJgeXBJwCdoO0erHAHcivJfD2pa1p3gv4W2Wj6hDZWmpxrb3S/ZQ7t+4Z8hicD7vp1IOcZBuQ+K/EqaPF/xNUlez8WDSLiea1TzLmAzKo+6AqthsEhee2DWrj7/Iu9vxS/VGfN7vM+36N/oz1WivMD4o8Zarrc134f06+ls7PVmspYWNkto0EcmyR2ZpPPEmAWGAF6DaetaWg33iXxV/xOrDWUtbdNTntJtMeFCiwRyNGWDbS/nfKGGTt5xt71C1V/66f5lPRtPp/wf8jtZr2CCFpCXkVZBGwgjaVgxIGCEBPcZPYcnA5qxXiWi6j4h0H4fDUrLxBcTtN4pa1nW8gikJja9MbbWCrhmzkk7hxhQtdDq3iXxBdab4u1vStUNivhm5lihsTbxtFdCKJHbzSyl/myQCjLjjrT6X/rp/mh2u7Lvb8/8j0yivKL/wATeKbvUfE3kayNOgsdAg1W0hhsoy8TssjFHaTduGUweBweNpGT2ranq+ofDmPVNHgR9VudOS4hi4wZGQNgbsDvxnjpmhppO/T/AIP+TJTTat1/4H+aN25uEtLdppVkZFxkRRNI3Jxwqgk/gKeJEMpiDqZFUMUzyAc4OPTg/lXlereNNUt/At3d6NrN4mo6fe2sF5b6xp0aXMQkdVKkKFTndkOFZSFIGeohvtS1Hw7458f61FqV5dGxsbMw2coiMRLh9oPyghVJJGGXqdxPYt/X3f5j6f13seuUVxfhC78XN4hvYNetL8aS8Cy21xqRsxMsucPGFtnIKYIIJGRyCTxXaUWFcKKKKQwooooAKKKKAOb+I/8AySzxX/2Bbz/0Q9dJXN/Ef/klniv/ALAt5/6IeukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm7H/AJKnrv8A2BdN/wDR99Wjq/ibQdAeJNe1vTtMaYExre3ccJcDqRuIzjIrOsf+Sp67/wBgXTf/AEffVj/Fkzro2gtZxRTXC+ILIxJLIY1ZvM4BYKxUe4B+ho6pd2l97sHRvyf4GxL8RPB0Wm3GoDxPpU1rbFRNJb3aTbC2dowhJycHA6nFdICGUEdDyK80+IZ1Wf4S+KLjxDptjZXgQRxGzmMwaHchH7wqpPzFuCq/TuU1PWteg1Tx1aW+t3EMem6PBf2BEEBNu5WUsozGdynywPmyeTgih2UW3/Wg0nJpL+tUv1PTCQASeAOprJ07xRo+saY+oaRefb7RJ/s5ltInlBfIBA2g5AJGWHA5JOAazdE8WxNo+iJqSalPfXtlbyvNBpVxJEWdRkmSOMxrznOSMd8CuBstX1bQ/CWo3mjXcVuW8bS284eASGSOS6VCFJOFPzdcH8OtVyvn5H/Tul+pCknBTX9Kzf6HqeneI9I1bVdQ03TL+K5u9NZVu448nyWbOFJ6Z+U8ZyO9adeQ6jrUlj8YPEWmW9/LpM2rf2dBHqYjRktyEkbb86su58bVBHJPXOKva1r3jKTVtU0zwpFqd/c6IIYkcLYCK7kaNXJuPMZGAIbH7pVA569BO6RXVnplxOlrayzyiRkiUuwijaRiAM8KoJY+wBJrLPizQl1G9sH1OBLqwtvtV3GxwbeLAO58/d4OcHmszx9q+raV8MdU1jSJ4rHULWzNwDJEJgpAyVAyBnsDyO+DWRYSNN8Y7qWQ5d/CtuzHHUmZ6Tuvx/Jv9B6ct/T80v1O20nVrHXNLg1LSbhbmzuAWimUEBxkjIz2yKuV4t4M1LXLbw38NtM0zVI7Ox1SK5juFW1V5cokjAh2JA7YG3qOcjir1l438RXljY6PG1/eX8t9qFu95YR2i3DpbS7VIWYrEGIYZ4PQ4HORclZtISvpf+v6set0V5e/iLxlp2ladd+LbfUtNtoVnF9cabb29y6lW/dvNGvmYQocnyuQe4FaF74mvrHxLbyalqN7baJdC2Wwv7a0ils7gvtz5rbS8bMchTlUww6mla4rnoFFFFIYUUUUAFFFFABRRRQAVzfjz/kXbX/sNaV/6cLeukrm/Hn/ACLtr/2GtK/9OFvQB0lFFFABRRRQAVzfxH/5JZ4r/wCwLef+iHrpK5v4j/8AJLPFf/YFvP8A0Q9AHSdetcy3w78MmWVobKe1jmYtNbWd9Pb28pJyd8MbiNs55ypz3zXQ3NzDZ2stzdypDBChkkkc4VFAyST6AVkaX4y0LWBefY71lNlGJbgXMEluUjIJEmJFUlCAcMODjrQPUW98H6HfrYCS0eBtOTy7SSzuJLZ4UwBsDRMp28D5c44HFVZ/h/4duNSur97e8W5urb7JM0WpXMYMP9wKsgAHU8AcknqTXOH4jw/8LKWJ9XSDw7Ho015MtzZPblGWSNRJvkALoQx2lQFP+126OD4h+GbryRbahJKbi1+126pZzE3EfrENmZCMjKrlh3AptXV31v8Aqvxsxbf16P8AyFj+H/hyHT9OtILW5hTTFKWckWoXCTQoeqCUOHKcD5S2OBxwKsWvg7RbPxG+u21vOmoPALdnN5MUMY6L5ZfZjv8Ad6knqSarL4z8PahNogtNfEb6nKxtIET5rraGDIyshZQpBz90gqAT1BbD8RvClzNsttXScC8Fi0sMUjxpOcYRpApVckgAkgE8A5GKNW/MNLf1/XS4W/w68M2jWzWtncQNamU25j1C4UwCQYdUxJ8qn+6MAHkAGtLw74Z0vwpph0/Q4ZoLUyNII5bqWfazcnBkZiMnnA4ySepNUovF+g+brE6a59qj0+VILmGNN4t5T8ojXYu53Y8bcsc4AA6Vn658SNN0m70eCO21CY6ld+Q2NNuC0QEfmHKBN27G35cZ5JxgGhXe3UH5+Zau/ht4Tv5bhrzSFmjuZxcy27TyeQ0oOd/k7tm49zt575qWy8BeH9OuLyezgu45L6Xzp2/tG4JMmCoYZk+UgHGVxxgdhUNv8S/B91JKtvrtvIsJlWSVVfy1MaB3Bkxt4U5684OM4OKWt/FHRbDwlq+r6d9quptNRQ9q9jPHIrOP3ZdHQMqH+9jGOhpdP6/rsPdmwfBWgnS47AWcixxzGdJkupVuBKeDJ54bzN5HBbdkjgmornwF4eu49PSa1uANOnNxbmO/njIlPWRirgu/+02TyeeTTtP8U6RqviCKytdVmW9FkbiTTJIDEyoWX95IroHQjOACRkMTg9QW/jvw3c3v2WPU1RmjaWOSaGSKKdFGWaOVlCSADklCcU9Vr/Wn/DE7r+uv/Dj9X8E+H9dv5LzUrFnnmtzbTNFcSwieI5+SQIwDgZON2cdsVGvgLw3D9j+x6cbH7FH5UP2G4ltvkyW2N5bLvXJJ2tkZJ9aTTPiB4Y1meyi0zUxcfb2kS1kWCTy5XTO5RIV27htJ25yRyMjmtTU9bsdIe3jvXl825bbDFBbyTO+Op2opOBkZbGBnkilsPco2fgzQ7DVdQ1G1t51udSi8m6LXszI6DgKELlVAHAwBgEgYFWtP8O6bpmoTX1rFKbqdQjTT3EkzBBzsUux2LnnauBntWfL4u0Q6xBBFrEklz9ge9GnW8JkaWHgiQqELgjsARnJ4OOKPh34j6XrPhC3125S7tluJHWOD7DO0j4JICIELS/KASUDAc+lAM0dW8DeHtcu7y41OxeWS+gFvchbmWNZkHTcqsFJGeGxkdjVOX4Z+GJ/7S8631CT+1I1ivd2r3Z89F6Kf3vQdMehI6Eiuh0vVbLWtNh1DS7lLm1mGUlTocHBHPIIIIIPIrOsfGegajq/9mWl/uuWV2j3QyJHME++Y5GUJJt77Ccd6NtAv1Klx8OvDF0qCawmbbafYmIvZwZoMYCSkPmUAHjfux2xW5pelWOiaZBp2k2sVpZ267YoYlwqjr/Osm38d+G7m9+yx6mqM0bSxyTQyRRTooyzRysoSQAckoTim6Z8QPDGsz2UWmamLj7e0iWsiwSeXK6Z3KJCu3cNpO3OSORkc09X/AF/XmG3yOjorz3xZ48MGu6BZeHtTUCfWY7K9H2J2SVSTuVJiPLypUhguWGf4cVPq3xK0bStCutV02+uNbjOqR2A8i2aVLeRigKAxoMgBs8liWO0EnACWqv8A10/zQPR2/rr/AJM7uiues/Feh3mqagIdbO6wtY5ru0mTy1tFOWDvuQMrEdVY8AD5Rzlsfj/wy6XbS6mLQWcPnzfbYJLY+VnAkUSKu9CeAy5Bz1o2A6Oiuf0/x14c1SRUs9SBD2f25HkhkjSSAYy6uyhWAyM4JK98Vf0rXbDWgxsGn+VQ+J7WWAlSSAwEiqSDtOCOD1p2YGZ8R/8Aklniv/sC3n/oh62tT0231fTZbG9MwgmGH8i4kgcj0DxsrD8DyOKxfiP/AMks8V/9gW8/9EPWvrGs6d4f0qbUtavIrKygAMk0rYVcnA/Ek4xUu1tRq99Dn7X4Y+FrOPTY7a2v0j0uUy2Sf2vdlbdsY+UGXAGOMdME+pzlXPgaC2vodK8P6TqFtatqsGq3eo3N+Z4pHjfewAklaTexABO0A9STgVvw+P8Aw3c2Ul1a38k8aMqBYbSZ5JCyBxsjCFnG05yoIxn0NPuPHXh230q11H+0Gnt7xWaD7LbyzyOE++fLjUvhf4sj5e+Kq7Tv2/4f9CdGrd/6/Un/AOET0f8AtyXV0t5Y7uYhphHcypFMwGAzxBgjsAByyk8D0oh8JaNbazNqdvayQ3Fw/mTJHcyrDK/HztCG8tn4HzFc8Dmob3xv4esdOtb6XUPNt7yH7RCbaCSctEACZNsasQgyMsQAM8ms5PiPpUvjQaLF5zWw04XxvhbSNCVY5VhIF2hNoY7yducAHORS2dv6/rQe6v8A12/Unu/hv4WvbSS2msJ1gku/trRw39xEPO3btw2OMfMS2BwGOcZ5q7deDdDvL43dxaSNIwUSqLqVY7jaAAZYw22UgAcuGPFVrPxnoK+H7bUo9Ym1O2u5ZRbSRWzSyz7XIYJHFHuYLjGQp4AJJ6lz/EHwpHaadcPrdsI9TkMVoMndK4OCu3G4EHgggYPB5p6rQN9Rt78P/D2o6hqV7dwXrT6pCLe7KancoJYx0TasgAHXgAdW9TnUtNA06x0GHRreKQWMCqkcb3EjsoU5Ub2YtxgY57YqjH440GbS/t0V1O8f2k2nkrZTGfzhyY/I2eZuABONvTnpzWL448cSaRo8L6Lh5bpX8t1GZ1Mciq2IGX5hyQSSMcdc0tlYOv8AX9dDSvfh34a1HTZ7G9tLqaG4nW4nZtRuPMmdfu75PM3sF7KSQMDAGBV3/hD9CN/PeSWPnT3FstpO00zyCaNQVAcMxDHDMNxBbBPNcr4j+IV3b+BU1HTktYru8S4WIw3IneJoyQCEKAPjHzg4289cV1vhnWz4g0Vb5o4oiZXjKRzeYV2sRhuBtbjlecHjJ607br+uwr9STRvDunaDGY9NS4CnhftF3LPsH91fMZti8D5VwPatOiikMKKKKACiiigAooooA5v4j/8AJLPFf/YFvP8A0Q9dJXN/Ef8A5JZ4r/7At5/6IeukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm7H/kqeu/8AYF03/wBH31WfEXhDR/FRtv7ajupRaSCWEQ389uFcHIfEbqCw7E8jtVax/wCSp67/ANgXTf8A0ffV0lAGTrnhjS/Emhf2PrMU9xYnbujF3LGX29NzKwZvXknJ5PNU7zwF4dv333tnNOxs/sMhe8mPnQ84WT5/3mMkgvkgnIOa6KigCpp2lWOkaXFpul2sdpZwrsjhhG1UHtj61zf/AAqzwodOksTa35tpLoXrodXu/mnznzM+bndnnPqAeorr6KOtw6WOTu/hn4Wv5dRkvbS8nbVFRbzzNUuiJQjBk48zA2kcEYxyBwTV5/BeiPeW92YboXNvCsAmW/nV5Y16LKQ+ZhyeJN3U+tb1FAGbrnh/TvEeiy6Rq0MkljMAskMU8kO5f7pKMpx7Zwayrf4eeHrXUHvoY9RF09r9jaY6vdlvJxgJky8YzkHqDyOea6eigDkrP4YeFtPbTms7W+i/sssbIDVrsrBu+9tBlxg5wR3HFSQfDfwxbaYbCGzuVh+1G8VzqNyZY5j1kSUyb0Y5OSrDOTnOa6mii4GLdeEdHvLQW1xFcmPYEfbfTo0qgk4kYODIDk53E5zzmkn8H6HczwyTWjlYZFkS3W4kWAsoUKTCG2NtCLjKnGARzW3RRsAUUUUAFFFFABRRRQAUUUUAFc348/5F21/7DWlf+nC3rpK5vx5/yLtr/wBhrSv/AE4W9AHSUUUUAFFFFABXN/Ef/klniv8A7At5/wCiHrpK5v4j/wDJLPFf/YFvP/RD0AaHiaG+ufCupwaTb21zeyWsiQQ3ahopHKkAMDwQfQ8V5pJ4J8R6ofEEbWV5anVtCt7eOfULqF8TxO5MbrGxCKQQMIu3BPQ5Fev0ULQd9Lf10/yPKdbsfF+ra9FrEXhCSIDQbnTprd7+3EnmSFcFMMVZcr/Ey8Z6EAFdG0vxLa6r4DkuPDF/HFouky2l632m1O12REGAJssMx5yOzL3yB6rRTTsrf11/+SYv6/L/ACR4vouieLLVfC0Fx4Q1FBpeuXV/cSG6syvlTGbbjE+SR5oyMdjjNPv9C8VXHh3xFbR+E7/z9Q8SxalApurQZhV42JJ87g/uiMerL749looUmnf+t0/0QPX+vX/NnmNroOp6lrvjA634V1BLDV7m1mt2F7BHIPKRV3K0cpKuGXcvTp1B4qNNB8ZSf8I/eX9vc6gNL1t54oryeAXaWrQNGvmsh8tmDMSdpJ246nivUqKE7beX4W/yB6nmWl6T4lXw144jPhzyLzU7+W6soL97eWOdHRV2kK7Ln5Dw+ByOvOMvUfBviPUNP8YxxaVe+ZrOmWgt2vr2F3aWItujba+1DyMBfk9xzXsNFCdvuS+4Ot/O/wCNzzm80vX9V+IiXUmh3dlYzaBNpzXouLdhDI7Bgdok3HAGDgH5umR81Q2vhzWp9M8Kabe6LNbnwo8cz3KTQst6Y4WQJD8+RuJGfMCAV6ZRRfS39bt/m2H9fgl+KX+R45pGgeKbXRPBtpP4Vvlk0vXJ7y7/ANKtSEicy4IxNz/rhwP7re2e48caPLqcVtNaWWqSXtosj211pN3HDPC52jbiRlRlYZJDZHydDxXV0UPUOt/66/5nm9rpvix/HPhq91rS3uWttGmtL/UIJYREJ5ChyFLhyBsOcL1IwMdMfTfBXiC08L+FlvtJvpH0NJ7W4srDVvss0yyMCJY5I5UBA2j5WcZDHOCAD7BRRf8Ar5t/qwWn9eVjA8P+HrXSvC0um6fZS6ZDcGV/JluWnkRpMlizlmy2SScMR7msDwzomqx+DrXwxrGifZrnTbJrKHVxJE8ZUxlBJFhjIGIxkMq9+T376ik9U0+v9fqC0tboeZ2vhzWp9M8Kabe6LNbnwo8cz3KTQst6Y4WQJD8+RuJGfMCAVjaX4f8AFVvoPg+ym8L30cuma3PeXZF1akRxOZcEfvuT++HA/ut7Z9loqnJttvrr8xW0svT5a/5s8hHhvxfB4b8OaBHoCTzeH9YiuPtz3sSQXUKlzvGCZAx3DcCnU8ZpJPDfie90PxFG3h25t5p/EsGr28UtzbkzwrJESoKyEBsRnhiByOeuPX6KSbTv/XR/+2octf69f82eU694W8ReJfEXiyP+yZtOt9W0aC0t7ySeFozLGzuVIVy+07wudvY8dM3de0fXPEF4msf8I9dWk+naVd2Udo1xbmS7kmVVG0iTaI1wTlip/wBmvSaKlq6t/Wt/8xp2d/66f5HkdloPiH7T4RS98I3ctvpvh+fT71JLq2CmR0RdvEpJU+WeQDw49wOq8FaVrekapqNtOdQTQI0RLGHVLiOedHBO4q6MxMWNuA7bs54ArsqKtybbfr+Lv+pKSSt/X9aHN/Ef/klniv8A7At5/wCiHqTx5a3t/wCANasdKspL68vLOS3hgjdEJZ1Kg5dlUAZyeeg4yeKj+I//ACSzxX/2Bbz/ANEPXSVElzKzLjJxaaPN9U8NardaX4Tvjpeou2l2jW13pdpqf2S4G5EXcskcqqSDH90uAQ3XIxTJvCd9p50q00DQbi10p0ujcCO9RryGSXB+eeRywRjuL+UxbIXGQDn0uiqk+Zu/W/4kx91JLoeU+EfD/iTwuNFvbnw/Ner/AGJFpV7ZR3EBlgeN2IcbpAjIwY5+bPTit2LR9U0r4j/2vZaGp01tCSzWK1miUQvHIzCMKSvVWAGPlz1IHNdzRRJtu/r+N/8ANh0a9Pwt/kjyLwh4c8TaFFoerXnh+7M+mC+tptNW5tjI63EwlWWNvN2HGNpDMp64zxmS58Ja7ZXGlXNrok9y0/ih9cu4oJ4ALSMqUCEvIu5uQTtyM7uemfWaKL6p9v8AO/56g9U13/ya/JnlNr4b1S6uPEj6t4Z1i3+0ay2o6fcWV/bR3Ef7kRhkIlxu+UghyFw4znkDstD0jUNS8Dw6d46Vby5fPnBiAWUPuj3lMLvAC7tvGQccV0lFF9Len4KwPV3Kup6baaxpdxp2pQie0uUMcsRJAZT1GRzVkAKoCjAAwBS0UgCiiigAooooAKKKKACiiigDm/iP/wAks8V/9gW8/wDRD10lc38R/wDklniv/sC3n/oh66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAObsf+Sp67/wBgXTf/AEffV0lc3Y/8lT13/sC6b/6Pvq6SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/wAi7a/9hrSv/Thb10lc348/5F21/wCw1pX/AKcLegDpKKKKACiiigArm/iP/wAks8V/9gW8/wDRD10lYnjXT7rV/APiDTdPi867vNMuYII9wXe7xMqjJIAySOScUAbdFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQAfEf/klniv/ALAt5/6IeukrhPFmp69r3gvW9Is/A+uJcahp89rE0txYBFZ42UFiLknGTzgGtf8A4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAD4j/APJLPFf/AGBbz/0Q9dJXCeLNT17XvBet6RZ+B9cS41DT57WJpbiwCKzxsoLEXJOMnnANa/8AwlGr/wDQieIP+/8Ap/8A8lUAdJRXN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVQB0lFc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVAHSUVzf/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lUAdJRXN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVQB0lFc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVAHSUVzf/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lUAdJRXN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVQB0lFc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVAHSUVzf/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lUAdJRXN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVQB0lFc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVABY/8lT13/sC6b/6Pvq6SuEttT16HxpqWrt4H1w291p9paoouLDeGikuGYkfacYxMuOex6cZ1/8AhKNX/wChE8Qf9/8AT/8A5KoA6Siub/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSqAOkorm/+Eo1f/oRPEH/f/T//AJKo/wCEo1f/AKETxB/3/wBP/wDkqgDpKK5v/hKNX/6ETxB/3/0//wCSqP8AhKNX/wChE8Qf9/8AT/8A5KoA6Siub/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSqAOkorm/+Eo1f/oRPEH/f/T//AJKo/wCEo1f/AKETxB/3/wBP/wDkqgDpKK5v/hKNX/6ETxB/3/0//wCSqP8AhKNX/wChE8Qf9/8AT/8A5KoA6Siub/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSqAOkorm/+Eo1f/oRPEH/f/T//AJKo/wCEo1f/AKETxB/3/wBP/wDkqgDpKK5v/hKNX/6ETxB/3/0//wCSqP8AhKNX/wChE8Qf9/8AT/8A5KoA6Siub/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSqAOkrm/Hn/Iu2v/Ya0r/04W9H/CUav/0IniD/AL/6f/8AJVZuu32t+ILSzsIvB2sWn/EzsZ3nuZ7Ly40iu4pXJ2XDN91G4AJzQB21FFFABRRRQAUUUUAFZHijXD4d0GTUViimZHRBHLN5e/cwXCnBy3PC9zgZGc1r0jAMpVgCCMEHvSd7aDW5y/w+8WT+MfDS6heW8NtOuxZI43O4MY1Y7kPMZ+bhctxg55rqaitraCytYrazgjt7eFQkcUSBURRwAAOAB6VKenrVSabuhIzY9YsoUle91fTyvnuiMriMJtG4o2XOWAyT047CnSeINGi0ZdXl1axTTGAZb1rlBCQTgEPnb+teUaX4W1e11vSmbwFPDBZeIrq/WQSWO2G2lR1UKBNkYYoxUD+HjJArR0PQ/Emn2+m6jP4buHaw1fUJ20xri2MjRXDMySxnzPL3KGwQzL1fHbIleKfkv0G1Zv5/r/kvvOqvPGX2Xxlp9m0unDQrvTJ746ibjp5ZTJzwgTDg7snPPTHO7a69pF7dRWtnqtlcXE1uLqOGK4R3eE8CQAHJQ/3ulcdLpepyeOdCuLLwvJY6ZBpd3byFJbdUtmmZCqlFfOf3Z3bQwywwW5Nc/aeEvF8+l6JYR6WumPZeHbvR5rua8jykjLGEkQJuLKTHxnaQCc4IAL0t9/8A7d/kvvDS/wB36f8ABOvg8brffEF9F0+70qfTU06W4a7hufNeOZJEQq4BCqBu6ZJPt32v+Ei0my02CfVdd0td0UbtceekUUm7ADqGc4Vj0+Y9eprz+48P67fX8dzL4LjS1j8OzaXNaPc27GRyVKBBkqy5XjcVwCSQCMHLsPDGvx6bdq/ge6iu38Jx6QJTNZbpbhQVPzCYnbgryccL06Ck9I+n46y/yX3oUfeeum3/ALb/AJv7j1fVvE2g6C0Q1zW9O00zAmIXl3HDvA6kbiM/hVptTsF0wai17brYmMSi6Mq+UUIyG35xjHfNeRappWqX08lkNJvHik0S0s9aSFrSWaIpubaGe5QRMAc7h5gO4HAIGey+INhL4r+FF3a6RpL6pNfW6G2t5PLVlJwQxMjAAjr1z6U2kvvFHVq/Y328V+HVVmbXtMAW4+ysTeR8Tf8APM8/f/2etTza9o9vq8OlXGq2MWozjMVm9yizSD1VCcnoegrzHxFoGvagnjAaf4OukbVdFtbO0PnWi/vEDblP77gDevt8hx/Dm3rukeK9YvrV7fw8bOK31DT70hJLYNchNvmea+4tvTkYXjAGGb7tFldK/wDX9f11C+l/6/roegR6taxPcm71bT2RLgxIFYIYjtB8tyXOX6n+HgjjucbW/GBt/wDhHrnQZNP1DTtV1FLOW6SfeFUhjlNvyt90jJPHoa4WHwtq0evAnwFMLdPFB1SORZLLZHAYgjEDzdwJYBsY5wD14q1Fo/idY7QHwtfAR+LZNVK/abX5Lc7sH/Xdfn6D0PtmVry/L/22/wCb+4ctE7ef/t1vyX3nocPi/wANXFn9qt/EOlS2xnFt5yXsbJ5p6R7g2Nx/u9av6hqdjpFk95qt7b2NqmN09zKsaLn1ZiAK5O00W4g+JN5BC8Z0dwmqvCOqXRDR4x02tt3/AO8pPerfi6w1Rta0HWNMsm1OLTJ5WnsEkRHcOmwSIXKruXJ4LDhjzmjov6/rW4dWv6/q1vmbNz4i0WzsYb271iwgtJ1LRTy3SLHIAM5VicEYBPHalXX9HfVE01NWsWv5IxKlqLlDKyHowTOSPfFecWXg7UtN8UeHNQi8OMypqt7ezmKSD/QIp1ZViyXBOGYOwTcM5xnjNmXwnrlytzod1ppdZNeGqxa4Jo9qx+cJNpXd5gkCgxgBSuMfNjiqSTa/rt/XnYT6/wBd/wDL8TvV8Q6NLfrYQ6tYSX0m7ZbC6TzGK/ewuc8d+OKx/B/jBddsUi1ebT7XWGuLqMWMFxlmWGZoyyhsMw+XrgfQVwfhjRbjU7GbStL0T7La2Piue9XUYjCscaxXBJjVQwcOQNn3du0/e7Vb0nRfEVs2gs/hG7he38RXt/csbi0+WKYShGJEpJOJlyBk/I3X5ckUnG7/AK2/z/DzKkrNrs/yv/kvvPSLbxJod7NdxWes6fcSWX/H0kV0jG3/AN8A/L0PXFV7bxl4YvdSTT7PxHpFxeyHCW0V9E0jcZ4UNk8c15jqXhXxVqS3M934UR0n0C504abE9okMEpkVo/LG7leNwZiD8ucKeD1Gr6dqVv4D8PX9lbCw13R/s6RQXDKclsRPEShYEMDkYJGQp7VK2/ru1+ifzE97Lz/Jf5v7jqh4r8OmyN4Ne0w2oDMZ/tkewBThjuzjgkA+hNSaj4k0PR7WC51fWdPsLe4/1Mt1dJEkvGflLEA8c8Vxeo+G7rT/ABvpV5Y+GptSis9EubWW+ja2VpJXKso+eRWJJV+cYBl68sRzEWja9FpGg6Qmj3H9o2/h9tP1S2BtLl44WYKMK1zGq52MVcM3TDJxw7aaf18X+S+8en9fL/P8Oh6yfFGgCKzlOuaaI784tHN3Hi5P/TM5+f8ADNSjXdIOs/2Quq2R1Pbv+xfaE87b67M7se+K80l8ILrOrR3U+i6rq+g3+l29mkcertbNbmIsCs6rMqyIcg7l38gkAggm7eaH4nuvGOmXUehx21npmsNOFglhEdxE1u0fnM5PmM+SAcgcdmxmnZXsRd2v5fpf/gf1Y6vwbr99r9jqUmqQW9vNZ6lPZ7LdmZcRkDOWAJJ+g+laNv4i0W61BbG11iwmvGDMtvHdI0hCnDHaDnggg+hFYPgCx1K1tdcj1rSJtP8AtWrXF1Es8kMnmRSNkf6t2x7g/rXE+CNGudS0fTLLTtEFpa6V4hvLxdQDRLHtSeZfKRQd4JyFOVC7e54FStUr9l+SuU9Oa3d2/Gx6nbeIdH1CS8g03WdPuLizB+0JFcJIbc8/fUNleR3x0qM+IdKsdLguNW1zTEDW6zNc+csUUinA8xdznCEkY+Y9QMmvNx4b8TXWoPeaj4WRreTQrnT20yJrVYY3Misixjd8ynGQWI6chOhTS/DmtWrafLN4KuPtNv4UbS5ZvNsyzTgABc+dkjCnB6fN25wbRv8A19r/ACX3g/it/XT/ADf3HrysroGRgysMgg5BFZOs+IbHTEktxqGnJqbJ/o1pdXaxGWQg7Fxy3JHYE9eKzPBN1eWWh6NoGq6ZdWt7a6XF5zySQuoZAEK5SRjnjIJGCD1yCBmJpeoWXxL8S6tbeGpzbXmlRRR3ML26/apk3kjBkDZIZVBYAfJyQAMlRWbSff8AAIO6Tfl+Nja8I+LbXxH4dsLma8sU1KawivLm0imBaAOoOSudwX3NXV1/TbLSobjVtc0wZg81rkSrDE6jALqGc4XJH8R6jmvN9G8O63aWvhu2vvBdzJBZeHLnT72LzbNleVyh24M2GDeUeenzjP8AFiPw94b1vTZ/DE934KuTPpnh6fT7mUS2ZYynbsUHzskfI4B6DzO2WxpNK75fP/27/JfeOK7/ANbf5v7j1K88QaNpy2rahq9jai8IFsZ7lE88noEyfmz7Ut1r2kWV7HZ3mq2VvdSlVjgluER3JzgBScnODj6V5d4d8MeJtK0RLfVPDMmoJe6DDpUls9zATZyR7wd2ZNpibeGyhZuPu5rT8MeE77QPFGpLeaBLe2b6Ba2Ml5m3I1CaJWD5UvuO4MqguAPl5IABMySTdun47/5fjoL+vy/zf3HQax45tLfU9Kg0a+0q9huL1be+ZbsM9srI7Btq9M+WwyxGMd+203iTQ00VdYfWtPXTGOFvTdIITzj/AFmdvXjrXnWleH9ctPA3grS5/ClwZdL1MTXcAmtSsSLvw3+tweZAQBk/KeBxmB/C3iC5MF3c+HtSWC21q9uX0+31RLaeaKc/JJHJFMBleQVZ1yGPWp7r+un+Y9NH/X2v8l96PTbzxHoenRW0moazp9rHdkC3ae6RBMT02En5vwrSryrxN4R1c+FZPDvhbw6LSzm0m4hjm+0RTTxuzlhC8kzEhG6nbv5OMqAGrvdA1Ka5V7C7sJrSeyjiV2eSN0clexRicjHIYA+mRgl6WJ1/r5FttZ0tNSfT21K0W9RA7WxnXzFUgkErnIGAefY0lprelX909tY6nZ3M6RrM0UNwjsqN0YgHIU9j0rh9b8Pauvii7n07SZr7TbxpJb2zuTay2837jy90e8iSOVuFwf3ZXOSM1ztp4O8TTaRoGlRaDcaS8Hhm70u4u/Pt9kM8gQKTslLEExk5AJ+cd84Fqr/1s/8AJL5/Iuyvb+tz1iz1/R9RhuZtP1axuorVitw8FyjrCR1DEH5SPeqz+MfDMWlR6pJ4j0lNPlkMUd219EInfn5Q+7BPB4z2rz5/AN5e+Db1LLQb/S9ZeG3im+267LP9qWGRX8qNxK5RGAYBvkIz0q3c6PqumaBKfCfhLVrS+1WcfbZ59Uiuru3XbteRWmuCpYqAq4f3IG0AjVv6/rT8iVrb+v6/U7m31/TdSa0uNK1zTLi0m8zmKVZfO2jnY6vgbcHPDfhVi01vSr+6a2sdTs7mdI1laKG4R2VG6MQDnB7Hoa8zvvD93/augzWHw6uxY2Njd2U0LTWLSPHIoCK+ZsNk72IyfvZ5JIqDSdF1XR7Tw2dW8OXGn2Gl+G7qy1Kc3VsiRuwQ5JSUnB8oncAcb198Glm/66/5L7xpX/r0/wCCelWPi3w5qmpHTtN1/S7y9Xdm2t72OSQbevyg547+la9eZfD21v7HWLJ/EGnXlrdtpiWVo/lW6RNDH82G8q4kLsM/fKovsCcH02m1YhO4UUUVJQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUEhVJY4A5JPaisjxRoZ8RaDLpwkiiLujB5YfM27WDZUZGG44bnacHBxik720Gty+l/ZyaeL+O6gezMfmi5WQGMpjO7d0xjnPSpkkSWNZImV0YBlZTkEHoQa80g+Fd5H8NT4fkv7Q3rESm5EJLiQQeX/ruu7PSXZkLxtrsfCXh+Twz4bj05pYriRCzmRU2bye7HJ3N6vgZPOB0qnZNi7GvbXdveRs9pPFOiO0bNE4YK6nDKcdwQQR2NS15xYeO/El/Doi/YNKhm1DV7zTJ282R1hMPm7SowC/8AqjkkrngYGciTSvG2ua2lhpVoNOttYnkvklupYHe3AtZhGSsQcNliynG/5Rnk4wSzG1Z/15/5Hem7theLaG4iFyyGRYd43lAQC23rgEgZ9xU1eZ6l/aFl8RYtQ8rTrfXP+EVuHmkSNpIWkSWMgHlGZRzjJBGasS/ELUNNt49Q1GK0ltH8NjV/JhiZJBKCgK7ixG0l/wC7kepoSulbz/8Abv8A5Fkt2dv6+z/8kjvJdQs4ZpIpruCOSOIzOjyAFIx1cjPC+/SpopY54UlhdZI5FDI6HIYHkEHuK8mubrWfD/jvxBrUlvpFzqaeGFuz5Eb28cgWVuHOXZiFGAe+BwvbVv8Axt4lEd2bO30qJbbw/HrAklEkhkJBLJsBXaDtYA7jjg89Km6td/18X+Q7Nysv6+H/AOSO1vfDuialfw32o6PYXd3B/qbie1R5I/8AdYjI/CtGvMfFXxE1qyWMaKdLtJ5dMhvbO21CJ5pNSkcnMMIWRPmUY/vE7hwBzXV+KPEV14W8Gf2lNAt7fAwwCOJRGrzSOqDAZ8KNzZwX/wCBd6pppfO3zEmmzo6K82bxd47s4tOh1bQ7GwlvtVSxW6uMfMjqWDiCKaTBBVgQZfQjqQLU3iPxTpusX+h6le6PJqMsMEmkyRadKkc26TY+9TOxO0kZAIwCDk9KW+39df1Htv8A1rY7q4uYLSEy3U0cEYIBeRwoyeByalrxvxBPrmpWPjCPWruw1CLS9XsY7OL7I0XlPugYMrF32jDkHgnknOPlroNS8d63pP8AalhJaWt9qUeqQWFkbaLYredEJBuWSUAlRkf6xQxA+7mjp/XW1vzHb+vTc7ux02x0yN49Nsre0SSQyOtvEsYZycliAOST1NWa88Pi3xrb/wBg2up6HY2F1qepSWUj3EgPyiJnSVY45HAztbKmQ4IxnnIbp3jbxC82jNqMemNDdaxcaPcLBFIrM8fmgTKS5Cg+V9whuv3qdv6/r1Qul/66/wCTPRaYksU/mLHIkmxtjhWB2nHQ+h5HHvXCaR45vz4sudM1efTbq2TTZdQEunQShYfLkCtH5jMVm4I5ULgjkcik0/UvEVp4osPD0S6dapdafJqlxPPHJPIZDMvmJtDIFH7wgHLdBxxgpK9vP/g/5MHpfy/4H+aOw0rQtI0KKSLRNLstNjlbfIlnbpEHb1IUDJ96sm7theLaG4iFyyGRYd43lAQC23rgEgZ9xXm+nfEfxHPZ3PiG58OMfDCW9xcLcKYleNYwxXkTsz7iuMeUm0nvjNZ19fa1pPjqXxDNb6Rcaj/witxdoIY3hVlWWNgkjZYuVGcNxn0Wjrr5/gm/0HZ7L+tUv1PX6rS6bYz6hDfzWVvJeQKUhuHiUyRqeoVsZAOBnFcBefETV9EW/bV7WzuWXSLfUbaK0DJteWTyvLZnbDDcQd2F4zkd6kPivxxZaLNPrPh/7IY7qNReLZifEJDF3NtBcSOdpAXiT+Ldjgint/XnYS1/ryueiVnal4e0XWpoZdY0iwv5Lc5he6tklMZ9VLA4/CuRuvHt3DcaVN9o0+PSr2BXGpfZppbaWVnK+X5qkCHAwf3gO4nHy4Nd/wDSl5gQ21xbXCuLSaKUQuYnETA+Ww6qcdCPSpiQoJJwBySe1eWX3i3xVqdjYfZp9P0q5/4Sg6VKqQvcIyJkjnehIJXn7uQccc56PStV1vxPNNPHHpTaEt1cWNxaTxOZ2WMtGz7txXll/wBWV+6c7u1LePMv60T/AFDZ2f8AWrX6M6uKa3vrUSQyRXFvICAyMHVx0PPQ1R0DTdC07TseF7PTrWymcv8A8S6JEjduhPyDBPGM+1cB4B1jWdO0LwvpcUOnva3ul3DW0WHRo5IiNu6TkbWDDgJlcdWq5pHjfxLrlv4bFta6VbPrVnczPNIZJBA8RwAIwRuHK/xAnnpTejdv63/yCz6no1FeYXPxJ1R/C+g3yS6RpD6nZzSvd6ijPA08eAIEUSIQzncRljwuMMa7nwtd6nf+FdNvNejji1C4t1lnijgaIRswzs2szEEZwcnqO3Snbf8Arv8A5C7GtRXH6/4rvtH8X21hN9nsdOnWJYrq6tZXjnkZ8MnnIdsTAAYDj5ywAIxXPXXj7xLpUhj1OTS3ey1wWWoLDp8i4tG8srOpM524Ei5J3DLDjjkWv9eaX6j/AK/C/wCh6jUD31pHcPBJdQpMkfmtG0gDKn94jqB79K8/1Hxp4pSSw0/RbC21PUb+Ce+ieC3UILdXVYwUkuUyWDAlg5x/cNU7i3/tDxlq0us6RBaXd74PV760YJKPM8xwVZhkPjGAeeAKiTaV/X8E3+asNLp6fi0v1uelQ6lY3EkCW97byvcQ+fCqSqxlj4+dQDyvzDkccj1qzXlvhrxTrOnaHoelWdlYyQL4RXUIGlmcM8kaxrtbC4Vfm7bifbvo6b43195IRfWVndPeeHjq9tbWaurCRduYizMQ24uMHC46c9a1nHlbXa/4c3/yLIi7pedv0/zR6DRXA+BvFuteJtfuFl1DRtQ0iKyimFxptpIu2Zycws7TMAyADI25+YZC9DueO9d1Dw14NvNW0m3tri4t9p2XTsqYLAE/KCSeenH1qWmtx3OiqK4u7ezRHu54oFd1jVpXChnY4VRnqSSAB3NcXL4o1+z1TWNIvZ9FjubaC3u7a9kjkjhSKWRkKum4lnUqcAMu/IHy1n2nxC1qbw7Z3gtrGaQ+IRpF1KY5YAUMoTzEibLAkHozcdeelCV2l/W6X5sb0V3/AFpf8j0mmCeJp2gWRDKihmjDDcoOcEj0OD+Rrz+08b+IWu7GXULbTIrWbXpdHkhg8yR+NwWQSEqBgpyNpyD1FQ+Ib3XIjpt/ol9DZPrOvx2xM9s0uYVDBBw6naTGWIzzv6julrbzt+Nv80wel0+l/wAL/wCTPSaK880Lxn4v17VvOsPDscmiNLcQC4keKMIYyyq5cTM7BmXBXyQVz1bHMOl/ETVxBo2oa7b2K2eqabdXZhtEcyQtAA33ycMGU9NoIPc0m0ld/wBb/wCQ0m3ZHojXdul2lq88S3Eil0hLgOyjqQOpAyKkdFkRkkUMrDDKwyCPSvHr3W7zTPGWmeMNat9PkZvDV7eKllCUkEa+S6xO7Md+Nxw3yj5j8o76Nz458eaf4cvdUv8Aw5Zwwqbdrae4dI12yOEK7Ippi5G5SGygIzwMYNOL6/1q1+grrdf1ov8AM9B0rw/o2hiUaJpNjpwmO6T7JbJFvPqdoGa0K891jxP4u0m91iyzokjabpJ1NbnyJQJQGb92Yt/y8IRu3nnnHO0Q3Hj7xPqOsGDwl4d+3xWsNtLdIzRAsZkD7Q7zoUwp67JMnjiktf69V+gPTf8ArZ/qj0iiuFi8Z6v/AG7qunT2sCXsKzvY6ZLbyxSXSoPkMcxJjl3cE7QCmcEHrWr4L8Ry+IbGc3Vzby3VsypNElnLaSwsRkiSGUll9uSDjINC1B6HS0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFIw3KQc4IxwcUtFAHKW3w08M2jWhgt79TZ3T3kGdXuzsmf7z8y8k5Oc9dzf3jmSH4deGrfT0s4LW7SOO5e6jkXUrnzo5X++yy+ZvXdzkBgDk56109FF2BgjwVoY1mLVTb3DXcNs1qrNezspib7yshfa2SckkEk8nnmq9p8O/Ctn5WzSI5jDbPaRm6le4KQtwYwZGbC44x2HA4rpqKP6/r7394HKH4Z+EzHIr6bK7SWpszM97O0ogJJMYkL7lXkjAI446cUp+G3hlllVoL9hNZCwfOrXZ3W46R/63p/ifU11VFG/wDX9dx3f9fL/Jfcjgb3wJdJrKHTId1ittFaxyL4hv7OaCNM4DCMnz8FiRuZSBx711s2i21/4d/sjWlGpQPAIp/PH+uwBlj75GfY1o0UbqzFs7o5uXwB4fnhsY5or6T7BMJ7d21S6Lq4+6S/mbmxkgBiQASBjJqy+kT3/im31LUrWzSPTRKtk8chkkfzFUFmyg2cAjaC2cg5GMVt0UAc5qngDw5rE17LfWUxe+kjluTDeTw+YyABT8jjB+VenXauc4GGyfD7w3P/AGl9os55/wC02R7rz76eTcyfcZdznYy4GGXBGBzXS0UBdnPXHgbQrp9Pe4ivHk02Xz7aQ6lc7xJgLvZvMzIdoxlyeMjoSKqp8M/C6JboLa+K21217EG1W7O2dvvPzLyTz19W9Tnq6KAOatPh74ZsXga305s20TQQh7qVxHGzBigDMQFyBgdB0GATV+TwzpkviiLxC8dx/acUJgSQXcoQRnqvlhthGeeV6gHqBWtRTuwMOz8GaDY3F1LbWO1btneaBppGgLOCHYQljGpYE5KqCcnPWs9/hh4Rki8uTS5HxA1sjtezl4om+9Gj79yKem1SBgkdCRXWUUg8zmo/h74bSd5Xsp5zJZDT3W5vp5ke3HRCjuVI75xnPOc1Yh8G6Nb6YtjFHdiJPuSNqFw0yYBACyl/MUAM2AG4ycVu0UAYUngvQZILeA2TiGBVVYkuJVRwpLASKGxIMsTh85Jyeav6Zpp05bkG5nnE87TASyu/l5/hXezED2BwM8ADir1FAHNRfD3w3DZSWq2dw8Ml6L9hLf3EhE4OfMDM5IJyc4IBzzmrB8GaJ/aFxeRwXEElzkzJBezxROxGN/lq4TfwMPjcCAQcgVu0UB1uctbfDjw3Z/YfssF/F/Z8UkNrt1W6/dI/3wP3nfP6D0FJafDbwzYfYvskF/F9gjkitdurXf7pZPvgfve/9B6CuqooA4C/+Hv2FtNg8NWYawsYZIo4X1++spYt7BmImj3s6navyHABGc10ek+H5tPmtZp9Su52ggaEo9zK6sC24Z3OQxUcByN5xy3atyindgZWoeGtL1S9jur6CSWRGR9onkWNyhyu9AwV8HkBgcHnrUd/4S0PU5tSlvtPSZ9UtRaXhLsPNiGcLweOp5GD054GNmikBj6n4U0bV/sJvLV1k0/i1mtriS3khGMFVeNlYAgDIzg4Gaq3HgPw/c6lPfSW90txcWn2KRotQuIwYf7gVXAA75ABySepzXRUUb7hscnH8M/C8Pk+Vb36eTZtYx41e7+WA9Yx+96f4D0GGXPw50eKzY6PHNFexac+nWz3N/cyxpCwxsKGQgj8OMD0FdfRQ7v+vX/N/ewVl/X9dkcTovg/UYbaeO8lm05ZIWh8qHxDfX6t0wwaQxtGRg8Jg8/e7Vd8c+HtR134f3Wg6Sbee4uI0iMl/OyKVBBLMyoxJOPTv1rqaKHqC0Oai8DaJLozWl9YyF53imnb7fPJIsqcrtnZhIAp+7grjsB0ptz8OvDN1btDJZXCK12L1jDf3ETGcdH3I4OQeevUk9Tmunoo/r+vuX3CtpY5SP4a+GYo4USDUCILw30e7V7tiJz1kyZeT9fU+prX1Dw1pOqaZaafe2m+2s5I5LdVkdDGyfdIZSD0468gkHOa1KKBmFB4L0K0vLu4tLSW3a8LNKkN3Mke9hgusYYKj/7agN3zVWy+HfhrT5tOktbS6B0xHjtFk1G5kSNX++u1pCGBzyCD29BXT0UAcxafDnwpZ3EE0WkJI9skkduLiWSZYEkGGRFdiEUjjaAAATgDJpJPhx4Zl0Q6Q9pdmx3qyw/2lc/JtIIVT5mVQEA7FIXIBxwK6iigDnL7wFoGpXdzc3sN7JLd2gsp2Gp3K74R/AQJAPqepyc9TlyeBPD0dza3EdnMstrbi1VxeTAyRDokvz/vVHYSbq6Gijb+v67sP6/r7l9xjN4S0V72S6ktXeSRJEKvcSNGokzvKoW2oWycsoBI4zVnS9DsNGa4exjkEly4eWSaeSZ3x0G52JwOy5wOwFaFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAf/Z" alt="" width="802" height="852" vspace="0" hspace="0" border="0" style="width:802px;height:852px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p><img src="data:image/jpeg;base64,/9j/4AAQSkZJRgABAQEAYABgAAD/4RESRXhpZgAATU0AKgAAAAgABAE7AAIAAAAYAAAISodpAAQAAAABAAAIYpydAAEAAAAwAAAQ2uocAAcAAAgMAAAAPgAAAAAc6gAAAAgAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAE11aGFtbWVkLCBVc21hbiAvU0EvRVhUAAAFkAMAAgAAABQAABCwkAQAAgAAABQAABDEkpEAAgAAAAM4MgAAkpIAAgAAAAM4MgAA6hwABwAACAwAAAikAAAAABzqAAAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAMjAyMTowMToxMSAwOTo0MTozMwAyMDIxOjAxOjExIDA5OjQxOjMzAAAATQB1AGgAYQBtAG0AZQBkACwAIABVAHMAbQBhAG4AIAAvAFMAQQAvAEUAWABUAAAA/+ELKmh0dHA6Ly9ucy5hZG9iZS5jb20veGFwLzEuMC8APD94cGFja2V0IGJlZ2luPSfvu78nIGlkPSdXNU0wTXBDZWhpSHpyZVN6TlRjemtjOWQnPz4NCjx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iPjxyZGY6UkRGIHhtbG5zOnJkZj0iaHR0cDovL3d3dy53My5vcmcvMTk5OS8wMi8yMi1yZGYtc3ludGF4LW5zIyI+PHJkZjpEZXNjcmlwdGlvbiByZGY6YWJvdXQ9InV1aWQ6ZmFmNWJkZDUtYmEzZC0xMWRhLWFkMzEtZDMzZDc1MTgyZjFiIiB4bWxuczpkYz0iaHR0cDovL3B1cmwub3JnL2RjL2VsZW1lbnRzLzEuMS8iLz48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOnhtcD0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wLyI+PHhtcDpDcmVhdGVEYXRlPjIwMjEtMDEtMTFUMDk6NDE6MzMuODIxPC94bXA6Q3JlYXRlRGF0ZT48L3JkZjpEZXNjcmlwdGlvbj48cmRmOkRlc2NyaXB0aW9uIHJkZjphYm91dD0idXVpZDpmYWY1YmRkNS1iYTNkLTExZGEtYWQzMS1kMzNkNzUxODJmMWIiIHhtbG5zOmRjPSJodHRwOi8vcHVybC5vcmcvZGMvZWxlbWVudHMvMS4xLyI+PGRjOmNyZWF0b3I+PHJkZjpTZXEgeG1sbnM6cmRmPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5LzAyLzIyLXJkZi1zeW50YXgtbnMjIj48cmRmOmxpPk11aGFtbWVkLCBVc21hbiAvU0EvRVhUPC9yZGY6bGk+PC9yZGY6U2VxPg0KCQkJPC9kYzpjcmVhdG9yPjwvcmRmOkRlc2NyaXB0aW9uPjwvcmRmOlJERj48L3g6eG1wbWV0YT4NCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgCiAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAKICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIAogICAgICAgICAgICAgICAgICAgICAgICAgICAgPD94cGFja2V0IGVuZD0ndyc/Pv/bAEMABwUFBgUEBwYFBggHBwgKEQsKCQkKFQ8QDBEYFRoZGBUYFxseJyEbHSUdFxgiLiIlKCkrLCsaIC8zLyoyJyorKv/bAEMBBwgICgkKFAsLFCocGBwqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKioqKv/AABEIAX4DFQMBIgACEQEDEQH/xAAfAAABBQEBAQEBAQAAAAAAAAAAAQIDBAUGBwgJCgv/xAC1EAACAQMDAgQDBQUEBAAAAX0BAgMABBEFEiExQQYTUWEHInEUMoGRoQgjQrHBFVLR8CQzYnKCCQoWFxgZGiUmJygpKjQ1Njc4OTpDREVGR0hJSlNUVVZXWFlaY2RlZmdoaWpzdHV2d3h5eoOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4eLj5OXm5+jp6vHy8/T19vf4+fr/xAAfAQADAQEBAQEBAQEBAAAAAAAAAQIDBAUGBwgJCgv/xAC1EQACAQIEBAMEBwUEBAABAncAAQIDEQQFITEGEkFRB2FxEyIygQgUQpGhscEJIzNS8BVictEKFiQ04SXxFxgZGiYnKCkqNTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqCg4SFhoeIiYqSk5SVlpeYmZqio6Slpqeoqaqys7S1tre4ubrCw8TFxsfIycrS09TV1tfY2dri4+Tl5ufo6ery8/T19vf4+fr/2gAMAwEAAhEDEQA/APpGiiigAooqhrGh6b4gs0tNas4b21WQSmCdA8bkZxuU8Ec5x7UAX6K8P+Fvg3w5qHi7x6lzolgfsGu4s3W2QNahSSBGcfIAQOBxXQX3xK1zTfG2m6beWeni1vdXbTGtoyZJYhjKSmZXK5YEHyiisPpg0R961utvxt/mD05m+l/wv/keoUV4No+r6j4PvPihrOhwWBt9N1hZ57WWJh5ybfmCMpARuSckNz271p3mrWdl+0AniEwFIf8AhDWvZQFAdgH3c++AB+FJNNJ+V/8AyXm/QaTbaX9apfqezUV558P/AIhar4tvLX7XpUyWd9ZG7juI9OuIYrY5AELSyDbKSDkOmBwRjvVX422yjQdHvUknSZdZs4vkuHVCjScgoDtOfcdh6VVmmk+rt+Nibqza6f5XPTaKhu7u2sLOW7vriK2toVLyzTOERFHUljwB7msSD4geDbm4jgtvFuhTTSsEjjj1KFmdicAABskk9qW+gzoaKoa5q1toei3OoXtxDbxQr/rJ5AiKScLljwBkjk15f8GfFEf/AAknirwlLrMGs/Zbx7+zvYJVkWeKU7mwVJHDNzz1Y+lC1bXlf+vzB6K56/RXgXjTXrrxx4P0zxHNa6elhH4mht9PHkt9pjRZtjOZCcfOV+6FXGBya7o+LfE1v8RtZ8MX0mlRD+z/ALZo0ospCZsvtxJ++5KkgEDGc5yvShar7/yT/UbVnb+t2vzPQ6K8r1L4o6xaeKtQ0ax0x9Sl0RbZb2Oz0u5ma8eQAv5bRllgCg5HmFt3I4xmtWLxV4ovviL4h8M6eulBbC1t7q0lngkHEh5STD8nAOCAMeh6U7Xt5iem539Fec2vxEvYvEuuWuuSWdgulR3E39lyWkiXM0EYJWaOYvslDAZICjbnBPHL/h/8QtV8W3lr9r0qZLO+sjdx3EenXEMVscgCFpZBtlJByHTA4Ix3pLXb+t/8n+W4PTf+v6v+ux6HRXEeKvFmtaN8R/C2haeli9nrguFkM0TmSJo03BgwcDHI4254PPPGJrvxK1/R9ebw/Fp8V7q1hpq3t2tlp1zcrdOxIEUQjyYs4+/JkDIGD1o7ef6f8MNq39fI9Soryvx58T9d8KW9xqEGnWcVpbQ204tbpS89ysrBXztcG3KE4y6MGPA54ran8Xa5rHjPUfD/AITXTI5tKtbe4uDqKyMJjLz5alCNmFGd2H5IG2nZi8zuqK8zXVfE918b9X0yHVLGOzsdHSaKCWyeRRvbnkSr825Rlj1AwAOtc/4D8e3i+C/CWn6Vp+nWF74g1C8iDBJZILfYzOz7Gk3sSe28Dn8KUfeV1/WrX6B38v8AK57ZRXkOq/FrWoPDSXWn22n/AG+18Sf2FepNHIY5DnHmR4cFMjBwd2M45xmtGL4ieITa+NLddNt77UPDl5HFEbS3ciSJ8EuYt5Zii5JUMN2OMUef9dP80DunZ/1v/kz02isDwXrh8ReG49R/tOw1NZHYLcWEDwoR6NG7MyOOhBNb9Nqwk7hRRRSGFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABVbUtQtdI0q71LUJfJtLOF555NpbYiKWY4AJOADwBmrNc38R/8Aklniv/sC3n/oh6AD/hPNI/58/EH/AITmof8Aximv470lkYC18QoSMBh4bv8AI9+YK6aigDy3wlF4f8H6xqmo2l/41vZNVlM93HeeHLkpJKf4/ks1IPXgEDnp0rPTw54KiuLeaJ/GiNbaw2sxf8SK9IWZvvLza8qcDrk+/WvYqKa0aa6f1+gPW9+v9fqeUXWmeDbufUiyeL47fV7j7RqdomgX3l3rA5UPm2LKB0whXI65qe6g8K3njhfE0o8WeaLE6cbIeHLv7O0BByhX7Lu6nPDfpxXqFFLpb+trfloO7/r7/wAzzvwpfaB4Q04afp8vjC4sYifs1tdaBeutspOdikWwYqM8bi2Kr+MpNC8bQ20F9e+M7K3tpknWGy8OXIDSocq5L2jNkemceor0yih6u7Ftocta+NtLt7SKKVPEl06IFaeXw3fB5CP4jttwuT7AD2qX/hPNI/58/EH/AITmof8AxiukooA4bVfEOm6nqOn3SXni+yWyk8z7PbeG7ry5z0w++1YkYyOCOueuCMXVLfw9qfj228XC/wDGtnqFrGIY0tfDtysZj7owNmWYHn7xOM8Y4r1OijYDyOfQvBFzZTafLH4y/syS/wD7QSwj0XUI44ZuSShW3DgEnOCxAPTFb97qfha/8SaVrtxY+JDe6VHLHbt/wj2oYIkAB3ZgyenHPWu9oo2/r5fkD13PN2l8NJ4ym8S2B8XWF5dxLFexW3h+9EV2qjC7w1sSCBwGUqfejT5/D2neO9R8VRzeMJbvUYVhmt5fD14YQq427QLUMMc/xdznNekUULQHqeeXV74a1DVor3U4/FN6kCSLDaz+Hb1o4zICrkH7NvOVYrgsVA6AUnhS+0Dwhpw0/T5fGFxYxE/Zra60C9dbZSc7FItgxUZ43FsV6JRRsG55trc3h7XfF+i+Ip5vGFvc6KWNtDB4duxE2/h9wa1JORxwRx0weadqE/hu98XQeJbY+LdN1OOH7PLJaeHr3bcxZzskV7ZgRnuMEetej0UbW8geu55Brvh7wT4huNdlvR4zT+3EgW6WLQ77AMP3GXdbEg8c5JB9K05P+EZ/4SmDxDaP4vstRS2W0uJLfw/egXkQ6CUG2IJGPvLtI9a9Moo2B67nnE1x4bfxXceIbf8A4S60vrmy+xS+T4fvirKDlWw1sfmU9Ox7g1kaPofhDRPDtjpNpN4zb+zbtrywu5PD12ZrWRgQ20i0CkHLcMrdfpj16ihabf1rf8w/r8LfkePXnh7wfd6Cml+f40hUas2ryXEfh6682W5JJ3MTaEYGeAAOgzmtLRl8PaJrOt6nbXfjSS41qZJ7jzPD92Ajr90rttRgY4wcgjrmvT6KNv69P8l9wPXf+v6uzgtK8TeGPCel3ssn/CQ7ZJHvL6+u/D14hdto3SOVt1RQFUZwAABWz/wnmkf8+fiD/wAJzUP/AIxR8R/+SWeK/wDsC3n/AKIeukoA5v8A4TzSP+fPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/wAYrpKKAOb/AOE80j/nz8Qf+E5qH/xij/hPNI/58/EH/hOah/8AGK6SigDm/wDhPNI/58/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/ABiukooA5v8A4TzSP+fPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/wAYrpKKAOb/AOE80j/nz8Qf+E5qH/xij/hPNI/58/EH/hOah/8AGK6SigDm/wDhPNI/58/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/ABiukooA5v8A4TzSP+fPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/wAYrpKKAOb/AOE80j/nz8Qf+E5qH/xij/hPNI/58/EH/hOah/8AGK6SigDm/wDhPNI/58/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/ABiukooA5a5+Iug2drLdXkWuQW8KGSWWXw9fqkagZLMTDgAAZJNS/wDCeaR/z5+IP/Cc1D/4xR8R/wDklniv/sC3n/oh66SgDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDm/+E80j/nz8Qf8AhOah/wDGKP8AhPNI/wCfPxB/4Tmof/GK6SigDll+IugtdSWqxa4biNFkeIeHr/eqsWCsR5OQCUYA99p9DUv/AAnmkf8APn4g/wDCc1D/AOMUWP8AyVPXf+wLpv8A6Pvq6SgDm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xiukooA5v/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YrpKKAOb/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GK6SigDm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xiukooA5v/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YrpKKAOb/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GK6SigDm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xiukooA5v/AITzSP8Anz8Qf+E5qH/xij/hPNI/58/EH/hOah/8YrpKKAOb/wCE80j/AJ8/EH/hOah/8Yo/4TzSP+fPxB/4Tmof/GK6SigDm/8AhPNI/wCfPxB/4Tmof/GKP+E80j/nz8Qf+E5qH/xiukooA5v/AITzSP8Anz8Qf+E5qH/xigePdE86COWPWLfz5o4EkudCvYY98jhEBd4Qq5ZlGSQMmukrm/Hn/Iu2v/Ya0r/04W9AHSUUUUAFFFFABXN/Ef8A5JZ4r/7At5/6Ieukrm/iP/ySzxX/ANgW8/8ARD0AbOrX/wDZei3t+IHuPssDzeTH96TapO0e5xXI+DvGl54osLPU7S+0fVLO4ObmKwV1m08eWW2uCzGRtwC5xH1zg11+pm9GlXR0pY2vfKb7OspwhfHy7j2GetednwH53xF0rXtH8OHw3eWk5fUr2C4jEF9EVO6NURtzksR8zonTPPFEfi1/4YH8P3nUab8Q/Der6ZNqGm3N5cW0N0tnIy6bc5WYnATaY89SATjAJGcVag8Y6NdanNYWs1zNNCZFZo7Kdoi0f31WUJsZh0KqxOQRjIrB0fwpcaX8WNcv7WdBpGoQw3ktrjJF386bh6AqMnrk4PGKbp3hjUNK+Ij32iQXenaZeGWXU4HuEktJ3OdrxJnekpOC3yhSO5NHT5fj/wAPf8Ael/60/q34ljwz8T9E8Q+HLzXJPtFhY287RiS6tZYw43lF2sVw7MR91SSCQCM1fvfiH4Y07S7fUL7UXgtri6FmrSWkwKTH/lnIuzMZ/wB8LXmY+G3ih/g5F4fNkI9S0rWTfxRreKgvUErPhJFOUyG4J2kEdutafizwVfSeDbSLwr4V1EXdzrNvqN9Bdaok0w8vG5mklmYEkKAMMffFNW0+X6Xf5+lhy0bt5/rb9PvOuuvit4Lsnu47vWfJmspfLuYHtZhLF0+Zk2bgnI+fG3kc811T3dvFYteSTxrbLH5rTFgFCYzuz6Y5zXiXiDwf4r1Gf4mPbeFrkt4ijto9Pdrm1BYRgK27978o/i+g9eK9Ml0G51n4VtoFyrWF1c6T9jdXKsYXMW3kqSDg+hNS/gbW9l+X6BpzpdNf0/r5FnT/ABtoGqeZ9hvJJGS3N0qG1lVpoQM+ZEpUGVeRym4ZOKg0z4heF9YsYLyw1Tfa3EM0yTvBLGmyI4kJZlAXHocHHI4ri9G8L+JY9f8ACt1eaPNbxeG9CnspdtzCRdzFVRVjw/3Tt3Avt7ZxTPC3hq90X9nXUtB8XaPcW80cF351vHcw7pVYs4KOrFR94D5u46Y61KyUmun+bX+TFHWyfdflf89DtNN+I/hjVdQeys72481Lf7UzTafcQxrDgkSGR4woQ4OGzg9s1Np3jzw7qtzc21jfSPcW1v8Aamha0mR3h/56RqyAyKezJuB4x1ryvwjeSXWsXEtzoutp4jk0NtM0qLW9FNjaTpGpYRt+8cOxxlidoI6KK0PCvg3xVpfjmz13UdFKx/8ACLmymjgngAjuQ27y0QMFVeyhflHcjmnJJXt2f/t1vyXzYo67+X6X/N/cd7o/xK8J69Np0Wl6qZW1TzBZl7aaNZjH99QzIBuH90nPfFbmraxYaFp7Xuq3At4FYIDtLMzE4VVUAlmJ4CgEnsK8P8LeBPGGl2fw5gvPDlwjaDf3Ut8wurYhElb5WGJctwckDng+2fRvih4c1jXtJ0m58PKk97o+qQ6itm7hBdBM5TceAeeCeKJJJ6d7fLTUfX5f56fgvvM/xL8THt7jwvN4Xktbqy1TWl0q9S7tZUmiYnkAEqUYYPDKeo/Hpp/Hnhu31qPSptSC3Mtx9lRvJkMJn/55edt8sSf7G7d7VyfxE0vxH4lm8G3eneHLpv7P1iK/uoWubcPDGg5BzJtLZJwFLDjqM4rnvEPgrxlrOtJetoVtGtp4shv40tJoYlltEGPNIyN8h7l/m4wOKIpOyff8Pd/zbE77+X/yX/APVP8AhLtG/t46OtxM92snlOUtJmhR9u/Y0wXy1bbztLA8j1FO0XxXpHiCd4tJmnm2J5gke0mijkTON0buoWRc91JFc3d+GdQt/iHBrHh+3u7FbqUnVv8ASI2s7yILtG6MncJuFwyrjGcntTvBfhnUPDniS9isYryx8OtDuWwurhJo47gkEm3IJZY8bgVbbz0GKUddxy02/r+v67HdUUUUgCiiigAooooAKKKKAOb+I/8AySzxX/2Bbz/0Q9dJXN/Ef/klniv/ALAt5/6IeukoAKKKKACiiigCO4uIrW1luLhwkUSF3Y9FUDJNcT4T8VeIPHdiNd0VdP07Q2ldLZLuCSae7VSV35V0EQJBwMPXY6jYxappd1YXOTDdQvDJj+6wIP6GuB+H2l+I/h94fi8K3eiTatbWsr/ZNSsriFUMbOWHmpI6upBPO0PQt3f5fqD2VvmdK/i+10u2to/Eo+x6nOJG+xWkct0+xGILgIhYpjB3FQOe1F3498NWU+kxTampOsgnT3ihkkS4wM4V1Urn2JyaxNZ0DWoviFpniy3svt5TTJdPubS2lRTGWcMrqZCoZRyCcg9CB2rjtI8DeKtF0z4bWz6NNdto13Pdai0dzB/o/mE4QbnG7G7+HI44zTWtr9/1f6WYPRO39af56HfQfFbwVcPAkWuIXmuPs2xreVWil3bQkoK5iJIIG/bnBxmrWofEPwzpWrahpl9fTR3um24urmEWU7lYuPnG1DuUZ5K5xznoa8jufA3jCXwdq9lH4TuVu73xZ/ayj7Xac2+7dyfN+8MYx7/Wuo8Q+H/Et38Q/FGp2nhy6ms7/wANHTbaUXNuN8xyehkBA+bGT6Htipe1/wCvhT/PQf2rdNP/AEqz/DU7bSviF4V1vVoNN0nWYbq5uImmh8tH2SquC22TGxiMjKg5HcCptP8AG3h7VL+OzsdREskzOkLmF1jnZM7ljkKhJCMHIUkjFeX6F4M8Twa98OWufDdxa22habPa6hL9otiI3kQpkBZCWGRuJA6MO+QLOjeAfEdhaeC/D8ti62/hzWJbubUlni8uaL94ybV3b8neFIKjHPUc1o4xva/9Xav91n5kXdn/AF0/z0O4tfij4Qu5FSHVXBa+/s4mWznjCXP/ADzYsgCn0zjPNdbXz3N4D8ZtoGo26eGLozT+MhrUafa7Xm369fNxu46e9fQYOVBIIJHQ9qn7N/62T/NtfIuWkrL+tX+lhaKKKQgooooA5v4j/wDJLPFf/YFvP/RD10lc38R/+SWeK/8AsC3n/oh66SgAooooAKKKKACiiigAooooA4X4ueLdb8DeCX1/QfsDm3lRJYb23eTzA7BRgrIu3Gc8g59qgi8X+JNL+IWi+HNYTT9Wh1e2efz9OtJLd7MIM5kVpJAVJIAOV59aj+N2ha34p+Hcuh+HNIm1G6upo3JWaGNIgjhjuMjr17YB98VkaZ4V1/wR4wtdc8GeHZv7F1eILq+grPbxNaSqMCWMeZ5f1Ct/9Zwt17/p/n1Ce2nb9f60O8Hjvw4dbi0kakPtU8zW8TeTJ5Ukq/ejWbb5Zcd1DZHpUcXj/wANzXt5Zx30v2iyu47K4jazmUxyyNtQHKdCcfN93kc8ivNrrwb4yv8AxFpepXOgwQiy8VNetFaTQxx/ZcACUKGG5zyWLfOTjtwOs8DaLrOn/EbxtqWqaPLZ2mrXMMlpcPNC/mLGmzojlhnqMgcHseKI6q7/AK+H/N/NCk2np/W/+S+86iHxdodxrjaRDfB7xZDFgRv5ZkAyYxJjYXA5KA7gOcVs15N4J+HM+j+IbyPxDpN5di31aXUtN1JNVcWw3nIzbiQYkAZhnyyDnrXrNL7KYfaaCiiigYUUUUAFFFFABRRRQBzdj/yVPXf+wLpv/o++rpK5ux/5Knrv/YF03/0ffV0lABRRRQAUUUUAFebeOfHXiTwL4hjvbmys9R8KKYzevb27rdWauSoYnzCrgFST8q9QPevSa59kn1DxNqVjqGg3DaXPZpCbuZ4WhmwXLLsDl+Q+OVHQ+2VrfQeltSKDX5BcXWsXWs6UfC62Ud1DKsDK4Vs/M0pkKlflPRB94enM9v410O6s724t7idzYw/aJoGtJUm8vBIcRModlODhgCDjg1wa/CC8sPA3i/wnpmos2n6iEfSRPIT9nGS5iPU7d/f0b1zVyw8M6/qfjy61q902XS7ceGhpSJPPE3mzFySf3bN8owME4PzdOopy2du2n3N/noEfPv8Aql+V2dZ4H8X2/jfwzDrFpb3NukpJCT27x8ZO3DMAH4xkqSM5Ga5zw38S5JJPEx8VCNIdI1k6bA+n2M8jSA/d3IvmNknjIwM49a1/hdpOp6B8OdK0fW7M2l3YxGF181XD4Y/MCpIwQRjPPqBXm9v4L8aaZr+u+JdM0a+Gop4gN/Y2bX0AhvbeQFJFYebhW2kkMRkZGM8gU7Ko0tv+Cv0uTG7p3e//AAH+tj0y/wDiX4V0y+vbK/v7iG5sbZbu5ibT7jdHCcfPgR8gZGcdOc4wavXvjPQbCOzeW+Mv26H7RbJawSXDyRYB8wJGrNtGRlsYGa8y8R+GvFes+K/FmqQeF7xItX8MjTrdXurXPnnBKn97wBkjP+yfbN/QvCHiDRbjwlrb6TNNPYeHzo95p6Tw+ZE+QVkBLhCuQc4bOMcHkVP2b/19r/JfePr/AF/d/wA39x3D+PvDaarpenLqDS3Grx+bYeRbSypcLzkrIqleMc88d+tM0v4geHdagjm0y4vLhJLtrIFdNuRiZRllIMfy4AOScAYPNcFZfDXxBbfCjwjYxbYfEOjalHe/NIrCFXlbzFznBARzkA87eK6vwt4QuvDfjbxBPEi/2LdNHdWcYYZE7Jsl47fcByeu8+9U0k38/wBP+D80J+X9b/8AAfoWrD4oeENSktUtNVcm7vGsYjJZzxr9oAyYmLIAregbGe2a62vnyHwJ4yXQNLt28MXQmt/GJ1mRTd2vFvnPXzfvc9PY+1fQdKy5U+v/AAE/zbXyDr/Xdr8rBRRRSGFFFFABXN+PP+Rdtf8AsNaV/wCnC3rpK5vx5/yLtr/2GtK/9OFvQB0lFFFABRRRQAVzfxH/AOSWeK/+wLef+iHrpK5v4j/8ks8V/wDYFvP/AEQ9AHSUEZBB6GiigCho2iaf4f08WWkwNDbhiwVpWkwSc9WJOPQdB0FX6KKACiiigAooooAKgvbK21Gyls76BJ7eZSkkUgyrA9jU9FAGRpnhjTNJuftFst1LMAQkl5fT3RjB6hDK7bAcdFxWvRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38R/+SWeK/wDsC3n/AKIeukrm/iP/AMks8V/9gW8/9EPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38R/+SWeK/8AsC3n/oh66Sub+I//ACSzxX/2Bbz/ANEPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzdj/yVPXf+wLpv/o++rpK5ux/5Knrv/YF03/0ffV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfjz/kXbX/sNaV/6cLeukrm/Hn/ACLtr/2GtK/9OFvQB0lFFFABRRRQAVzfxH/5JZ4r/wCwLef+iHrpK5v4j/8AJLPFf/YFvP8A0Q9AHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AdJRXN/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHQB0lFc39u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdAHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AdJRXN/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHQB0lFc39u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdAHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AdJRXN/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHQB0lFc39u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdAHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AdJRXN/bvG/wD0L3h//wAH0/8A8h0fbvG//QveH/8AwfT/APyHQB0lFc39u8b/APQveH//AAfT/wDyHR9u8b/9C94f/wDB9P8A/IdAHSUVzf27xv8A9C94f/8AB9P/APIdH27xv/0L3h//AMH0/wD8h0AHxH/5JZ4r/wCwLef+iHrpK878fXnjFvht4lW80LQ4rc6TdCWSLWpndV8lslVNqoYgdASM+o610H27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAHSUVzf27xv/ANC94f8A/B9P/wDIdH27xv8A9C94f/8AB9P/APIdAB8R/wDklniv/sC3n/oh66SvO/H154xb4beJVvNC0OK3Ok3Qlki1qZ3VfJbJVTaqGIHQEjPqOtdB9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQB0lFc39u8b/8AQveH/wDwfT//ACHR9u8b/wDQveH/APwfT/8AyHQAWP8AyVPXf+wLpv8A6Pvq6SvO7O88Y/8ACydZZdC0M3B0mwDxnWpgir515tIb7LkkktkYGMDk5IHQfbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJRXN/bvG/8A0L3h/wD8H0//AMh0fbvG/wD0L3h//wAH0/8A8h0AdJXN+PP+Rdtf+w1pX/pwt6Pt3jf/AKF7w/8A+D6f/wCQ6w/Fl34ql0uxTVdG0e2tDrWl+ZLbavLNIv8Ap8GMI1sgPOB94YHPPQgHoFFFFABRRRQAVzfxH/5JZ4r/AOwLef8Aoh66Sub+I/8AySzxX/2Bbz/0Q9AHSUVV1OytdR0u4tNQtobq2ljIkhnjDo49Cp4NeQeB9QuPCHw18DJ4b0nTF/t68FvezSlkcsxchsKvzHCkZJ4wBjHQWrt6fiD2v6/ge00V5he+PvEunaTr13Oukyt4d1OO1uQlvKv2uN/LIKAyHymAlHJLgkHgU7VfH3iezXxnNFaaTFD4YeOQI3mytcxFPMK5yoRipHOGAORg9aP6/L/MOtj02ivOtT8aeIbC91mzH9lmWHQTrNm/2eQrGAxBikHmAvnHDDZ/u0r+NvEQ1DQkgh0yZNW0GXUBC6SRFJ40RseYGb5D5nTYSMdTmjpf+uv/AMiw62/rp/8AJI9Eorzfw98QNau5PCtxrUOnraeIdOmufLtY3DwPGgfO5mIZSpPG0EHuad4Y+Ier67r2lD+yriXStWhaQSJpF3B9g+Xcu+eQeXKGHG5duDjG4HNVyu9v66/5CurXPRqK47xX4uuNB8QWtnJc2Wl2c0BdL7ULaR4ZZskCIyKyrEfunLZznAGapz+KfEGmeJ9c03VZ9L8qPTTfaQ0NpJum+YqVbMvzFTsBC7d28HK9Klar7/wK2/D8TvaK4RfF2rWfimDRNdvdK0+4ZIVj86zmSO/dsF/JlMm1SPmURncxIByAawNJ8V63oY8VXuqXcOoFvEP9n28cOnzMyOVjAbajOzKE/gVckg/Nzwdf67pfqLpf+tr/AKHrVFeVt8RvFcNvEjaLCWOs22ni9vLK6sI7mKYjDxwyguCDuU5YgYB5ziptU8d+JtMsPFcrDSJH8LzI0pFvKBdwuiuFA8z92wDY3ZcEj7op2v8A16f5oOtv66/5Hp1QNf2iXRtXuoFuFjMpiMgDhBwWx1xyOelZfibxGvh3wpNq/kec4EawwltoeSRgiKW7Dcwyewrz2d9b0P4razqUsGkXOpp4XNwGgie2jm2zdH5diQFwDnnA4XtLdnr5/gmw3V15fi0v1PWbe4hu7aK4tJo54JkDxyxMGV1IyCCOCCO9SV5y/wAQr9LHw9cX02n6RDqmlx3TXl5bStbSTuv+pEgcCHBIOXLZBwBmrWp+L9dnfxDN4cj05oPDhC3EN1G7PeMIllZUdWAjwrYBKvk9hVSXK3fpf8NAj71rdf1O8qGe8traSFLm4ihed9kSyOFMjeig9T7CvPdM8e+Ite8QzxadaaVbaZDp9nqge4eR5Xt5ixYHGAr7VOOoyByc8Y2p6hqHiHWPh74mvYdOSzvNT8yzSOBvtNvE0EjBWlLENuABICrggD5utPlaevf+v1+4V002u1/wuew0V5hp/wASde1a9spdI0d7yy1FZPKV9LvIFtcKTG8l0yGN0YgA7F4zxupLDx74sufAlj4nvLbTILO+CAvb2s9y1ll3DSPGrAumAn3SpBJJOBUj62PUKKzdA1JdX0WG+ivbK/jmLGO4sSTFIu4gEZJwcdRk4Oa0qbVmG4UUUUgOb+I//JLPFf8A2Bbz/wBEPXSVzfxH/wCSWeK/+wLef+iHrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+I/wDySzxX/wBgW8/9EPXSVzfxH/5JZ4r/AOwLef8Aoh60vEVhZ6n4cv7XUrWG7t3gYtDPGHQkDIJB44IB+oqZPlTY4q7saVFfPt4sB/ZkjtP+EDukgGlx3Ivyll5Qm2DNxgTeZk/3tm7npXodtq9/4X8UWuiTDSLHw3Jpclxp4gsmjZHjALxsfM28Al+FGRnpjJ0lHlbXb9CVqk+//A/zO/orznT/ABJ45u/EaeHrldBtrx9IGoi5+zzMu4uFCNF5gIxyD859f9mq/wDwtC/v9K05LCz+y6lcWs00+NMutQSN4pTEUCQDdhmVsOSMADgk4qdv69f8mP8Ar77W/M9OorzLTvHPjTXNcsNNttE0/SZbvSTfmLUvO8xHWVEdGXClRy2OvBUn+6bEPxJe3h1ufVprOK40uOeeTRjbSw3Sxx5CsGZiJVbAO9VCjOOcU2rfj+DsC1/D8T0WivLpfiN4mtrPWpRowu0s9NfUILqfS7zT4UKn5oHMykuwXkMuA2Oi9auw+OPEcF6kF1YWV9LeeH21a0trKN1YSJtBiLFjvBLjBCqR0wetFv6+/wDyYf1+X+aO/urq3sbWS5vZ47e3iUtJLK4REHqSeAKkyNu7IxjOa82vviHqUHw61LX9IvNF1i4sAgmQQzWpgYkhleFmZwwyuFJXPzcjilbUvEyfFPxF9lvLCe3stGgngs54HQHcZSF8wOdp3LktsbIwABjNJ6b/ANaXBa7f1rY9Etbq3vbWO5sp47i3lUNHLE4dXB6EEcEUTXdvbSQpcTxRPO/lwrI4UyPgnauepwCcDsDXn+meNfEN5H4J1O5OmQaV4giVboC1kMkU5jLqqv5mArYwMqcEd88Tt4s8SWmreHobldKuLLXNRngSeKKSN0iVHaM7C7BiQmS24dQNveqcWnb5CurX8rnfUV4zYeIPHOmeFPEevw6lpF5HY63cJdJPpkpcRRuEd1K3AGFQZCY6D71el6VqN9qOv32y4s5dIgjiSIxwsJGlZQ7HfvKldrLjC/xdeOUtUn/W1xvRtebX3Oxt0UUUgCiiigAooooAKKKKAObsf+Sp67/2BdN/9H31dJXN2P8AyVPXf+wLpv8A6Pvq6SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/yLtr/ANhrSv8A04W9dJXN+PP+Rdtf+w1pX/pwt6AOkooooAKKKKACub+I/wDySzxX/wBgW8/9EPXSVzfxH/5JZ4r/AOwLef8Aoh6ANy/tXvbCa2iu5rJ5F2i4gCF4/cb1Zc/UGuJtfhNbWml6Pp0PijX/ALLotyLqyRjanY4zjJ8jJHzNwf730x31FC0dw3Vjhrz4WWl9Y63az+Ida8vXLpLq7wbYHeuMBT5PA+VP++R6nLZfhXb3FrrsF14o16Ya+iJfM32UFwqhRjEAC/KNvA6e/Nd3RQBySfD62Ourql1rWqXb/wBm/wBmSQS+QI5YMchgsQOSfmyCOfbiqo+FtgF09m13XGn0y0ks7Sf7TGGiicAY2hArYCgfMpz3zgY7eij+vz/zf3h/X5f5L7jidP8AhjZ6fN4fZNe1iWPw/E0NpDL9nKMjDDK+IQWyuF6jgeuSdjQvCcPh8iKz1PUJNPiObbT5nQw23XhCEDlRnhWZgOwGBW9RTuxWRieIfDCeI7ae1udTv7e0uYxFcW8DR7Jo/myp3oxXduwSpVuBgjFY+q6LZeIPFGhQ29rdxjw/cGSSV4JYoygT5Y1dgBKC2xvlLAeXzziuzopLQb1MDWfCUGvTp/aGo37WYuEuXsQ0flO6bSnJQuACgbCsMknOQcVUk+HukynVd1xfBdSvBfFVmA+zXA2/vIiBkNlFPJbuOhIPVUUbf16f5L7gOR1bwD/bdjYwX/ibW2ks7lLpbhTbB3dDmPcPJ24U56KM5+bPFVr34YWl/F4hjufEGslPERU3oH2YYCgKAn7ngbQF78e/NdvRR/X9fcgMm+8OWeq+Fm0HV5Jr63eERSSyELI+MYfKBQGBAOQByK5+b4Y2lzcyXl14i16a+ewOnfa2uIg3kkkkFRGEY8kZZT6/e5rtqKHruC0VkciPh9B/wisPh19e1iTTktktJI2aDM0K7hsb91xkNtLLtbCrzkZqe68B6fNcXJtLy+063vY1jvrS0dBHdqECDeWQsp2gLlGUkdTXT0U223dhtsc5p3gq00zxVea3Bf3jfa7WOzaxcQ/Z0iTOxVAjDDGW6sevOeMZifCzSUGnw/2prBsdLu/tdjZC6CR2xww2KyqJCnzHgscdBgZB7aii7Fbp/XY5my8FR6ZDcWum61qttYybzBZo0JjtGbnMe6MtgEkhWLKP7uMCnaJ4NTw/4VtNC03W9USKzLeRcM0JlUEMNp/d7GA3Ejcp5AznFdJRSH1uZnh/QLTw3pX2GyaWQNK88ssxBeWR2LO5wAASSTgAAdgK06KKACiiigDm/iP/AMks8V/9gW8/9EPXSVzfxH/5JZ4r/wCwLef+iHrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOb+I//ACSzxX/2Bbz/ANEPWxq1g+qaXPZR3txYmZdpntghkUd8b1ZeRxyD19eax/iP/wAks8V/9gW8/wDRD1a8Y6ve6B4N1TV9Mt4Li4sbZ51juJGRGCjJ5AJ6A4Hc8ZHWplazuVFNySW5kS/Dm3m+Hq+DX17V/wCzlQQ+YPs/nGEDAiz5ONvA5xu/2qg1/QLfXRo/h+ZtSvZ9Mu4biS/ntzGPLAbcDIqJG+5f3ZVP73I61r6f400SXRUu9R1vS7eaG2hmvla7RBbGRQRvBbKAk4G7rV1fFGgNHZyLrmmlL/cbRhdx4uNv3vLOfmx3xnFaO6lr3/H+vvM42cdO35nEarZXOp/HDbBLrumQ/wBi/Zf7Qs7JvKMnm7ynmvE0f3e/Y8AhuK6R/AenRQaaujXV7o8+mwmCC6s3RpDGxBZX81XVwSM/MCc81r2XiDRtSvDaadq1jd3IjEphguUdwh6NtBzg+vSlh17SLi+ubKDVbKW6tBm5gS4RpIR6uoOV/GpWiS7f5v8AzKesm/T8kv0MqHwZFD4zi8Sf2vqT3EVq1qLdzEYmjY7mz+735LDdnd14GBxTbrwLp2p3qT63dXmqxxW8lvFb3ZjKRrIu1zlUDMSOPmY47YrQbxX4dW1luW17TFghCGSU3ke1A/3CTnA3dvXtU134g0bT7SK6v9Xsba3mfy4pprlESRs42hicE5HQUdLf1r/w4db/ANaGLP4FW68M3eh3XiLWpra5ha3V5HgMkMTcMinyucgY3OGbGcEHmoIfh1FDq9hqI8R60ZrCwOnxDdbqDEcZzthBzlVOQR90dsg9Ffa9o+mAnUtVsbMLF5x+0XKR4jyBv5P3ckDPTkUlzr+j2QtjearY24uwWt/NuUXzhjOUyfm4547U7u9/66r/AD/ELaW/rp/wDnNV+GdjrNlq0N7rGqmbWPLW7u0MCyNFGSUiGItoUFjzt3Huxq3L4Fgk1GfUF1nVIr2509LCedGhBlVd22Qjy9u8b26ALz93gYuav4m07QU1C91TVrGOzsbZZZYOPOjyT8xO7kNwFG0cg8nOBHp3i3S9W03TtTttZ0yO0uIGnkQzq5IC5bDhwBsIO7g9D0pbp/13QbNf12/4BTX4d6afh9B4Qnv9RnsrYIILlpES4h2MGTa6IoBXAwcZqzrXg231nUNFuhqd/YjRZfNtobTydhbaV+bfGxPykrgEcH15q3H4u8Ny2MV7F4h0p7Waf7PFOt7GUkl/55q27Bb/AGRzWbrfjzRvDNilzq+safItxqC2kPlyLGEyyghyWIygJZjwMdhTu7/P8RWVrBHouleErfUuNTvLfWLuSRrRIHuVSSXlwBGhKqT1ZzgZ6gcUzQvDV54e+G1to+mz3UF9HED5iSRvIrk5wWlVlKj7ucE7RxzitO08ZeGNQt7mew8R6TdQ2kfmXMkN9E6wp/echsKPc1audf0ez0dNWvNWsYNNkCsl5LcosLBvukOTtOe3PNLZfd/wB7u/qXYRIsEYnZWlCjeyjAJxyQKfWaviPQ3nt4E1nT2luoPtFvGLpC00WM+Yoz8y4BO4ccUWXiPRNTsJ77TdY0+7tLckTXEF0kkcWBk7mBwOPWhguxpUVnDxForaS+qLrFgdPQAvdi6TylBAIJfOBwQevemxeJdCnnt4Yda06SW6hM9vGl0haaIZy6jPzLweRxxQBp0Vx3iHxv8AZrHRL/wxNpmq2OoarDYTXMdz5ioHcKSmzIY9erDHv0q5r3jLTfC+i6vq2qapZSwWTBVhiIWRH2giJjuOXJ5HC4BHHGSdL/10/wA0Pd2/r+tDpaKy7DWrLU7hJNP1fT7q2ktvOWOCRXcjP+s3hsbO33evftU+nazpmroz6TqNpfKhwzW06yBeSOdpPcEfgaCb31Mix/5Knrv/AGBdN/8AR99XSVzdj/yVPXf+wLpv/o++rpKBhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfjz/AJF21/7DWlf+nC3rpK5vx5/yLtr/ANhrSv8A04W9AHSUUUUAFFFFABXN/Ef/AJJZ4r/7At5/6Ieukrm/iP8A8ks8V/8AYFvP/RD0AdJRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/wCSWeK/+wLef+iHrpK5v4j/APJLPFf/AGBbz/0Q9dJQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxH/5JZ4r/AOwLef8Aoh6T4i+Y3w31+KC3ubmaewlhihtbd5pHd1KqAqAnqRzjA6nil+I//JLPFf8A2Bbz/wBEPXSUpLmVioy5ZKXY8n0WCOfxt4btm0TUY7BvC72F0ZdJnihVyYyI3LIFHCv1+nUjLtD0qafQtb0HXrRbi08MW0+n25nUOlwrrvjbBzkrF5a5PctXqF3BJc2csMN1LaSOpCzwhC8Z9QHVlz9QR7VnP4ejPh+70yO+u4nvA3n3q+WZnZhhn5Qpkjj7uAOgGBTqNyi15P722/wuyYJRt5W/BJfjZHmPhG1l17w/8PU0Wwu7SfSLLzbm+ltHhjVHtiuxXIAk3uyt8hYDbk4OKi0rwrFJotn/AMJMPE15qGh2U0EthNpcbWzb4yr7WjtwbhWOCAHZs4JGQa9W8NaDF4Y8OWejW13c3cFlGIopLrYXCDhVJRVBwOOmfXNalXUalKVuv/B/zFG6S8jyTQPD0EXwp8Lzra6loes6fChNzBo7yTRSxo4KywlN7qd7jAHJbKkZzVdrTX7+8sr/AMUx6tpdpfadJZyDRNMSfDmZyxkheGV4xKhRuBwQQxzivY6KUnzSbfUForf13R47aaNY+HPiFaCLRdXntrLwzJZm9k0qWd5HBUorSRx4Z/LBHH+714qlo9vq+n/D/RL3TLbWLfXLXSksJdNvNEllgvcM+IXBUNHgg/PlVAZckivb6KXM/wCvVv8A9uY9P6+X+SPHtT0+5u/FHj2Kx0G8gn1Tw4kKsmnyJFPcqku9RLtCO3zoM556DOKsWgB8feAr0aFqkTw6TLa3dy2kzDZuRFjWR9nyjcH4YjbnJwDk+s0UJ2/r1/zE9V/Xl/kef+GtIvdN8Sah4fnsJV0Owu31OzuDF+7kE2SIR6lHaU4HQbPWuN02wuE8HmKx0HVLeGz8aJfLbf2VNCVtTPlXSMoCVC9lHHcCvcqKE7NPtb8Gn+g5aprv/k1+rZ5vr2n3dl48iXT7N1svGEC218oAHkyRfMXbB6tD5i5GeVWu61fSLXWdBu9Ju4wbW6gaB1x0UjHH0qODRxHqz6hc311eSfMIEm8sJbK2MqgRVz90csWPvya0qTs48o7tSujy+GHWr74baq+v+H572+srF9KWydGQ3gU4eVdpDFXAUgDBOzjrVLT9Jl1DWPFC6nFrS2+qWenNDdxaU0BVkZhlEZeNh2kq+5sZzkV67RTu3v8A1/TJtbb+tv8AI8jhm8SS6hpWsazpt1qWm6Xqkhe4i0t4Li6RoNiXD2pG8sjZXhckcquK0b/T7TTPE3hLWtF0XUItKiurxp1hsZmkRriPO8xYLopfIOVGCeQBzXpdFFx2/r7/APM8OKanZ+FrWC78O63E6+M2v9senvMTbi4LmTEQYgAEdcZ/hz1p9xps934T+J1lo+hajD9tvRc2cJ0uaATrsjDGMMg3EsrnA5PXHNe3UUJ2Vl/Xw/8AyKDrf+t2/wBTylI7a8+KGuTtoOrw2eo+HRbzzR6VNGZ5AWJG/aAX8sqBk56L1GB0HgVtYh1bUNPvTNfadZwxRWup3enNZzuQWBiYEKJAowQ6qFO49Tmu2ooTt/Xm3+ov6/BL9Dm7H/kqeu/9gXTf/R99XSVzdj/yVPXf+wLpv/o++rpKQwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/wAi7a/9hrSv/Thb10lc348/5F21/wCw1pX/AKcLegDpKKKKACiiigArm/iP/wAks8V/9gW8/wDRD10lc38R/wDklniv/sC3n/oh6AOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDpKK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDpKK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDpKK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgDpKK5v/hXHgj/AKE3w/8A+CuD/wCJo/4Vx4I/6E3w/wD+CuD/AOJoA6Siub/4Vx4I/wChN8P/APgrg/8AiaP+FceCP+hN8P8A/grg/wDiaAOkorm/+FceCP8AoTfD/wD4K4P/AImj/hXHgj/oTfD/AP4K4P8A4mgA+I//ACSzxX/2Bbz/ANEPXSV534+8A+D7P4beJbqz8J6HBcQ6TdSRSxabCrxsIWIZSFyCCMgiug/4Vx4I/wChN8P/APgrg/8AiaAOkorm/wDhXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImgDpKK5v8A4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJoA6Siub/AOFceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8AiaAOkorm/wDhXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImgDpKK5v8A4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJoA6Siub/AOFceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8AiaAOkorm/wDhXHgj/oTfD/8A4K4P/iaP+FceCP8AoTfD/wD4K4P/AImgDpKK5v8A4Vx4I/6E3w//AOCuD/4mj/hXHgj/AKE3w/8A+CuD/wCJoA6Siub/AOFceCP+hN8P/wDgrg/+Jo/4Vx4I/wChN8P/APgrg/8AiaAD4j/8ks8V/wDYFvP/AEQ9dJXnfj7wD4Ps/ht4lurPwnocFxDpN1JFLFpsKvGwhYhlIXIIIyCK6D/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgAsf+Sp67/2BdN/9H31dJXndn4B8Ht8SdZtW8J6GbePSbCRIjpsOxWaa8DMBtwCQignvtHoK6D/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Siub/wCFceCP+hN8P/8Agrg/+Jo/4Vx4I/6E3w//AOCuD/4mgDpKK5v/AIVx4I/6E3w//wCCuD/4mj/hXHgj/oTfD/8A4K4P/iaAOkorm/8AhXHgj/oTfD//AIK4P/iaP+FceCP+hN8P/wDgrg/+JoA6Sub8ef8AIu2v/Ya0r/04W9H/AArjwR/0Jvh//wAFcH/xNYfizwV4V0jS7G+0rw1o9jdxa1pfl3FtYRRyJm/gBwyqCMgkfQ0AegUUUUAFFFFABXN/Ef8A5JZ4r/7At5/6Ieukrm/iP/ySzxX/ANgW8/8ARD0AbmoS3UGnzS6fBDcXKLmOKeYxIx9C4ViP++TXA2PxP1L+ydA1nW/DtvaaTrk8dvDNaakZ5YXkOE3xtEnGepVmx6V3mp3aWOl3FzKk8iRoSUt4Hmc/REBZj9BXi/hPRbnQvD3hvxImj61qB01Ps+o6TfW1w81s56T2sUo4K7sERjBUnHIojbm120/X+r9Bv4dNz2W91rS9Nu7e11HUrO0uLo7beGedUeY+ignLfhQda0tdUOmnUrMX6qGNqZ180A9DsznB+leX6vpDeI/EGsx6xP4ottJ16OE2ostKUhkVApjkMlu0kDhwWBYovzZBzmtMWOo6Z4rgt9KjvNQsdSuwdR0/UtNLxxAJsadLkAKD8oO1ixbPAFC8/wCv66/0xPTVf1/X9djuIvEeiT38djBrGny3cu7y7dLpDI+0kNhQcnBBB9MUi6xZwS3bXmr6d5Uc6whQ4QwsQMRuS5yxJyOF4IGD1PkHhWzXVPAumaDoulXMV5b+I5LpbmOzZILeKO8cs4lxszsBTYDu5xjFZ+tadbSP4hto/CmqOJPFNrfWgTw9clfJXyhNIpEWBnbJnu2e+apK7t/W8f8AN/cwel/67/5fie2S+LPDsENtLNr+lxx3blLd3vIwJmBwQhz8xzxgd6qHxvoY8cDwr/aFsNS+z+cY2nUNnIwgHdiMtgcgDPeuC+IelTTPr9jomgXFst3oTCKey055TeOWdzF0KREE5OV3uX4ORVq+0/WLvxXeSaZZ3sD6n4RWztLp7d0WKcM5w5I/dkbgcNg+gOKnpf1/J/5Dsu/b84/o/wAPu9EtPEGjX93c2tjq1jc3Fp/x8Qw3KO8P++Acr+NUbnx14Rs5FjvPFOi27su5Vl1GJSRnGQC3TIP5VwcmlxatD4WX+wr23Xw/aSR6rHPpkoVoTblGgUbcThnwcJvBxn0yvhHwVDq3wKtdNbS20zWY7YhJLmyaCaGdJDJGfmUNgOQcjg5PvTaSv5flrqhLW3S56dFq2nTanJp0N/ayX0cYle1SZTKiHoxTOQD64xVHxX4o07wf4butZ1eZI4YF+VWYKZX/AIUGe5NYnhTXTL4Xfxbr9pcWct/sDxLbtK8KINmCIwx27t756ANk4qf4oWV1qvwu1u20y3ku55bcGOKFSzPhgflA5JwOgoasENWrlO3+ItsfGd3aX17o9voCaZFfW+pC9BWXfIU5c4QcqwwCc8c9q6rUdd0nR7NLvVtUsrG2kICTXVwkaNnphmIBrzTULhbv4h6zqEuhau0DeGPskUj6NcNuk3uxRSEOSVZePwPIIEfhFb3Sx4d1bX9L1SWxXw3Hppi/syaSa2uFYeYrxBC4DAAbtu07euMZEtP6/vf5JfNC8/T8o/5t/I9Ou9f0ewVGvtWsbZXj81TNcom5Mgbhk8jJHPuKE1/R5NYOkx6tYvqSrvNmtyhmC+uzO7HvivH/AAp4PTTPHmhW2r+H5pIzYX6SO+mvLDEkswaCF5dhT5Y9wwThckdxm4lrft4q0WcaJqFjDZ+Jbh5baHTpWjjWSOVRO0pBL7iQcoQihsEcA07LTz/zsD2fl/lf+v6R6suuaS2sNpK6nZnUlTzGsxcJ5wX+8Uzux74qGLWbK30mfUNQ1jTmtIpXDXaOscUYDEbWYuRuXoTkcg8DpXE+E7C1i0+HSfFOgX0ur6ZfXF0Lg2UjxzF3f98JgNjbkflCxbttOBXN+FrW807SdCuxoGqLpuk67fy3Fj/ZksbxxymTyZUhKAuFDDhASM9OKSG9P69f6/z0PaLS8ttQs4ruwuIrq2mXdHNC4dHHqGHBFVbfxBo13qVxp9rq1jPe2ozPbR3KNJEPVlByv41D4etdOtNJf+xdPlsraaV7gRSxPEzM53M2x8MmSTwQMeleT2NtKdV0C71Tw7qUOnwQ6lBdacujTSx23mDOwkqzzbufnGUYngDpUvQaVz1228Q6Ne3yWVnq9hcXTxmVIIrlGdkBwWCg5IzxnpXPeK/HI0bXdG0vSp9Lup7vUobS9ge5zPbpJ0YRrzzg8kjHHBrz7wvb3Gn6R8M7aPQ9WtJ7G4uPtuNHuEEG+N0Bc+XgAsycnjv0Gam+y6nH4b8LaZL4Y1W41rRfECXF88dmdsvzSM86zNiNg+QSd3GcHHFXb3l6r8/8tyX8L9H99n/ke20UUVIwooooA5v4j/8AJLPFf/YFvP8A0Q9amu3t5puh3V7ptpDeXFvGZBBPcGFXA5PzhGwcZxx19OtZfxH/AOSWeK/+wLef+iHrb1K2a80q7tYyA00LxqT0BKkf1qZ35XbcqNuZXOds/FOr3fw2XxONGs0uZLQXkdkdQYqYiofmXyeG2542kZ4z3q9B4qsbXSYbnxPfaVo9y0aySwtqCskYY/L87hCc8fwjngZ61ymj6neRfDa38KT6Jqq65Fpw09ovsMog3iPZv+0bfK2d87s47Z4rPcaboPxf1lZtImuzceHrWOQWVg07TOXkX59ikjcFA3NxgDJHFaTspPl26fj+ehEb8ib36/ev82ek32vaPpib9S1Wxs18vzd1xcpGNmQN3J6ZI56cikvNf0fT9Nj1C/1WxtbKXHl3M9yiRvnphicHNeRaHp8fgvxp4TGt6dNLexeGZ47j7JZtdTKRLGFUiNWZgoOzIBA+lPsvDOr6MmmTakda07TJIb2NYtLsorySzE1wXWJ4jDKQpjwDsHBXB4oa2t5/g2vxt+I/+B+KX5Hrd5r2kaeFN/qtlaho/MUz3CJlMgbhk9Mkc+4qe71CzsI0kvruC2SRgiNNKEDMTgAEnkk9q8n03wjpWlfEXw1p6aJqF5Y2+i3NpJd3+mtKGDOpiSWURhPuBwAcbQcHBODu/Fiyt7m38Nk6PcahLbazbzbrbTpLkwQq4MhyiNtGAOOM474osrq3V2/G3/BF38l+l/8AgHXv4n0GKCzmk1vTUivm22kjXcYW4Pohz8x+mamk1vSotUGmy6nZpflQ4tWuFEpUnAOzOcE8Zx1rzfxJ4VSTxRqtjetrVjoesWcVvCuiabFNERl98cn7iRojuYtuyq/MTnIqw2n6joXiC1i0KPUL+K+ubdNQ0/UtPMsbBERGuFuQAiMqqDhidxU7QKUdX/X9f121G9P6/r+vuO8HiPRGv4bFdZ083c7MsVuLpPMkK/eCrnJI746ULq9pC97Jeavp/kQTLHw4Q25Kj5JGLkFiTkcLwQMHqfHtEsI9Q8FX/hrQ9IuI7z/hJ5pbeaGyZILZI7zPmeaBsXaqkBc7uwGKpeINLgn0bxnZReFdTk+0eIbe6sUTQLgqyjyhLImIsDO2XJHXPfcMi1t/X8v+b+71B6Nr+uv+X4ntM/izw7bW0Vxc6/pcME0rQxSyXkarJIDgoCTgsCCCBzVX/hN9D/4TdfCw1C1/tE2/nGMzqGySNqAfxMRlsDkAZ71xfjnTmmu7610XQbi3S+0GdY7u0015DO7ksYSMbIicBiXXc2cAgjk0qy1U+KIZrewv7c3vhCGzguJLV0WGdWbIkyBsI3A4bBPbNTrvb+rS/wAvx+8f9ffH9G/u+70W38QaNd39xY2urWM93ajNxbx3KNJCPVlByv41RufHXhGzkWO88U6Lbuy7lWXUYlJGcZALdMg/lXnTaL/aHh3wjp0+h3sdz4dT/ia+dpsjIYhAyyxodpE/mNj5Y9+e9WvCPgqHVvgVa6a2ltpmsx2xCSXNk0E0M6SGSM/MobAcg5HByfeqdlfsvxXdAtbef9WPTotW06bU5NOhv7WS+jjEr2qTKZUQ9GKZyAfXGKt1y3gK7udb0U+ItStGtLvUguYXA3RJGNu3jtuDsP8AfrqaGraCTurhRRRSGc38R/8Aklniv/sC3n/oh66Sub+I/wDySzxX/wBgW8/9EPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzdj/wAlT13/ALAum/8Ao++rpK5ux/5Knrv/AGBdN/8AR99XSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXN+PP8AkXbX/sNaV/6cLeukrm/Hn/Iu2v8A2GtK/wDThb0AdJRRRQAUUUUAFc38R/8Aklniv/sC3n/oh66Sub+I/wDySzxX/wBgW8/9EPQB0lFZ3iG+utM8N6hf6fDDPc21u8scc7lEYqM8kAnt6VxOmeMvFF/deGbeQaRE3iPSmu4mEErC1kREY5G8eYpD/d+QjH3j1oWt/wCu/wDkw/r8v8z0emSoZIXRJGiZlIEiAblPqMgjI9wRXmtv8Tb+58PaSDAkOrX0l3G8kGm3N7Gn2eTy2cQw5chjtwCwxnknHNvTfG+ua9FpWkx6bHpOtX0dzLMdStJfLjihcJvELFHO/euASMAnOcYJZvRBtubPg7S9H8J6ONOsfEL6jDPeyiJrueFm85izvGpjVcnO5tvJHPYcdTXjPgDXNR8O2uj6RbWGnx2WpeJNRtJ/LLDySrSOFiQAAL8mMk8cDHcdIfHWsQ+OrHTLhdNa1vNRmsTawqzzQBY2dJHmVzGCwXPlFVYBupware39dv8AMHpfyv8Am/8AI9CqKW7t4JoIZ54o5bhikKO4DSsAWIUHqcAnjsDXmN9461jUPB/iNrfU9O0/V7GxuJ30+SylS6tNg44d8SDhv3gAXJXAPe7p/iHxHpC+CdJdNMvU1a0cNPiSFgyW5dF25fA4UF8nPOFFSv8AL9f8gen4/hb/ADPRqpanYTahAkcOpXWnhXDO1qI8yL3Ql0bAPquG9CK4DQPiD4hvrfwxf6pbaZHba1qM+nyQWyyF42Qy7XDs2MfusEbec5yPuixaeN9Xl8c2OjajHpj2mo3N1atawRvJJaiJWZS8wZo2LquTHhWG7vg0+V7Be2v9df8AJnZ21rpV5oyWVmYZ7CECEJDLuTCcbDg89MEH8at3V5bWMIlvbiG2i3BQ8rhFyTgDJ7k1xfwghitvA88FvGkUMWrX6RxooVUUXLgAAdAB2rlfHmq33ivwmNVSHThpFpr8FvbpLAzXIeO7WJphJu2rkhl27c7Tndzina8ku9vxt/mLZPyv+F/8j1+O6t5biaCKeN5oMebGrgtHkZG4dRkdM1LXn0/jnXYm8XRf2bbGTRLq3hh+zpLcfupAGMroMM+1W3FFx0IBPWpl8cT3dvo1ro2o6TqV3rVzJBb30MT+REscW92eLfu3BgRs3jqMmpWq0G9N/wCrHd02SRIo2klZURRlmY4AHqTXmF78RvE1lO2mHT9Ll1Cz1u20u7nLyJG6ThWSSNOSCVJyC3ykD71WtX1TxBren634euItEkn03T/M1MyQSSQ3BkDlY41LAp8qglm34JwAetKTtByX9aX/AFQ0ve5X/Wtj0K2uYLy1iubOaO4gmUPHLE4ZXU9CCOCPepa8a0Lx1qOleBNB0rQbV5ruz0C0unX+yrq8E5dCFiBgGIidh+dsjn7pwcdBpXjPxfrniifT7bSdOsIoLKzv2hvTL5+yUtvjYYGyQBWwMEAgZzn5dJx5ZOK6P+vyJT0v/XT/ADPRaK47wR4tuPEkkkd9d2C3kSFrnTFtpILmyYkbUdXY7wPm+cBQeMCuxqWrDCiiikAUUUUAFFFFAHN/Ef8A5JZ4r/7At5/6Ieukrm/iP/ySzxX/ANgW8/8ARD0/x9d3+n/D3XL3SLlLW7trGWWOV49+3apJwMjnA4PY84PSpk+WLZUY80lHudDXP2/hKO38c3PigarqD3FzbrbPav5PkCNSSoAEYfgknO7PPPHFcdpviHxpa3Hh7w5ZjQp5LzQ2u4ruZJkGUEYCsgY44cAkMc8nAxtNw+PdYtvGljp16umm2utQmsntYFeSa3CRs6yNMrFAWC58oqrAMOeDWjjyy+//ACM0+aN/67/1/mdLP4SjuPHNt4oOq6glxbW7WyWq+T5BjYgsCDHv5IBzuzx6cV0FcToPiDxV4hg07V7K207+xdUWQopRvOslwfLkclwJckAFFVSN33jgmmfCO51e+8DLea3fQ3kk13csrR25jYfv5A24l2ByemAuBgc4zSs0rPp/mU+53NRW11b3tutxZzx3EL52yROGVsHBwRx1FcXovjPUNV1DUrEz6ZFqlt5xTR7mGW3nRVJCMXJbzEY4JdEwAcDJFVbDx5rGq+D/AApeW8NlaX/iKZojNLG8lvbEK7fdDKWJ2YA3DJOfalv+H4h/wfwPQ6RwWRgGKEjAYYyPfmvL4/iR4nnXS/K0jR1jutdfRpLj7XK25kLBpFTywADsJHzt2HrieT4ga1baXqC3q2aT6brLadd6lFYzSW8MXliQTNCshcD5lU/PgE5JxxRa6/ry/wA0PVO39df8mdZ4T8JxeEbK6tbfU7/UEubl7pje+USsjks5HlonBJzg59sVvVnaXqJ1DQY7+G4tL8SI0kUtm/7qVcnbgknHGM88HNcLovj/AMQXmqz2E8WkXU7aPJqMKW/mRxwSI4UwNMDIsuN3LpjkdORQ97Pp+i/yQlqr9/1f/BPS6hmvbW2ngguLmGKW4YpDG8gVpWAJIUHqcAnjsK850b4jaw0Phm/16HT1sdc0ue8aO1jfzLdooxITuZiGUqTxtBB7ms+7uNT1jxx8Ode1ODTUjvp5pLdYISJ7dGtXYRvIWIfPU4CgEdD1quV81n/W/wDkK6tfyPXKp6nYTahAkcOpXen7XDO1qI8yL3Q70bAPquG9CKuUVIyK0tYbGzhtbWMRwQII40H8KgYAqWiijcAooooA5v4j/wDJLPFf/YFvP/RD10lc38R/+SWeK/8AsC3n/oh66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAObsf8Akqeu/wDYF03/ANH31dJXN2P/ACVPXf8AsC6b/wCj76ukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACub8ef8i7a/8AYa0r/wBOFvXSVzfjz/kXbX/sNaV/6cLegDpKKKKACiiigArm/iP/AMks8V/9gW8/9EPXSVzfxH/5JZ4r/wCwLef+iHoA1ta0wazot3prXVxaLdRmJ5rbZ5iqeDjerDkZHIPWuasvhtBY3mhXEXiLWWbQrV7W0V/sxHlsMEN+55OAoz/sjvkns6KP6/r72BxVh8MbHTdLt7W21vV1uLS6lurW/wB0AngaUkyKMRBGRiSSrKw+mBjS1HwZb6jJYXZ1PUbfVLAsYtSgeMTMGADqwKGMq2B8uzAwMAV0dFO4HCW/wn02zvbO5s9c1yFrTUJNRVDcRyK00mdxIeNsDDMMLjrk5PNW4vhvYQXVtLBquqxpaak+pW8IkiKRSPv3qMx5Kt5jdSSM8EV2FFF/6/r0D+vz/wA2ctc+ALDUZ5ZdY1DUNR3WElhGLh4x5MUihZNpRFYs2ASXLc9MVWufhzHO+iSR+Jdct5dEjKWskZtmOSmwsweFgTt4wAB3xnJrsqKX9f197G9dzhbT4V2lnZ6PaxeItbMWj3r31sGNtzIxJO4+TyPmfj/bPoMWbb4bWVnNYPa6zq0Y067murNN8JWEyhg6DMZ3L87H5sn3xxXY0U7sX9f195g+EvCkXhDTJrG21K+v4priS43XpiLK7sWfHlovBYk8568cVkah8LtJ1CK9tTqWrW2nXt0t7JYW1wqRLOHDl1O3euWGSAwHJIAPNdrRR1uByumeBI9K1bVNRtvEGstLqckckwkkhIUxgBMHysnCgL8xOR1yeabH8PNMityy3l9/aZvGvv7VDRi4E7JsL4CeXygC7dm09xnmusopAcdqHw3stQt4FbWNUhnjvk1Ga6iMHmXVwgAR5N0RX5QowqhV9qu6r4Js9T1mbU4tQ1DT7i6tvst59jkQLdRjOA4ZWwRuOGXa3PWukooeqt/Xb8tA8/67/mchp3w307RY7AaFqmq6dLZW62pmjnSVriFSSEk81HBAJOMAFQcDA4q5p/gyHTvFV7rseralJNeWyWrwSNEY1RM7MERh8gsxyWOdxznjHR0U229WFrGFYeFLe08Q/wBtXN/e6heJbfZYGujH+5iJBZRsRS2SoJLbj6EVu0UUXAKKKKQBRRRQAUUUUAc38R/+SWeK/wDsC3n/AKIetnVdNt9Z0e80y+DG2vIHglCtg7WBBwe3BrG+I/8AySzxX/2Bbz/0Q9dFLLHBE8szrHGgLM7nAUDqSe1J2a1Gm07o5TT/AIfwafr+lasuu6vPLpdmbOKKZoCjxnGQ2Igcnap4I+7x1OWRfDfT4Lq2lh1XVES01J9St4PMiKRSPv8AMXmPJVvMb7xJGeCK1ZfGnhaCyivJ/Eujx2sxxFO9/EEkPorFsH8KtTeItFt7uW1n1iwiuIUWSSF7pA6I3CsVJyAcjB71V3f+vUnRL+vT/gFDQvB9v4dkaPTdS1BdO3tJFpjSIYIGY5Ow7PMxkn5S5XnpU/hnwza+FdPksdPuLqW3aZ5US4cN5W92cquAOMseuT6k4FPk8WeHYoJp5df0tIoJvs80jXkYWOX+4xzw3seam1DxBo2kqW1XV7GyCoHJublI8LkDd8xHGSBn3FIfUy5vBkVzqUV9caxqUtxbQSQ2buYSbUuu1nU+XlmI/v7h7VyGueCrbRPDeh+GpJtevtBtpJJJLiOxhv3j4wkbwCBg65ZmDGNipXqOCOwvPHegWXirTvD82p2gvNQiMsQa4UDGQEA55Lk/KB1wcVqQa9pFzq0ul22q2M2oQjMtpHco0sY9WQHI/EUf19wf195xtl4HbV7XTPN1rWLew0i6S60xTaWtq5IXHzxCAbVGSAu1Dy2R901q6b4D/sm41S4s/EutLNqdybqVybY7JCmzKjycdAvDAj5QfXO0viPQ3uorZNZ09p5i4jiF0hZyhw+BnJ2459O9InibQpNIk1WPWtOfTomKyXi3aGFCDggvnAP407/193+SC3T+uv8AmyLS/DGnaR4ZbQrUSG0dZBIzv88hkJLsSMAElieAAM8AViW3w2trT7M0HiDWVltdPk02KUtASsDFSFwYtuV2jBxn1zVnxj41i8PeGJNS04R3heOTyJwyvAJF6ByrbsE8fKDz1xW1omrx65paX0MEsMcjEIJduWAONwwTweozg46gHije7/r+tWG1jl7P4W2No2gqdc1eeDQYHt7WCX7OUeNxtZXxCC2VwvUHA9ckyW3ww0y3l0ndquszW+izmbTrZ7sKtuCMbAyqHZcHGGY8cZwSK7Sii7vcVugUUUUhhRRRQAUUUUAc38R/+SWeK/8AsC3n/oh66Sub+I//ACSzxX/2Bbz/ANEPXSUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzdj/yVPXf+wLpv/o++rpK5ux/5Knrv/YF03/0ffV0lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVzfjz/kXbX/sNaV/6cLeukrm/Hn/ACLtr/2GtK/9OFvQB0lFFFABRRRQAVzfxH/5JZ4r/wCwLef+iHrpK5v4j/8AJLPFf/YFvP8A0Q9AHSUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc38R/+SWeK/8AsC3n/oh6v+J7CDVPDN9Y3QuTDcx+UxtF3SrkgblGDnHXoenQ1Q+I/wDySzxX/wBgW8/9EPXSUnqB5pBpGs+LfCev6Vq+ZXhdG0rV5tPaymllQbkd4mAOUcAbgFDAnAArC8VLN4r+ErazqXh+6udT1O8tWitIrBrmSBYnUNwittGBMc9w+O+K9c1Owm1CBI4dSu9P2uGdrUR5kXuh3o2AfVcN6EVPaWsNjZw2trGI4IEEcaD+FQMAVV+vp+H+egf8E8l1gifxN43nttE1Uw3nhuK2tXGi3IEsmJAUX931+eMY9v8AZOKfh66sNK8eaXd3miX3nSeEIoriNNJla4MiyCMh4wm/+HbuIxgDnGDXtdc+PCMY8eHxV/a2ofaDbfZPsn7nyPKznbjy9/3vmzuzn24pLf8ArtL/AOSB6x/rvH/5E4Dw/wCHtb0HWPCYnsLtNulX9uDHH5i2byzI8UbsvChVGMk4+XA7Ciy0W5uvDfhHRJdLvYNX8P3kc1/cvZSCMIobzisu3bL5mcbULE7uR1r1+inf+vm3+vzF3/rpY8EsLRbTwJpVnD4Z1WF4fFpu2gXQbgbLbz2bft8r7vlsB9OOxFbqWhvfEniwvDr+mN/bEN9Y30GjzOoMdsELhWjIkUlWXABJyCOxr16ii+n9f3f/AJFD/r8/8zitH0aTxh4G8rxfp0dreSm4jS4gtvs8ux2I85VfLQs64JU888+lddZ2Nrp8BhsbaK3jLs7LEgUMzHLMcdSTyT3NT0UNiCiiikMKKKKACiiigAooooA5v4j/APJLPFf/AGBbz/0Q9dJXN/Ef/klniv8A7At5/wCiHrpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5ux/5Knrv/YF03/0ffV0lc3Y/wDJU9d/7Aum/wDo++rpKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigArm/Hn/Iu2v8A2GtK/wDThb10lc348/5F21/7DWlf+nC3oA6SiiigAooooAK5v4j/APJLPFf/AGBbz/0Q9dJXN/Ef/klniv8A7At5/wCiHoAP+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfrevLuCwsp7u8kWK3t42klkboqqMkn8BWBZeNYrxrMNo2q2y6gxFi88Ue25AjaQEFXOzKqcCTaeenXAAv/AAgekf8AP54g/wDCj1D/AOP0f8IHpH/P54g/8KPUP/j9TeDfEx8W6AdSawfT2W5mt2t5JFdlMchQ5K8ZyvbI9z1rZia4aaYTxRJGrAQskpZnXAyWBUbTnIwC3ABzzgOwGB/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8ACj1D/wCP10lFIDm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfrpKx/Fmvt4X8Kahra2Mt+LGEzNBE6oSo6nLHGAOe544BPFJuw0m3ZFP8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfrdsbn7bp9vdbNnnxLJtznbkA4z+NT1TTTsyU01dHN/8ACB6R/wA/niD/AMKPUP8A4/R/wgekf8/niD/wo9Q/+P1L4x8UN4S0mC/GnS3yS3cNs2yRUEXmOEDMTyRkjgAnnsOa36XS4zm/+ED0j/n88Qf+FHqH/wAfo/4QPSP+fzxB/wCFHqH/AMfrpKpaxq1noWj3Wp6lKIrW1jMkjew7D1J6AetAbmR/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9dGrblDDoRmloA5v8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfrpKKAOb/AOED0j/n88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8AH66SigDm/wDhA9I/5/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/AB+tfWNXs9C0qbUNRk8uCLGT3Yk4Cj1JJAH1qwrXBvHVoohbBAUkEpLl8nIK7cAYxzuOcngY5AMD/hA9I/5/PEH/AIUeof8Ax+j/AIQPSP8An88Qf+FHqH/x+ukooA5v/hA9I/5/PEH/AIUeof8Ax+j/AIQPSP8An88Qf+FHqH/x+ukooA878feCtLtfht4luIrrXGeHSbp1Euv30iEiFiNyNMVYeoIIPQiug/4QPSP+fzxB/wCFHqH/AMfo+I//ACSzxX/2Bbz/ANEPWzql82maXcXqWc96YE3mC3KCRwOuN7KvTnkjpSbSV2NK7sY3/CB6R/z+eIP/AAo9Q/8Aj9H/AAgekf8AP54g/wDCj1D/AOP1R0j4lafqb6R9r0rVNJh1tQdOuL1IjHckruCgxyPtYjkB9pNdlVNNbk3Ob/4QPSP+fzxB/wCFHqH/AMfo/wCED0j/AJ/PEH/hR6h/8frpKila4WaEQRRPEzHzmeUqyLg4KgKdxzgYJXgk54wUMwP+ED0j/n88Qf8AhR6h/wDH6P8AhA9I/wCfzxB/4Ueof/H619L1ez1m3ln06USxRTyQFx0LI21sewII/CrtAHN/8IHpH/P54g/8KPUP/j9H/CB6R/z+eIP/AAo9Q/8Aj9dJRQBzf/CB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wAKPUP/AI/XSUUAc3/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8ACj1D/wCP10lFAHN/8IHpH/P54g/8KPUP/j9H/CB6R/z+eIP/AAo9Q/8Aj9dJRQBzf/CB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wAKPUP/AI/XSUUAc3/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8ACj1D/wCP10lFAHnfj7wVpdr8NvEtxFda4zw6TdOol1++kQkQsRuRpirD1BBB6EV0H/CB6R/z+eIP/Cj1D/4/R8R/+SWeK/8AsC3n/oh61ta1NtH0e41BbG5vxbpvaC12eYVHUjeyrwOevbjJ4pNpK7Gld2Rk/wDCB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P0W3jFbrwL/wlMWh6p9naH7QlqfIE7xYzvA83bjbzgsDx0zxWzpV8+p6XBeSWVxYmZd3kXJQyKO2djMvI54J61TTTafQm90mY3/CB6R/z+eIP/Cj1D/4/R/wgekf8/niD/wo9Q/+P1o2mspq9jLcaF5N2IrlrcmSUohKPtkIYBs4w2OOSMZHWtOkM5v/AIQPSP8An88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8frpKbKZBC5gVXkCnYrttUnsCQDge+D9KAOd/4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfroojIYUMyqkhUb1RtwB7gHAyPfA+lOoA5v8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfrpKKAOb/AOED0j/n88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8AH66SigDm/wDhA9I/5/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/AB+ukooA5v8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfrpKKAOb/AOED0j/n88Qf+FHqH/x+j/hA9I/5/PEH/hR6h/8AH66SigDm/wDhA9I/5/PEH/hR6h/8fo/4QPSP+fzxB/4Ueof/AB+ukooA5v8A4QPSP+fzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/wAfrpKKAPO7PwVpbfEnWbc3WubI9JsHBGv3wclprwHL+duI+UYBOByQBuOeg/4QPSP+fzxB/wCFHqH/AMfosf8Akqeu/wDYF03/ANH31dGSFUljgAZJPagDnP8AhA9I/wCfzxB/4Ueof/H6P+ED0j/n88Qf+FHqH/x+rPhXxbpnjHTZ77R2lMUFzJbOJVCtuU9cZPBBDA9wRW3QBzf/AAgekf8AP54g/wDCj1D/AOP0f8IHpH/P54g/8KPUP/j9dJUUbXBuJhLFGsIx5TrIWZ+Ody7QFwemCc+1AGB/wgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9dJRQBzf8Awgekf8/niD/wo9Q/+P0f8IHpH/P54g/8KPUP/j9S2Xihrvx3qPhp9OlgNlaRXS3LyKRMrsR8qjJABUjnB46YwTv0dLh1sc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9H/CB6R/z+eIP/Cj1D/4/XSUUAc3/AMIHpH/P54g/8KPUP/j9Yfizwlp2maXY3dtc6w8setaXtW51u8uIzm/gHMckrKevcHB56ivQK5vx5/yLtr/2GtK/9OFvQB0lFFFABRRRQAVzfxH/AOSWeK/+wLef+iHrpK5v4j/8ks8V/wDYFvP/AEQ9AGp4gkgh8N6lLd2n22BLWVpLbGfOUKcp+I4/GvMNFlj8L+KtK03wp4iGs6K8pFxot6RJPoqeWzebvPzxKB8u2T1wK9fooWjuD1Vv6/r+mfPngfXvDs+qWsXixtJu9IfVb5tJuGkjkSG6Nw7Hzc/dLIUKHp+JU1W8Rap4eXQ/HdquvRh18S2zwKNVbe4IiD878so/e8HIXaem0Y+jKKadrf11T/QOr8/+D/mea+Cb/RIfi74r0vQbuyFvJaWlyLe1lUh5fnEkmAeWwY9x9xnrXM/E6602TXtcmzDDqeltYyJNePmaJPMUs1qoAMaYOHk3EE5BHAr3Cijqn2De9+p87+I77wxJb/E+8i1Szuri3mt5tOlkvvOaKYRg7otzHBEhYfL05XoMVoeLdQ0XV9I8av4klt7jUnsPN8PySENvtjbKd1se+X37ynOPvcV7xRS+zby/r8hp2dzlJxFq/wAK0jW9l01LrT44luJYHVoiQFBZDhsZ4I44/OvNdRmsrjwkJX0nRYI/D2vae7alo/Nk0YkXe8fH7vaMh1BOO5Ne60VXN7/N5p/c7kJWio/1tY8C137Bd6j48XRbVntZr/SbwyWlq/lSKrxtLIHVdp+9uJB5BLcjJrR1gRxXWuaj4BG7wxMlk2oPpXMUzfaD9oaLZ1byvvlOfXmvbKKSdreX/AWvloU9b/1/TPHPFmj+EF8AXuqeEHtbjT49Qsr4rZlZLWz2TKJHiCjbGdm7eAc9yBnnA8aromp3fxFl06zhure50qyu47iG0LwyOrMXlEgXYThx82ckZxnBx9BUUX/r7v8AJDX9ffc8D+IL+HnttVTRorK2l03SYJ7BpVwIVDs2+yjUKU/2pQ2Pu8EVB4kvvCt3e/Ey4Oq2V3ImmW0to0t/5uy4CvzHuY4ZXZQNv3S2BjOK+g6KL6feJaW+X4W/r5nhepD/AISzVZYtU8TaPpjXVrayaJe3Vm08zDyl3PaSidFEnmbgVVSx4zkECtDW4dPuLnxTB41kj/tnYp8PPL8lwQIFw1qM7g/m7shOc4B4xXslFD1vb+vNefmEdLeX9fceEX1vbaa/jC08Ww2q6jqvhW1neJ4gTd3MccvmOqgfO6sFJIGRwferMd5b6faaDrPlafqrNYWdidJv4ng1CFgAGNruGTnILIFGdud2K9uop82t/T8L/o7EtXSX9dP8jgfjTZWt38Mbp7y1inS3ubaUmWMMI1Eyb256DaWyfTPauZsZfDjfEDxlpOi6xDp1vcaDbpF9mmJ+zEeYGMceflCgodqgAAg8ZzXslFStL/10sXd/163PFoDaX2h3+j/8Uzp66bcQ5vbZN+kahtWVmhlTICEYdmXJwSpJPApNN1DSJfF3hTXtS0ux0e1vLbUdPlcMHt7li6lAkhA3o/zlBjkEgCvaqKd9b/1tZi6W/rufO+itG3hnR7G9fT9L8OJc6lHKdc0uR7NZTcBoQyl4gPkJ2sSVByPvdPaPA2nS6T4NsrGfVjrHkBlS9MRTzE3HbgFmJAGADuOQAa6CinzaW/r+v0B6u5zfxH/5JZ4r/wCwLef+iHrT8Q31rp3hy/utQuYbW3jgffLNIEVcjAyTx1IH41mfEf8A5JZ4r/7At5/6IeukrOS5otDi7NM8b8EeHE8VfDvwrqGv+J7O40XRbVJlt7GI25hkWLb++nErHKAn7oQg8nFczY6D4cvfgnB4mt4YL3UdO1IeZfGUzSQRLf72ySSRhDuyecMT0Jz9FUVq5Xk5LvclL3bP+kfPvjW+0B7r4kXFpMIbe+0a1mgu7UvFDczjzORKmFcnenGTu9Dg427m18I6N4/8BT6fe28Z1UyyTq2oM8c++2MavsZymWb5dwGWPGSa9noqU7f10G9f69P8j58ttJ0Kx+HrXcOm2NtdaT4uWW8nS2VHtolvTgswGQBGenZT6Vfnj0e/8X+MYtPu9PsbWe7s7xJL2zZtOvdsDPIJWACFW3bs7uThua90oovpb+un+Qdf67v/ADOa8AammreEIbqPTotOUzSjy4JDJC+HP7yJiBujb7ynAGDxxXS0UUN3YgooopDCiiigAooooAKKKKACiiigDm/iP/ySzxX/ANgW8/8ARD1s6rBJdaNe28IzJLbuiD1JUgVjfEf/AJJZ4r/7At5/6IeukqZLmTQ07O55honivSP+FT23h57uNdfj0kWL6PuH2sTCLZt8r73XvjGOc45rPXRfDes/G+80XV5Yr5hodu0llLeM4E6SZ4Td8pCqhwAODnHzHPr9FaOV5873/wCH/wAybWhyL+tV/kfOjJ4a0P4edbPS7+DxcBKEb7OSi3pIVwMBwsRJCtnauCAODXa20fh/WPFurReLLsW+uxaotxpE4k2TvbBUaMWx5LIQGDBM5yc16tRSTt/Xp/l+LB6/16/5/gjwvVb/AEj/AITyDVElt7S5tvFC215cXUv+mJGUZdpYbfKgJHyqSwbrkGqFhZ+FLj4U+N9XXUVluLK61GK1vRqkhdUYjyl378sGKJgEnd75NfQdFRb3XHyt+X+X4l83vqXnf8/8/wAD5/8AF+oaPq/hnEEtrPdW3hWK4tJ7mXzFVlDZa0RRnzQVIeQMNmF4PNe2aNrWnX9ta29vqNtcXRtI5zEk6tIUYcORnOCc81qVWNjG2prfOzvIkZjjUkbYwSC2B6nA5OenGOc6uV7+ev5majZJdv8Agf5FmiiioKCiiigAooooAKKKKACiiigAooooAKKKKAObsf8Akqeu/wDYF03/ANH31UfiL4hhstNt/D9ve2cOra7ILW2iuroQAofvndhivy5UEKfmZQAavWP/ACVPXf8AsC6b/wCj76uko9Rp2PHrTXYvAvxXubTxZLo2g2PiGwVxFb6oZEhlhGwMzNHEY96cA4wTH1zXK6LqfhrT9D8M6hb6rZfbo/F88S3Ml4JJhbGWQMC7MW2FGQnJwdyseTmvouimnZp9v87/APAJaumu/wDlb/gnhOrT6bd+M9Q06TUbK31ltdQjWX1eK0mjtcrutQBItwONyhVXa2Q27NPkvkGqfECx8N6g90y6pYtcJFeNNMtsNguSpLFsDLggdORx0r0m28LavAt5Yy69DcaRdySu8clh/pWJGJZfOEm0jkgZjzjHPGa6lVCIFUYVRgD0pR0il/XT/L8WN6tv+uv+fyPFdUjEFxrd18K5Lf8AsF9MiN0NLXzLdZvPG9o1jIBfyRJuCEMflzyRTDZtpvhfWNU8L6/Yajpd29p9stfDli0ENtEso891AlkKyNGTuAwcDOM17dRTTt/Xnez8gev9eR4HfXOm23ifxH/wrdYhbXGh2bo+l2zyQKguH84r5eBnZu+UMpJyB82aqeJrLRdP8D6nqNr4t0mewvbmzEVpoiPY20UolG84E75cxliy/wCzuIyM19D0UXt/XncHrv8A1pY8J1yXwe2v+PbWG50lrMaDFeRRCdDH9qxIPNAzgycxfN97JXnnnL8S6vpeu+FpbyO7t7nVLPw/ZzxXd3N5roy8u9qq4KuGBEkm7ggAjg19FUUJ2/D8L/5/gD1/r0/y/EitZo7i0imhkWWORAyupyGBHUHvUtFFJiWisFFFFAwooooAKKKKACiiigArm/Hn/Iu2v/Ya0r/04W9dJXN+PP8AkXbX/sNaV/6cLegDpKKKKACiiigArm/iP/ySzxX/ANgW8/8ARD10lc38R/8Aklniv/sC3n/oh6ANjV9VtdD0W81TUHKWtnC00rAZIVRk4Hc15w19qtx8YtAv7/R3tHl0e8kht4tQM3mqPLKqVYKkcnzEHGRyPnOOPRNc0e18Q6DfaRqAY217A0Mmw4IDDGQfWuUg8Ca7/bekareeK1mudItZraDZpqoJlcLgy5c7j8gzt2Z7beci3v8A1s/+AN7f13X/AASvpPxDtT4f0Oay0ey0o6xdXMaQXd2tvFGySsHy6owMjHLBQOTu+bvWxeeLNS/tE6Vo+ixXeqwWSXt5bzX3lJCrkgIrhG3OSrYGAOOSKzNL+H2qaf4IPhy41jS9Qh3TH/S9GLxN5j7/AJo/OySCXAIYD5hkHHNiw8AT6A1pN4a1gW91HYRafcS31sbkTxR5KHAdNrjccHJGOCDim7a/10F/X4/5Gfp/xVude1K1tPDvhe5ujc2BvUa4u44MhZVjkTHzcqxYc4yV44O6sj4ja/ceIfDaz2Gnt/ZNprdvbrfC+aN3lS5WN/3IGHjzuXLN1GdvRq6TQvh5N4e8WWOpWOqQmws9PexFo9mTLIHfzHkMokxuMnP3MYJGO9VNQ+GF5c6Ze6PY+IzZ6Pc366hHD9hWSa3l84SsFkLbShYEgFCQT1I4LVrxfn/7d/kD2a/rb/MTU/jBpGneIPsQawngW/GnyhdST7WspbbuFtjJjDcFtwPU4xzRbfFC+m0fUdXn8LS2mn6dcTWtxLPfR7opY3VRuCggJljlgTtCk8itzTPC2p6LfXS6brqjS7uZriS2ns98qSvy5SUOoUM2WIKHBJwRxiLwx4R1Tw/pGpWk2tWt1Lfag995qaeY1UyPukQq0rblPIHIIB7mpW2vb8dP+CN2vp3/AA1/4BuaHqNxqmni5uYbVA2DG9nd/aYpVKg7lfauRkkcgdM1o1zng/wkvhWLUD58Dy6hdG5kjs7b7NbxttC/u4tzbc4yfmOSSfaujpu3QkKKKKQwooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4j/8AJLPFf/YFvP8A0Q9dJXN/Ef8A5JZ4r/7At5/6IeukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA5v4j/8ks8V/wDYFvP/AEQ9amva1a+HdBvNX1A4t7SIyPggZx2ySByeOTWX8R/+SWeK/wDsC3n/AKIetTXdHg8QaFd6XdtIkV1HsLxnDIeoYH1BAP4Une2g1ucPZ/GTS5rm/s5ksri7gWFrZdK1FLyK586QRonmBVCPuIDAjABzkiuhg17xLNBewv4Ygg1C1lRR5uoMLSWNlzvWfytxxjBHl5Bx25qK/wDCGpa74efTfEWvLPKjpJa3VlZ+Q0ToyukjBncMwZR02ggnim674Y8Sa/4Sm0m48TWsFxcFUmuLfTWRHiz8ybPO3AsOCwfpnABOap7ab/1/T/AS31/r+un4mNa/FZxob6lq+n6bp0M96bLTriTVsW12yqxaQyvEhSMbSA20knoDxlum/F+PVpNLh07Rvtc17qUumyyW99G9vFKiF8rJ1kUryCFHGe+FOq/gvWbi1sxPrlhBcaW6PpTWGltDFbFVZGDo0zmRWVtpG5cAcYPNP1fwjrur6poF/N4gskm0m6N06jTGKSsUMZCjzsou1m6ljk5zgYp6X/ry/wCCLW39ef8AwCgfiXew6fLeXmgRxR2Oqrpeo7L/AHmKRnVFaL92PMX51J3bCAe9W9X8f3Gj+JILK50YR2E2oxaclxNd+XNNJIAQ8UJTEkYJALBweG44rLufhlrdzo2r2LeJbEHU9Xj1VpBpD/u2VlbYB9o5GY059N3qCLV58N7+7vrm5bXrfzJtSt9RDtp251eIqfLLebkx/L8q8Fc9WojbTm8r/wDkt/8A24Jdbedvxt+hu+NPFcnhHS7W8j0qbUhcXkNqVilSPyzI4UMSx55IGADz1wOawNR+JV9pg1OO50GD7Tpeo2tpcRrqBKmK4KiOVW8rk5YZQgYwfmPGdzxv4YvvFekWtjZanb6eYbyG6d5bMz7zE4dQAJEwNyjPJ49OtYV98NdR1O78Rz3uv22dae2liEOnFfs0luwMTcynePl5HGexFKNuvf8ADT/gjfl/W/8AwB3iD4mXfh658TRT+HvtQ0OG3nQ296P30cxYAsGVdmCvIG/rxmrVz451eHVtT0uPw9Ab2zsU1GNZNR2pJASwIZhGSrgqRtAZenzCszXvhbq2uvrM8nitYrjWrWC1ulGmKYQsZyCi+YGByTjLnAY5zwRoyeCNdm8R32sSeINP8270gaYYxpThVxk7/wDj45+ZmOPTAzxkp/Dpvr+Wn4j0v935q/4XI7T4kXWralZWei+HZJTf6KNWglurxIYyp2/Idodh97GcdexHIXS/iPPqjeHJV0VYbLxFG4tJHvMyJMiM5V0CYCfKQGDE/wCyKp6F8N/EGh32n3KeJ9Om/s7RzpMKnRnGY+Crt/pHLBlXOMAjI4zkO0z4aavpln4Ttl8RWcieGppJEJ0tgbgOrKQf3/yna7c884OOMG3y30/rV/pYnW39dl+tyWz+JV7c6NoGoyaFDHHqmrvpU6C/LG3cSOgZf3Q8wHYx524469qHhLULjQLXxb/Z1jPqUv8Awk0kESSzuQgMcfzSSkMVjXu2Dgdqut8L7s2ttYxeJHt7Gy1ltWtVhsk81GZncozszBgGc4O0ccEHqGJ8NNXMN+tx4js5WutYXVwh0pvKL4wY5EMx3pwpAyCGXOT0Extdvv8A5x/ykOXl/Xxf/ahF8VpprHTJIPDzXEt9q0mkM1vfRvBHMpPIkwC6kAkEIOAc4OAe70y4vLrS7efU7IWF26AzWwmEoibuN4wG+uBXBt8M9WW6tWt/EdmsFtrj6yqSaUzMXYEbNwmA2/M3Qenpz6NQvh13/wCAv1uJ/Fpt/wAF/pYKKKKQwooooAKKKKAObsf+Sp67/wBgXTf/AEffV0lc3Y/8lT13/sC6b/6Pvq6SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/wAi7a/9hrSv/Thb10lc348/5F21/wCw1pX/AKcLegDpKKKKACiiigArm/iP/wAks8V/9gW8/wDRD10lc38R/wDklniv/sC3n/oh6AOkorm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkygDpKK5v7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMoA6Siub+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTKAOkorm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkygDpKK5v7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMoA6Siub+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTKAOkorm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkygDpKK5v7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMoA6Siub+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTKAOkorm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkygDpKK5v7D43/6GHw//AOCGf/5Mo+w+N/8AoYfD/wD4IZ//AJMoA6Siub+w+N/+hh8P/wDghn/+TKPsPjf/AKGHw/8A+CGf/wCTKAOkorm/sPjf/oYfD/8A4IZ//kyj7D43/wChh8P/APghn/8AkygA+I//ACSzxX/2Bbz/ANEPXSV534+s/GK/DbxK15ruhy240m6MscWizI7L5LZCsbpgpI6Eg49D0roPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygDpKK5v7D43/6GHw//wCCGf8A+TKPsPjf/oYfD/8A4IZ//kygA+I//JLPFf8A2Bbz/wBEPXSV534+s/GK/DbxK15ruhy240m6MscWizI7L5LZCsbpgpI6Eg49D0roPsPjf/oYfD//AIIZ/wD5MoA6Siub+w+N/wDoYfD/AP4IZ/8A5Mo+w+N/+hh8P/8Aghn/APkygDpKK5v7D43/AOhh8P8A/ghn/wDkyj7D43/6GHw//wCCGf8A+TKAOkorm/sPjf8A6GHw/wD+CGf/AOTKPsPjf/oYfD//AIIZ/wD5MoA6Siub+w+N/wDoYfD/AP4IZ/8A5Mo+w+N/+hh8P/8Aghn/APkygDpKK5v7D43/AOhh8P8A/ghn/wDkyj7D43/6GHw//wCCGf8A+TKAOkorm/sPjf8A6GHw/wD+CGf/AOTKPsPjf/oYfD//AIIZ/wD5MoA6Siub+w+N/wDoYfD/AP4IZ/8A5Mo+w+N/+hh8P/8Aghn/APkygDpKK5v7D43/AOhh8P8A/ghn/wDkyj7D43/6GHw//wCCGf8A+TKAOkorm/sPjf8A6GHw/wD+CGf/AOTKPsPjf/oYfD//AIIZ/wD5MoA6Siub+w+N/wDoYfD/AP4IZ/8A5Mo+w+N/+hh8P/8Aghn/APkygDpKK5v7D43/AOhh8P8A/ghn/wDkyj7D43/6GHw//wCCGf8A+TKACx/5Knrv/YF03/0ffV0led2dn4x/4WTrKrruhi4Gk2BeQ6LMUZfOvNoC/asgghsnJzkcDBJ6D7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Siub+w+N/+hh8P/8Aghn/APkyj7D43/6GHw//AOCGf/5MoA6Sub8ef8i7a/8AYa0r/wBOFvR9h8b/APQw+H//AAQz/wDyZWH4stPFUWl2L6rrOj3NoNa0vzIrbSJYZG/0+DGHa5cDnB+6cjjjqAD0CiiigAooooAK5v4j/wDJLPFf/YFvP/RD10lc38R/+SWeK/8AsC3n/oh6AOkrMl8S6FBq66VPrWnR6i/3bN7tBM30Qnd2PbtVLx5e6jp3w/1280QMdQgsZXg2jJDBTyB6jrXOaLFp9p8C7efRNMs9XtpdNFxcw3U3li6JTdKXcI+XJ3dRye460m7Jvt+t/wDIaV2l3/4H+Z6EjrIivGwZWGVZTkEetLXklv4s8Sanpuk6Z4f02/s5f7Dhv4102a0uGAclYlka58sFcKN2xc5OAR1MkWu+OL7W73TtU1OPRpofDiag0FnbRSPBcbirDexdWGUPbo2BgjdVS91u/S/4X/yFG7/D8bf5o9XorygeNvE3iGx0i30W21Bb240KDU5ZNNW0OZZMgKwuXUeXlTnaN3I5HefSdV8dav40XSNU1W20Z00e3v5raCzjl8uXzdskZcswYHY/IIxuGORktxalyvz/AAv/AJMV9L+n42t+aPTZpo7eB5p3WOKNS7uxwFAGSSfSqmja1p3iHSo9S0W6S7s5SwjmQHa+1ipxnqMg8968/wDD/ijXZ/HGkQXGqvqFhqsd4X22qJaqYiNn2d9qyMMHktuU/wAJrY+EP/JNLP8A6+bv/wBKZKlbX/rqNnSax4h0nQPsn9sX0dqb24S2tlbJaWRjgKoHJ6/h1NXYrlJppokWUNAwVy8TIpJAPykgBhg9VyM5HUEV494h1HU/EvhbRvEM2pslrN4ltol0xYU8uJEu9indt3+Z8oJy23nAUda249f8XXFv4ugt5nvrjTNYjt4vsFvEkqWxjjdvLWQlWcBz98kE9ugppXjf+vs//JA97f11/wAj0uivOYfGE2tX2h6Lous3iHUpLoXF7NZJFdW3kKuYjG6bVkywyShGM4HINY03izxgmpWmkDVrdTb+JBo9xeGyUyXUbRCVX67FYDggLgnB46Es27f1ul+bDpf+tE3+h6pqmq2OiaXPqOrXUdpZ267pZpWwqDp/OpLK8g1GwgvbN/Mt7iNZYnwRuVhkHB5HB715hrl1r2p6F4w0mbxA4Ph/TPKldbSJTfu9uzs8gIO1cEABNvIJzjiqdv4h8WXOi22leELW/e40zRrGSL7MLMxyyvFnbN58it5ZwB+7APXntSXX5fjf/IHo153/AAt/mexUV5po+peNdY8Y61Zy6xb2Y06GzuY7KOzRlPmI5aFn3EnkAb1I6AgAZB1vA2v3d/dS6brt3qUeswwCW5sNRtIoyuTjfE8ahXjzwMFiONxzTtrYV+p2tFeZfEbxPrujXGqXGi6q6DS7OG4WztLZJQSXO43LSLhUKgbQjhz8xweKq6/4j8VW9547aHXUgi0GwgvrKOCyj6sjuUcvuLA7QCRg9Mbecrpcq2tkemapqtjomlz6jq11HaWduu6WaVsKg6fzqSyvINRsIL2zfzLe4jWWJ8EblYZBweRwe9eZa/reqeKtD8XRW2onTYNJ0oFreOFH+0vLbGRi5YEhMMANu05BOT0rufBf/Ih6D/2Drf8A9FrTtvfpb8b/AORN/ht1v+Fv8zbooopDCiiigAooooA5v4j/APJLPFf/AGBbz/0Q9beoalY6TYyXuq3lvZWseN89zKsaJk4GWYgDkgVifEf/AJJZ4r/7At5/6IetnVRnR73P/Pu//oJqZPli2VFXaQzStc0rXrZrjQ9Ts9SgR9jS2dwkyq2M4JUkA4I496nuruOzWMyrMwkkWJfJgeXBJwCdoO0erHAHcivJfD2pa1p3gv4W2Wj6hDZWmpxrb3S/ZQ7t+4Z8hicD7vp1IOcZBuQ+K/EqaPF/xNUlez8WDSLiea1TzLmAzKo+6AqthsEhee2DWrj7/Iu9vxS/VGfN7vM+36N/oz1WivMD4o8Zarrc134f06+ls7PVmspYWNkto0EcmyR2ZpPPEmAWGAF6DaetaWg33iXxV/xOrDWUtbdNTntJtMeFCiwRyNGWDbS/nfKGGTt5xt71C1V/66f5lPRtPp/wf8jtZr2CCFpCXkVZBGwgjaVgxIGCEBPcZPYcnA5qxXiWi6j4h0H4fDUrLxBcTtN4pa1nW8gikJja9MbbWCrhmzkk7hxhQtdDq3iXxBdab4u1vStUNivhm5lihsTbxtFdCKJHbzSyl/myQCjLjjrT6X/rp/mh2u7Lvb8/8j0yivKL/wATeKbvUfE3kayNOgsdAg1W0hhsoy8TssjFHaTduGUweBweNpGT2ranq+ofDmPVNHgR9VudOS4hi4wZGQNgbsDvxnjpmhppO/T/AIP+TJTTat1/4H+aN25uEtLdppVkZFxkRRNI3Jxwqgk/gKeJEMpiDqZFUMUzyAc4OPTg/lXlereNNUt/At3d6NrN4mo6fe2sF5b6xp0aXMQkdVKkKFTndkOFZSFIGeohvtS1Hw7458f61FqV5dGxsbMw2coiMRLh9oPyghVJJGGXqdxPYt/X3f5j6f13seuUVxfhC78XN4hvYNetL8aS8Cy21xqRsxMsucPGFtnIKYIIJGRyCTxXaUWFcKKKKQwooooAKKKKAOb+I/8AySzxX/2Bbz/0Q9dJXN/Ef/klniv/ALAt5/6IeukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm7H/AJKnrv8A2BdN/wDR99Wjq/ibQdAeJNe1vTtMaYExre3ccJcDqRuIzjIrOsf+Sp67/wBgXTf/AEffVj/Fkzro2gtZxRTXC+ILIxJLIY1ZvM4BYKxUe4B+ho6pd2l97sHRvyf4GxL8RPB0Wm3GoDxPpU1rbFRNJb3aTbC2dowhJycHA6nFdICGUEdDyK80+IZ1Wf4S+KLjxDptjZXgQRxGzmMwaHchH7wqpPzFuCq/TuU1PWteg1Tx1aW+t3EMem6PBf2BEEBNu5WUsozGdynywPmyeTgih2UW3/Wg0nJpL+tUv1PTCQASeAOprJ07xRo+saY+oaRefb7RJ/s5ltInlBfIBA2g5AJGWHA5JOAazdE8WxNo+iJqSalPfXtlbyvNBpVxJEWdRkmSOMxrznOSMd8CuBstX1bQ/CWo3mjXcVuW8bS284eASGSOS6VCFJOFPzdcH8OtVyvn5H/Tul+pCknBTX9Kzf6HqeneI9I1bVdQ03TL+K5u9NZVu448nyWbOFJ6Z+U8ZyO9adeQ6jrUlj8YPEWmW9/LpM2rf2dBHqYjRktyEkbb86su58bVBHJPXOKva1r3jKTVtU0zwpFqd/c6IIYkcLYCK7kaNXJuPMZGAIbH7pVA569BO6RXVnplxOlrayzyiRkiUuwijaRiAM8KoJY+wBJrLPizQl1G9sH1OBLqwtvtV3GxwbeLAO58/d4OcHmszx9q+raV8MdU1jSJ4rHULWzNwDJEJgpAyVAyBnsDyO+DWRYSNN8Y7qWQ5d/CtuzHHUmZ6Tuvx/Jv9B6ct/T80v1O20nVrHXNLg1LSbhbmzuAWimUEBxkjIz2yKuV4t4M1LXLbw38NtM0zVI7Ox1SK5juFW1V5cokjAh2JA7YG3qOcjir1l438RXljY6PG1/eX8t9qFu95YR2i3DpbS7VIWYrEGIYZ4PQ4HORclZtISvpf+v6set0V5e/iLxlp2ladd+LbfUtNtoVnF9cabb29y6lW/dvNGvmYQocnyuQe4FaF74mvrHxLbyalqN7baJdC2Wwv7a0ils7gvtz5rbS8bMchTlUww6mla4rnoFFFFIYUUUUAFFFFABRRRQAVzfjz/kXbX/sNaV/6cLeukrm/Hn/ACLtr/2GtK/9OFvQB0lFFFABRRRQAVzfxH/5JZ4r/wCwLef+iHrpK5v4j/8AJLPFf/YFvP8A0Q9AHSdetcy3w78MmWVobKe1jmYtNbWd9Pb28pJyd8MbiNs55ypz3zXQ3NzDZ2stzdypDBChkkkc4VFAyST6AVkaX4y0LWBefY71lNlGJbgXMEluUjIJEmJFUlCAcMODjrQPUW98H6HfrYCS0eBtOTy7SSzuJLZ4UwBsDRMp28D5c44HFVZ/h/4duNSur97e8W5urb7JM0WpXMYMP9wKsgAHU8AcknqTXOH4jw/8LKWJ9XSDw7Ho015MtzZPblGWSNRJvkALoQx2lQFP+126OD4h+GbryRbahJKbi1+126pZzE3EfrENmZCMjKrlh3AptXV31v8Aqvxsxbf16P8AyFj+H/hyHT9OtILW5hTTFKWckWoXCTQoeqCUOHKcD5S2OBxwKsWvg7RbPxG+u21vOmoPALdnN5MUMY6L5ZfZjv8Ad6knqSarL4z8PahNogtNfEb6nKxtIET5rraGDIyshZQpBz90gqAT1BbD8RvClzNsttXScC8Fi0sMUjxpOcYRpApVckgAkgE8A5GKNW/MNLf1/XS4W/w68M2jWzWtncQNamU25j1C4UwCQYdUxJ8qn+6MAHkAGtLw74Z0vwpph0/Q4ZoLUyNII5bqWfazcnBkZiMnnA4ySepNUovF+g+brE6a59qj0+VILmGNN4t5T8ojXYu53Y8bcsc4AA6Vn658SNN0m70eCO21CY6ld+Q2NNuC0QEfmHKBN27G35cZ5JxgGhXe3UH5+Zau/ht4Tv5bhrzSFmjuZxcy27TyeQ0oOd/k7tm49zt575qWy8BeH9OuLyezgu45L6Xzp2/tG4JMmCoYZk+UgHGVxxgdhUNv8S/B91JKtvrtvIsJlWSVVfy1MaB3Bkxt4U5684OM4OKWt/FHRbDwlq+r6d9quptNRQ9q9jPHIrOP3ZdHQMqH+9jGOhpdP6/rsPdmwfBWgnS47AWcixxzGdJkupVuBKeDJ54bzN5HBbdkjgmornwF4eu49PSa1uANOnNxbmO/njIlPWRirgu/+02TyeeTTtP8U6RqviCKytdVmW9FkbiTTJIDEyoWX95IroHQjOACRkMTg9QW/jvw3c3v2WPU1RmjaWOSaGSKKdFGWaOVlCSADklCcU9Vr/Wn/DE7r+uv/Dj9X8E+H9dv5LzUrFnnmtzbTNFcSwieI5+SQIwDgZON2cdsVGvgLw3D9j+x6cbH7FH5UP2G4ltvkyW2N5bLvXJJ2tkZJ9aTTPiB4Y1meyi0zUxcfb2kS1kWCTy5XTO5RIV27htJ25yRyMjmtTU9bsdIe3jvXl825bbDFBbyTO+Op2opOBkZbGBnkilsPco2fgzQ7DVdQ1G1t51udSi8m6LXszI6DgKELlVAHAwBgEgYFWtP8O6bpmoTX1rFKbqdQjTT3EkzBBzsUux2LnnauBntWfL4u0Q6xBBFrEklz9ge9GnW8JkaWHgiQqELgjsARnJ4OOKPh34j6XrPhC3125S7tluJHWOD7DO0j4JICIELS/KASUDAc+lAM0dW8DeHtcu7y41OxeWS+gFvchbmWNZkHTcqsFJGeGxkdjVOX4Z+GJ/7S8631CT+1I1ivd2r3Z89F6Kf3vQdMehI6Eiuh0vVbLWtNh1DS7lLm1mGUlTocHBHPIIIIIPIrOsfGegajq/9mWl/uuWV2j3QyJHME++Y5GUJJt77Ccd6NtAv1Klx8OvDF0qCawmbbafYmIvZwZoMYCSkPmUAHjfux2xW5pelWOiaZBp2k2sVpZ267YoYlwqjr/Osm38d+G7m9+yx6mqM0bSxyTQyRRTooyzRysoSQAckoTim6Z8QPDGsz2UWmamLj7e0iWsiwSeXK6Z3KJCu3cNpO3OSORkc09X/AF/XmG3yOjorz3xZ48MGu6BZeHtTUCfWY7K9H2J2SVSTuVJiPLypUhguWGf4cVPq3xK0bStCutV02+uNbjOqR2A8i2aVLeRigKAxoMgBs8liWO0EnACWqv8A10/zQPR2/rr/AJM7uiues/Feh3mqagIdbO6wtY5ru0mTy1tFOWDvuQMrEdVY8AD5Rzlsfj/wy6XbS6mLQWcPnzfbYJLY+VnAkUSKu9CeAy5Bz1o2A6Oiuf0/x14c1SRUs9SBD2f25HkhkjSSAYy6uyhWAyM4JK98Vf0rXbDWgxsGn+VQ+J7WWAlSSAwEiqSDtOCOD1p2YGZ8R/8Aklniv/sC3n/oh62tT0231fTZbG9MwgmGH8i4kgcj0DxsrD8DyOKxfiP/AMks8V/9gW8/9EPWvrGs6d4f0qbUtavIrKygAMk0rYVcnA/Ek4xUu1tRq99Dn7X4Y+FrOPTY7a2v0j0uUy2Sf2vdlbdsY+UGXAGOMdME+pzlXPgaC2vodK8P6TqFtatqsGq3eo3N+Z4pHjfewAklaTexABO0A9STgVvw+P8Aw3c2Ul1a38k8aMqBYbSZ5JCyBxsjCFnG05yoIxn0NPuPHXh230q11H+0Gnt7xWaD7LbyzyOE++fLjUvhf4sj5e+Kq7Tv2/4f9CdGrd/6/Un/AOET0f8AtyXV0t5Y7uYhphHcypFMwGAzxBgjsAByyk8D0oh8JaNbazNqdvayQ3Fw/mTJHcyrDK/HztCG8tn4HzFc8Dmob3xv4esdOtb6XUPNt7yH7RCbaCSctEACZNsasQgyMsQAM8ms5PiPpUvjQaLF5zWw04XxvhbSNCVY5VhIF2hNoY7yducAHORS2dv6/rQe6v8A12/Unu/hv4WvbSS2msJ1gku/trRw39xEPO3btw2OMfMS2BwGOcZ5q7deDdDvL43dxaSNIwUSqLqVY7jaAAZYw22UgAcuGPFVrPxnoK+H7bUo9Ym1O2u5ZRbSRWzSyz7XIYJHFHuYLjGQp4AJJ6lz/EHwpHaadcPrdsI9TkMVoMndK4OCu3G4EHgggYPB5p6rQN9Rt78P/D2o6hqV7dwXrT6pCLe7KancoJYx0TasgAHXgAdW9TnUtNA06x0GHRreKQWMCqkcb3EjsoU5Ub2YtxgY57YqjH440GbS/t0V1O8f2k2nkrZTGfzhyY/I2eZuABONvTnpzWL448cSaRo8L6Lh5bpX8t1GZ1Mciq2IGX5hyQSSMcdc0tlYOv8AX9dDSvfh34a1HTZ7G9tLqaG4nW4nZtRuPMmdfu75PM3sF7KSQMDAGBV3/hD9CN/PeSWPnT3FstpO00zyCaNQVAcMxDHDMNxBbBPNcr4j+IV3b+BU1HTktYru8S4WIw3IneJoyQCEKAPjHzg4289cV1vhnWz4g0Vb5o4oiZXjKRzeYV2sRhuBtbjlecHjJ607br+uwr9STRvDunaDGY9NS4CnhftF3LPsH91fMZti8D5VwPatOiikMKKKKACiiigAooooA5v4j/8AJLPFf/YFvP8A0Q9dJXN/Ef8A5JZ4r/7At5/6IeukoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDm7H/kqeu/8AYF03/wBH31WfEXhDR/FRtv7ajupRaSCWEQ389uFcHIfEbqCw7E8jtVax/wCSp67/ANgXTf8A0ffV0lAGTrnhjS/Emhf2PrMU9xYnbujF3LGX29NzKwZvXknJ5PNU7zwF4dv333tnNOxs/sMhe8mPnQ84WT5/3mMkgvkgnIOa6KigCpp2lWOkaXFpul2sdpZwrsjhhG1UHtj61zf/AAqzwodOksTa35tpLoXrodXu/mnznzM+bndnnPqAeorr6KOtw6WOTu/hn4Wv5dRkvbS8nbVFRbzzNUuiJQjBk48zA2kcEYxyBwTV5/BeiPeW92YboXNvCsAmW/nV5Y16LKQ+ZhyeJN3U+tb1FAGbrnh/TvEeiy6Rq0MkljMAskMU8kO5f7pKMpx7Zwayrf4eeHrXUHvoY9RF09r9jaY6vdlvJxgJky8YzkHqDyOea6eigDkrP4YeFtPbTms7W+i/sssbIDVrsrBu+9tBlxg5wR3HFSQfDfwxbaYbCGzuVh+1G8VzqNyZY5j1kSUyb0Y5OSrDOTnOa6mii4GLdeEdHvLQW1xFcmPYEfbfTo0qgk4kYODIDk53E5zzmkn8H6HczwyTWjlYZFkS3W4kWAsoUKTCG2NtCLjKnGARzW3RRsAUUUUAFFFFABRRRQAUUUUAFc348/5F21/7DWlf+nC3rpK5vx5/yLtr/wBhrSv/AE4W9AHSUUUUAFFFFABXN/Ef/klniv8A7At5/wCiHrpK5v4j/wDJLPFf/YFvP/RD0AaHiaG+ufCupwaTb21zeyWsiQQ3ahopHKkAMDwQfQ8V5pJ4J8R6ofEEbWV5anVtCt7eOfULqF8TxO5MbrGxCKQQMIu3BPQ5Fev0ULQd9Lf10/yPKdbsfF+ra9FrEXhCSIDQbnTprd7+3EnmSFcFMMVZcr/Ey8Z6EAFdG0vxLa6r4DkuPDF/HFouky2l632m1O12REGAJssMx5yOzL3yB6rRTTsrf11/+SYv6/L/ACR4vouieLLVfC0Fx4Q1FBpeuXV/cSG6syvlTGbbjE+SR5oyMdjjNPv9C8VXHh3xFbR+E7/z9Q8SxalApurQZhV42JJ87g/uiMerL749looUmnf+t0/0QPX+vX/NnmNroOp6lrvjA634V1BLDV7m1mt2F7BHIPKRV3K0cpKuGXcvTp1B4qNNB8ZSf8I/eX9vc6gNL1t54oryeAXaWrQNGvmsh8tmDMSdpJ246nivUqKE7beX4W/yB6nmWl6T4lXw144jPhzyLzU7+W6soL97eWOdHRV2kK7Ln5Dw+ByOvOMvUfBviPUNP8YxxaVe+ZrOmWgt2vr2F3aWItujba+1DyMBfk9xzXsNFCdvuS+4Ot/O/wCNzzm80vX9V+IiXUmh3dlYzaBNpzXouLdhDI7Bgdok3HAGDgH5umR81Q2vhzWp9M8Kabe6LNbnwo8cz3KTQst6Y4WQJD8+RuJGfMCAV6ZRRfS39bt/m2H9fgl+KX+R45pGgeKbXRPBtpP4Vvlk0vXJ7y7/ANKtSEicy4IxNz/rhwP7re2e48caPLqcVtNaWWqSXtosj211pN3HDPC52jbiRlRlYZJDZHydDxXV0UPUOt/66/5nm9rpvix/HPhq91rS3uWttGmtL/UIJYREJ5ChyFLhyBsOcL1IwMdMfTfBXiC08L+FlvtJvpH0NJ7W4srDVvss0yyMCJY5I5UBA2j5WcZDHOCAD7BRRf8Ar5t/qwWn9eVjA8P+HrXSvC0um6fZS6ZDcGV/JluWnkRpMlizlmy2SScMR7msDwzomqx+DrXwxrGifZrnTbJrKHVxJE8ZUxlBJFhjIGIxkMq9+T376ik9U0+v9fqC0tboeZ2vhzWp9M8Kabe6LNbnwo8cz3KTQst6Y4WQJD8+RuJGfMCAVjaX4f8AFVvoPg+ym8L30cuma3PeXZF1akRxOZcEfvuT++HA/ut7Z9loqnJttvrr8xW0svT5a/5s8hHhvxfB4b8OaBHoCTzeH9YiuPtz3sSQXUKlzvGCZAx3DcCnU8ZpJPDfie90PxFG3h25t5p/EsGr28UtzbkzwrJESoKyEBsRnhiByOeuPX6KSbTv/XR/+2octf69f82eU694W8ReJfEXiyP+yZtOt9W0aC0t7ySeFozLGzuVIVy+07wudvY8dM3de0fXPEF4msf8I9dWk+naVd2Udo1xbmS7kmVVG0iTaI1wTlip/wBmvSaKlq6t/Wt/8xp2d/66f5HkdloPiH7T4RS98I3ctvpvh+fT71JLq2CmR0RdvEpJU+WeQDw49wOq8FaVrekapqNtOdQTQI0RLGHVLiOedHBO4q6MxMWNuA7bs54ArsqKtybbfr+Lv+pKSSt/X9aHN/Ef/klniv8A7At5/wCiHqTx5a3t/wCANasdKspL68vLOS3hgjdEJZ1Kg5dlUAZyeeg4yeKj+I//ACSzxX/2Bbz/ANEPXSVElzKzLjJxaaPN9U8NardaX4Tvjpeou2l2jW13pdpqf2S4G5EXcskcqqSDH90uAQ3XIxTJvCd9p50q00DQbi10p0ujcCO9RryGSXB+eeRywRjuL+UxbIXGQDn0uiqk+Zu/W/4kx91JLoeU+EfD/iTwuNFvbnw/Ner/AGJFpV7ZR3EBlgeN2IcbpAjIwY5+bPTit2LR9U0r4j/2vZaGp01tCSzWK1miUQvHIzCMKSvVWAGPlz1IHNdzRRJtu/r+N/8ANh0a9Pwt/kjyLwh4c8TaFFoerXnh+7M+mC+tptNW5tjI63EwlWWNvN2HGNpDMp64zxmS58Ja7ZXGlXNrok9y0/ih9cu4oJ4ALSMqUCEvIu5uQTtyM7uemfWaKL6p9v8AO/56g9U13/ya/JnlNr4b1S6uPEj6t4Z1i3+0ay2o6fcWV/bR3Ef7kRhkIlxu+UghyFw4znkDstD0jUNS8Dw6d46Vby5fPnBiAWUPuj3lMLvAC7tvGQccV0lFF9Len4KwPV3Kup6baaxpdxp2pQie0uUMcsRJAZT1GRzVkAKoCjAAwBS0UgCiiigAooooAKKKKACiiigDm/iP/wAks8V/9gW8/wDRD10lc38R/wDklniv/sC3n/oh66SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAObsf+Sp67/wBgXTf/AEffV0lc3Y/8lT13/sC6b/6Pvq6SgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5vx5/wAi7a/9hrSv/Thb10lc348/5F21/wCw1pX/AKcLegDpKKKKACiiigArm/iP/wAks8V/9gW8/wDRD10lYnjXT7rV/APiDTdPi867vNMuYII9wXe7xMqjJIAySOScUAbdFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQB0lFc3/AMJRq/8A0IniD/v/AKf/APJVH/CUav8A9CJ4g/7/AOn/APyVQAfEf/klniv/ALAt5/6IeukrhPFmp69r3gvW9Is/A+uJcahp89rE0txYBFZ42UFiLknGTzgGtf8A4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAOkorm/8AhKNX/wChE8Qf9/8AT/8A5Ko/4SjV/wDoRPEH/f8A0/8A+SqAD4j/APJLPFf/AGBbz/0Q9dJXCeLNT17XvBet6RZ+B9cS41DT57WJpbiwCKzxsoLEXJOMnnANa/8AwlGr/wDQieIP+/8Ap/8A8lUAdJRXN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVQB0lFc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVAHSUVzf/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lUAdJRXN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVQB0lFc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVAHSUVzf/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lUAdJRXN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVQB0lFc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVAHSUVzf/AAlGr/8AQieIP+/+n/8AyVR/wlGr/wDQieIP+/8Ap/8A8lUAdJRXN/8ACUav/wBCJ4g/7/6f/wDJVH/CUav/ANCJ4g/7/wCn/wDyVQB0lFc3/wAJRq//AEIniD/v/p//AMlUf8JRq/8A0IniD/v/AKf/APJVABY/8lT13/sC6b/6Pvq6SuEttT16HxpqWrt4H1w291p9paoouLDeGikuGYkfacYxMuOex6cZ1/8AhKNX/wChE8Qf9/8AT/8A5KoA6Siub/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSqAOkorm/+Eo1f/oRPEH/f/T//AJKo/wCEo1f/AKETxB/3/wBP/wDkqgDpKK5v/hKNX/6ETxB/3/0//wCSqP8AhKNX/wChE8Qf9/8AT/8A5KoA6Siub/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSqAOkorm/+Eo1f/oRPEH/f/T//AJKo/wCEo1f/AKETxB/3/wBP/wDkqgDpKK5v/hKNX/6ETxB/3/0//wCSqP8AhKNX/wChE8Qf9/8AT/8A5KoA6Siub/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSqAOkorm/+Eo1f/oRPEH/f/T//AJKo/wCEo1f/AKETxB/3/wBP/wDkqgDpKK5v/hKNX/6ETxB/3/0//wCSqP8AhKNX/wChE8Qf9/8AT/8A5KoA6Siub/4SjV/+hE8Qf9/9P/8Akqj/AISjV/8AoRPEH/f/AE//AOSqAOkrm/Hn/Iu2v/Ya0r/04W9H/CUav/0IniD/AL/6f/8AJVZuu32t+ILSzsIvB2sWn/EzsZ3nuZ7Ly40iu4pXJ2XDN91G4AJzQB21FFFABRRRQAUUUUAFZHijXD4d0GTUViimZHRBHLN5e/cwXCnBy3PC9zgZGc1r0jAMpVgCCMEHvSd7aDW5y/w+8WT+MfDS6heW8NtOuxZI43O4MY1Y7kPMZ+bhctxg55rqaitraCytYrazgjt7eFQkcUSBURRwAAOAB6VKenrVSabuhIzY9YsoUle91fTyvnuiMriMJtG4o2XOWAyT047CnSeINGi0ZdXl1axTTGAZb1rlBCQTgEPnb+teUaX4W1e11vSmbwFPDBZeIrq/WQSWO2G2lR1UKBNkYYoxUD+HjJArR0PQ/Emn2+m6jP4buHaw1fUJ20xri2MjRXDMySxnzPL3KGwQzL1fHbIleKfkv0G1Zv5/r/kvvOqvPGX2Xxlp9m0unDQrvTJ746ibjp5ZTJzwgTDg7snPPTHO7a69pF7dRWtnqtlcXE1uLqOGK4R3eE8CQAHJQ/3ulcdLpepyeOdCuLLwvJY6ZBpd3byFJbdUtmmZCqlFfOf3Z3bQwywwW5Nc/aeEvF8+l6JYR6WumPZeHbvR5rua8jykjLGEkQJuLKTHxnaQCc4IAL0t9/8A7d/kvvDS/wB36f8ABOvg8brffEF9F0+70qfTU06W4a7hufNeOZJEQq4BCqBu6ZJPt32v+Ei0my02CfVdd0td0UbtceekUUm7ADqGc4Vj0+Y9eprz+48P67fX8dzL4LjS1j8OzaXNaPc27GRyVKBBkqy5XjcVwCSQCMHLsPDGvx6bdq/ge6iu38Jx6QJTNZbpbhQVPzCYnbgryccL06Ck9I+n46y/yX3oUfeeum3/ALb/AJv7j1fVvE2g6C0Q1zW9O00zAmIXl3HDvA6kbiM/hVptTsF0wai17brYmMSi6Mq+UUIyG35xjHfNeRappWqX08lkNJvHik0S0s9aSFrSWaIpubaGe5QRMAc7h5gO4HAIGey+INhL4r+FF3a6RpL6pNfW6G2t5PLVlJwQxMjAAjr1z6U2kvvFHVq/Y328V+HVVmbXtMAW4+ysTeR8Tf8APM8/f/2etTza9o9vq8OlXGq2MWozjMVm9yizSD1VCcnoegrzHxFoGvagnjAaf4OukbVdFtbO0PnWi/vEDblP77gDevt8hx/Dm3rukeK9YvrV7fw8bOK31DT70hJLYNchNvmea+4tvTkYXjAGGb7tFldK/wDX9f11C+l/6/roegR6taxPcm71bT2RLgxIFYIYjtB8tyXOX6n+HgjjucbW/GBt/wDhHrnQZNP1DTtV1FLOW6SfeFUhjlNvyt90jJPHoa4WHwtq0evAnwFMLdPFB1SORZLLZHAYgjEDzdwJYBsY5wD14q1Fo/idY7QHwtfAR+LZNVK/abX5Lc7sH/Xdfn6D0PtmVry/L/22/wCb+4ctE7ef/t1vyX3nocPi/wANXFn9qt/EOlS2xnFt5yXsbJ5p6R7g2Nx/u9av6hqdjpFk95qt7b2NqmN09zKsaLn1ZiAK5O00W4g+JN5BC8Z0dwmqvCOqXRDR4x02tt3/AO8pPerfi6w1Rta0HWNMsm1OLTJ5WnsEkRHcOmwSIXKruXJ4LDhjzmjov6/rW4dWv6/q1vmbNz4i0WzsYb271iwgtJ1LRTy3SLHIAM5VicEYBPHalXX9HfVE01NWsWv5IxKlqLlDKyHowTOSPfFecWXg7UtN8UeHNQi8OMypqt7ezmKSD/QIp1ZViyXBOGYOwTcM5xnjNmXwnrlytzod1ppdZNeGqxa4Jo9qx+cJNpXd5gkCgxgBSuMfNjiqSTa/rt/XnYT6/wBd/wDL8TvV8Q6NLfrYQ6tYSX0m7ZbC6TzGK/ewuc8d+OKx/B/jBddsUi1ebT7XWGuLqMWMFxlmWGZoyyhsMw+XrgfQVwfhjRbjU7GbStL0T7La2Piue9XUYjCscaxXBJjVQwcOQNn3du0/e7Vb0nRfEVs2gs/hG7he38RXt/csbi0+WKYShGJEpJOJlyBk/I3X5ckUnG7/AK2/z/DzKkrNrs/yv/kvvPSLbxJod7NdxWes6fcSWX/H0kV0jG3/AN8A/L0PXFV7bxl4YvdSTT7PxHpFxeyHCW0V9E0jcZ4UNk8c15jqXhXxVqS3M934UR0n0C504abE9okMEpkVo/LG7leNwZiD8ucKeD1Gr6dqVv4D8PX9lbCw13R/s6RQXDKclsRPEShYEMDkYJGQp7VK2/ru1+ifzE97Lz/Jf5v7jqh4r8OmyN4Ne0w2oDMZ/tkewBThjuzjgkA+hNSaj4k0PR7WC51fWdPsLe4/1Mt1dJEkvGflLEA8c8Vxeo+G7rT/ABvpV5Y+GptSis9EubWW+ja2VpJXKso+eRWJJV+cYBl68sRzEWja9FpGg6Qmj3H9o2/h9tP1S2BtLl44WYKMK1zGq52MVcM3TDJxw7aaf18X+S+8en9fL/P8Oh6yfFGgCKzlOuaaI784tHN3Hi5P/TM5+f8ADNSjXdIOs/2Quq2R1Pbv+xfaE87b67M7se+K80l8ILrOrR3U+i6rq+g3+l29mkcertbNbmIsCs6rMqyIcg7l38gkAggm7eaH4nuvGOmXUehx21npmsNOFglhEdxE1u0fnM5PmM+SAcgcdmxmnZXsRd2v5fpf/gf1Y6vwbr99r9jqUmqQW9vNZ6lPZ7LdmZcRkDOWAJJ+g+laNv4i0W61BbG11iwmvGDMtvHdI0hCnDHaDnggg+hFYPgCx1K1tdcj1rSJtP8AtWrXF1Es8kMnmRSNkf6t2x7g/rXE+CNGudS0fTLLTtEFpa6V4hvLxdQDRLHtSeZfKRQd4JyFOVC7e54FStUr9l+SuU9Oa3d2/Gx6nbeIdH1CS8g03WdPuLizB+0JFcJIbc8/fUNleR3x0qM+IdKsdLguNW1zTEDW6zNc+csUUinA8xdznCEkY+Y9QMmvNx4b8TXWoPeaj4WRreTQrnT20yJrVYY3Misixjd8ynGQWI6chOhTS/DmtWrafLN4KuPtNv4UbS5ZvNsyzTgABc+dkjCnB6fN25wbRv8A19r/ACX3g/it/XT/ADf3HrysroGRgysMgg5BFZOs+IbHTEktxqGnJqbJ/o1pdXaxGWQg7Fxy3JHYE9eKzPBN1eWWh6NoGq6ZdWt7a6XF5zySQuoZAEK5SRjnjIJGCD1yCBmJpeoWXxL8S6tbeGpzbXmlRRR3ML26/apk3kjBkDZIZVBYAfJyQAMlRWbSff8AAIO6Tfl+Nja8I+LbXxH4dsLma8sU1KawivLm0imBaAOoOSudwX3NXV1/TbLSobjVtc0wZg81rkSrDE6jALqGc4XJH8R6jmvN9G8O63aWvhu2vvBdzJBZeHLnT72LzbNleVyh24M2GDeUeenzjP8AFiPw94b1vTZ/DE934KuTPpnh6fT7mUS2ZYynbsUHzskfI4B6DzO2WxpNK75fP/27/JfeOK7/ANbf5v7j1K88QaNpy2rahq9jai8IFsZ7lE88noEyfmz7Ut1r2kWV7HZ3mq2VvdSlVjgluER3JzgBScnODj6V5d4d8MeJtK0RLfVPDMmoJe6DDpUls9zATZyR7wd2ZNpibeGyhZuPu5rT8MeE77QPFGpLeaBLe2b6Ba2Ml5m3I1CaJWD5UvuO4MqguAPl5IABMySTdun47/5fjoL+vy/zf3HQax45tLfU9Kg0a+0q9huL1be+ZbsM9srI7Btq9M+WwyxGMd+203iTQ00VdYfWtPXTGOFvTdIITzj/AFmdvXjrXnWleH9ctPA3grS5/ClwZdL1MTXcAmtSsSLvw3+tweZAQBk/KeBxmB/C3iC5MF3c+HtSWC21q9uX0+31RLaeaKc/JJHJFMBleQVZ1yGPWp7r+un+Y9NH/X2v8l96PTbzxHoenRW0moazp9rHdkC3ae6RBMT02En5vwrSryrxN4R1c+FZPDvhbw6LSzm0m4hjm+0RTTxuzlhC8kzEhG6nbv5OMqAGrvdA1Ka5V7C7sJrSeyjiV2eSN0clexRicjHIYA+mRgl6WJ1/r5FttZ0tNSfT21K0W9RA7WxnXzFUgkErnIGAefY0lprelX909tY6nZ3M6RrM0UNwjsqN0YgHIU9j0rh9b8Pauvii7n07SZr7TbxpJb2zuTay2837jy90e8iSOVuFwf3ZXOSM1ztp4O8TTaRoGlRaDcaS8Hhm70u4u/Pt9kM8gQKTslLEExk5AJ+cd84Fqr/1s/8AJL5/Iuyvb+tz1iz1/R9RhuZtP1axuorVitw8FyjrCR1DEH5SPeqz+MfDMWlR6pJ4j0lNPlkMUd219EInfn5Q+7BPB4z2rz5/AN5e+Db1LLQb/S9ZeG3im+267LP9qWGRX8qNxK5RGAYBvkIz0q3c6PqumaBKfCfhLVrS+1WcfbZ59Uiuru3XbteRWmuCpYqAq4f3IG0AjVv6/rT8iVrb+v6/U7m31/TdSa0uNK1zTLi0m8zmKVZfO2jnY6vgbcHPDfhVi01vSr+6a2sdTs7mdI1laKG4R2VG6MQDnB7Hoa8zvvD93/augzWHw6uxY2Njd2U0LTWLSPHIoCK+ZsNk72IyfvZ5JIqDSdF1XR7Tw2dW8OXGn2Gl+G7qy1Kc3VsiRuwQ5JSUnB8oncAcb198Glm/66/5L7xpX/r0/wCCelWPi3w5qmpHTtN1/S7y9Xdm2t72OSQbevyg547+la9eZfD21v7HWLJ/EGnXlrdtpiWVo/lW6RNDH82G8q4kLsM/fKovsCcH02m1YhO4UUUVJQUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUEhVJY4A5JPaisjxRoZ8RaDLpwkiiLujB5YfM27WDZUZGG44bnacHBxik720Gty+l/ZyaeL+O6gezMfmi5WQGMpjO7d0xjnPSpkkSWNZImV0YBlZTkEHoQa80g+Fd5H8NT4fkv7Q3rESm5EJLiQQeX/ruu7PSXZkLxtrsfCXh+Twz4bj05pYriRCzmRU2bye7HJ3N6vgZPOB0qnZNi7GvbXdveRs9pPFOiO0bNE4YK6nDKcdwQQR2NS15xYeO/El/Doi/YNKhm1DV7zTJ282R1hMPm7SowC/8AqjkkrngYGciTSvG2ua2lhpVoNOttYnkvklupYHe3AtZhGSsQcNliynG/5Rnk4wSzG1Z/15/5Hem7theLaG4iFyyGRYd43lAQC23rgEgZ9xU1eZ6l/aFl8RYtQ8rTrfXP+EVuHmkSNpIWkSWMgHlGZRzjJBGasS/ELUNNt49Q1GK0ltH8NjV/JhiZJBKCgK7ixG0l/wC7kepoSulbz/8Abv8A5Fkt2dv6+z/8kjvJdQs4ZpIpruCOSOIzOjyAFIx1cjPC+/SpopY54UlhdZI5FDI6HIYHkEHuK8mubrWfD/jvxBrUlvpFzqaeGFuz5Eb28cgWVuHOXZiFGAe+BwvbVv8Axt4lEd2bO30qJbbw/HrAklEkhkJBLJsBXaDtYA7jjg89Km6td/18X+Q7Nysv6+H/AOSO1vfDuialfw32o6PYXd3B/qbie1R5I/8AdYjI/CtGvMfFXxE1qyWMaKdLtJ5dMhvbO21CJ5pNSkcnMMIWRPmUY/vE7hwBzXV+KPEV14W8Gf2lNAt7fAwwCOJRGrzSOqDAZ8KNzZwX/wCBd6pppfO3zEmmzo6K82bxd47s4tOh1bQ7GwlvtVSxW6uMfMjqWDiCKaTBBVgQZfQjqQLU3iPxTpusX+h6le6PJqMsMEmkyRadKkc26TY+9TOxO0kZAIwCDk9KW+39df1Htv8A1rY7q4uYLSEy3U0cEYIBeRwoyeByalrxvxBPrmpWPjCPWruw1CLS9XsY7OL7I0XlPugYMrF32jDkHgnknOPlroNS8d63pP8AalhJaWt9qUeqQWFkbaLYredEJBuWSUAlRkf6xQxA+7mjp/XW1vzHb+vTc7ux02x0yN49Nsre0SSQyOtvEsYZycliAOST1NWa88Pi3xrb/wBg2up6HY2F1qepSWUj3EgPyiJnSVY45HAztbKmQ4IxnnIbp3jbxC82jNqMemNDdaxcaPcLBFIrM8fmgTKS5Cg+V9whuv3qdv6/r1Qul/66/wCTPRaYksU/mLHIkmxtjhWB2nHQ+h5HHvXCaR45vz4sudM1efTbq2TTZdQEunQShYfLkCtH5jMVm4I5ULgjkcik0/UvEVp4osPD0S6dapdafJqlxPPHJPIZDMvmJtDIFH7wgHLdBxxgpK9vP/g/5MHpfy/4H+aOw0rQtI0KKSLRNLstNjlbfIlnbpEHb1IUDJ96sm7theLaG4iFyyGRYd43lAQC23rgEgZ9xXm+nfEfxHPZ3PiG58OMfDCW9xcLcKYleNYwxXkTsz7iuMeUm0nvjNZ19fa1pPjqXxDNb6Rcaj/witxdoIY3hVlWWNgkjZYuVGcNxn0Wjrr5/gm/0HZ7L+tUv1PX6rS6bYz6hDfzWVvJeQKUhuHiUyRqeoVsZAOBnFcBefETV9EW/bV7WzuWXSLfUbaK0DJteWTyvLZnbDDcQd2F4zkd6kPivxxZaLNPrPh/7IY7qNReLZifEJDF3NtBcSOdpAXiT+Ldjgint/XnYS1/ryueiVnal4e0XWpoZdY0iwv5Lc5he6tklMZ9VLA4/CuRuvHt3DcaVN9o0+PSr2BXGpfZppbaWVnK+X5qkCHAwf3gO4nHy4Nd/wDSl5gQ21xbXCuLSaKUQuYnETA+Ww6qcdCPSpiQoJJwBySe1eWX3i3xVqdjYfZp9P0q5/4Sg6VKqQvcIyJkjnehIJXn7uQccc56PStV1vxPNNPHHpTaEt1cWNxaTxOZ2WMtGz7txXll/wBWV+6c7u1LePMv60T/AFDZ2f8AWrX6M6uKa3vrUSQyRXFvICAyMHVx0PPQ1R0DTdC07TseF7PTrWymcv8A8S6JEjduhPyDBPGM+1cB4B1jWdO0LwvpcUOnva3ul3DW0WHRo5IiNu6TkbWDDgJlcdWq5pHjfxLrlv4bFta6VbPrVnczPNIZJBA8RwAIwRuHK/xAnnpTejdv63/yCz6no1FeYXPxJ1R/C+g3yS6RpD6nZzSvd6ijPA08eAIEUSIQzncRljwuMMa7nwtd6nf+FdNvNejji1C4t1lnijgaIRswzs2szEEZwcnqO3Snbf8Arv8A5C7GtRXH6/4rvtH8X21hN9nsdOnWJYrq6tZXjnkZ8MnnIdsTAAYDj5ywAIxXPXXj7xLpUhj1OTS3ey1wWWoLDp8i4tG8srOpM524Ei5J3DLDjjkWv9eaX6j/AK/C/wCh6jUD31pHcPBJdQpMkfmtG0gDKn94jqB79K8/1Hxp4pSSw0/RbC21PUb+Ce+ieC3UILdXVYwUkuUyWDAlg5x/cNU7i3/tDxlq0us6RBaXd74PV760YJKPM8xwVZhkPjGAeeAKiTaV/X8E3+asNLp6fi0v1uelQ6lY3EkCW97byvcQ+fCqSqxlj4+dQDyvzDkccj1qzXlvhrxTrOnaHoelWdlYyQL4RXUIGlmcM8kaxrtbC4Vfm7bifbvo6b43195IRfWVndPeeHjq9tbWaurCRduYizMQ24uMHC46c9a1nHlbXa/4c3/yLIi7pedv0/zR6DRXA+BvFuteJtfuFl1DRtQ0iKyimFxptpIu2Zycws7TMAyADI25+YZC9DueO9d1Dw14NvNW0m3tri4t9p2XTsqYLAE/KCSeenH1qWmtx3OiqK4u7ezRHu54oFd1jVpXChnY4VRnqSSAB3NcXL4o1+z1TWNIvZ9FjubaC3u7a9kjkjhSKWRkKum4lnUqcAMu/IHy1n2nxC1qbw7Z3gtrGaQ+IRpF1KY5YAUMoTzEibLAkHozcdeelCV2l/W6X5sb0V3/AFpf8j0mmCeJp2gWRDKihmjDDcoOcEj0OD+Rrz+08b+IWu7GXULbTIrWbXpdHkhg8yR+NwWQSEqBgpyNpyD1FQ+Ib3XIjpt/ol9DZPrOvx2xM9s0uYVDBBw6naTGWIzzv6julrbzt+Nv80wel0+l/wAL/wCTPSaK880Lxn4v17VvOsPDscmiNLcQC4keKMIYyyq5cTM7BmXBXyQVz1bHMOl/ETVxBo2oa7b2K2eqabdXZhtEcyQtAA33ycMGU9NoIPc0m0ld/wBb/wCQ0m3ZHojXdul2lq88S3Eil0hLgOyjqQOpAyKkdFkRkkUMrDDKwyCPSvHr3W7zTPGWmeMNat9PkZvDV7eKllCUkEa+S6xO7Md+Nxw3yj5j8o76Nz458eaf4cvdUv8Aw5Zwwqbdrae4dI12yOEK7Ippi5G5SGygIzwMYNOL6/1q1+grrdf1ov8AM9B0rw/o2hiUaJpNjpwmO6T7JbJFvPqdoGa0K891jxP4u0m91iyzokjabpJ1NbnyJQJQGb92Yt/y8IRu3nnnHO0Q3Hj7xPqOsGDwl4d+3xWsNtLdIzRAsZkD7Q7zoUwp67JMnjiktf69V+gPTf8ArZ/qj0iiuFi8Z6v/AG7qunT2sCXsKzvY6ZLbyxSXSoPkMcxJjl3cE7QCmcEHrWr4L8Ry+IbGc3Vzby3VsypNElnLaSwsRkiSGUll9uSDjINC1B6HS0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFIw3KQc4IxwcUtFAHKW3w08M2jWhgt79TZ3T3kGdXuzsmf7z8y8k5Oc9dzf3jmSH4deGrfT0s4LW7SOO5e6jkXUrnzo5X++yy+ZvXdzkBgDk56109FF2BgjwVoY1mLVTb3DXcNs1qrNezspib7yshfa2SckkEk8nnmq9p8O/Ctn5WzSI5jDbPaRm6le4KQtwYwZGbC44x2HA4rpqKP6/r7394HKH4Z+EzHIr6bK7SWpszM97O0ogJJMYkL7lXkjAI446cUp+G3hlllVoL9hNZCwfOrXZ3W46R/63p/ifU11VFG/wDX9dx3f9fL/Jfcjgb3wJdJrKHTId1ittFaxyL4hv7OaCNM4DCMnz8FiRuZSBx711s2i21/4d/sjWlGpQPAIp/PH+uwBlj75GfY1o0UbqzFs7o5uXwB4fnhsY5or6T7BMJ7d21S6Lq4+6S/mbmxkgBiQASBjJqy+kT3/im31LUrWzSPTRKtk8chkkfzFUFmyg2cAjaC2cg5GMVt0UAc5qngDw5rE17LfWUxe+kjluTDeTw+YyABT8jjB+VenXauc4GGyfD7w3P/AGl9os55/wC02R7rz76eTcyfcZdznYy4GGXBGBzXS0UBdnPXHgbQrp9Pe4ivHk02Xz7aQ6lc7xJgLvZvMzIdoxlyeMjoSKqp8M/C6JboLa+K21217EG1W7O2dvvPzLyTz19W9Tnq6KAOatPh74ZsXga305s20TQQh7qVxHGzBigDMQFyBgdB0GATV+TwzpkviiLxC8dx/acUJgSQXcoQRnqvlhthGeeV6gHqBWtRTuwMOz8GaDY3F1LbWO1btneaBppGgLOCHYQljGpYE5KqCcnPWs9/hh4Rki8uTS5HxA1sjtezl4om+9Gj79yKem1SBgkdCRXWUUg8zmo/h74bSd5Xsp5zJZDT3W5vp5ke3HRCjuVI75xnPOc1Yh8G6Nb6YtjFHdiJPuSNqFw0yYBACyl/MUAM2AG4ycVu0UAYUngvQZILeA2TiGBVVYkuJVRwpLASKGxIMsTh85Jyeav6Zpp05bkG5nnE87TASyu/l5/hXezED2BwM8ADir1FAHNRfD3w3DZSWq2dw8Ml6L9hLf3EhE4OfMDM5IJyc4IBzzmrB8GaJ/aFxeRwXEElzkzJBezxROxGN/lq4TfwMPjcCAQcgVu0UB1uctbfDjw3Z/YfssF/F/Z8UkNrt1W6/dI/3wP3nfP6D0FJafDbwzYfYvskF/F9gjkitdurXf7pZPvgfve/9B6CuqooA4C/+Hv2FtNg8NWYawsYZIo4X1++spYt7BmImj3s6navyHABGc10ek+H5tPmtZp9Su52ggaEo9zK6sC24Z3OQxUcByN5xy3atyindgZWoeGtL1S9jur6CSWRGR9onkWNyhyu9AwV8HkBgcHnrUd/4S0PU5tSlvtPSZ9UtRaXhLsPNiGcLweOp5GD054GNmikBj6n4U0bV/sJvLV1k0/i1mtriS3khGMFVeNlYAgDIzg4Gaq3HgPw/c6lPfSW90txcWn2KRotQuIwYf7gVXAA75ABySepzXRUUb7hscnH8M/C8Pk+Vb36eTZtYx41e7+WA9Yx+96f4D0GGXPw50eKzY6PHNFexac+nWz3N/cyxpCwxsKGQgj8OMD0FdfRQ7v+vX/N/ewVl/X9dkcTovg/UYbaeO8lm05ZIWh8qHxDfX6t0wwaQxtGRg8Jg8/e7Vd8c+HtR134f3Wg6Sbee4uI0iMl/OyKVBBLMyoxJOPTv1rqaKHqC0Oai8DaJLozWl9YyF53imnb7fPJIsqcrtnZhIAp+7grjsB0ptz8OvDN1btDJZXCK12L1jDf3ETGcdH3I4OQeevUk9Tmunoo/r+vuX3CtpY5SP4a+GYo4USDUCILw30e7V7tiJz1kyZeT9fU+prX1Dw1pOqaZaafe2m+2s5I5LdVkdDGyfdIZSD0468gkHOa1KKBmFB4L0K0vLu4tLSW3a8LNKkN3Mke9hgusYYKj/7agN3zVWy+HfhrT5tOktbS6B0xHjtFk1G5kSNX++u1pCGBzyCD29BXT0UAcxafDnwpZ3EE0WkJI9skkduLiWSZYEkGGRFdiEUjjaAAATgDJpJPhx4Zl0Q6Q9pdmx3qyw/2lc/JtIIVT5mVQEA7FIXIBxwK6iigDnL7wFoGpXdzc3sN7JLd2gsp2Gp3K74R/AQJAPqepyc9TlyeBPD0dza3EdnMstrbi1VxeTAyRDokvz/vVHYSbq6Gijb+v67sP6/r7l9xjN4S0V72S6ktXeSRJEKvcSNGokzvKoW2oWycsoBI4zVnS9DsNGa4exjkEly4eWSaeSZ3x0G52JwOy5wOwFaFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAf/Z" alt="" width="814" height="373" vspace="0" hspace="0" border="0" style="width:814px;height:373px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p>Paediatric population<br />The European Medicines Agency has deferred the obligation to submit the results of studies with Praluent in one or more subsets of the paediatric population in the treatment of elevated cholesterol (see section 4.2 for information on paediatric use).<br />The European Medicines Agency has waived the obligation to submit the results of studies with Praluent in all subsets of the paediatric population in the treatment of mixed dyslipidaemia (see section 4.2 for information on paediatric use).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />After subcutaneous administration of 50 mg to 300 mg alirocumab, median times to maximum serum concentration (tmax) were 3-7 days. The pharmacokinetics of alirocumab after single subcutaneous administration of 75 mg into the abdomen, upper arm or thigh were similar. The absolute bioavailability of alirocumab after subcutaneous administration was about 85% as determined by population pharmacokinetic analysis. Monthly exposure with 300 mg every 4 weeks treatment was similar to that of 150 mg every 2 weeks. The fluctuations between Cmax and Ctrough were higher for the every 4 weeks dosage regimen. Steady state was reached after 2 to 3 doses with an accumulation ratio up to a maximum of about 2-fold.<br />Distribution<br />Following intravenous administration, the volume of distribution was about 0.04 to 0.05 L/kg indicating that alirocumab is distributed primarily in the circulatory system.<br />Biotransformation<br />Specific metabolism studies were not conducted, because alirocumab is a protein. Alirocumab is expected to degrade to small peptides and individual amino acids.<br />Elimination<br />Two elimination phases were observed for alirocumab. At low concentrations, the elimination is predominately through saturable binding to target (PCSK9), while at higher concentrations the elimination of alirocumab is largely through a non-saturable proteolytic pathway.</p><p>Based on a population pharmacokinetic analysis, the median apparent half-life of alirocumab at steady state was 17 to 20 days in patients receiving alirocumab as monotherapy at subcutaneous doses of either 75 mg Q2W or 150 mg Q2W. When co-administered with a statin, the median apparent half-life of alirocumab was 12 days.<br />Linearity/non-linearity<br />A slightly greater than dose proportional increase was observed, with a 2.1- to 2.7-fold increase in total alirocumab concentrations for a 2-fold increase in dose from 75 mg to 150 mg Q2W.<br />Special populations<br />Elderly<br />Based on a population pharmacokinetic analysis, age was associated with a small difference in alirocumab exposure at steady state, with no impact on efficacy or safety.<br />Gender<br />Based on a population pharmacokinetic analysis, gender has no impact on alirocumab pharmacokinetics.<br />Race<br />Based on a population pharmacokinetic analysis, race had no impact on alirocumab pharmacokinetics.<br />Following single-dose subcutaneous administration of 100 mg to 300 mg alirocumab, there was no meaningful difference in exposure between Japanese and Caucasian healthy subjects.<br />Body weight<br />Body weight was identified as one significant covariate in the final population PK model impacting alirocumab pharmacokinetics. Alirocumab exposure (AUC0-14d) at steady state at both the 75 and 150 mg Q2W dosing regimen was decreased by 29% and 36% in patients weighing more than 100 kg as compared to patients weighing between 50 kg and 100 kg. This did not translate into a clinically meaningful difference in LDL-C lowering.<br />Hepatic impairment<br />In a phase 1 study, after administration of a single 75 mg subcutaneous dose, alirocumab pharmacokinetic profiles in subjects with mild and moderate hepatic impairment were similar as compared to subjects with normal hepatic function. No data are available in patients with severe hepatic impairment.<br />Renal impairment<br />Since monoclonal antibodies are not known to be eliminated via renal pathways, renal function is not expected to impact the pharmacokinetics of alirocumab. Population pharmacokinetic analyses showed that alirocumab exposure (AUC0-14d) at steady state at both the 75 and 150 mg Q2W dosing regimen was increased by 22%-35%, and 49%-50% in patients with mild and moderate renal impairment, respectively, compared to patients with normal renal function. The distribution of body weight and age, two covariates impacting alirocumab exposure, were different among renal function categories and most likely explain the observed pharmacokinetic differences. Limited data are available in patients with severe renal impairment; in these patients the exposure to alirocumab was approximately 2-fold higher compared with subjects with normal renal function.</p><p>Pharmacokinetic/pharmacodynamic relationship(s)<br />The pharmacodynamic effect of alirocumab in lowering LDL-C is indirect, and mediated through the binding to PCSK9. A concentration-dependent reduction in free PCSK9 and LDL-C is observed until target saturation is achieved. Upon saturation of PCSK9 binding, further increases in alirocumab concentrations do not result in a further LDL-C reduction, however an extended duration of the LDL-C lowering effect is observed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazard for humans based on conventional studies of safety pharmacology and repeated dose toxicity.<br />Reproductive toxicology studies in rats and monkeys indicated that alirocumab, like other IgG antibodies, crosses the placental barrier.<br />There were no adverse effects on surrogate markers of fertility (e.g. estrous cyclicity, testicular volume, ejaculate volume, sperm motility, or total sperm count per ejaculate) in monkeys, and no alirocumab-related anatomic pathology or histopathology findings in reproductive tissues in any rat or monkey toxicology study.<br />There were no adverse effects on fetal growth or development in rats or monkeys. Maternal toxicity was not evident in pregnant monkeys at systemic exposures that were 81 times the human exposure at the 150 mg Q2W dose. However, maternal toxicity was noted in pregnant rats at systemic exposures estimated to be approximately 5.3 times greater than the human exposure at the 150 mg Q2W dose (based on exposure measured in non-pregnant rats during a 5-week toxicology study).<br />The offspring of monkeys that received high doses of alirocumab weekly throughout pregnancy had a weaker secondary immune response to antigen challenge than did the offspring of control animals. There was no other evidence of alirocumab-related immune dysfunction in the offspring.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Histidine<br />Sucrose<br />Polysorbate 20<br />Water for injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the absence of compatibility studies, this medicinal product must not be mixed with other medicinal products.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Praluent 75 mg solution for injection in pre-filled pen
30 months.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store in a refrigerator (2&deg;C to 8&deg;C). Do not freeze.<br />Praluent can be stored outside the refrigerator (below 25 &deg;C) protected from light for a single period not exceeding 30 days. After removal from the refrigerator, the medicinal product must be used within 30 days or discarded.<br />Keep the pen in the outer carton in order to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>1 ml solution in a siliconised Type 1 clear glass syringe, equipped with a stainless steel staked needle, a styrene-butadiene rubber soft needle shield, and an ethylene tetrafluoroethylene -coated bromobutyl rubber plunger stopper.<br />Pre-filled pen 75 mg<br />The syringe components are assembled into a single-use pre-filled pen with a blue cap and a light green activation button.</p><p>Pack size:<br />1, 2, or 6 pre-filled pens.<br />Not all presentations and pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>After use, the pre-filled pen should be placed into a puncture resistant container. The container should not be recycled.<br />Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                sanofi-aventis groupe
54, rue La Boétie
F – 75008 Paris
France
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                March 2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>